Skip to main content
Δημοσιεύσεις σε Ελληνικά περιοδικά

ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΕΛΛΗΝΙΚΑ ΠΕΡΙΟΔΙΚΑ ΚΑΙ ΠΡΑΚΤΙΚΑ ΣΥΝΕΔΡΙΩΝ (202)

 

 

(1) 4. ΠΕΙΡΑΜΑΤΙΚΗ ΑΛΛΕΡΓΙΚΗ ΦΛΟΙΪΤΙΣ: Μ.Τσολάκη, Σ.Μπαλογιάννης

Γαληνός 21: 703-715, 1983. Μέρος της Διδακτορικής Διατριβής.

 

(2) 6. ΜΕΛΕΤΗ ΤΗΣ ΨΥΧΟΝΟΗΤΙΚΗΣ ΑΝΑΛΗΨΕΩΣ ΜΕΤΕΓΧΕΙΡΗΤΙΚΑ ΜΕ ΚΑΙ ΧΩΡΙΣ ΧΟΡΗΓΗΣΗ ΟΞΥΓΟΝΟΥ (ΠΡΟΔΡΟΜΟΣ ΜΕΛΕΤΗ)

Μ.Τσολάκη, Μ.Κωνσταντινίδου, Χ.Τσιότρας, Ν.Μπαλαμούτσος. Γαληνός 26: 763-768, 1984.

 

(3) 7. ΕΠΙΠΕΔΑ ΦΑΙΝΥΤΟΪΝΗΣ ΣΤΟ ΠΛΑΣΜΑ ΜΕΤΑ ΑΠΟ ΔΙΕΓΧΕΙΡΗΤΙΚΗ ΕΝΔΟΦΛΕΒΙΑ ΧΟΡΗΓΗΣΗ ΓΙΑ ΤΗΝ ΠΡΟΛΗΨΗ ΤΗΣ ΑΜΕΣΩΣ ΜΕΤΑ ΚΡΑΝΙΟΤΟΜΙΑ ΕΠΙΛΗΨΙΑΣ.  Μ.Γιαννάκου, Μ.Τσολάκη, Γ.Σαρηγιάννης, Ι.Βότσης, Ε.Αναστασίου, Ε.Σοφιανος

Ανακοινώθηκε: Ελληνική Αναισθησιολογική Εταιρεία Αθηνών (20/2/1984).

Ελληνική Αναισθησιολογία 18: 236-240, 1984.

 

(4) 11. ΥΠΟΤΑΣΗ ΜΕ ΝΙΤΡΟΠΡΩΣΣΙΚΟ ΝΑΤΡΙΟ ΚΑΙ ΕΠΙΒΙΩΣΗ ΚΑΤΑ ΤΗΝ ΕΚΘΕΣΗ ΤΩΝ ΕΠΙΜΥΩΝ ΣΤΗΝ ΥΠΟΤΑΞΙΑ. Α.Ζαραλίδου, Μ.Τσολάκη, Ε.Βαγάνωφ, Ε.Σοφιανός

Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985

Ελληνική Αναισθησιολογία 22: 184-187, 1988.

 

(5) 12. ΑΞΙΟΛΟΓΗΣΗ ΕΓΚΕΦΑΛΙΚΗΣ ΛΕΙΤΟΥΡΓΙΑΣ ΜΕΣΑ ΣΤΟ ΧΕΙΡΟΥΡΓΙΟ ΜΕ ΤΗ ΒΟΗΘΕΙΑ ΗΛΕΚΤΡΟΕΓΚΕΦΑΛΟΓΡΑΦΗΜΑΤΟΣ

Μ.Τσολάκη.

Ελληνική Αναισθησιολογία 19: 104-122, 1985.

 

(6) 13. ΧΟΡΗΓΗΣΗ ΦΑΙΝΥΤΟΪΝΗΣ ΓΙΑ ΤΗΝ ΠΡΟΦΥΛΑΞΗ ΚΑΙ ΘΕΡΑΠΕΙΑ ΑΠΟ ΤΟΥΣ ΣΠΑΣΜΟΥΣ ΠΟΥ ΠΡΟΚΑΛΕΙ Η ΛΙΔΟΚΑΪΝΗ. Θ.Σφακιωτάκη, Μ.Τσολάκη, Ο.Θωμαρέις, Ν.Μπαλαμούτσος. Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985. Ελληνική Αναισθησιολογία 19: 288-292, 1985.

 

(7) 22. ΕΠΙΔΡΑΣΗ ΤΟΥ ΕΝΦΛΟΥΡΑΝΙΟΥ ΣΤΗ ΣΥΜΠΕΡΙΦΟΡΑ ΥΠΟΓΛΥΚΑΙΜΙΚΩΝ ΕΠΙΜΥΩΝ. Π.Λαζαρίδου-Παγιαβλά, Μ.Τσολάκη, Ο.Θωμαρέις, Ε.Βαγάνωφ, Μ.Γκιάλα

Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985

 Ελληνική Αναισθησιολογία 20: 165-171, 1986.

 

(8) 23. ΕΠΙΔΡΑΣΗ ΤΗΣ ΑΝΑΙΣΘΗΣΙΑΣ ΜΕ ΕΝΦΛΟΥΡΑΝΙΟ ΣΤΟ ΝΕΦΡΙΚΟ ΠΑΡΕΓΧΥΜΑ ΣΚΥΛΩΝ. Χ.Χαλκιάς, Α.Σιόγκα, Λ.Οικονόμου, Χ. Φόρογλου, Μ.Τσολάκη, Μ.Γκιάλα

Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985

Ελληνική Αναισθησιολογία 20: 172-176, 1986.

               

(9) 24. ΣΥΜΒΟΛΗ ΣΤΗΝ ΑΝΑΚΟΥΦΙΣΗ ΤΟΥ ΠΟΝΟΥ ΤΗΣ ΟΣΦΥΟΙΣΧΙΑΛΓΙΑΣ ΜΕ ΕΠΙΣΚΛΗΡΙΔΙΕΣ ΕΓΧΥΣΕΙΣ ΒΟΥΠΙΒΑΚΑΪΝΗΣ ΚΑΙ ΔΕΞΑΜΕΘΑΖΟΝΗΣ

Ε.Τζοβαρη-Τσάκωνα, Μ.Τσολάκη, Μ.Γκιάλα, Λ.Σέττας, Α.Τσάκωνας

Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985

Ελληνική Αναισθησιολογία  20: 179-184, 1986.  

 

(10) 25. ΕΓΚΕΦΑΛΙΚΗ ΠΡΟΣΤΑΣΙΑ ΣΕ ΜΥΣ από ΤΗ ΣΦΑΙΡΙΚΗ ΥΠΟΞΙΑ ΜΕ ΜΙΔΑΖΟΛΑΜΗ. Μ.Τσολάκη, Π.Μαιδάτση, Ο.Θωμαρέις, Α.Λάζου, Α.Ζαμπούρη, Ε.Σοφιανός

Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985

Ελληνική Αναισθησιολογία 20: 93-96, 1986.

 

(11) 26.Η ΥΠΟΓΛΥΚΑΙΜΙΑ ΠΑΡΑΓΟΝΤΑΣ ΑΥΞΗΣΕΩΣ ΤΗΣ ΣΠΑΣΜΟΓΟΝΟΥ ΔΟΣΕΩΣ ΤΗΣ ΛΙΔΟΚΑΪΝΗΣ. Θ.Σφακιωτάκη, Μ.Τσολάκη, Ο.Θωμαρέις, Ν.Μπαλαμούτσος

Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985

Ελληνική Αναισθησιολογία 20: 97-100, 1986.

 

(12) 27. ΕΙΝΑΙ Η ΜΟΝΑΔΑ ΕΝΤΑΤΙΚΗΣ ΠΑΡΑΚΟΛΟΥΘΗΣΗΣ ΠΗΓΗ ΑΓΧΟΥΣ;

Μ.Τσολάκη, Ο.Διορίτου, Ν.Μπαλαμούτσος. Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985.

Ελληνική Αναισθησιολογία, 20: 116-121, 1986.

 

(13) 28. ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΤΩΝ ΖΩΤΙΚΩΝ ΛΕΙΤΟΥΡΓΙΩΝ ΚΑΤΑ ΤΗΝ ΑΝΑΙΣΘΗΣΙΑ ΣΤΗ ΝΕΥΡΟΧΕΙΡΟΥΡΓΙΚΗ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΤΟΥ Κ.Ν.Σ. Μ.Γιαννάκου-Πεφτουλίδου, Μ.Τσολάκη, Ε.Σοφιανός.

Ελληνική Αναισθησιολογία 20: 282-307, 1986.

 

(14) 29. ΠΟΣΟΤΙΚΗ ΜΕΤΡΗΣΗ ΣΕ ΥΠΕΡΗΧΟΥΣ ΤΗΣ ΚΥΚΛΟΦΟΡΙΑΣ ΤΩΝ ΑΚΡΩΝ ΤΩΝ ΣΚΥΛΩΝ ΜΕ ΔΥΟ ΔΙΑΦΟΡΕΤΙΚΟΥΣ ΤΡΟΠΟΥΣ ΑΝΑΙΣΘΗΣΙΑΣ

Χ.Σπυρίδης, Μ.Βρεττός, Ο.Θωμαρέις, Μ.Τσολάκη, Μ.Γκιάλα. Ανακοινώθηκε:

1ο Βορειοελλαδικό Συνέδριο, Θεσσαλονίκη, Μάιος 1986.

Πρακτικά Συνεδρίου Β: 705-709, 1986.

 

(15) 30. ΑΛΛΟΙΩΣΕΙΣ ΤΟΥ ΕΓΚΕΦΑΛΙΚΟΥ ΙΣΤΟΥ ΕΠΙΜΥΩΝ ΜΕΤΑ ΑΠΟ ΔΥΟ ΕΒΔΟΜΑΔΕΣ ΕΝΤΕΡΙΚΗ ΔΙΑΤΡΟΦΗ ΧΩΡΙΣ ΠΡΩΤΕΪΝΗΣ. Μ.Τσολάκη, Δ.Μπότσιος, Λ.Οικονόμου, Ι.Δαδούκης, Μ.Γκιάλα, Χ.Φόρογλου, Ο.Αλετράς. Ανακοινώθηκε: 1ο Βορειοελλαδικό Συνέδριο, Θεσσαλονίκη, Μάιος 1986.

Πρακτικά Συνεδρίου Β: 597-604, 1986.

Η εργασία βραβεύτηκε από την Ιατρική Εταιρεία Θεσσαλονίκης.

 

(16) 31. ΜΕΛΕΤΗ ΤΩΝ ΕΠΙΠΕΔΩΝ ΤΟΥ ΣΑΚΧΑΡΟΥ ΤΟΥ ΑΙΜΑΤΟΣ ΣΕ ΥΠΟΓΛΥΚΑΙΜΙΚΟΥΣ ΚΑΙ ΥΠΕΡΓΛΥΚΑΙΜΙΚΟΥΣ ΕΠΙΜΥΕΣ

Ο.Θωμαρέις, Μ.Τσολάκη, Ε.Βλαχάκη, Π.Μαϊδάτση, Ε.Βαγάνωφ, Μ.Γκιάλα

Ανακοινώθηκε: 1ο Βορειοελλαδικό Συνέδριο, Θεσσαλονίκη, Μάιος 1986

Πρακτικά Συνεδρίου Β: 270-275, 1986.

 

(17) 32. ΕΠΙΔΡΑΣΗ ΤΟΥ ΣΥΝΔΥΑΣΜΟΥ ΦΑΙΝΥΤΟΪΝΗΣ ΚΑΙ ΜΙΔΑΖΟΛΑΜΗΣ ΣΤΟ ΧΡΟΝΟ ΕΠΙΒΙΩΣΗΣ ΤΩΝ ΜΥΩΝ ΣΤΗΝ ΥΠΟΞΙΑ

Α.Ζαμπούρη, Μ.Τσολάκη, Ε.Σοφιανός. Ανακοινώθηκε: 15ο Πανελλήνιο Συνέδριο Χειρουργικής, Θεσσαλονίκη, Οκτώβριος 1986.

Πρακτικά Συνεδρίου.

 

(18) 33. ΘΕΡΑΠΕΙΑ ΤΗΣ ΝΕΥΡΑΛΓΙΑΣ ΤΟΥ ΤΡΙΔΥΜΟΥ ΜΕ ΔΙΗΘΗΣΕΙΣ ΒΟΥΠΙΒΑΚΑΪΝΗΣ. Μ.Τσολάκη, Ε.Τσάκωνα, Α.Φίστα, Ι.Αδρίτης, Μ.Γκιάλα

Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985

Ελληνική Αναισθησιολογία 21: 34-36, 1987.

 

(19) 34. ΘΕΡΑΠΕΥΤΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΜΕΣΟΠΛΕΥΡΙΑΣ ΝΕΥΡΑΛΓΙΑΣ

Ε.Τσάκωνα, Μ.Τσολάκη, Α.Αναγνωστίδου, Χ.Τσιότρας, Α.Καρδαμύλας, Μ.Γκιάλα

Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985

Ελληνική Αναισθησιολογία 21: 37-40, 1987.

 

(20) 35. ΠΑΡΑΓΟΝΤΕΣ ΠΟΥ ΕΠΗΡΕΑΖΟΥΝΤΟ ΑΓΧΟΣ ΤΩΝ ΑΡΡΩΣΤΩΝ ΣΤΗΝ ΑΜΕΣΗ ΠΡΟΕΓΧΕΙΡΗΤΙΚΗ ΠΕΡΙΟΔΟ. Μ.Τσολάκη, Ο.Διορίτου, Β.Δημητρίου, Ν.Κωνσταντινίδου, Μ.Σουέις, Χ.Νάσρο, Ν.Μπαλαμούτσος. Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985.

Ελληνική Αναισθησιολογία 21: 28-33, 1987.

 

(21) 37. Η ΣΧΕΣΗ ΤΟΥ STRESS ΜΕ ΤΗΝ ΕΠΙΒΙΩΣΗ ΚΑΤΑ ΤΗΝ ΕΚΘΕΣΗ ΣΤΗΝ ΥΠΟΞΙΑ

Ο.Θωμαρέις, Μ.Τσολάκη, Π.Μαιδάτση, Α.Ζμπούρη, Α.Λάζου, Μ.Γκιάλα

Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Θεσσαλονίκη, Μάιος 1985

Ελληνική Αναισθησιολογία 21: 111-116, 1987.

 

(22) 38. ΕΠΙΔΡΑΣΗ ΠΡΟΣΤΑΤΕΥΤΙΚΩΝ ΑΠΟ ΤΗΝ ΥΠΟΞΙΑ ΠΑΡΑΓΟΝΤΩΝ ΣΤΟ ΧΡΟΝΟ ΕΠΙΒΙΩΣΗΣ ΚΑΙ ΣΤΗ ΣΥΓΚΕΝΤΡΩΣΗ ΟΡΙΣΜΕΝΩΝ ΙΧΝΟΣΤΟΙΧΕΙΩΝ ΣΤΟΝ ΕΓΚΕΦΑΛΟ ΜΥΩΝ. Μ.Τσολάκη, Τ.Ράλλης, Α.Ζαμπούρη, Ε.Σοφιανός, Α.Παπαστεριάδης

Ανακοινώθηκε: 2η Συνάντηση Νευροεπιστημών, Θεσσαλονίκη, Νοέμβριος 1986

Ελληνική Αναισθησιολογία 21: 37;100-105, 1987.

 

(23) 39. ΕΠΙΔΡΑΣΗ ΤΟΥ ΕΝΦΛΟΥΡΑΝΙΟΥ ΚΑΙ ΜΙΓΜΑΤΟΣ ΕΝΦΛΟΥΡΑΝΙΟΥ-ΑΙΘΕΡΑ ΣΤΗΝ ΥΠΕΡΜΙΚΡΟΣΚΟΠΙΚΗ ΥΦΗ ΤΟΥ ΗΠΑΤΟΣ ΣΚΥΛΩΝ.

Α.Αλβανού-Αχπαράκη, Φ.Ευαγγελίδης, Ο. Θωμαρέις, Μ.Τσολάκη, Μ.Γκιάλα, Χρ.Φόρογλου

Ανακοινώθηκε: 15ο Πανελλήνιο Συνέδριο Χειρουργικής, Θεσσαλονίκη, Οκτώβριος 1986

Ελληνική Αναισθησιολογία, 21: 105-111, 1987.

 

(24) 40. ΑΛΛΟΙΩΣΕΙΣ ΤΟΥ ΝΕΦΡΙΚΟΥ ΙΣΤΟΥ ΕΠΙΜΥΩΝ ΜΕΤΑ ΑΠΟ 2 ΕΒΔΟΜΑΔΕΣ ΕΝΤΕΡΙΚΗ ΔΙΑΤΡΟΦΗ ΧΩΡΙΣ ΠΡΩΤΕΪΝΕΣ

Λ.Οικονόμου, Μ.Τσολάκη, Δ.Μπότσιος, Α.Σιόγκα, Κ.Τσαλής, Ι.Δαδούκης

Ανακοινώθηκε: 15ο Πανελλήνιο Συνέδριο Χειρουργικής, Θεσσαλονίκη, Οκτώβριος 1986

Ελληνική Αναισθησιολογία 21: 175-180, 1987.

 

(25) 41. ΜΕΤΑΒΟΛΕΣ ΤΩΝ ΕΠΙΠΕΔΩΝ ΓΑΣΤΡΙΝΗΣ ΚΑΙ ΙΝΣΟΥΛΙΝΗΣ ΚΑΤΑ ΤΗ ΔΙΑΡΚΕΙΑ ΕΝΤΕΡΙΚΗΣ ΔΙΑΤΡΟΦΗΣ ΜΕ ΕΚΛΕΚΤΙΚΗ ΣΤΕΡΗΣΗ ΟΡΙΣΜΕΝΩΝ ΘΡΕΠΤΙΚΩΝ ΣΥΣΤΑΤΙΚΩΝ. Μ.Τσολάκη, Κ.Τσαλής, Ι.Γιώβος, Δ.Μπότσιος, Α.Φαρμακιώτης, Ι.Δαδούκης. Ανακοινώθηκε: 2ο Βορειοελλαδικό Συνέδριο, Θεσσαλονίκη, Μάιος 1987

Πρακτικά του Συνεδρίου: 152-155, 1987.

 

(26) 42. ΣΥΓΚΡΙΤΙΚΗ ΥΠΕΡΜΙΚΡΟΣΚΟΠΙΚΗ ΜΕΛΕΤΗ ΤΗΣ ΔΕΞΑΜΕΘΑΖΟΝΗΣ ΜΕ ΤΗΝ ΕΤΟΜΙΔΑΤΗ ΣΤΗΝ ΙΣΧΑΙΜΙΑ ΤΟΥ ΕΓΚΕΦΑΛΟΥ ΤΩΝ ΕΠΙΜΥΩΝ

Μ.Τσολάκη, Α.Μάνθος, Λ.Οικονόμου, Π. Μαϊδάτση, Α.Σιόγκα, Λ.Σακκάς, Ε.Σοφιανός, Χρ.Φόρογλου. Ανακοινώθηκε: 2ο Βορειοελλαδικό Συνέδριο, Θεσσαλονίκη, Μάιος 1987

Πρακτικά Συνεδρίου: 236-241, 1987.

 

(27) 43.Επιδραση της υπεροξιασ στις αμινοτρανσφερασες του ηπατοσ με και χωρισ βιταμινη Ε. Α. Χατζηαγοράκης, Κ.Χατζηνικολάου, Μ.Τσολάκη, Χ. Μοσχονάς, Μ.Γκιάλα. Ανακοινώθηκε: 2ο Βορειοελλαδικό Συνέδριο, Θεσσαλονίκη, Μάιος 1987

Πρακτικά Συνεδρίου: 724-729, 1987

 

(28) 44. ΑΙΜΟΔΥΝΑΜΙΚΕΣ ΜΕΤΑΒΟΛΕΣ ΚΑΤΑ ΤΗΝ ΑΝΑΙΣΘΗΣΙΑ ΜΕ ΕΝΦΛΟΥΡΑΝΙΟ ΚΑΙ ΜΙΓΜΑ ΕΝΦΛΟΥΡΑΝΙΟΥ-ΑΙΘΕΡΑ 1:1 ΣΕ ΣΚΥΛΟΥΣ. Κ.Παπαδοπούλου, Ο. Θωμαρέις, Μ. Τσολάκη, Μ. Γκιάλα. Ανακοινώθηκε: 7ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Χανιά, Μάιος 1987. Ελληνική Αναισθησιολογία 21: 187-193, 1987.

Επιστημονική Επετηρίδα Ιατρικού Τμηματος 17: 19-27, 1988.

 

(29) 45. Η ΕΠΙΔΡΑΣΗ ΤΗΣ ΥΠΕΡΟΞΙΑΣ ΣΤΟ ΝΕΦΡΙΚΟ ΠΑΡΕΓΧΥΜΑ ΕΠΙΜΥΩΝ ΜΕ ΚΑΙ ΧΩΡΙΣ ΒΙΤΑΜΙΝΗ Ε. Μ. Τσολάκη, Α.Αλβανού-Αχπαράκη, Κ. Χατχηνικολάου, Α. Χατζηαγοράκης, Χρ. Φόρογλου. Ανακοινώθηκε: 7ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Χανιά, Μάιος 1987. Ελληνική Αναισθησιολογία 21: 181-186, 1987.

 

(30) 46. ΥΠΕΡΜΙΚΡΟΣΚΟΠΙΚΗ ΜΕΛΕΤΗ ΤΟΥ ΕΓΚΕΦΑΛΟΥ ΕΠΙΜΥΩΝ ΜΕΤΑ ΣΤΕΡΗΣΗ ΛΙΠΟΥΣ Ή ΥΔΑΤΑΝΘΡΑΚΩΝ. Μ. Τσολάκη, Λ. Οικονόμου, Α. Μάνθος, Δ. Μποτσιος, Α. Σιόγκα, Μ. Γκιάλα, Ι. Δαδούκης. Ανακοινώθηκε: 1ο Πανελλήνιο Συνέδριο Παρεντερικής και Εντερικής διατροφφής, Πάτρα, Νοέμβριος 1987. Πρακτικά του Συνεδρίου.

 

(31) 47. ΥΠΕΡΜΙΚΡΟΣΚΟΠΙΚΗ ΜΕΛΕΤΗ ΤΟΥ ΗΠΑΤΟΣ ΕΠΙΜΥΩΝ ΜΕΤΑ ΣΤΕΡΗΣΗ ΥΔΑΤΑΝΘΡΑΚΩΝ Ή ΠΡΩΤΕΪΝΩΝ

Α. Μάνθος, Δ. Μπότσιος, Λ. Οικονόμου, Μ. Τσολάκη, Α. Σιόγκα, Ι. Δαδούκης, Μ. Γκιάλα.

Ανακοινώθηκε: 1ο Πανελλήνιο Συνέδριο Παρεντερικής και Εντερικής διατροφφής, Πάτρα, Νοέμβριος 1987. Πρακτικά του Συνεδρίου.

 

(32) 48. ΙΧΝΟΣΤΟΙΧΕΙΑ, ΕΓΚΕΦΑΛΟΣ ΚΑΙ ΚΑΘΗΜΕΡΙΝΗ ΙΑΤΡΙΚΗ ΠΡΑΞΗ

Μ.Τσολάκη, Τ. Ράλλης, Ο. Θωμαρέις, Ε. Βαγάνωφ, Μ. Γκιάλα, Α. Παπαστεριάδης  

Ανακοινώθηκε: 1ο Πανελλήνιο Συνέδριο Παρεντερικής και Εντερικής διατροφής, Πάτρα, Νοέμβριος 1987. Πρακτικά του Συνεδρίου.

 

(33) 49. THE ULTRASTRUCTURAL EFFECTS OF BUPIVACAINE INJECTIONS ON RAT TRIGEMINAL NERVE. M. Tsolaki, A. Alvanou, Th. Loizou, M. Giala, Ch. Foroglou

Επιστημονική Επετηρίδα Ιατρικού Τμήματος 17: 213-226, 1988.

 

(34) 50. EFFECTS OF ENFLURANE AND ENFLURANE ETHER ANAESTHESIA ON THE ULTRASTRUCTURE OF THE BRAIN IN DOGS.

M. Τsolaki, A. Alvanou, O. Thomareis, M. Giala, Ch. Foroglou

Επιστημονική Επετηρίδα Ιατρικού Τμήματος 17: 199-212, 1988.

 

(35) 54. ΣΥΝΔΥΑΣΜΕΝΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΗΣ ΜΕΘΕΡΠΗΤΙΚΗΣ ΝΕΥΡΑΛΓΙΑΣ

Ε.Τσάκωνα, Μ. Τσολάκη, Μ. Πεφτουλίδου, Γ. Ιωάννου, Γ. Κάσινος.

Ανακοινώθηκε: 7ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Χανιά, Μάιος 1987

Ελληνική Αναισθησιολογία 1988;22.

 

(36) 56. ΕΠΙΔΡΑΣΗ ΤΩΝ ΕΓΧΥΣΕΩΝ ΒΟΥΠΙΒΑΚΑΙΝΗΣ  ΣΤΗΝ ΥΠΕΡΜΙΚΡΟΣΚΟΠΙΚΗ ΥΦΗ ΤΟΥ ΤΡΙΔΥΜΟΥ ΝΕΥΡΟΥ ΤΟΥ ΕΠΙΜΥΑ.

Μ. Τσολάκη, Α. Αλβανού, Θ. Λοϊζου, Μ. Γκιάλα, Χ. Φόρογλου.

Πρακτικά 3ου Βορειοελλαδικού Ιατρικού Συνεδρίου, Θεσσαλονίκη, 1988; 70-87

 

(37) 57. ΕΠΙΔΡΑΣΗ ΤΗΣ ΑΝΑΙΣΘΗΣΙΑΣ ΜΕ ΕΝΦΛΟΥΡΑΝΙΟ ΚΑΙ ΜΙΓΜΑ ΕΝΦΛΟΥΡΑΝΙΟΥ-ΑΙΘΕΡΑ ΣΤΗΝ ΥΠΕΡΜΙΚΡΟΣΚΟΠΙΚΗ ΥΦΗ ΤΟΥ ΦΛΟΙΟΥ ΤΩΝ ΗΜΙΣΦΑΙΡΙΩΝ ΤΟΥ ΣΚΥΛΟΥ (Η ΙΔΙΑ ΕΡΓΑΣΙΑ ΜΕ ΤΗΝ 50)

Μ. Τσολάκη, Α. Αλβανού, Ο. Θωμαρέις, Μ. Γκιάλα, Χ. Φόρογλου.

Ανακοινώθηκε: 3ο Βορειοελλαδικό Συνέδριο, Θεσσαλονίκη12-14 Μαϊου 1985.

Πρακτικά.

 

(38) 58. ΕΠΙΔΡΑΣΗ ΤΩΝ ΠΡΟΣΤΑΤΕΥΤΙΚΩΝ ΑΠΟ ΤΗΝ ΙΣΧΑΙΜΙΑ ΕΓΚΕΦΑΛΟΥ ΠΑΡΑΓΟΝΤΩΝ ΣΤΑ ΕΠΙΠΕΔΑ LDH ΚΑΙ CPK ΤΟΥ ΟΡΟΥ ΤΟΥ ΕΠΙΜΥΑ

Α. Τακούδα, Π. Μαϊδάτση, Μ. Τσολάκη, Δ. Τακούδας, Ε. Καλαϊτζής, Σ. Χρυσοχοϊδου, Μ. Γκιάλα. Ανακοινώθηκε: 3ο Βορειοελλαδικό Συνέδριο, Θεσσαλονίκη12-14 Μαϊου 1985.

Πρακτικά.

 

(39) 59. ΒΙΟΦΥΣΙΚΕΣ ΚΑΙ ΝΕΥΡΟΧΗΜΙΚΕΣ ΘΕΩΡΙΕΣ ΑΝΑΙΣΘΗΣΙΑΣ

Μ. Τσολάκη. Ελληνική Αναισθησιολογία 22: 87-94, 1988.

 

(40) 60. Ο ΚΑΡΔΙΟΧΕΙΡΟΥΡΓΙΚΟΣ ΑΡΡΩΣΤΟΣ ΠΡΙΝ ΚΑΙ ΜΕΤΑ ΤΗΝ ΕΓΧΕΙΡΗΣΗ

Μ. Τσολάκη, Μ. Γκιάλα. Ανακοινώθηκε: 6ο Πανελλήνιο Συνέδριο Αναισθησιολογίας, Μάϊος 1985.  18η Επιστημονική Επετηρίδα Α.Π.Θ.

    

(41) 63. ΕΓΚΕΦΑΛΙΚΗ ΠΡΟΣΤΑΣΙΑ ΣΕ ΕΠΙΜΥΕΣ ΑΠΟ ΤΗ ΣΦΑΙΡΙΚΗ ΥΠΟΞΙΑ ΜΕ ΦΑΙΝΥΤΟΪΝΗ. Π.Μαϊδάτση, Μ.Τσολάκη, Λ.Οικονόμου, Χ.Δεστούνη-Ευτυχιάδου, Χρ.Κεραμέως-Φόρογλου, Ε.Σοφιανός.

Ανακοινώθηκε: 6o Πανελλήνιο Συνέδριο Αναισθησιολογίας, ΘεσσαλονίκηΜάιος 1985.

Ελληνική Αναισθησιολογία 22: Ιούλιος-Αύγουστος-Σεπτέμβριος 1988, 173-178.

 

(42) 65. Κ. Ρουτσώνης, O. Αργυροπούλου-Ράκα-Μπομπότη, Μ. Τσολάκη, Κ. Δεληγιάννης, Σ. Μποσταντζοπούλου. Εξάλειψη Βατταρισμού μετά την εγκατάσταση κροταφικής επιληψίας.

Τιμητικός Τόμος Καθηγητού Δ.Λαζαρίδη 1988; 222-226.

 

(43) 67.  Ζαμπούρη  Α., Τσολάκη Μ.,  Σοφιανός  Ε.:  Επίδραση  του  συνδυασμού  φαινυτοΐνης  και  μιδαζολάμης  στον  χρόνο  επιβίωσης  των  μυών  στην  υποξία

Ελληνική  Αναισθησιολογία 1989:23:27-31.

 

(44) 68 Θ. Δαρδαβέσης, Μ. Ευσταθίου, Π. Νικολαίδης, Μ. Τσολάκη,  Δ Δαρδαβέσης,  Θ. Λοιζίδης,  Ζ.  Γιαννόπουλος,  Αχ. Τουρκαντώνης.  Δημοσκόπηση  δειγμάτων  ιατρικού  και  νοσηλευτικού  προσωπικού  σχετικά  με  την  έννοια του  εγκεφαλικού  θανάτου  και  της  μεταμόσχευσης. Ελληνική Ιατρική 1989;55:142-149. Μεταμόσχευση 1990;1:52-59.

 

(45) 69. Μ. Τσολάκη, Ε. Νενοπούλου,  Α. Ζαμπούρη, Μ. Πεφτουλίδου,  Ε.  Σοφιανός

Είναι η φλουμαζενίλη ένας ακόμη προστατευτικός παράγοντας από την εγκεφαλική υποξία; Σύγκριση με την μιδαζολάμη.  8ο Πανελλήνιο Συνέδριο Αναισθησιολογίας  Κύπρος Μάρτιος 1989. Is flumazenil a protective agent from brain hypoxia? Correlation with midazolam.

Scientific Annals of the Faculty of Medicine 1991;18: 173-181

 

(46) 71. Μ. Τσολάκη, Α. Μάνθος, Λ. Oικονόμου, Π. Μαιδάτση, Α. Σιόγκα, O. Θωμαρέις, Μ. Γκιάλα, Χ. Φόρογλου.     Bραβείο: Υπερμικροσκοπική μελέτη της επίδρασης της μιδαζολάμης και της προποφόλης στο ΚΝΣ επιμύων μετά από εμβολή αέρος.

4ο Βορειοελλάδικό Συνέδριο Θεσσαλονίκης Μάιος 1989. Πρακτικά, 537-543.

 

(47) 72.   M.  Tsolaki,  A. Zambouri, M. Peftulidou, N.  Kapanidis, E.  Sofianos.

Preventive  and  Curative  autinconvulsaut  effect  of  Flumazenil  versus  Lidocaine  - induced  seizures.  European Congress of Anaesthesiology Varsovia 1991.Προφυλακτική  και θεραπευτική   αντισπασμωδική  δράση  της  φλουμαζενίλης  στους  σπασμούς  που  προκαλεί  η  λιδοκαϊνη . 4ο Βορειοελλαδικό Συνέδριο Θεσσαλονίκης 1989. Πρακτικά: 934-937.

 

(48) 73. Routsonis K, Bostanzopoulou M, Kazis A, Kapinas K, Tsolaki M, Argyropoulou-Raka O, Deligiannis K. Mirror writing and reading. Neurol Psychiatr 1991;12: (Suppl 1):27-31.

 

(49) 74. Μ. Τσολάκη, Κ. Καπινάς, Ι. Καλογερόπουλος, R. Propato, Ν. Γοργίας, Α. Κάζης,  Κ. Ρουτσώνης . Πειραματικά πρότυπα επιληψίας. Σύγκριση. VIDEO. 1ο Πανελλήνιο Επιστημονικό Συνέδριο  Φοιτητών  Ιατρικής Δεκεμβριος 1989. Πρακτικά Συνεδρίου: 183-193.

 

(50) 75. Κ. Καπινάς, Μ. Τσολάκη, Α. Κάζης, Κ. Ρουτσώνης. Περίπτωση αντανακλαστικής ακουστικής επιληψίας. 1ο Πανελλήνιο  Επιστημονικό Συνέδριο Φοιτητών Ιατρικής Δεκέμβριος 1989. Πρακτικά Συνεδρίου:50-57.

 

(51) 79. Daggilas A, Tsolaki M., Kapinas K. The effect of diazepam on Evoked Braistem Potentials. Review of Clinical  Pharmacology and  Pharmacokinetics  1993;7:89-93.

 

(52) 80. Μ. Τσολάκη, Α. Κοπράς, Σ. Σπυρόπουλος, Θ. Παπαγεωργίου, Γ. Παυλίδης, Κ.Καπινάς, Κ.Ρουτσώνης.  Εντόπιση  εγκεφαλικών  επεισοδίων  επί  υπερτάσεως και σε  συνδυασμό  με  άλλους  προδιαθετικούς παράγοντες. 5ο Βορειοελλαδικό Συνέδριο Θεσσαλονίκης 1990; 12.

Πρακτικά: 34-42.

 

(53) 81. Μάνθος Α., Oικονόμου Λ, Τσολάκη Μ, Τσικόπουλος Γ, Δαδούκης Ι, Φόρογλου Χ.

Η επίδραση της ναλοξόνης  σε πειραματική ηπατική ισχαιμία. Υπερμικροσκοπική  μελέτη.

5ο Βορειοελλαδικό Συνέδριο 1990.  Πρακτικά: 12-17. Βραβείο.

 

(54) 82.  Μ. Tsolaki, M. Petridou, K. Kapinas, M. Karamouzis, K. Routsonis.

Interleukin-2:Is a marker of clinical severity in chronic progressive multiple sclerosis.

VI Congress of the International Society of Greek Neuroscientists. Corfu 1990.

Scientific Annals of the Faculty of Medicine 1993;202:181-185

 

(55) 83. M. Tsolaki, A.Dagillas, M. Petridou, K. Kapinas, K.Routsonis

Auditory  Brainstem  evoked  potentials in  patients  presenting  with   dementia

6o Congress  of The  International  Socienty  οf  Greek Neuroscieutists, Corfu 1990

Scientific Annals of the Faculty of Medicine 1993;202:167-175.

 

(56) 84. Ν. Γοργίας, Μ. Τσολάκη, Λ. Oικονόμου, Α. Μάνθος, Π. Μαιδάτση, Α. Ζαμπούρη, Κ. Χατζηνικολάου, Χ. Φόρογλου, Κ. Ρουτσώνης. Εγκεφαλική προστασία σε μυς από την σφαιρική υποξία με συνδυασμό μιδαζολάμης και  Ν2O. 1ο Συνέδριο Αναισθησιολογίας και Εντατικής Ιατρικής 1990:14. Πρακτικά Συνεδρίου 66-67.

 

(57) 85. Α. Καρδαμύλας, Μ. Τσολάκη, Γ. Σαρηγιάννης, Β. Παπαιωάννου, Ε. Μερτζανίδου, Μ. Γκιάλα. Επίδραση της υπογλυκαιμίας στο αντανακλαστικό των τασεουποδοχέων επιμύων σε συνθήκες γενικής αναισθησίας με ισοφλουράνιο. 1ο Συνέδριο Αναισθησιολογίας και Εντατικής Ιατρικής  1990:15. Πρακτικά Συνεδρίου: 68-69.

 

(58) 86. Α. Ζαμπούρη, Μ. Τσολάκη, Ε. Σοφιανός.Επίδραση του συνδυασμού  θειοπεντάλης και φαινυτοΐνης στον χρόνο επιβίωσης των μυών στην υποξία. 1ο Συνέδριο Αναισθησιολογίας και Εντατικής Ιατρικής 1990:13. Πρακτικά Συνεδρίου:63-65

 

(59) 88. Κ. Καπινάς, Μ. Τσολάκη, Π. Σακελλαρίου. Αυτόματο επισκληρίδιο αιμάτωμα της ΘΜΣΣ Νωτιαίου Μυελού: Η διαγνωστική αξιοπιστία της ΝΜR και συντηρητική θεραπευτική αντιμετώπιση. Συμπόσιο Ελληνικής Εταιρείας Νευρομυοπαθολογίας 1990.Τιμητικός τόμος καθηγητού Α. Διακογιάννη. Eπιστημονική Επετηρίδα του τμήματος Ιατρικής 1994; 24:195-203.

 

(60) 89. Μ. Τσολάκη, Κ. Νανάσης, Α. Κάζης, Κ. Ρουτσώνης. Έκτοπος φαιά ουσία με εστιακές κρίσεις. ΜR απεικόνιση. Συμπόσιο Ελληνικής Εταιρείας  Νευρομυοπαθολογίας 1990. Τιμητικός τόμος καθηγητού  Α. Διακογιάννη. Eπιστημονική Επετηρίδα Τμήματος Ιατρικής 1994;21:433-438

Θέματα Νευροφυσιολογίας 1994; 2:32-35. Diagnosis of cortical heterotopia with MRI. Tsolaki, M., Nanassis, K., Alexiadou, C., Kazis, A. Hellenic Medical Journal,1999: 3; Nr 1:19-20

 

(61) 93. K. Kαπινάς, Μ. Τσολάκη,  O. Χατζηζήση,  Σ. Καραχριστιανού,  Γ. Κυριαζής.

Θεραπευτικό αποτέλεσμα ενδοφλέβιας χορήγησης υψηλών δόσεων μεθυλπρεδνιζολόνης στην πολλαπλή σκλήρυνση. 12ο Πανελλήνιο Συνέδριο Νευρολογίας  Βόλος 1991:112.

Γαληνός 1991;33:235-242.

 

(62) 95. Ν. Γοργίας, Π. Μαιδάτση, Μ.Τσολάκη, Α. Φακίδου. Γ. Ρουτσώνης.

Προστασία από την διεγερτική επίδραση της ξυλοκαίνης στο ΚΝΣ επιμύων με Ν2O.

9ο Πανελλήνιο Συνέδριο Αναισθησιολογίας  Πάτρα 1991.

Eλληνική Αναισθησιολογία 1991;25: 42.

 

(63) 98. Μ.  Τσολάκη, Π. Δώμου, Ε. Ψωμά,  Κ. Καπινάς,  Κ. Χατζηνικολάου,  Κ. Ρουτσώνης.

Επίδραση  της  υπεροξίας στα  ενζυμα  L.D.H., S.G.O.T., SGPT,  γGT και  C.P.K. με  και  χωρίς   βιταμίνη  Ε. 6ο  Βορειοελλαδικό Συνέδριο   Θεσσαλονίκης   Μάϊος  1991: 56.

Πρακτικά: 791-796.

 

(64) 99. Μ. Τσολάκη, Μ. Πεφτουλίδου, Χ. Τσιότρας,  Δ. Κολέτσος, Ε. Αναστασίου, Κ. Χατζηνικολάου,  Δ. Ρίγγος, Κ. Ρουτσώνης . Αίτια  εγκεφαλικού  θανάτου  στις  ΜΕΘ  Θεσσαλονίκης. 6ο  Βορειοελλαδικό  Συνέδριο   Θεσσαλονίκης  Μάϊος  1991.37

Πρακτικά:  486-490. Μεταμόσχευση 1991;2:21-25.

 

(65) 100. Καπινάς   Κ., Κάζης  A, Τσολάκη Μ.,  Αργυροπούλου  Oυ. Προσβολή  του  ΚΝΣ από  AIDS . Διαγνωστική  συμβολή   της  NMR. 2ο  Πανελλήνιο  Επιστημονικό  Συνέδριο  Φοιτητών   Ιατρικής  Θεσσαλονίκη 1991 . Εγκέφαλος  1991;  28:  184-187.

 

(66) 104. Μ. Peftulidou,  E. Tsakona, M. Tsolaki,  D.Vasilakos,  J.Vavalekas.

Effect of intravenous lidocaine in the treatment of migraine attacks.

Scientific Annals of the Faculty of Medicine, 1991;182:19-22.

 

(67) 106.  Μ.  Τσολάκη, Καλαϊτζόγλου Ι,  Αβραάμ  Ξ,  Καπινάς  Κ,  Κάζης  Α.

Σύνδρομο Tolosa-Hunt. Φθινοπωρινή Συνάντηση Ελληνικής Νευρολογικής Εταιρείας, Θεσσαλονίκη, 1991. Κεφαλαλγία 1994;2:76-79.

                 

(68) 108.  K. Kαπινάς, Α. Δρεβελέγγας, Μ. Τσολάκη, Ρουτσώνης Κ. Διαφορική διάγνωση περικοιλιακών εστιών υψηλού σήματος  (ΣΚΠ-Αγγειακή νόσος)-Imaging.  4ο Πανελλήνιο Συνεδριο Απεικονιστικών Διαγνωστικών Μεθόδων. Θεσσαλονίκη 1991:108. K. Kapinas, M. Tsolaki, Drevelegas A. Routsonis K. Magnetic Resonance Imaging of white matter lesions: differentation between MS and vascular patients. Postgraduate Course Neuroimaging Graz, 1992:17. J. Neuroimaging 1992;2:220. Scientific Annals of the Faculty of Medicine, 1993;202:93-103.

 

(69) 109.  A.  Kονδυλίδου,  Σ.  Βαγιωνά,  Κ.  Αντωνιάδης,  Μ. Τσολάκη. Ψυχιατρικά προβλήματα που ενδιαφέρουν τον οδοντίατρο. Ελληνικά Στοματολογικά Χρονικά 1991;35:201-207.

 

(70) 111. Νενοπούλου Ε, Τσολάκη Μ, Κοφανάς Α, Μουσαφίρης Κ, Χατζηνικολάου Κ, Ρουτσώνης Κ, Παπαδημητρίου Κ. Συγκριτική μελέτη αυτομάτων όγκων μαστού μυών C3H με ή χωρίς υπεροξία. 3ο Πανελλήνιο Συνέδριο Παθολογικής Ανατομικής Αθήνα 1991:87-88.

Αρχεία Παθολογικής Ανατομικής 1992;6:109-114

 

(71) 112.  Ν. Καβάκα, Μ. Τσολάκη. Φυσικοθεραπευτές που εργάζονται σε νοσοκομείο- Κίνδυνοι και προφυλάξεις. 7ο Βορειοελλαδικό Συνέδριο Θεσσαλονίκη, 1992. Πρακτικά: 256-260.

 

(72) 113. Ν. Γοργίας,  Γ. Κυριαζής, Π. Μαιδάτση, Μ. Τσολάκη, O. Αντώνογλου, Κ. Ρουτσώνης.

Μεταβολές της δισμουτάσης του ανιόντος υπεροξειδίου της δισμουτάσης (SOD) στο μυοκάρδιο επιμύων  μετά  υποξία- επανοξυγόνωση.

Βραβείο. 7ο Βορειοελλαδικό Συνέδριο Θεσσαλονίκη1992. Πρακτικά: 984-993.

 

(73) 114. Μ. Τσολάκη, Ι. Ψαχούλας, Κ. Καπινάς, Δ. Διβάνογλου, Φ. Γραμματικός, Κ. Ρουτσώνης.

Βιταμίνη Β12, Φολικό οξύ και πολλαπλή σκλήρυνση..

7ο Βορειοελλαδικό Συνέδριο Θεσσαλονίκη1992. Πρακτικά: 1154-1158.

 

(74) 115. M. Tσολάκη. Πρόληψη  των Αγγειακών Εγκεφαλικών Επεισοδίων

Στρογγύλη  Τράπεζα. 7ο Βορειοελλαδικό Συνέδριο, Θεσσαλονίκη 1992. Πρακτικά: 59-75.

 

(75) 116.  Ν. Γοργίας, Π.Μαιδάτση, Κ. Καρακούλας, Π. Δώμου, Μ. Τσολάκη.

Επίδραση της θειοπεντάλης στον ανταγωνισμό των βενζοδιαζεπινών από την φλουμαζενίλη  σε επίμυες. 2ο Συνέδριο Αναισθησιολογίας και εντατικής Ιατρικής 1992:117.

Eλληνική Aναισθησιολογία 1992: 26: 277-283.

 

(76) 123. M.Tσολάκη,  Α. Δρεβελέγγας, Κ. Πολυζωίδης,  Α. Παπαγόρας,  Κ. Καπινάς,  Α. Σκορδαλάκη,  Μ. Φυλακτάκης, Α. Κάζης. Συσχέτιση Ιστολογικών και Νευροαπεικονιστικών ευρημάτων σε υπερσκηνίδιους όγκους. 6ο Συνέδριο Νευροχειρουργικής. Θεσσαλονίκη 1992:8

Eλληνική Νευροχειρουργική 1993; 1: 54-57.

 

(77) 129. Τσολάκη Μ. Σύγχρονες Θεραπευτικές απόψεις στις άνοιες.

Στρογγύλη Τράπεζα, Λάρισα 13/2/93, Καβάλα  2/4/93, Ιατρική Εταιρεία Θεσσαλονίκης 9/6/93.

 Νευρολογία  1993;2:64-74, Aρχεία ΕΨΨΕΠ; 1994;1:12-19.

 

(78) 130.Μ.Τσολάκη, Μ. Καραμούζης, Β. Ιακωβίδου,  Α. Δημητριάδου, Α. Κάζης.Επίπεδα προλακτίνης στις άνοιες. 8ο Βορειελλαδικό Συνέδριο, Θεσσαλονίκη 1993. Πρακτικά:  803-806.

 

(79) 133. Μ. Τσολάκη,  Μ. Καραμούζης,  Κ. Καπινάς,  Κ. Ρουτσώνης.

Ανίχνευση βασικής πρωτείνης της μυελίνης στα ούρα ασθενών με νευρολογικές παθήσεις.

Εκπαιδευτικό Πρόγραμμα Περιόδου 1990-91. Γ.Π.Ν. "Γ. Παπανικολάου"

Oλοκληρωμένη εργασία: Δημητριάδου-Βαφειάδου  Α., Κάζης  Α.,Τρακατέλλης Α.

Προσδιορισμός της ανοσοδραστικής ΜΒΡ στα ούρα στην διαγνωστική προσέγγιση της πολλαπλής σκλήρυνσης. 8ο Βορειοελλαδικό Συνέδριο 1993. Πρακτικά: 916-923

Βραβείο: Ελληνική Ιατρική 1993;59:208-212.

 

(80) 134.  M. Tσολάκη. Γενετική στη Νόσο του Αlzheimer

Συμμετοχή σε Στρογγύλη Τράπεζα προς τιμήν του Γ. Ζερβόπουλου

Ιατρική Εταιρεία Θεσσαλονίκης, Mάρτιος 1993. Τιμητικός τόμος:1993;77-85.

 

(81) 135. Μ. Τσολάκη, Τ. Ράλλης,  Ν. Ρουμπιές, Κ. Δεληγιάννης,  Α.  Παπαστεριάδης,  Α. Κάζης.

Ιχνοστοιχεία και νόσος Alzheimer. Hμερίδα στη μνήμη του Νευρολόγου-Ψυχιάτρου, Γ. Ζερβόπουλου. Θεσσαλονίκη1992. Τιμητικός τόμος: 1993;129-135

 

(82) 136. Α. Κάζης, Β. Κιμισκίδης, Σ. Μποσταντζοπούλου, Μ. Τσολάκη, O. Αργυροπούλου, Κ. Καπινάς, Κ. Δεληγιάννης, Κ. Ρουτσώνης.

Φαρμακευτική Θεραπεία της Επιληψίας. Νεώτερες απόψεις.

Τιμητικός τόμος καθηγητού κ. Αγαπητού Διακογιάννη

Επιστημονική Επετηρίδα του Τμήματος Ιατρικής 1994;21:183-194.

Review of Clinical Pharmacology and Pharmacokinetics 1993:7:74-78.

 

(83) 140. Φουντουλάκης Κ, Τσολάκη Μ, Χαντζή  Ε, Κάζης Α.

MINI MENTAL STATE EXAMINATION (MMSE). Εφαρμογή του στον Ελληνικό πληθυσμό σε ασθενείς με άνοια.  9η Πανελλήνια Συνάντηση για τις Νευροεπιστήμες.Θεσσαλονίκη, 25-28 Νοεμβρίου 1993. Εγκέφαλος 1994:31:93-102.

 

(84) 141. Τσολάκη Μ,  Φουντουλάκης Κ, Τσώκος Ν, Κουκουρίκου Ν, Κάζης Α.

Η νιμοδιπίνη ως θεραπευτικός παράγοντας στις άνοιες. Διπλή τυφλή διασταυρούμενη μελέτη.

13ο Πανελλήνιο Συνέδριο Νευρολογίας, 1993. Πρακτικά: 233-248.

 

(85) 143. Αβραάμ Ξ, Τσολάκη Μ, Διβάνογλου Δ, Τριανταφύλλου Α, Βαφειάδης Ε, Kάζης  Α.

Oξεία  τοξική  εγκεφαλοπάθεια από φυτά. 13ο Πανελλήνιο Συνέδριο Νευρολογίας Θεσσαλονίκη 1993. Νευρολογία 1993;2:57-60.

 

(86) 144. Τσολάκη Μ, Κάζης Α. Βραδέως εξελισσόμενη προοδευτική αφασία χωρίς άνοια.

3ο Πανελλήνιο Συνέδριο Γεροντολογίας Γηριατρικής Αθήνα 1993. Εγκέφαλος 1995;32:266-270.

 

(87) 145. Τσολάκη Μ, Oικονόμου Λ, Μάνθος Α, Κάζης Α.

Υπερμικροσκοπική μελέτη του ιππόκαμπου επιμύων μετά από ενδομυική χορήγηση ατροπίνης.

3rd International Congress of Appac Developments in Psychiatry and Neurology of the Adult and the Child. Athens 1993. Αρχεία ΕΨΨΕΠ 1994;2:73

 

(88) 146. M.Tσολάκη, Κ. Φουντουλάκης, Ε. Χαντζή, Α. Κάζης. Παράγοντες κινδύνου της νόσου Alzheimer στη Μακεδονία. Επιστημονικόν Συμπόσιον επί της νόσου του Alzheimer. Θεσσαλονίκη 1994. M.Tsolaki, K.Fountoulakis, E.Chantzi, A.Kazis. Risk Factors for clinically diagnosed Alzheimer's Disease: a case control study of a Greek population

Νέοι ορίζοντες εις την Νόσον του Alzheimer, 1994;153-171.

 

(89) 148.  M. Tσολάκη, Ε. Δεδούση, Α. Κοτανίδης, Φ. Γραμματικός, Α. Κάζης.

Επίπεδα νεοπτερίνης στις άνοιες. 9ο Βορειοελλαδικό Συνέδριο, Θεσσαλονίκη 1994

Πρακτικά: 611-616.

 

(90) 149. Μ. Τσολάκη, Παυλίδης Γ., Κουκουρίκου Κ., Μαράγκα Α., Κουκουρίκος Σ., Α. Κάζης. Επαναλαμβανόμενο ΑΕΕ. Προδιαθετικοί  παράγοντες. 9ο Βορειοελλαδικό Συνέδριο, Θεσσαλονίκη 1994. Πρακτικά: 453-456.

 

(91) 152. Μ. Τσολάκη, Ι. Πήττας. Eφαρμογή  του SKT στην εκτίμηση των ανοιών στην Ελλάδα.

13o  Πανελλήνιο Συνέδριο Ψυχιατρικής 1994:44. Εγκέφαλος 1995;32:336-345.

 

(92) 155. Μ.Tsolaki, K. Kapinas, K. Routsonis.  Paroxysmal  Kinesigenic Chorioathetosis.

Review of Clinical Pharmacology and Pharmacokinetics 1995;9:41-43.

 

(93) 156. K. Καπινάς, Μ. Τσολάκη,  Α. Σκορδαλάκη, Δ. Μπότσιος, B.Kασελάς, Α. Κάζης. Η  θυμεκτομή  στη βαρεία  μυασθένεια.  A΄ Συνέδριο Νευροεπιστημών Θεσσαλονίκης-Λευκωσίας, Ιούνιος 1994. Eλληνική Ιατρική 1995;61:127-131.

 

(94) 159. M. Tsolaki, K. Fountoulakis, E. Chanzi, A. Kazis.  The Cambridge Cognitive Examination for the elderly (CAMCOG). A validation study in demented patients from the elderly Greek  population. 8th Congress of the International Society of the Greek Neuroscientists. Rhodes 1994. Εγκέφαλος 1996;33:57-75.

 

(95) 167. Μ. Τσολάκη. Νευροφαρμακολογία του πόνου.

Θέματα Αναισθησιολογίας και Εντατικής Ιατρικής  1994;4:7-24

 

(96) 168.  M. Tσολάκη. Πιθανοί προστατευτικοί παράγοντες  στη Νόσο του Alzheimer.

4th International Congress of APPAC . Athens, December 1994.

Iατρικές Εξελίξεις, Δεκέμβριος 1994. Αρχεία ΕΨΨΕΠ 1995;2:16-20.

 

(97) 172. Μ. Τσολάκη, Δ. Διβάνογλου, Μ.Καταροπούλου, Α.Κάζης.

Επίπεδα α1-αντιθρυψίνης στον ορό αρρώστων με άνοια.  Εαρινή συνάντηση των Ελλήνων Νευρολόγων, Δελφοί, Απρίλιος 1995. Nευρολογία 1996;5:28-31.

 

(98) 173. Μ. Τσολάκη. Διαφορική διάγνωση γνωσιακών διαταραχών. Συμμετοχή σε στρογγυλή τράπεζα  με θέμα  "Νοητικές διαταραχές των ηλικιωμένων. O ρόλος της Ανιρασετάμης ".  Θεσσαλονίκη 13/5/95.

 

(99) 177. M. Tsolaki,  A. Kazis. Nimodipine versus dihydergocristine in the treatment of old age dementias. Blind randomized, cross-over, placebo-controlled study.

VIIIth Congress of the European College of Neuropsychopharmacology Venice, Italy, 30 September- 4 October 1995. European Neuropsychopharmacology 1995;5:384.

Review of Clinical Pharmacology and Pharmacokinetics International Edition 1996;10:16-24.

 

(100) 183. Μ. Τσολάκη, Καραμούζης Μ, Διβάνογλου, Αμύντα Μ, Δημητριάδου-Βαφειάδου Α, Κάζης Α. Επίπεδα θεικής δευδροεπιανδροστερόνης  (DHEA-S) στον ορό ηλικιωμένων με άνοια.

14ο Πανελλήνιο Συνέδριο Ελλήνων Νευρολόγων, Αθήνα 15-18 Νοεμβρίου 1995.

Νευρολογία 1995: 101, Εγκέφαλος  1996; 33: 120-125, Nευρολογικά  Θέματα  1996;

 M. Tsolaki, M. Karamouzis, D. Divanoglou, M. Aminta, A. Dimitriadou - Bafiadou, K. Fountolakis, A. Kazis. Dehydroepiandrosterone Sulfate (DHEA-5) in the Serum of patieuts with  Dementia. 6th World Congress of Biological Psychiatry Nice, France June 22/27, 1997.

 

(101) 184. Μ. Τσολάκη, O. Χατζηζήση, Σ. Παπαγιαννόπουλος, Κ. Καπινάς, Κ. Φουντουλάκης,  Γ. Κυριαζής,  Α. Κάζης. Επίπεδα Ινερλευκίνης-1α και ιντερλευκίνης-6 στο ΕΝΥ ασθενών  με Alzheimer, Πολλαπλή σκλήρυνση, και άλλα Νευρολογικά νοσήματα. 14ο Πανελλήνιο Συνέδριο Ελλήνων Νευρολόγων, Αθήνα 15-18 Νοεμβρίου 1995. Νευρολογία 1995-113. Νευρολογικά Θέματα 1996; Επιστημονική Επετηρίδα Τμήματος Ιατρικής ΑΠΘ, 1999;26:37-42. M. Tsolaki, O. Chatririsi, K. Fountoulakis, S. Papagiannopoulos, K. Kapinas, G. Kyriagis, A. Kazis.Cerebrospinal  fluid Interleukin 1a και 6  in patieuts with AD, Multiple Sclerosis and  Other Neurological Disorders. 6th World Congress of Biological Psychiatry Nice France June 22//27, 1977.

 

(102) 186. Μ. Τσολάκη, O. Χατζηζήση, Σ. Ποζίδου, Γ. Κυριαζής, Ζ. Πολυμενίδης, Α. Κάζης.

Μελέτη των HLA-Α,Β,C, DR και DQ αντιγόνων στη νόσο Alzheimer (NA) στο Βορειοελλαδικό χώρο.14ο Πανελλήνιο Συνέδριο Ελλήνων Νευρολόγων, Αθήνα 15-18 Νοεμβρίου 1995.

Νευρολογία 199:115. Nευρολογικά  θέματα  1996: 3;67-70 . M. Tsolaki, Chatzizisi O., Fountoulakis  K., Kyriazis G.  Polymenides Z,  Kazis A. An HLA Study in AD patients in Northern Greece.6th World Congress of Biological Psychiatry Nice, France June 22/27, 1997.

 

(103) 188. Μ. Τσολάκη.  Επιδημιολογία της Νόσου Alzheimer. ΕΨΨΕΠ Αθήνα 8-10 Δεκεμβρίου 1995. Ιατρικές εξελίξεις Έξτρα 1996:80;6-9. Aρχεία EΨΨEΠ 1996; 3: 126-7

 

(104) 189. Μ. Τσολάκη. Επιδημιολογία της Νόσου Alzheimer. Συμμετοχή σε στρογγύλη Τράπεζα στο 4ο Συνέδριο Γεροντολογίας Γηριατρικής. Αθήνα 14-16 Δεκεμβρίου 1995.

Ιατρικές εξελίξεις Έξτρα 1996:80;6-9. Εγκέφαλος 1996; 33: 164-177

 

(105) 191 . Φουντουλάκης Κ, Τσολάκη Μ., Κάζης Α. Η επίδραση της φλουβοξαμίνης στις Ανώτερες Γνωσιακές Λειτουργίες  Ηλικιωμένων που πάσχουν από κατάθλιψη και άνοια ή διαταραχές μνήμης συνδεόμενες  με την ηλικία.

14ο Πανελλήνιο Συνέδριο Ψυχιατρικής Αθήνα 30/3-3/4 1996. Εγκέφαλος; 33: 182-90

 

(106) 192. Μ.Τσολάκη, Α.Μάνθος, Oικονόμου Λ., Φουντουλάκης Κ, Κάζης Α, Φόρογλου Χρ.

Σύγκριση υπερμικροσκοπικής υφής ιππόκαμπου μετά χορήγηση αλοπεριδόλης και ατροπίνης.

11ο Βορειοελλαδικό Συνέδριο Απρίλιος 1996;102. Βραβείο M. Tsolaki, A.Manthos, L. Economou, C.Fountoulakis, A. Kazis, Ch Foroglou. Hypermicroscopic findings in rat hippocampus after intramuscular atropine or neuroleptics administration. X World Congress of  Psychiatry, Madrid, Spain 23-28 August, 1996; 214.  Πρακτικά Συνεδρίου. Ελληνική Ιατρική

 

(107) 193. Μ. Τσολάκη, Γ. Παυλίδης, Σ. Παπαγιαννόπουλος, Ζ. Σαχλά, Σ. Κουκουρίκος, Α. Κάζης. Προδιαθετικοί παράγοντες σε σχέση με την ηλικία σε ασθενείς με ΑΕΕ.

11ο Βορειοελλαδικό Συνέδριο Απρίλιος 1996;98. Πρακτικά Συνεδρίου.

 

(108) 195. Μ. Τσολάκη,  Α. Ρέπτσης,  Δ. Ζαφειρίου, Κ. Ζησιάδης, Α.Κάζης. Η αντίδραση της κόρης ως νευροβιολογικό φαινόμενο μπορεί να συμβάλλει στη διάγνωση της άνοιας τύπου Alzheimer? 11ο Βορειοελλαδικό Συνέδριο Απρίλιος 1996;100. Πρακτικά Συνεδρίου

 

(109) 210. Τσιούρη  Ι., Τσολάκη Μ, Ευκλείδη Α. Διαταραχές του λόγου σε ασθενείς  με άνοια τύπου Alzheimer.Συσχέτιση με τη γενική νοητική κατάσταση (προκαταρκτική μελέτη)

5ο Πανελλήνιο Συνέδριο Ψυχολογικής Έρευνας ΕΛΨΕ Πάτρα 23-26 Μαίου 1996;103. 

Eγκέφαλος 1997;34:38-51.

 

(110) 212. Μ.Τσολάκη. Μνήμη και Μάθηση. Λήκυθος, Φεβρουάριος-Απρίλιος 1996: 14-22.

 

(111) 231. M. Tσολάκη, Γ. Γερασίμου, Ο. Χατζηζήση, Κ. Φουντουλάκης, Γ. Κυριαζής, Α. Κάζης.

Συσχέτιση της περιοχικής αιματικής εγκεφαλικής ροής (SPECT) και των επιπέδων τ πρωτείνης στο ΕΝΥ ασθενών με Νόσο Alzheimer. Ελληνική Ιατρική 1997; 63:311-320

 

(112) 238. Οκαλίδου Α., Τσολάκη Μ, Κάζης Α.  Διαταραχές επικοινωνίας  και σχέσεις μεταξύ  νευρογλωσσικών, γνωστικών και  λειτουργικών διαταραχών  σε ασθενείς με νόσο του Alzheimer. Ψυχολογία Communication Disorders-Relationships among neurolinguistic, cognitive and functional disorders in patients with Alzheimer's Disease. Οκαλίδου, Αρετή Okalidou, Areti Τσολάκη, Μ. Tsolaki, M. Κάζης, Α. Kazis, A., 03-12-2008. http://hdl.handle.net/2159/5709

 

(113) 240. M.Πετρίδου, Μ.Τσολάκη, Α.Κάζης. Μελέτη του γενεαλογικού υλικού οικογενειών με νόσο Alzheimer στον ελληνικό πληθυσμό. Εγκέφαλος, 1999;36:39-42

 

(114) 249. Κόκκας Β.  και Τσολάκη Μ. Στοιχεία  Χρονοφαρμακολογίας

Eπιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής 1997; 15:181-187

 

(115) 252. Φουντουλάκης Κ., Ιακωβίδης Α, Τσολάκη Μ,. Ιεροδιακόνου Χ.Η κατάθλιψη στην Τρίτη Ηλικία. Ι.: Επιδημιολογία και Κλινική Εικόνα. Eγκέφαλος 1997:34;173-196.

 

(116) 263. Φουντουλάκης Κ., Ιακωβίδης Α., Τσολάκη Μ., Ιεροδιακόνου Χ.

Η κατάθλιψη στην τρίτη ηλικία-ΙΙ: Θεραπευτική αντιμετώπιση  και μελλοντικές προοπτικές. Εγκέφαλος 1998:35: 91-105

 

(117) 276. Tsolaki M., Iakovidou V., Papadopoulou E, Aminta M, Nakopoulou E., Kazis A. Μια 7-λεπτη Συστοιχία Δοκιμασιών για την εκτίμηση των Νευρογνωστικών λειτουργιών ασθενών με νόσο Alzheimer στον Ελληνικό πληθυσμό. Εγκέφαλος, 2000:37: 29-40

 

(118) 287. Μ. Τσολάκη, Γ. Μουζόπουλος, Γ. Βασιλειάδης, Π. Σουβατζίδης, Α. Κάζης.  Αξιοπιστία του πρώτου συμπτώματος  για τη διάγνωση της άνοιας τύπου  Alzheimer.

Εγκέφαλος 1998; 35:165-178.

 

(119) 293. M. Τσολάκη, Α. Κούρτης, Σ. Μποσταντζοπούλου, Α. Κάζης.

Μονοθεραπεία  με λαμοτριγίνη  ηλικιωμένων ασθενών  με επιληπτικές κρίσεις και άνοια  ή ήπιες γνωστικές διαταραχές. Εγκέφαλος 1999; 36:121-125

 

(120) 298. M. Τσολάκη, Γ. Γερασίμου. Η Συμβολή της Πυρηνικής Ιατρικής  στη Διάγνωση  και τη Διαφορική διάγνωση της Άνοιας. Ανασκόπηση. Ελλ. Πυρηνική  Ιατρική 1999:2:11-18

 

(121) 300. M. Tsolaki, V. Iacovidou, Ch Navrozidou, M.Aminta, A. Kazis. To HINDI ως δοκιμασία σάρωσης (screening) για αναλφάβητους ασθενείς. Εγκέφαλος 37, 119-138, 2000

 

(122) 366. Τσάνταλη Ε., Τσολάκη Μ., Ευκλείδη Α., Κιοσέογλου Γ. Η εφαρμογή του Boston Diagnostic Aphasia Examination σε ασθενείς  με νόσο Alzheimer.Εγκέφαλος 2001:38;146-166

 

(123) 378. Οκαλίδου Α., Τσολάκη Μ., Σαραφίδου Γ., Κάζης Α. Διαταραχές της Ικανότητας κατονομασίας που εμφανίζουν ασθενείς με νόσο Alzheimer. Ψυχολογία  2001; 8:60-70

 

(124) 405. Τσολάκη Μ., Αλεξιάδου Α., Κουντή Φ., Κιοσέογλου Γ., Κάζης Α.

Συσχετίσεις των νευροψυχολογικών δοκιμασιών FUCAS και ADAS στην παρακολούθηση  ασθενών με άνοια. Νευρολογία 2003:12;39-50

 

(125) 431. Τσολάκη Μ., Βασιλειάδης Γ., Πανταζή Χ., Πετροβίτσος Ε., Κάζης Α., Κάζη Ε.  Ο ρόλος της εκπαίδευσης στην εξέλιξη των ασθενών με άνοια τύπου Alzheimer

Νευρολογία 2003: 14;75-89

 

(126) 460. Doudoumi Soultana, Tsolaki Magda, Kiosseoglou Grigoris, Deoudi Pagona, Sagiadinou Maria-Magdalini, Kazis Aristides.: QUALITY OF LIFE OF CAREGIVERS OF PEOPLE WITH ALZHEIMER’S DISEASE. 2nd Hellenic Conference on AD and Related Disorders 2002.   Εγκέφαλος: 40, 122-130, 2003.

 

Δουδούμη, Σ., Τσολάκη, Μ., Σαγιανίδου, Μ., Δεούδη, Π, Κάζη, Ε., Κιοσέογλου Γ., & Κάζης, Α. (2003).  Ποιότητα ζωής φροντιζόντων τους ασθενείς με νόσο Alzheimer. Εγκέφαλος,40, 122-130.

 

(127) 463. Mολυβά Δ., Τσολάκη Μ., Κάζης Α. Μελέτη Γενεαλογικών Δεδομένων σε ασθενείς με Νόσο Alzheimer. 18o  Πανελλήνιο  Συνέδριο Ελλήνων Νευρολόγων, Νοέμβριος  2002. Νευρολογία; 11:183-184. Επετηρίδα του Ιατρικού Τμήματος 2002;29:101-112

 

(128) 470. Μ. Τσολάκη, Γ. Συμεωνίδης, Α. Κάζης. Διαβητική κετοξέωση ως ανεπιθύμητη ενέργεια θεραπείας με ολανζαπίνη. Ψυχιατρική 2002:13:222-227.

 

(129) 472. Τσολάκη Μ., Βασιλειάδης Γ. Μη φαρμακευτικές παρεμβάσεις  σε ασθενείς  με άνοια και τους περιθάλποντές τους. Εγκέφαλος 2002; 39:157-173.

 

(130) 486. Μ. Τσολάκη. Προστατευτικοί παράγοντες της άνοιας, Grosso modo + lege artis Το περιοδικό των γιατρών της Ρόδου, Απρίλιος, 2002

 

(131) 486. Ε. Τσάνταλη, Μ. Τσολάκη, Γ. Κιοσέογλου και Γ. Πήττα. Προσαρμογή  του Ψυχομετρικού εργαλείου: Διαγνωστική εξέταση της Βοστώνης για την Αφασία

Τα ψυχομετρικά Εργαλεία στην Ελλάδα από τους Αναστάσιο Σταλίκα, Σοφία Τριλιβά, Πάτζια Ρούσση. Ελληνικά Γράμματα: 2002;159-161

 

(132) 487. Ε. Τσάνταλη, Γ. Πήττα, Μ. Τσολάκη  και Γ. Κιοσέογλου.

Προσαρμογή του Ψυχομετρικού εργαλείου: Ψυχογλωσσολογική Εκτίμηση της Γλωσσικής Διεργασίας στην Αφασία.  Τα ψυχομετρικά Εργαλεία στην Ελλάδα από τους Αναστάσιο Σταλίκα, Σοφία Τριλιβά, Πάτζια Ρούσση. Ελληνικά Γράμματα: 2002; 214-215

 

(133) 492. Κόκκας Β., Κίτσιος Γ., Τσολάκη Μ. Δομικές και μοριακές μεταβολές  στη Νόσο  Alzheimer: Στόχοι  φαρμακολογικών  παρεμβάσεων  σε μοριακό επίπεδο. Ψυχιατρική 2003; 14:28-45. Επιστημονική Επετηρίδα Τμήματος Ιατρικής 2003:209-224.

 

(134) 513. Κίτσιος Γ., Τσολάκη Σ., Τσολάκη Μ. Παθογένεια της Νόσου Alzheimer, Ψυχιατρική 2004; 15: 1-16 .

 

(135) 534. Τσάνταλη Ε., Λέκκα Σ., Τσολάκη Μ., Κάζη Ε., Κάζης Α. Παρουσίαση και προσαρμογή του  Boston Naming Test (BNT) στα ελληνικά δεδομένα  και η ικανότητα αξιοπιστίας και εγκυρότητάς του σε σχέση με το MMSE. Eγκέφαλος 2003; 40: 190-200

 

(136) 547. Τσολάκη Μ., Κουντή Φ., Πέτκαρη Ε., Κιοσέογλου Γ., Ξανθούλης Φ., Κάζη Ε., Διαμαντίδου Α., Κάζης Α. Οι διαταραχές της προσοχής στους φυσιολογικούς ηλικιωμένους, σε ηλικιωμένους  με ήπια νοητική διαταραχή  και σε ασθενείς με νόσο Alzheimer’s.  Ψυχολογία 2004:11;4:553-570

 

(137) 576. Τσολάκη Μ.  Νόσος Alzheimer, Παράγοντες κινδύνου. Άξων 2003;3:9-22

 

(138) 617. Κουντή Φ., Κίτσιος Γ., Τσολάκη Μ., Τσολάκη Σ., Κάζης Α. Προοδευτική οπτικο-κατασκευαστική δυσλειτουργία: Περίπτωση ανοϊκού συνδρόμου. Εγκέφαλος 2004; 41:96-106

 

(139) 774. Ελευθερίου Μ., Νικολαϊδου Ε, Τσολάκη Μ., Κουντή Φ., Κιοσέογλου Γ., Τσολάκη Σ., Κάζης Α. Προσαρμογή της κλίμακας D σε ελληνικό Πληθυσμό Ηλικιωμένων

4ο Πανελλήνιο Συνέδριο Νόσου Alzheimer και Συναφών Διαταραχών, Εγκέφαλος 2005;42: 35. Εγκέφαλος 42, 156-166, 2005

 

(140) 792. Τσολάκη Μ.,  Τρόντζος Χ., Κάζης Α. Η συμβολή της πυρηνικής Ιατρικής στη διάγνωση της άνοιας τύπου Alzheimer. H δυνατότητα απεικόνισης αμυλοειδικών πλακών. Hell J Nucl Med 2005; 8(3) 187-190

 

(141) 791. G. Gerasimou, M. Tsolaki, S. Bostanjopoulou, G. Liaros, E. Papanastasiou, V. Balaris, Z. Katsarou, F. Fotiou, E. Dedousi, S. Baloyannis, I,. Mylonas. Findings from molecular imaging with SPET camera and 123I-ioflupane in the differential diagnosis of Parkinsonism and essential tremor. Hell J Nucl Med 2005; 8(2)81-85

 

(142) 849. Μποζίκη Μαρίνα-Κλεοπάτρα, Τσολάκη Μάγδα, Αβδελίδου Ευγενία, Πατούση Αθανασία, Παπαλιάγκας Βασίλειος, Ζήση Φωτεινή, Πρόγια Ευαγγελία, Κάζης Αριστείδης. Επίπεδα ινσουλίνης ορού αίματος σε ασθενείς με Άνοια τύπου Alzheimer. Ο ρόλος της ινσουλίνης στην παθογένεση της νόσου. Νευρολογία 2005;14:189-198

 

(143) 875. Τσολάκη Μ., Μποζίκη Μ., Μολυβά Δ., Πιτσαλίδης Χ., Παπασωτηρόπουλος Α., Κάζης Α.  Ο πολυμορφισμός  (Τ/C) του γονιδίου CYP 46 δεν σχετίζεται  με την εμφάνιση της Νόσου Alzheimer στον Ελληνικό πληθυσμό.

20ο Πανελλήνιο Συνέδριο Ελλήνων Νευρολόγων, Λάρισα, Μάρτιος 2006:72-73

 

(144) 876. Τσολάκη Μ., Μποζίκη Μ., Μολυβά Δ., Πιτσαλίδης Χ., Παπασωτηρόπουλος Α., Κάζης Α. Κατανομή αλληλίων απολιποπρωτεϊνης Ε σε ασθενείς με νόσο Alzheimer  και σε φυσιολογικούς ηλικιωμένους  σε δείγμα ελληνικού πληθυσμού. Νευρολογία 2006; 15(2): 96-108.

 

(145) 910. Μ. Τσολάκη. Συμμετοχή στο 3ο Εκπαιδευτικό Σεμινάριο της Ε.Ν.Ε με θέμα:

Στοιχεία Επιδημιολογίας και Γενετικής των Ανοιών. Γιάννενα, 7/10/2006, Κυκλοφόρησε σε  CD

 

(146) 986. Τσάνταλη Ε., Τσολάκη Μ.  Η αποτελεσματικότητα της γνωστικής παρέμβασης στις μνημονικές διαταραχές στα πρώτα στάδια της άνοιας τύπου Alzheimer. Ψυχολογία 2007;14 (2), 152-166.

 

(147) 998. Τσολάκη Μ., Παπαλιάγκας Β., Κουντή Φ.  Άνοια μετά από στρες, ένα προτεινόμενο μοντέλο νευροεκφύλισης και προτάσεις για την πρόληψη. Νευρολογία 2007;16:3:154-173                                                                                                             

 

(148) 1038. Τσολάκη Μ., Μαϊόβης  Π.   Ήπια Νοητική Διαταραχή και εξέλιξη σε Νόσο Alzheimer: Η σημασία της πρώιμης διάγνωσης.  Νευρολογία 17:1; 5-19, 2008                                                                                                     

 

(149) 1081. Τσολάκη Μ. ΄Ηπια Νοητική Διαταραχή: Η σημασία της πρώιμης διάγνωσης για την εξέλιξη σε νόσο Alzheimer. Πρακτικά Μετεκπαιδευτικών Μαθημάτων Γηριατρικής και Γεροντολογίας, Θεσσαλονίκη, 2007; 289-303.

 

(150) 2985. Elisavet Neofytidou, Pavlos Ponos, Giorgos Evangelidis. Magda Tsolaki,  Eleni Kassapi. Interdisciplinary Research and Construction Diagnostic Instruments of Premorbid Intelligence. Διεπιστημονική έρευνα και κατασκευή διαγνωστικών εργαλείων προνοσηρής νοημοσύνης. The MIBES 2016 proceedings are now on-line at http://mibes.teithessaly.gr/pro2016.html , pages 71-86

 

Νεοφυτίδου, Ε., Πόνος, Π., Ευαγγελίδης, Γ., Τσολάκη, Μ. & Κασάπη, Ε. (2016). Διεπιστημονική έρευνα και κατασκευή διαγνωστικών εργαλείων προνοσηρής νοημοσύνης.  On-line Practical Research in Innovative Management & Entrepreneurship (Prime), 9 (2), 72-86.

 

(151) 1231. Τσολάκη Α., Σιαπέρα Μ., Τσολάκη Μ, Βλαϊκίδης Ν. Συννοσηρότητα, βιολογικοί δείκτες πλάσματος και ευρήματα σε Μαγνητική Τομογραφία ασθενών με Νόσο Alzheimer.

24o Βορειοελλαδικό Ιατρικό Συνέδριο, Θεσσαλονίκη, 26-28 Μαρτίου, 2009

Βραβείο, Υπό δημοσίευση στο περιοδικό Ελληνική Ιατρική

 

(152) 1342. Koυντή Φ., Μπακογλίδου Ε., Τσολάκη Μ.

Γνωστική Κινησιοθεραπεία σε ασθενείς με Ήπια Νοητική Διαταραχή. ΑθληΙατρική 2009:2;44-55

 

(153) 1279. Πρόσκληση για διάλεξη στο Αιγαιοπελαγίτικο Ιατρικό Συνέδριο με θέμα:  Νεότερα θεραπευτικά δεδομένα για την Άνοια, 26-29 Iουνίου, 2009. Πρακτικά συνεδρίου 2009; 389-400

 

(154). 1379. Γκαβοπούλου Ε., Μαϊόβης Π., Ελευθερίου Μ., Τσοκανάρη Ι., Τσολάκη Μ.,: Οδοντιατρική εκτίμηση ασθενών με άνοια μετρίου και σοβαρού βαθμού και συσχέτιση με τη νοητική και λειτουργική κατάστασή τους. Ελληνικά Στοματολογικά Χρονικά: 2009; 53: 169-175.

 

(155). 1385. Η επίδραση της Μουσικής των LV Beethoven  και WA Mozart σε έργα αντίστροφης μνημονικής ανάκλησης. Ψυχιατρική 2010; 21 (1): 60-67.

 

(156) 1396. Παττακού Β,, Αδρακτά Θ, Τσαπάκη Ε.M., Μαρκάκη Ι., Τσολάκη Μ.

 Το τελικό στάδιο νοσηλείας ασθενών με άνοια σε ψυχογηριατρική Κλινική στην Ελλάδα. Νευρολογία 2009;5:18: 245-253

 

(157) 1409. Πόπτση Ε.,  Κουντή Φ.,  Τσολάκη, Μ. Μη φαρμακευτική θεραπεία νοερής απεικόνισης-χαλάρωσης σε ασθενείς με Ήπια Νοητική Διαταραχή.  Εγκέφαλος 2010:47;1:23-36

(158) 1479. Τσολάκη Μαγδαληνή. Νευροηθική. Κεφάλαιο  στο Βιβλίο:  Προβληματισμοί στα θέματα Βιοηθικής,  2010;107-130.

(159) 1522. Μαλεγιαννάκη Αμαρυλλίς Χρυσή, και Τσολάκη Μαγδαληνή. Μορφές ανοιών με πρώιμη έναρξη: επιπολασμός, νοητικά χαρακτηριστικά και αντιμετώπιση. Νευρολογία 2010;19:223-236

 

(160) 1523. Τσολάκη Μάγδα, Κύργια Ελένη, Μούτλα Γεωργία, Τσιρούλη Σουλτάνα, Τσολάκη Ανθούλα, Παττακού Βασιλική. Επιπολασμός της άνοιας στο Δήμο Μ. Αλεξάνδρου του Ν.Πέλλας. Νευρολογία 2010;19:277-294.

 

(161). 1582.Στεργίου Β. Τσατάλη Μ., Τσολάκη Μ., Καρλοβασίτου Α. Παράγοντες συσχέτισης της άνοιας στη Νόσο του Πάρκινσον. Νευρολογία 2011;20: 47-5.

 

(162). 1652. Τσολάκη Μάγδα: Σύγχρονη κλινική Αντιμετώπιση της Νόσου Alzheimer.  Medic all about Health, Ίούνιος 2011;07: 6-14

 

(163). 1660. Iωάννης Ταρνανάς, Σταύρος Ζαφειρόπουλος, Μάγδα Τσολάκη, ΕΙΚΟΝΙΚΗ ΠΡΑΓΜΑΤΙΚΟΤΗΤΑ: ΜΙΑ ΥΠΟΣΧΟΜΕΝΗ ΚΑΙ ΕΝΔΙΑΦΕΡΟΥΣΑ ΠΑΡΕΜΒΑΣΗ ΓΙΑ ΤΟΥΣ ΗΛΙΚΙΩΜΕΝΟΥΣ ΜΕ ΑΝΟΙΑ. Νευρολογία 2011;

 

(164). 1682. Κάζη Ε., Τσολάκη Μ.,Βλαϊκίδης Ν., Διακογιάννης Ι., Αργυροπούλου Ου., Ιεροδιακόνου Ι., Καπρίνης Γ., Καρακώστας Δ. Οι συμπεριφορρικές και ψυχολογικές διαταραχές σε ασθενείς με Νόσο Alzheimer  και η ψυχολογική επιβάρυνση των περιθαλπόντων, Νευρολογία 2011;20 (4): 24-31

 

(165). 1739. Γιαννούλη Β. και Τσολάκη Μ. Δικαιοπραξία και Άνοια: Μια σύγχρονη πρόκληση. Νευρολογία 2011; 20 (6): 12-19

 

(166). 1740. Τατιάνα Δημητρίου και Μάγδα Τσολάκη. Οι κοινωνικές σχέσεις και η προσωπικότητα του ατόμου έχουν σχέση με την άνοια; Νευρολογία 2011;20 (6) 5-11

 

(167). 1730. Τατιάνα Δημητρίου, Μάγδα Τσολάκη. Μη φαρμακευτικές παρεμβάσεις των διαταραχών συμπεριφοράς στην άνοια. Νευρολογία 2012; 21(1): 29-38

 

(168). 1793. Τσολάκη Μ. Άγχος: Γονίδιο, τρόπος ζωής ή έλλειψη πνευματικότητας; Κεφάλαιο στο βιβλίο «Το αντίδοτο του Άγχους» Ιερά Αρχιεπισκοπή Κύπρου, 2011; 10-20

 

(169). 1796. Συμμετοχή σε Δορυφορικό συμπόσιο:  “Medicine in view of the latest economic downturn”, Η ιατρική υπό το φως της πρόσφατης οικονομικής ύφεσης» και Εισηγήτρια με θέμα: Greek experience from generic medication in clinical praxis-Η ελληνική εμπειρία των γενόσημων φαρμάκων στην κλινική πράξη. 25th International Conference of Alzheimer’s Disease International, Thessaloniki, 10-13 March, 2010: 56. Πρακτικά 11-15

 

(170). 1853. Τσολάκη Μ. Φαρμακευτική και μη φαρμακευτική αντιμετώπιση των ψυχολογικών και συμπεριφορικών διαταραχών στην άνοια. Νευρολογία 2012;21 (4):6-16.

(171). 1857. O. Γκατζίμα, Μ. Τσολάκη. Παθογένεια της Άνοιας. Η κληρονομικότητα των πιο συχνών ανοιών. Ιατρική 2012; 101 (2): 97-105.

(172). 1859. Μ. Σιαπέρα, Μ.Τσολάκη. Η συμβολή των βιολογικών δεικτών και των διαγνωστικών κριτηρίων στη διάγνωση της Νόσου Alzheimer. Ιατρική 2012; 101 (2): 112-127

(173). 1860. Μ. Τσολάκη, Ι. Μαυρουδής. Φαρμακευτική αντιμετώπιση της άνοιας. Ιατρική 2012; 101 (2):128-154.

(174). 1861.Ι. Κατσούρη, Μ. Τσολάκη. Εκτίμηση της ικανότητας οδήγησης σε ασθενείς με νόσο Alzheimer και άλλες μορφές άνοιας. Ιατρική 2012; 101 (3):218-230

(175). 1920.  Μάγδα Τσολάκη: Η Γλώσσα και η Μετάφραση ως διεπιστημονικό πεδίο έρευνας. ITI-Intercultural Translation Intersemiotic e-issn 2241-3863 Vol.1, no.1 (2012)  http://ejournals.lib.auth.gr/iti/issue/current.

 (176). 2039. Α. ΔΙΑΜΑΝΤΙΔΟΥ, Μ. ΤΣΟΛΑΚΗ, Θ. ΠΑΝΤΑΖΗ, Α. ΚΑΖΗΣ. Χαρακτηριστικά προσωπικότητας των ασθενών με νόσο Alzheimer πριν και μετά την εμφάνιση της νόσου. Εγκέφαλος  38; 2, ΑΠΡΙΛΙΟΣ-ΙΟΥΝΙΟΣ 2001

(177). 2104. Κατσούρη Ι. Τσολάκη Μ. Εργοθεραπευτική Εκτίμηση της Ικανότητος ασφαλούς οδήγησης Ηλικιωμένων με Νόσο Alzheimer. Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής 2013;31:158-164.

 

(178) 2290. Τσολάκη Μ.,  Ζαμπάκη Μ., Βαφειάδης Ε., Πετρίδης Α., Βλαϊκίδης Ν. Λιμβική Εγκεφαλίτις: Παρουσίαση περιπτώσεως. Νευρολογία 2009;18:150-154.

 

(179) 2485. Κασάπη, Ε., Νεοφυτίδου, Ε., Τσολάκη, Μ. & Κουντή, Μ. (2015) Ο παράγοντας "μεταφραστική επιλογή" και η σιωπή του Υποκειμένου απέναντι στη διαγνωστική εκτίμηση νοητικού λεξικού. Πρακτικά 4ης Συνάντησης Ελληνόφωνων Μεταφρασεολόγων, Τμήματος Γαλλικής Γλώσσας και Φιλολογίας, Επιμ. Κουρδής, Ε. & Λουπάκη, Ε., Θεσσαλονίκη.

 

(180) 2649. Ανθούλα Χ. Τσολάκη, Ολυμπία Γκατζήμα, Παναγιώτης Μπαμίδης, Βασίλειος Κιμισκίδης, Ζαφειρούλα Ιακωβίδου- Κρίτση, Μάγδα Τσολάκη. . Προδιαθεσικά γονίδια στη νόσο Alzheimer: Από το παλιό (APOE) έως το νέο (TREM2). Νευρολογία 2015, τόμος 24: 20-34

 

(181) 2674. Ζηλίδου, Β., Δούκα, Σ., & Τσολάκη, Μ. Τα αποτελέσματα ενός παρεμβατικού προγράμματος παραδοσιακών χορών, ως δραστηριότητα αναψυχής, στη βελτίωση της ποιότητας ζωής ηλικιωμένων σε ΚΑΠΗ του Δήμου Θεσσαλονίκης. Ελληνικό Περιοδικό Διοίκηση Αθλητισμού & Αναψυχής τόμος 12 (1), 13– 25 Δημοσιεύτηκε: Ιούλιος, 2015.

 

(182). 2745. Παπαγιουβάννη Ι., Αραμπατζής Α., Ανεστάκης Δ., Τσολάκη Μ. Ευρωπαϊκές βιοτράπεζες νευρολογικών νοσημάτων. Ιατρικά θέματα 2015;69:7-10.

 

(183) 2952. Σοφία Σέγκουλη, Ιωάννης Παλιόκας, Δημήτριος Τζοβάρας, Χαράλαμπος Καραγιαννίδης and Μάγδα Τσολάκη. Eκπαίδευση Ηλικιωμένων με Υποστήριξη Γλωσσικών Παρεμβάσεων για Νοητική Ενδυνάμωση. 10ο Πανελλήνιο και Διεθνές Συνέδριο «Οι ΤΠΕ στην Εκπαίδευση». Hcicte 2016. Σεπτέμβριος Ιωάννινα. Πρακτικά του Συνεδρίου

 

(184) 3001. Hippokratis Apostolidis, Thrasyvoulos Tsiatsos, Konstantina Karagkiozi, Magdalini Tsolaki (2016). Supporting distant PSYCHO-eDucational activities with a bio – feedback device. Proceedings of the 10th Pan-Hellenic and International Conference “ICT in Education”, Ioannina: HAICTE. 23-25 September 2016. ISSN 2529-0916, ISBN 978-960-88359-8-6: 115-142, 8ο Συνέδριο «Διδακτική της Πληροφορικής»

 

(185) 3311. Γάτος Κ. Τσολάκη Μ. Ο θάνατος του ασθενή στο τελικό στάδιο της άνοιας. Ομιλία στο συνέδριο με τίτλο: Πότε πρέπει να πεθαίνουμε. Ιωάννινα 28-30.4.2017. Πρακτικά Συνεδρίου.

 

(186) 3312. Τσολάκη Μ. Ο θάνατος στην Ελληνική Φιλοσοφία και στην Ορθόδοξη Πίστη. Ομιλία στο συνέδριο με τίτλο: Πότε πρέπει να πεθαίνουμε. Ιωάννινα 28-30.4.2017. Πρακτικά Συνεδρίου.

 

(187) 3409. Ελένη Αντωνιάδου, Στέλιος Ζυγούρης, Μαγδαληνή Τσολάκη Αύξηση της προσδόκιμης διάρκειας ζωής: Πηγή προβλημάτων ή βιολογικό προνόμιο; Επιστημονική Επετηρίδα, Παιδαγωγικού Τμήματος Νηπιαγωγών Πανεπιστημίου Ιωαννίνων. 2017; 108- 123.

 

(188) 4163. Κωνσταντινίδης Γ. Τέγος Θ. Ξέρρας Χρ. Παντελής Δ. Καϊάφα Γ. Μαργαρίτη Ε., Χατζόπουλος Γ., Καρλάφτη Ε., Σαββόπουλος Χρ. Χατζητόλιος Απ., Τσολάκη Μ. Διαφορική διάγνωση Παροδικών Ισχαιμικών αγγειακών εγκεφαλικών επεισοδίων . Ελληνική Ιατρική Επιθεώρηση 2019 122; 219-222

(189) 3959. Τσολάκη Χ. Α., Ρουντολφ Γιομπστ, Τσολάκη Μ., Κωνσταντινίδης Γ., Ξέρρας Χ., Τσιρώνης Γ., Κούκου Σ., Μιχάλης Ν., Τέγος Θ. Ενδοφλέβια θρομβόλυση στο οξύ ισχαιμικό αγγειακό εγκεφαλικό επεισόδιο: Από τις διεθνείς κατευθυντήριες οδηγίες στην κλινική πράξη. Νευρολογία 2019;28:6-23

(190) 4070. Erkotidou Sofia, Nasios Grigorios, Arnaoutoglou Marianthi, Dionisios Tafiadis , Magda Tsolaki: Comparative Study and Application of the EFA-4 Diagnostic Tool to Alzheimer’s Disease and Mild Cognitive Impairment. Aristotle Biomedical Journal, Vol 1, No 1 e-ISSN: 2653-9748

 

(191) 4071. Κωνσταντίνα Βασιλική Ιακώβου, Ελένη Αντωνιάδου, Μάγδα Τσολάκη.  Ιατρικός τουρισμός σε περιβάλλοντα φιλικά προς ασθενείς με άνοια. Επιστημονική Επετηρίδα, Παιδαγωγικού Τμήματος Νηπιαγωγών Πανεπιστημίου Ιωαννίνων. 2019; 12

https://ejournals.epublishing.ekt.gr/index.php/jret/article/view/17723

(192) 4163. Κωνσταντινίδης Γ. Τέγος Θ. Ξέρρας Χρ. Παντελής Δ. Καϊάφα Γ. Μαργαρίτη Ε., Χατζόπουλος Γ., Καρλάφτη Ε., Σαββόπουλος Χρ. Χατζητόλιος Απ., Τσολάκη Μ. Διαφορική διάγνωση Παροδικών Ισχαιμικών αγγειακών εγκεφαλικών επεισοδίων . Ελληνική Ιατρική Επιθεώρηση 2019 122; 219-222.

 

(193) 4462. Κασσεροπούλου, Μ.1, Κόνιαρη, Γ.1, Φρόση, Λ.1, Παπαντωνίου, Γ.2,,4,5, Τσολάκη, Μ.3,4,5, & Μωραΐτου, Δ. Πιλοτικό διαγενεακό πρόγραμμα αλληλεπίδρασης σε δημοτικό σχολείο: Έλεγχος της επίδρασής του στις γνωστικές ικανότητες μαθητών Α΄ Δημοτικού. Επετηρίδα αφιερωμένη στην κ. Ευκλείδη Αναστασία 2020

 

(194) 4595. Ιωάννα Προβατά, Μάγδα Τσολάκη, Θεόδωρος Κουκουλίδης, Ευφροσύνη Κουτσουράκη. H ατομική υποστηρικτική ψυχοθεραπεία σε ανθρώπους με πολλαπλή σκλήρυνση.  ΕΓΚΕΦΑΛΟΣ 57, 63-65, 2020

 

(195) 4600. Τσιβγούλης Γ., Παλαιοδήμου Λ., Βουμβουράκης Κ., Βαδικόλιας Κ., Γιαννόπουλος Σ., Δαρδιώτης Ε., Ελλούλ Ι., Ηλιόπουλος Ι., Καράκαλος Δ., Καραπαναγιωτίδης Θ., Κιμισκίδης Β., Κονιτσιώτης Σ., Κυρίτση Α., Τσολάκη Μ., Μήτσιας Π., Ταβερναράκης Α., Χατζηγεωργίου Γ., Χρόνη Ε., Τσιόδρας Σ., Γρηγοριάδης Ν.  Συστάσεις για τη διαχείριση ασθενών που νοσηλεύονται σε νευρολογικές Κλινικές Νοσοκομείων αναφοράς κατά τη διάρκεια της Πανδημίας COVID-19: Κείμενο ομοφωνίας της Ελληνικής Νευρολογικής Εταιρείας. Νευρολογία Μάρτιος Απρίλιος 2020; Τόμος 29;τεύχος 2: 6-23

 

(196) 4638. Στέλιος Ζυγούρης, Μάγδα Τσολάκη. Πέρα από την Ιδιωτικότητα: Κόστος, Προσβασιμότητα και ο Ρόλος των Νέων Τεχνολογιών. CND, Θεσσαλονίκη 2015:1-5

 

(197) 4702. Τέγος Θωμάς,  Ζηλακάκη Μαρία, Καϊάφα Γεωργια, Μύρου Αθηνά, Δάϊος Στυλιανός, Τσολάκη Μαγδαληνή, Σαββόπουλος Χρήστος. Αγγειακή άνοια: Παλαιές και νεότερες αντιλήψεις. Ελληνική Ιατρική Επιθεώρηση 129: 209-248

 

(198) 5055. Τσολάκη Μ. Σαουλίδης Ι. Δημητρίου Τ. Μη φαρμακευτικές παρεμβάσεις των συμπεριφορικών και ψυχολογικών διαταραχών ασθενών με άνοια : Νοητικές και αισθητηριακές παρεμβάσεις. Νευρολογία 30: 1, Ιανουάριος-Φεβρουάριος 2021; 6-20.

 

(199) 5022. Προβολή ερευνητικών αποτελεσμάτων Αριστοτελείου  Πανεπιστημίου  Θεσσαλονίκης Τεύχος #13  Μάιος 2021

(200) 5025. Δημοσίευση άρθρου σε μέσα μαζικής ενημέρωσης: forma. και bestofyou.gr του ομίλου Αντέννα.

(201) 6281. Bourakis I, Tegos T, Konsta A, Makri M, Tsolaki M. Taste and Olfactory Dysfunctions on Parkinson’s and Alzheimer’s Diseases: A Systematic Review. Med Discoveries. 2025; 4(8): 1272.

 

(202) 4208. ΄Αρθρο στο Health Daily με θέμα την Νόσο Alzheimer

Δημοσιεύσεις σε Διεθνή περιοδικά

ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΔΙΕΘΝΗ ΠΕΡΙΟΔΙΚΑ Η ΠΡΑΚΤΙΚΑ ΣΥΝΕΔΡΙΩΝ

(115 εκτός PubMed) 

 

 

(1) 118. M. Tsolaki, M. Karamouzis, K. Fountoulakis, V. Iakovidou, A. Kazis. Are serum Melatonin Levels a Marker for Differential Diagnosis of Dementia?German Journal of Psychiatry 2000;3:1-11

 

(2) 127. M. Tsolaki, Ch.Tronzos, Iakobidou B,  Chantzi E., Grammaticos P., Kazis A.Vitamin B12 in Dementia. PSIGE NEWSLETTER 1993;47:11-16.

 

(3) 137. Μaidatsi P, Gorgias N, Tsolaki M, Kapinas K. Continuous spinal anaesthesia with combination of local anesthetics: Combination of Hyperbaric lidocaine with two different concentrations of Bupivacaine for spinal anesthesia. Review of Clinical Pharmacology and Pharmacokinetics 1993:7:74-78.

 

(4) 140. Fountoulakis Κ, Tsolaki Μ, Chatzi  Ε, Kazis A. MINI MENTAL STATE EXAMINATION (MMSE). A validation study in greek patients with dementia. American Journal of Alzheimer’s Disease 2000;15:342-347

 

(5) 159. M. Tsolaki, K. Fountoulakis, E. Chanzi, A. Kazis. The Cambridge Cognitive Examination for the elderly (CAMCOG). A validation study in demented patients from the elderly Greek  population. American Journal of Alzheimer’s Disease 2000;15:269-278.

 

(6) 177. M. Tsolaki,  A. Kazis. Nimodipine versus dihydergocristine in the treatment of old age dementias. Blind randomized, cross-over, placebo-controlled study. VIIIth Congress of the European College of Neuropsychopharmacology Venice, Italy, 30 September- 4 October 1995.European Neuropsychopharmacology 1995;5:384. Review of Clinical Pharmacology and Pharmacokinetics International Edition 1996;10:16-24. International Clinical Practice Series

 

 (7) 180. Μ.Tsolaki, C.Fountoulakis, I.Pavlopoulos, E. Chantzi, A.Kazis. Prevalence of Alzheimer's Disease and other dementing disorders in Pilea, Greece. American Journal of Alzheimer΄s Disease 1999;14:138-148

http://aja.sagepub.com/content/14/3/138

 

(8) 195. Μ. Tsolaki,  Α. Reptsis, D. Zafiriou, Κ.Zisiades, Α.Kazis. Is cholinergic sensitivity of the pupil of demented AD patients different from other dementias? Alzheimer Research 1997;105-108

 

(9) 227. M. Tsolaki, P. Sakka, O. Chatzizisi, G. Kyriazis, J. Papanastasiou,  and A. Kazis. CSF tau Protein levels Before and After Tacrine therapy in patients with Dementia of Alzheimer’s Type. Alzheimer’s Disease and Related Disorders Edited by Khalid Iqbal, D. F. Swaab, B. Winblad, H.M. Wisniewski, 1999; 85: 741-745

 

(10) 254. C. Mouzakidis, M. Tsolaki, J Theodorakis, E. Efraimidou, C. Kampitsis. Dealing with cognitive and functional impairments through special structured exercise programs in pati ents with Alzheimer’s Disease. Alzheimer’s Disease and Related Disorders Edited by K. Iqbal, DF Swaab, B. Winblad and HM Wisniewski, John Wiley & Sons Ltd, 1999

 

 (11) 266. M. Tsolaki, Κ. Fountoulakis, E. Nakopoulou and A. Kazis. The effect of antidepressant pharmacotherapy with venlafaxaxine in geriatric depression. Int. J. Geriatric Psychopharmacology 2000; 2:81-85.

 

(12) 278. K. Kapinas, S. Tzartos, B. Kokkas, D. Divanoglou, M. Tsolaki, G. Anogiannakis and A. Kazis.  Absence of oligoclonal IgG bands and anti-AchR antibodies in the cerebrospinal fluid of patients with Μyasthenia Gravis. International Journal of Immunopathology and Pharmacology 1998; 11:87-90

 

(13) 293. M. Τsolaki, Α. Κourtis, S. Bostanzopoulou, Α. Κazis. Monotherapy with Lamotrigine. Αm J Alzheimer’s Disease 2000;15:74-79

 

(14) 310. Fountoulakis K., Tsolaki M., Kazis A.  Does Cognitive Disorder Affect Antidepressant Pharmacotherapy in Geriatric Depression? International Journal of Geriatric Psychopharmacology, 1999;2:28-32

 

(15) 311. Fountoulakis K. Tsolaki M., Kazis A. Target symptoms for Fluvoxamine in Geriatric Depression. International Journal of Psychiatry in Clinical Practice, 2000;4: 127-134

 

(16) 402. Efklides A., Yiultsi E., Kangellidou T., Kounti F., Dina F., Tsolaki M.  Wechsler Memory Scale, Rivermead Behavioral Memory Test and Everyday Memory Questionnaire in healthy adults and Alzheimer Patients. European Journal of Psychological Assessment 2002;18:63-77

 

(17) 404. Tsolaki M., Pantazi C., Stiliou F., Aminta M., Diudi P., Karasoulas S.,  Kazis A., Pollen D. Prevalence of Dementia in Greek Orthodox Monasteries: The role of diet poor in lipids. Second International Congress on Vascular Dementia, Salzburg, Austria, January, 2002. Brain Aging 2003; 3:13-17

 

(18) 407. Tsolaki M., Tarnanas J., Brilakis S., Fountoulakis K., Griva K., Kazis A. Visuo-Constructional ability: a Solitary Brain Process or part of a Complex System? Brain Aging 2001:1:43-47

 

(19) Tzimos A., Pittas I., Kazis A., Tsolaki M.,  Kapaki M., Sgouropoulos G., Karageorgiou K., Kontogianni V., Visviki A., Papapetropoulos T., Paschalis Ch., Metallinos I., Mylonas I., Mentenopoulos G., Bostanzopoulou S., Katsarou Z., Plaitakis A., Klados G., Baloyiannis S., Kosta V., Papadimitriou A., Aspiotis A., Giasakis G., Voulgari A., Dalakas M.  Efficacy and Safety of Rivastigmine in patients with mild to Moderate Probable Alzheimer’s Disease in a Community Setting. Brain Aging  2003, 3: 31-40

 

(20) 543. Tsolaki, M., Tsantali, E., Lekka, S., Kiosseoglou, G., & Kazis, A. Can the Boston Naming test be used as clinical tool for differential diagnosis in dementia? Short Greek Edition.  41st Academy of Aphasia Meeting, Vienna, October, 19-21, 2003. Austrian Academy of Sciences. Brain and Language 2003: 87, 185-186.

 

(21) 408. Kapinas K., Tsolaki M., Zaphiriou D., Grammaticos P., Dedussi E. Are CSF neopterin levels a marker of disease activity in multiple sclerosis? Nuclear Medicine Review 2001;4:107-111.

 

(22) 842. Kovatsi L.,  Touliou K., Tsolaki M., Kazis A. Cerebrospinal fluid levels of calcium, magnesium, copper and zinc in patients with Alzheimer’s Disease and Mild Cognitive Impairment. Trace Elements & Electrolytes. 2006 4th Quarter, Vol. 23 Issue 4, 247-250.

 

(23) 930. Ioannis Ilias, Marina Boziki, Christodoulos S. Fordellis, M. Tsolaki. Cognitive changes and basal Thyrotropin in treated and untreated patinets with Alzheimer’s Disease.  Pharmacology on Line, 2006; 1:135-139

 

(24) 991. Tsolaki M., Papaliagkas V., Kounti F., Tsantali E., Papapostolou P., Kotras N., Vlaikidis N., Kazis A. Memory and Dementia Clinic in Thessaloniki: Twenty years of experience. Middle East Journal of Age and Ageing 2007; 4;7-11.

 

(25) 1126. Badiavas K., Iakovou I., Molyvda E., Tsolaki M., Psarrakos K., Karatzas N. The two box quantiSPECT automated quantification method derived dopamine transporters (DAT) specific  binding indexes in comparison to the binding  ratios produced by a semiquantitative manual evaluation  procedure and visual assessment. European Journal of Nuclear Medicine and Molecular Imaging 2008;35LSuppl 2): S216-S402

 

(26) 1144. Vassilis Papaliagkas, Georgios Anogianakis, M. Tsolaki.  Role of Testosterone in patients with Alzheimer’s Disease. Journal of Neurodegeneration Regeneration 2008;1:1:35-42

 

(27) 1212. Tsantali E., Tsolaki M., Economidis D. Cognitive training program to trained and untrained cognitive functions of normal elderly and Alzheimer’s Patients

file:///C:/Users/Magda/AppData/Local/Temp/The%20effects%20of%20a%20cognitive%20training%20program%20on%20trained%20and%20untrained%20cognitive%20functions%20of%20non%20demented%20elderly%20and%20Alzheimer’s%20patients..html  

The International Journal of Psychosocial Rehabilitation 2009; 14 (1), 77-98

www.psychosocial.com/  IJPR_14

(28)  89. Tsolaki, M., Nanassis, K., Alexiadou, C., Kazis, A. Diagnosis of cortical heterotopia with MRI. Hellenic Medical Journal,1999;Vol 3; Nr 1:19-20

 

(29) 128. Tsapkini K, Tsolaki M., Fountoulakis  K., Kazis A. Assessment scales of the mental, functional, emotional and neurological state of patients with dementia. Psige Conference 1993, University of Kent, Canterbury.

 (30) 1981. Tsantali E, Economidis D, Tsolaki M. Could language deficits really differentiate Mild Cognitive Impairment (MCI) from mild Alzheimer's disease? Arch Gerontol Geriatr. 2013 Apr 26. IF=1,496

(31) 1309. Lovestone S.  Discovering biomarkers for Alzheimer’s Disease. MedNous 2008; 8-9

 

(32) 1402. Tsantali E, Economides D, Rigopoulou S, Tsolaki M. Language abilities for non demented and demented middle aged and elderly people. The Greek Norms of the Boston Diagnostic Aphasia Examination (BDAE). JOMP 2009 1(2): 41-54.

 

 (33) 1452. Tsolaki M., Martinez-Lage P. Caregiver Insights into optimal dementia management. MEDIMOND, INTERNATIONAL PROCEEDINGS pages 17-21

 

(34) 1451. K. Siampani, M. Tsolaki. POLARITIES AMONG CAREGIVERS OF PATIENTS WITH DEMENTIA: EXPLORATION AND MANAGEMENT IN GESTALT PSYCHOTHERAPY. 25th International Conference of Alzheimer’s Disease International, Thessaloniki, 10-13 March, 2010:135. MEDIMOND, INTERNATIONAL PROCEEDINGS pages 127-133

 

(35)  1441. M. Tsolaki, M. Gkini. ALZHEIMER’S DISEASE AND GLAUCOMA-A LITERATURE REVIEW. 25th International Conference of Alzheimer’s Disease International, Thessaloniki, 10-13 March, 2010:117. MEDIMOND, INTERNATIONAL PROCEEDINGS pages 67-70

 

(36) 3296. Frantzidis C., Semertzidou A., Ladas,A., Karagianni, M., Lithari, C., Kyrillidou, A., Grigoriadou, E., Klados, A., M., Vivas, A., Kounti, F., Tsolaki, M., Pappas, C., Bamidis P. Detecting neurophysiological alterations during Mild Cognitive Impairment and Dementia using wavelet-based energy computation and a Mahalanobis Distance classifier. Abstracts of SAN Meeting/ Neuroscience Letters 500S, 2011. e1–e54

 (37) (127) 1716. Bamidis PD, Konstantinidis EI, Billis A, Frantzidis C, Tsolaki M, Hlauschek W, Kyriacou E,  A Web services-based exergaming platform for senior citizens: The long lasting memories project approach to e-health care.  Conf Proc IEEE Eng Med Biol Soc. 2011 Aug;2011:2505-9.

(38) 1615. Tsatali M. Tsolaki M., Cristodoulou TP. The complex nature of inappropriate sexual behaviors in patients with dementia; Can we put it into a frame? Sex Disabil. 2011;29:143-156

 

(39). 1671. F. Kounti, E. Bakoglidou, PT; C. Agogiatou; N.B. Emerson Lombardo, L. L. Serper, EdD; M. Tsolaki, RHEA, a Nonpharmacological Cognitive Training Intervention in Patients With Mild Cognitive Impairment. Topics in Geriatric Rehabilitation  2011; 27,(4); 289–300

 

(40). 163. 2074. Kosmidou, V., Tsolaki, A., Papadaniil, C., Tsolaki. M., Hadjileontiadis, L.J., Kompatsiaris, I., (2014). Cognitive Brain signal Processing: Healthy vs Alzheimer’s disease patients, In HCI International 2014

 (41). 2089. C.N. Anagnostopoulos, I. Giannoukos, C. Spenger, A. Simmons, P. Mecocci, H. Soininen, I. Kłoszewska, B. Vellas, S. Lovestone, M. Tsolaki, "Classification models for Alzheimer’s Disease Detection", Communications in Computer and Information Science,  2013; 384: 193-202.

 

(42). 2093. Anestakis D., Petanidis S., Salifoglou A., Tsolaki M. Clinicopathological Guidelines for the Management of Brain and Tissue Banking in Greece. Research in Neurology: An International Journal. (RNIJ)» vol.2014 (2014), p.1-13, December 2013. [doi: 10.5171/2014.121634].

 (43) 1959. Aharon Satt, Alexander Sorin, Orith Toledo-Ronen, Oren Barkan, Ioannis Kompatsiaris, Athina Kokonozi, Magda Tsolaki.  Evaluation of Speech-Based Protocol for Detection of Early-Stage Dementia. 14th Annual Conference of the International Speech Communication Association. Special Focus: Speech in Life Sciences and Human Societies.(http://www.interspeech2013.org/).

 (44). 2222. Ippokratis Apostolidis, Anastasios Karakostas, Tatiana Dimitriou, Thrasyvoulos Tsiatsos and Magda Tsolaki Andvanced Bio-feedback and Collaborative Techniques to Support Caregivers of Alzheimer Patients. http://ieeexplore.ieee.org/xpl/login.jsp?tp=&arnumber=7057170&url=http%3A%2F%2Fieeexplore.ieee.org%2Fxpls%2Fabs_all.jsp%3Farnumber%3D7057170 International Conference on Intelligent Networking and Collaborative Systems (INCoS) 2014 ΙF= 6.911

 

 (45) 2296. Nikolaidou, Ε., Kounti, F., Tsolaki, Μ. Emotional Reactions towards Dementia: The Right to Life. International Journal of Academic Research in Psychology, July, 2014, Vol. 1, No. 2: 58-76.

 

(46) 2297. Konstantina Karagiozi, Vasileios Papaliagkas, Georgios Giaglis, Evridiki Papastavrou, Vassiliki Pattakou, Magdalini Tsolaki . Combined Intervention for Caregivers of Patients with Dementia: A Randomized Controlled Trial. International Journal of Academic Research in Psychology, July, 2014, Vol. 1, No. 2: 77-95.

 

(47). 2440. Leda Kovatsi, Magda Tsolaki, Olymbia Gkatzima, Maria Petrocheilou & Victoria Samanidou (2015) Simple UHPLC-DAD Method for the Direct Determination of Donepezil in Cerebrospinal Fluid, Journal of Liquid Chromatography & Related Technologies, 38:10, 1068-1072, DOI: 10.1080/10826076.2015.1020165

(48). 2491. Ioanna Katsouri, Loukas Athanasiadis, Evangelos Bekiaris, Katerina Touliou, Magda Tsolaki. Mild Cognitive Impairment and Driving Habits. International Journal of Prevention and Treatment 2015;  4(2A): 1-10 doi:10.5923/s.ijpt.201501.01

http://www.sapub.org/Journal/articles.aspx?journalid=1067

http://article.sapub.org/10.5923.s.ijpt.201501.01.html

(49). 2527. Anastasios Karakostas, Ioulietta Lazarou, Georgios Meditskos, Thanos G. Stavropoulos, Ioannis Kompatsiaris, Magda Tsolaki. Supporting Cognitive Skills of People Suffering from Dementia through a Sensorbased System. 2015 IEEE 15th International Conference on Advanced Learning Technologies 460-461.

http://ieeexplore.ieee.org/xpl/login.jsp?tp=&arnumber=7265381&url=http%3A%2F%2Fieeexplore.ieee.org%2Fxpls%2Fabs_all.jsp%3Farnumber%3D7265381

(50) 2587. C. Papadaniil, L. Hadjileontiadis, Kosmidou V, Tsolaki CA, Tsolaki M., and Kompatsiaris I. Age Effect in Human Brain Responses to Emotion Arousing Images: The EEG 3D-Vector Field Tomography Modeling Approach. IEEE Transactions on Autonomous Mental Development, Volume: 7, Issue: 3  10.1109/TAMD.2015.2416977

 

(51) . I. Apostolidis, A. Karakostas, T. Dimitriou, Th. Tsiatsos and M. Tsolaki. «Advanced Bio-feedback and Collaborative Techniques to Support Caregivers of Alzheimer Patients», 6th International Conference on Intelligent Networking and Collaborative Systems (INCoS-2014) Salerno, Italy, September 10 - 12, 2014.

 

http://ieeexplore.ieee.org/xpl/login.jsp?tp=&arnumber=7057170&url=http%3A%2F%2Fieeexplore.ieee.org%2Fxpls%2Fabs_all.jsp%3Farnumber%3D7057170

 

(52) 2177. Chaldogeridis Α.,  Tsiatsos T., Gialaouzidis M., Tsolaki M. Comparing data from a computer based intervention program for patients with Alzheimer’s disease. 29th Alzheimer Disease Conference, San Juan, Puerto Rico, 1-4 May, 2014. HCII 2014. Comparing data from a computer based intervention program for patients with Alzheimer’s disease. adfa, p. 1, 2011. © Springer-Verlag Berlin Heidelberg 2011 (http://www.hci.international/). Comparing data from a computer based intervention program for patients with Alzheimer's disease. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), vol. 8526 LNCS, issue PART 2 (2014).

(53). 2618.Tsolaki M., Zygouris S., Tsoutsikas V., Anestakis D., Koliakos G. Treatment with adipose stem cells in a patient with moderate Alzheimer’s disease: case report.  Journal of Neurorestoratology.   Journal of Neurorestoratology 2015:3 115–120.

 

(54) 2737. K. Votis, S. Segkouli, A. Drosou, D. Tzovaras, M. Tsolaki, "An Ambient Intelligence System for the Monitoring, Empowerment and Disease Evolution Prediction for Patients with Μild cognitive impairments", IGI Global Topic Selections, 2014.

 

(55) 2738. S. Segkouli, I. Paliokas, T. Tsakiris, M. Tsolaki, K. Votis, D. Tzovaras, "Enabling accessibility features in enhanced VR environments for supporting spatial abilities and social interaction in elderly and MCI patients", IGI Global Topic Selections, 2014.

 

(56) 2743. Evangelia Tigka, Magda Tsolaki. Pathogenetic mechanisms of dyslexia: a review | Tigka | Aristotle University Medical Journal. Pathogenetic mechanisms of dyslexia: a review. Aristotle University Medical Journal, Vol. 43, Issue 1, February 2016; 10-17.

 

 (57) 2888. Dimzas Dimitris, Papaioannou Nikos, Tsolaki Magda. CANINE COGNITIVE DISFUNCTION SYNDROME. Review paper. Veterinary Journal of Republic of Srpska (Бања Лука-Banja Luka), Вол/Vol.XIV, бр./No.2, 190‒296, 2015

 

(58) 2894. Arampatzis A, PapagiouvanniI, Anestakis D,Tsolaki M. A Classification and Comparative Study of European Biobanks: an Analysis of Biobanking Activity and its Contribution to Scientific Progress. Arch Med. 2016, 8:3

 

(59) 2985. Elisavet Neofytidou, Pavlos Ponos, Giorgos Evangelidis. Magda Tsolaki,  Eleni Kassapi. Interdisciplinary Research and Construction Diagnostic Instruments of Premorbid Intelligence. The MIBES 2016 proceedings are now on-line at http://mibes.teithessaly.gr/pro2016.html

 

(60) 3389. Evdokia Nikolaidou, Magda Tsolaki, Dimitris Niaka, Konstantia  Ladopoulou

Attitudes and  Understandings of the Grandchildren of People with Dementia. International Journal of Academic Research in Business and Social Sciences 2017, Vol. 7, No. 6, 924-933.

 http://hrmars.com/hrmars_papers/Attitudes_and_Understandings_of_the_Grandchildren_of_People_with_Dementia.pdf

 

(61) 3002. Aggelos C. Iliopoulos, Magdalini Tsolaki and Elias C. Aifantis. Tsallis statistics and neurodegenerative disorders. J Mech Behav Mater 2016; 25(3-4): 129–139

(62) 3268. Katsouri I.,  Tsolaki M. Occupational therapy assessment of safe driving ability for elderly with Αlzheimer’s  disease. Epitheorese Klinikes Farmakologias kai Farmakokinetikes, 2013, vol. 31, issue 3.

(63) 3273. Erkotidou Sofia, Grigorios Nasios, Tafiadis Dionisios, Magda Tsolaki. Application of the diagnostic tool EFA-4 in Dementia. Hellenic Journal of Nuclear Medicine January-April 2015, 1-10.

 

(64) 3307. Glykeria Tsentidou, Despina Moraitou, Christina Petridou, Dimitra Petridou, Panagiotis Beredimas, Fotini Kounti, Moisis Gialaouzidis, Magdalini Tsolaki1, Georgia Papantoniou4 and Elvira Masoura. Sarcasm Understanding in Patients Diagnosed with Mild Cognitive Impairment and Community Dwelling Older Adults with Risk Factors for Vascular Disease Development: A Brief Report. BAOJ Psychology 2017 2: 12: 022

 

(65) 2162. Magda Tsolaki, Tania Kakoudaki, Anthoula Tsolaki, Eleni Verykouki, Vassiliki Pattakou. Prevalence of Mild Cognitive Impairment in Individuals Aged over 65 in a Rural Area in North Greece. Advances in Alzheimer’s Disease, 2014, 3, 11-19. Published Online March 2014 in SciRes. http://www.scirp.org/journal/aad

http://dx.doi.org/10.4236/aad.2014.31002.How to cite this paper: Tsolaki, M., et al. (2014) Prevalence of Mild Cognitive Impairment in Individuals Aged over 65 in a Rural Area in North Greece. Advances in Alzheimer’s Disease, 3, 11-19. http://dx.doi.org/10.4236/aad.2014.31002

(66) 3455. Fereshteh Sedaghat, Styliani Spyridi, Jannis Nimatoudis, Amin Rakhshani, Sygkliti-Herietta Pelidou, Alexandra Papazisi, Eleni  Dedousi, Magdalini Tsolaki and Stavros J Baloyannis.  Dopamine transporter density of striatum showed to be increased in Schizophrenia first-episode drug-naïve patients. Brain Nerves, Volume 1(3): 1-5,  2017 doi: 10.15761/JBN.1000116

(67) 3420. Magda Tsolaki, Eleni Poptsi, Christina Aggogiatou, Nefeli Markou, Stavros Zafeiropoulos, and Fotini Kounti. Computer-Based Cognitive Training Versus Paper and Pencil Training: Which is more Effective? A Randomized Controlled Trial in People with Mild Cognitive Impairment.  JSM Alzheimer’s Disease and Related Dementia. 4(1): 1032 (2017)

 

(68) 3421. Irene Maria Tabakis, Minas Dasygenis and Magda Tsolaki: A monitoring system for people living with Alzheimer’s disease. PACET 2017. 4th Panhellenic Conference on Electronics and Telecommunications, PACET 2017, 2018-January, pp. 1-4                                                                                                                           

     

 

(69) 3516. Tsolaki M, Pathak KP, Verikouki E, Messini CZ, Gaire T and Devranis P. Depression in Alzheimer’s disease: Citalopram and Rivastigmine can better? SM J Neurol Neurosci. 2017; 1(1): 1007.

 

(70) 3736. Nigdelis, V., Tsolaki, M. Neuropricing: Perspectives of brain reactions to price exposure. Hellenic Journal of Nuclear Medicine. 2017 ; 20, pp. 196-203.

 

(71) 3737. Kanaki, M., Tsolaki, M. Testamentary capacity of patients with dementia and of the role of law courts in such cases. 2017; Hellenic Journal of Nuclear Medicine 20, pp. 204-208

 

(72) 3738. Batzikosta, A., Moraitou, D., Tsolaki, M., Steiropoulos, P. Brief review and research proposal about mind, dimensia, sleep and MCI. Hellenic Journal of Nuclear Medicine 2017; 20, pp. 30-39.

 

(73) 3739. Katsouri, I., Athanasiadis, L., Bekiaris, E., Tsolaki, M.Driving practices in professional drivers with dementia. Hellenic Journal of Nuclear Medicine. 2017; 20, pp. 73-89

 

(74) 3740. Bampa, G., Moraitou, D., Metallidou, P., Tsolaki, M. Metacognition in MCI: A research proposal on assessing the efficacy of a metacognitive intervention. Hellenic Journal of Nuclear Medicine. 2017; 20, pp. 12-20

 

(75)  3741. Tsikoudi, M., Fykari, E., Tsolaki, M. Primary care services provided to persons with dementia under the "Help at Home" scheme of the Municipality of Chios. Hellenic Journal of Nuclear Medicine. 2017; 20, pp. 209-217.

 

(76). 3742. Solias, A.A., Degleris, N.E., Beratis, I., Tigka, E.G., Tsolaki, M.N. Gender differences in senile depression. Ilion Municipality Hellenic Study (I.M.H.S.). Hellenic Journal of Nuclear Medicine. 2017; 20, pp. 180-195

 

(77)  3734. Poptsi, E., Kounti, F., Samakouri, M., Vorvolakos, T., Tsolaki, M. Longitudinal cognitive training program in people with mild Alzheimer's disease: A Randomized Controlled Trial. Hellenic Journal of Nuclear Medicine. 2017; 20, pp. 233-243

 

(78) 3731. Segkouli, S., Paliokas, I., Tzovaras, D., Karagiannidis, C., Tsolaki, M. Media enhanced educational and training interventions for people at risk of Alzheimer's disease . Hellenic Journal of Nuclear Medicine . 2017; 20, pp. 104-111

 

(79) 3730. Solias, A.A., Degleris, N.E., Kompatsiaris, I., (...), Hadjileontiadis, L.J., Tsolaki, M.N.A folk legend for the detection of dementia: An active part of online medical data entry channel. Hellenic Journal of Nuclear Medicine . 2017; 20, pp. 169-179.

 

(80) 3884. Minopoulou Despoina, Tsatali Marianna, Gialaouzidis Moses, Tsolaki Magda. Differences in religiosity among cognitively intact, mildly cognitively impaired, and mildly demented elderly, and its possible relationship with depressive mood. Applied Nursing Research 2018;43: 69-74    https://doi.org/10.1016/j.apnr.2018.07.006

 

(81) 3901. Giannouli V, & Tsolaki M. A neglected drama for elders: Discrepancy between self-perception and objective performance regarding financial capacity in patients with cognitive deficits. Psychological Thought. 2015; 8(2): 142-147.

 

(82) 3902.  Dimitriou TD., Verykouki E;, Papatriantafyllou J., Konsta A., Kazis D., Tsolaki M. Non pharmacological interventions for sleeping disorders in patients with dementia. Paripex Indian Journal of Research. 2018; 7:12: 500-503

 

(83) 3903.  Giannouli V, & Tsolaki M. Questions about dementia with Lewy bodies, personal beliefs and real performance for financial capacity tasks. European Psychiatry. 2016;  33: S469-S470.

 

(84) 3951. Tsolaki Anthoula, Siapera Marianna, Mauredaki Penelope, Kantoglou Eleni, Patrizia Mecocci, Bruno Vellas, Hilkka Soininen, Iwona Kloszewska, Anna Kisney, Andy Simmons, Simon Lovestone, Tsolaki Magda, On behalf of the Addneuromed consortium. Co morbidity and Neuroimaging in Alzheimer’s Disease. Gerontology and Geriatrics studies 2018;3:4; 1-9

(85) 3602. Magda Tsolaki. “Monoclonal Antibodies or Natural Products will be the Ideal Medicines for Different Stages of Alzheimer’s Disease”. EC Nutrition 13.4 (2018): 214-217.

 

(86) 3973. KONSTANTINA VASILIKI IAKOVOU, KYRIAKI TSOUKALA, MAGDA TSOLAKI. ARCHITECTURE AS A MEANS FOR SOCIAL INCLUSION FOR PEOPLE WITH DEMENTIA. VI. INTERNATIONAL ARCHITECTURAL DESIGN CONFERENCE. ARCHDESIGN '19. Πρακτικά συνεδρίου. Αθήνα 22 Μαρτίου 2019; 121-134

 

(87) 4070. Erkotidou Sofia, Nasios Grigorios, Arnaoutoglou Marianthi, Dionisios Tafiadis , Magda Tsolaki: Comparative Study and Application of the EFA-4 Diagnostic Tool to Alzheimer’s Disease and Mild Cognitive Impairment. Aristotle Biomedical Journal, Vol 1, No 1 e-ISSN: 2653-9748, MARCH

 

(88) 4400. Mouzakidis, C., Garopoulou, V., Poptsi, E., Antonopoulos, A., Markou,

N., Tambaki, E., Meke, M., Moraitou, D., Tsolaki, M. Scientific planning of physical exercise protocols to prevent Dementia in elderly. The “Fitness Alzheimer Mobility Exercise” (FAME) project. A roadmap. Journal of Physical Activity, Nutrition and Rehabilitation, 2019; 573-579.

(89) 4408. Solias, A., Chaldogeridis, A., Batzikosta, A., & Tsolaki, M. (2020). Tablet-Administered Screening Tests for the Detection of Major and Mild Cognitive Disorders-Preliminary Findings of a Comparative Study. International Journal of Interactive Mobile Technologies, 14(11).https://doi.org/10.3991/ijim.v14i11.14629

(90) 4410. Poptsi, E., Kounti, F., Agogiatou, C., Bakoglidou, E., Soumpourou, A., Zafeiropoulos, S., Batsila, G., Liapi, D., Nikolaidou, E., Vasiloglou, M., Ouzouni, F., Markou, N., Zafeiropoulou, M., Mouzakidis C., Tsolaki, M. (2017). Use it more and keep it alive: a Longitudinal Randomized Controlled Trial in people with Mild Cognitive Impairment. Hellenic Journal of Nuclear Medicine; (20): 218-233.

(91). 4544.  Thanos G. Stavropoulos, Ioulietta Lazarou, Dimitris Strantsalis, Spiros Nikolopoulosand Ioannis Kompatsiaris,  George Koumanakos, Maria FroudaFrontida Zois Magda Tsolaki. Human Factors and Requirements of People with Mild Cognitive Impairment, their Caregivers and Healthcare Professionals for eHealth Systems with Wearable Trackers. ICHMS 2020 1st IEEE International Conference on Human-Machine Systems 7-9.9.2020

 

(92) 4571. Anastasia Ntracha, Dimitrios Iakovakis, Stelios Hadjidimitriou, Vasileios S. Charisis, Magda Tsolaki  and Leontios J. Hadjileontiadis. Detection of Mild Cognitive Impairment Through Natural Language and Touchscreen Typing Processing. Frontiers in Digital Health published: 08 October 2020 doi: 10.3389/fdgth.2020.567158

(93) 4591. Tsolaki Magda., et al. “Amyotrophic Lateral Sclerosis and Idiopathic Normal Pressure Hydrocephalus: A Random Combination or a Genetic Explanation?”. EC Neurology 12.12 (2020).

(94) 4602. Study Shows Extra Virgin Olive Oil Helps Deter Alzheimer’s

http://www.greekliquidgold.com/index.php/en/health-benefits/olive-oil-health-benefits/419-study-shows-extra-virgin-olive-oil-helps-deter-alzheimer-s

 

(95) 4603. Magda Tsolaki, Antonios Frontistis, Paschalis Devranis, Maria Zilakaki, Iordanis Saoulidis, Vasileios Siokas, Ioannis Papagiannis, Eleni Liouta, Evagelos Papatolis, Evripidis Pityrigkas, Vasiliki Poulidou, Evangelia Chartampila, Sofia Pettemeridou, Hadar Halivni, Cindy Cheng, Thomas Tegos. Brain Disorders at Admission, During and After SARS-CoV-2 Infection. Acta Scientific Neurology (ISSN: 2582-1121) Volume 3 Issue 11 November 2020.

(96) 3655. Iordanis Demirtzoglou, MD; Magda Tsolaki, M.D, PhD; Kyriakos Gougoulias, M.D; Panagiotis Oikonomidis, M.D, PhD; Vasileios Karampatakis, M.D, PhD. Inner retina layers as biomarkers of disease in patients with mild cognitive impairment. Journal of Clinical and Experimental Ophthalmology, IF= 0.65

 

(97) 4696. Dimitriou Tatiana-Danai1*, Papatriantafyllou John2, Konsta Anastasia3, Kazis Dimitrios4, Athanasiadis Loukas3, Ioannidis Panagiotis5, Koutsouraki Efrosini5, Tegos Thomas5 and Tsolaki Magda6. Non-pharmacological Interventions for the Apathy in Patients with Dementia. A Cross-over Randomized Controlled Trial. Acta Scientific Neurology (ISSN: 2582-1121) Volume 4 Issue 2 February 2021

 

(98) 4723. Kartheka Bojan, Thanos G. Stavropoulos, Ioulietta Lazarou, Spiros Nikolopoulos,, Ioannis Kompatsiaris, Magda Tsolaki, Elizabeta Mukaetova-Ladinska, Aikaterini Christogianni. The Effects of playing the COSMA Cognitive Games in Dementia. International Journal of Serious Games. Volume 8, Issue 1, March 2021

 

(99) 4724. Makri M, Tsolaki M & Zygouris S. Development of the Training Platform “AD-GAMING” for the Improvement of Quality of Life of People with Dementia through “Serious Games”. Journal of Family Medicine. 2020 April, Volume 7 Issue 4: 1207. 

 

(100) 5001. Garopoulou, V. , Meke, M. , Latsiou, E., Papakonstantinou, G., Mouzakidis, C., Notas, K.,  Orologas, A., Tsolaki M. The efficacy of different Aerobic, Pilates and combined therapeutic exercise protocols to functional capacity, fatigue and quality of life in adults with Multiple Sclerosis: controlled experimental intervention. Journal of Physical Activity, Nutrition and Rehabilitation, 2019 :554-572. 

 

(101) 5029. Tzekaki E 1, 4, Prodromou S 3, 4, Tsolaki M 2, 3, 4, * and Pantazaki Α A. The multifunctional therapeutic potentiality of extra virgin olive oil administration through the intervention in pathophysiological mechanisms: Focus on Alzheimer's disease. GSC Advanced Research and Reviews, 2021, 07(01), 101–113 

 

(102) 5076. Marina Makri, Konstandina Vasiliki Iakovou, Minas Dasygenis, Nikolaos Baras, Asimina Brouzou, Ioannis Brouzos, Evanggelia Angelidou, Ioana Caciula, Sara Beccati, Alexandra Manattini, Magda Tsolaki. The “Bridge” Project: Α European Innovative Intergenerational Approach Using Serious Games for People with Dementia Psychology Vol.12 No.9,  September 29, 2021 DOI: 10.4236/psych.2021.129091 

 

(103) 5112. Kaltsa, M., Papadopoulou, D., Gialaouzidis, M. & M. Tsolaki (2021). The processing of lexical ambiguity: the effect of Mild Cognitive Impairment and Alzheimer’s disease in the monolingual lexicon. In: Markopoulous, Th., Vlachos, Chr., Archakis, A., Papazachariou, D., Xydopoulos, G. I. & Α. Roussou (Ed.) Proceedings of 14th International Conference of Greek Linguistics (ICGL 14) (pp. 467-476). Patra: Patra University Press. (https://doi.org/10.26220/icgl.v1i1.3685, https://pasithee.library.upatras.gr/icgl/issue/view/387  & https://icgl14.events.upatras.gr/)

 

(104) 5135. Tabakis, I., Dasygenis, M., & Tsolaki, M. (2017). A monitoring system for people living with Alzheimer's disease. Panhellenic Conference On Electronics And Telecommunications (PACET).

 

(105) 5132. Chouvarda I., Tsolaki M.   ''Exploring Classification in Open and Closed Eyes EEG Data for People with Cognitive Disorders'', BIOSIGNALS 2022, 11. 2. 2022 PP-43

(107) 5146. Gkenios G., Latsiou K., Diamantaras K., Chouvarda I., Tsolaki M., Diagnosis od Alzheimer’s Disease and Mild Cognitive Impariment using EEG and Recurrent Neural Networks. EMBC 2022.

(108) 5156. Marina Makri, Magda Tsolaki. Innovative Serious Games for People with Dementia developed through intergenerational interventions. Petra, 2022

 

(109) 4755. Eleni G. Andreadou, Georgios Katsipis, Magda Tsolaki, and Anastasia A. Pantazaki. Bacterial rhamnolipids (RLs) in saliva of Alzheimer's disease and Mild Cognitive Impairment patients and correlation with neuroinflammation and cognitive state. GSC Advanced Research and Reviews, 2021, 06(03), 209–219

 

(110) 4675.  Papadopoulou L.,  Alexandri  F.,  Tsolaki A. , Tsolaki M. Neuropsychiatric Symptoms in Dementia. The added value of cannabinoids. Are they a safe and effective choice?  An observational study with Cannabidiol 3%. Annals of Case Reports 2022; 21 March, 7:799 

 

(111) 6073. Tsolaki M, Katsoulas I, Dardiotis E, Siokas V, Christodoulou S and Arnaoutoglou E. Cauda Equina Syndrome due to Arachnoiditis after Cesarean Section Under Combined Spinal-Epidural Anesthesia. Clin Case Rep Int. 2024;8(1):1672.  DOI:10.25107/2638-4558.1672

(112) 6135. Tsolaki M. Introduction to a New Open Access Journal by MDPI: Journal of Dementia and Alzheimer’s Disease. J. Dement. Alzheimer’s Dis. 2024, 1, 1–2. https://doi.org/10.3390/jdad1010001

(113) 6252. Theodosis Georgiadis,  Ioanna Giannoula Katsouri, Charalampos Tsormpatzoudis,  Magdalini Tsolaki.  Home-Based Occupational Therapy Intervention for the Improvement of Quality of Life in Individuals With Moderate to Severe Dementia and Their Caregivers. Dement Neurocogn Disord. 2025 Oct;24(4):233-245

https://doi.org/10.12779/dnd.2025.24.4.233 

 

(114) 2719. Myserlis P, Stachteas P, Dimitriadis I and Tsolaki M. Development of Glioblastoma Multiforme in a Patient with Relapsing-Remitting Multiple Sclerosis. Austin J Clin Neurol 2017; 4(7): 1128.

 

(115) 6281. Bourakis I, Tegos T, Konsta A, Makri M, Tsolaki M. Taste and Olfactory Dysfunctions on Parkinson’s and Alzheimer’s

Diseases: A Systematic Review. Med Discoveries. 2025; 4(8): 1272.

(113) 6252. Theodosis Georgiadis,  Ioanna Giannoula Katsouri, Charalampos Tsormpatzoudis,  Magdalini Tsolaki.  Home-Based Occupational Therapy Intervention for the Improvement of Quality of Life in Individuals With Moderate to Severe Dementia and Their Caregivers. Dement Neurocogn Disord. 2025 Oct;24(4):233-245

https://doi.org/10.12779/dnd.2025.24.4.233 

 

(114) 2719. Myserlis P, Stachteas P, Dimitriadis I and Tsolaki M. Development of Glioblastoma Multiforme in a Patient with Relapsing-Remitting Multiple Sclerosis. Austin J Clin Neurol 2017; 4(7): 1128.

 

(115) 6281. Bourakis I, Tegos T, Konsta A, Makri M, Tsolaki M. Taste and Olfactory Dysfunctions on Parkinson’s and Alzheimer’s

Diseases: A Systematic Review. Med Discoveries. 2025; 4(8): 1272.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Δημοσιεύσεις σε PubMed

 

ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΤΟ PUBMED 576.

Άθροισμα Impact Factor=31256,8828,

CITATIONS 65360

h-INDEX =115

 i10 index= 447 (5/1/2026)

594. 6308. Giannouli V, Leliopoulou EC, Chouvarda I, Tsolaki M. EEGs, Neuropsychological Performance and Financial Capacity in aMCI Patients: a Preliminary Longitudinal Study. Adv Exp Med Biol. 2026;1490:7-13. doi: 10.1007/978-3-032-03402-1_2. IF=8

 

593. 6309        Rabl M, Hartog WL, van der Flier WM, Pijnenburg YAL, Teunissen CE, Tsolaki M, Freund-Levi Y, Vandenberghe R, Froelich L, Streffer J, Lovestone S, Bertram L, Zetterberg H, Gobom J, Vos SJB, Visser PJ, Tijms BM, Popp J.  Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's disease. Alzheimers Dement. 2025 Dec;21(12):e71054. doi: 10.1002/alz.71054. IF=13,1

 

592. 6255. Tsatali M, Dimou AL, Ntova T, Angelidou A, Dolza E, Hoffmann-Lamplmair D, Burgstaller ML, Chatziavannidou K, Karar E, Goulas T, Maggiora ND, Seifert R, Ströbele T, Woll B, Atkinson J, Tsolaki M, Teichmann B.  Dementia Care Research and Psychosocial Factors. Alzheimers Dement. 2025 Dec;21 Suppl 4:e106336. doi: 10.1002/alz70858_106336.

 

591. 6307. Delaby C, Ladang A, Yriarte J, Zecca C, Logroscino G, Koertvelyessy P, Tumani H, Parchi P, Quadrio I, Hart M, Olsen DA, Alcolea D, Blennow K, Fortea J, Lleó A, Algeciras-Schimnich A, Ayrignac X, Bedel A, Santos GAA, Borelli WV, Amar EB, Baldeiras I, Bigot-Corbel E, Bjerke M, Perez MC, Casoli T, Chabrashvili T, Chapman MD, Cusato J, Dursun E, Fourier A, Galimberti D, Gezen-Ak D, Gordon BA, Gouju J, de Las Heras Florez S, Sánchez JJH, Herwerth M, Imperiale D, Kaczorowski F, Kasuga K, Keshavan A, Khalil M, Kuhle J, Leithner C, Lewczuk P, Letournel F, Tsolaki M, Giuffrè GM, Blanc MC, Mroszko B, Rodríguez-Álvarez J, Musso G, Kulczynska-Przybik A, Nogueira L, Paquet C, Baiardi S, Gaetani L, Parnetti L, Garay RP, Poesen K, Quillard-Muraine M, Borja ER, Schraen-Maschke S, Terracciano D, Bachhuber F, Halbgebauer S, Tzartos S, Tzartos J, Unterwalder N, Vermunt L, Wellington CL, Zetterberg H, Teunissen CE, Lehmann S.  Biomarkers. Alzheimers Dement. 2025 Dec;21 Suppl 2:e104274. doi: 10.1002/alz70856_104274. IF=13,1

590. 6305. Amanatidou D, Fouskas V, Tsolaki M, Anastasiou A, Papageorgiou A, Eleftheriou P. Developing Topics. Alzheimers Dement. 2025 Dec;21 Suppl 7:e108938. doi: 10.1002/alz70861_108938.PMID: 41434378 IF=13.1

589. 6306. van der Veere PJ, van Harten AC, van Maurik IS, Teunissen CE, Barkhof F, Vos SJB, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Frisoni GB, Spiru L, Freund-Levi Y, Wallin ÅK, Hampel H, Tsolaki M, Kłoszewska I, Mecocci P, Vellas B, Lovestone S, Galluzzi S, Herukka SK, Santana I, Baldeiras I, Mendonca A, Silva D, Chételat G, Poisnel G, Visser PJ, Johnson SC, Stomrud E, Hansson O, Palmqvist S, Piñol-Ripoll G, Berkhof J, van der Flier WM. Developing Topics. Alzheimers Dement. 2025 Dec;21 Suppl 7:e108352. doi: 10.1002/alz70861_108352. IF=13,1

588. 6214. Dodich A, Panzavolta A, Funghi G, Meli C, Festari C, Chatzikostopoulos T, Chicherio C, Clarens F, de Oliveira FF, Filardi M, Ibanez A, Invernizzi L, Lebouvier T, Logroscino G, MacPherson SE, Manca R, Marra C, Matias-Guiu JA, Montembeault M, Papagno C, Pomati S, Possenti M, Piguet O, Sacco L, Schild AK, Sollberger M, Tábuas-Pereira M, Tsatali M, Tsolaki M, van den Berg E, Cappa SF, Bertoux M, Kumfor F, Van den Stock J, Boccardi M, Welsh-Bohmer KA, Cerami C, Agosta F, Canu E, Almkvist O, Hagman G, Winblad B, Altomare D, Angioni D, Annoni JM, Beretta L, Berres M, Bessi V, Fimm I, Kilimann I, Bora E, Brioschi-Guevara A, Buchmann A, Gietl A, Bussè C, Cagnin A, Chander R, Kliegel M, Mella N, Costa A, Coulangers C, Ousset PJ, Cupidi C, Démonet JF, Didic M, Di Lorenzo F, Dubois B, Andrade AC, Fimm B, Galasko D, Girtler N, Nobili F, Pardini M, Henry J, Bourdage R, Jiskoot L, Poos J, Seelaar H, Klöppel S, Krebs C, Kukull WA, Levy R, Lima M, Luca A, Luzzi S, Matarrubia MF, Mecocci P, Pigliautile M, Menichelli A, Mitolo M, Monsch AU, Moraitou D, Novak P, Ortiz ME, Papageorgiou S, Scarmeas N, Papatriantafyllou J, Plutino A, Quaranta D, Ramakers I, Rossi S, Russo M, Sensi S, Sachdev P, S 

International consensus for the assessment of social cognition in neurocognitive disorders: framework definition and clinical recommendations of the SIGNATURE initiative.

…See abstract for full author list ➔Alzheimers Res Ther. 2025 Dec 6. doi: 10.1186/s13195-025-01908-2. IF=7,6

 

587. 6140. Alopoudi A, Moraitou D, Tegos T, Tsolaki M. The MINT Sprint 2.0: a Picture Naming Test for Detection of Naming Impairments in ΜCI Due or Not to AD, Greek Version. Arch Clin Neuropsychol. 2025 Dec 2:acaf106. doi: 10.1093/arclin/acaf106. IF=2,1

586. 6274. Batzikosta A, Moraitou D, Steiropoulos P, Masoura E, Papantoniou G, Katsouri IG, Sofologi M, Tsentidou G, Tsolaki M. Sleep Trajectories in Amnestic and Non-Amnestic MCI: Longitudinal Insights from Subjective and Objective Assessments. Diagnostics (Basel). 2025 Nov 6;15(21):2815. doi: 10.3390/diagnostics15212815. IF=3,3

 

585. 6272. Georgiadis T, Katsouri IG, Tsormpatzoudis C, Tsolaki M. Home-Based Occupational Therapy Intervention for the Improvement of Quality of Life in Individuals With Moderate to Severe Dementia and Their Caregivers.

Dement Neurocogn Disord. 2025 Oct;24(4):233-245. doi: 10.12779/dnd.2025.24.4.233. ΙF=1,9

 

584. 6250. van Gils V, Jansen WJ, van der Flier WM, Martinez-Lage P, Hort J, Ramakers IHGB, Rouaud O, Laakso M, Engelborghs S, Popp J, Lleó A, Wallin A, Tsolaki M, Teunissen CE, Vandenberghe R, Freund-Levi Y, Frölich L, Zetterberg H, Streffer J, Lovestone S, Moonen J, van Harten A, Veverová K, Legdeur N, den Braber A, Damian D, Hall A, Bralten J, Fanelli G, Franke B, Poelmans G, Bulló M, Jimenez-Murcia S, Fernandez-Arande F, Salvadó JS, Dalsgaard S, Visser PJ, Vos SJB. The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts. Alzheimers Dement. 2025 Oct;21(10):e70804. doi: 10.1002/alz.70804.PMID: 41165072 IF=13,1

 

583. 6251. Chatzidimitriou E, Ntritsos G, Lagoudaki R, Poptsi E, Tsardoulias E, Symeonidis AL, Tsolaki M, Konstantinopoulou E, Papadopoulou K, Charalambous P, Rankin KP, Aretouli E, Sioka C, Iakovou I, Afrantou T, Ioannidis P, Moraitou D. Functional Impairment in Behavioral Variant Frontotemporal Dementia: Cognitive, Behavioral, Personality, and Brain Perfusion Contributions.

J Pers Med. 2025 Oct 1;15(10):466. doi: 10.3390/jpm15100466.IF=3

 

582. 6217. Paradisi R, Baldimtsi E, Ntailakis P, Ntritsos G, Papantoniou G, Konsta A, Tsolaki M. Modified Cued Recall Test for the Diagnosis of Alzheimer's Disease in a Greek Sample of Adults With Down Syndrome: A Preliminary Study. Am J Intellect Dev Disabil. 2025 Nov 1;130(6):503-511. doi: 10.1352/1944-7558-130.6.503.  IF=2,6

 

581. 6213. Vromen EM, Lageman SB, Gobom J, van der Kant R, Dobricic V, Bertram L, Streffer J, Lovestone S, Vos SJB, Tainta M, Freund-Levi Y, Frölich L, Popp J, Peyratout G, Tsolaki M, Verhey F, Vandenberghe R, Schaeverbeke J, Blennow K, van der Lee SJ, Scheltens P, Pijnenburg YAL, van der Flier WM, Teunissen CE, Zetterberg H, Visser PJ, Tijms B. Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease. Alzheimers Dement. 2025 Oct;21(10):e70738. doi: 10.1002/alz.70738. IF=13,1

 

580. 6237. Makri M, Angelidou IA, Moraitou D, Fidani L, Tegos T, Kimiskidis V, Tsolaki M. Tele-Genetic Versus Onsite Counseling for APOE Disclosure: A 6-Month Study of Empowerment, Psychological Distress, and Behavioral Outcomes in Cognitively Diverse Individuals.

J Gene Med. 2025 Oct;27(10):e70041. doi: 10.1002/jgm.70041.ΙF=2,78

 

579. 6239.  Tommasini C, Mantzoukas S, Buitenkamp C, van der Vaart N, Zampira I, Laiou E, Paschou A, Lazarou E, Makri M, Kuvajainen M, Liljeström V, de Haan N, van Ooijen M, Tsolaki M, Chiappinotto S, Palese A, Cadorin L

Integrating Creative Approaches to Dementia Care Into Nursing Programmes: Findings From an International Qualitative Study.

.Scand J Caring Sci. 2025 Dec;39(4):e70131. doi: 10.1111/scs.70131. IF= 1,8

 

 

578. 6226. Objective Assessment of Cognition for Detecting Subjective Cognitive Decline Is More Accurate than Subjective Estimations: The Role of Trait Affect.

Frantzi N, Moraitou D, Emmanouilidou E, Poptsi E, Tsardoulias E, Symeonidis AL, Papantoniou G, Sofologi M, Masoura E, Tsentidou G, Katsouri IG, Tsolaki M.

J Intell. 2025 Sep 11;13(9):118. doi: 10.3390/jintelligence13090118. IF=2,842

 

577. 6221. Tsolaki M. 14th Panhellenic Conference on Alzheimer's Disease and the 6th Mediterranean Conference on Neurodegenerative Diseases, 13 February-16 February, Thessaloniki, Greece.

NeuroSci. 2025 Jun 20;6(3):57. doi: 10.3390/neurosci6030057. IF=2

 

576. 6215. Emmanouilidou E, Moraitou D, Frantzi N, Poptsi E, Tsardoulias E, Symeonidis AL, Papantoniou G, Sofologi M, Masoura E, Tsentidou G, Katsouri IG, Tsolaki M. Early Detection of Cognitive Decline: Executive Functioning Index R4Alz-pc Predicts Memory-Related Concerns in Community Adults. Diagnostics (Basel). 2025 Aug 26;15(17):2158. doi: 10.3390/diagnostics15172158. IF=3,3

 

575. 6202. Deda O, Adams S, Tsolaki M, Lioupi A, Tsolaki AC, Theodoridis G, Wilson ID, Plumb RS, Gika H.J 

UHPLC-MS/MS analysis of PFAS in the serum of patients with Alzheimer's disease, mild cognitive impairment and controls: A preliminary study.

J Chromatogr B Analyt Technol Biomed Life Sci. 2025 Aug 15;1266:124738. IF=0,568

574. 6203. Amanatidou D, Tsolaki M, Fouskas V, Gavriilidis I, Myriouni M, Anastasiou A, Papageorgiou E, Porfyriadou D, Parcharidi Z, Papasavva E, Fili M, Eleftheriou P. Increased Concentration of Anti-Egg Albumin Antibodies in Cerebrospinal Fluid and Serum of Patients with Alzheimer's Disease-Discussion on Human Serpins' Similarity and Probable Involvement in the Disease Mechanism.

.Biomolecules. 2025 Jul 27;15(8):1085. doi: 10.3390/biom15081085. IF=4,8

573. 6192. Katsipis G, Tzekaki EE, Andreadou EG, Mouzakidis C, Baldimtsi EN, Karathanasi EM, Hassandra M, Galanis E, Hatzigeorgiadis A, Goudas M, Zikas P, Evangelou G, Papagiannakis G, Bellis G, Kokkotis C, Tsatalas T, Giakas G, Theodorakis Y, Tsolaki M, Pantazaki AA.
The effect of physical exercise with cognitive training on inflammation and Alzheimer's disease biomarkers of Mild Cognitive Impairment patients. Neurosci Appl. 2024 Jul 29;3:104085.

 doi: 10.1016/j.nsa.2024.104085. eCollection 2024. IF=0,8

572. 6194. Rajabli F, Benchek P, Tosto G, Kushch N, Sha J, Bazemore K, Zhu C, Lee WP, Haut J, Hamilton-Nelson KL, Wheeler NR, Zhao Y, Farrell JJ, Grunin MA, Leung YY, Kuksa PP, Li D, da Fonseca EL, Mez JB, Palmer EL, Pillai J, Sherva RM, Song YE, Zhang X, Ikeuchi T, Iqbal T, Pathak O, Valladares O, Reyes-Dumeyer D, Kuzma AB, Abner E, Adams LD, Adams PM, Aguirre A, Albert MS, Albin RL, Allen M, Alvarez L, Apostolova LG, Arnold SE, Asthana S, Atwood CS, Auerbach S, Ayres G, Baldwin CT, Barber RC, Barnes LL, Barral S, Beach TG, Becker JT, Beecham GW, Beekly D, Benitez BA, Bennett D, Bertelson J, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Brewer J, Burke JR, Burns JM, Buxbaum JD, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carlsson CM, Carney RM, Carrasquillo MM, Chasse S, Chesselet MF, Chin NA, Chui HC, Chung J, Craft S, Crane PK, Cribbs DH, Crocco EA, Cruchaga C, Cuccaro ML, Cullum M, Darby E, Davis B, De Jager PL, DeCarli C, DeToledo J, Dick M, Dickson DW, Dombroski BA, Doody RS, Duara R, Ertekin-Taner N, Evans DA, Faber KM, Fairchild TJ, Fallon KB, Fardo DW, Farlow MR, Fernandez-Hernandez V, Ferris S, Friedland RP, Foroud TM, Frosch MP, Fulton-Howard B, Galasko DR, Gamboa A, Gearing M, …
 

Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's disease.

See abstract for full author list ➔Genome Biol. 2025 Jul 17;26(1):210.

doi: 10.1186/s13059-025-03564-z.  IF=9,4

 

571. 6190. Delvenne A, Gobom J, Reus LM, Dobricic V, Ten Kate M, Schindler SE, Ramakers I, Tijms BM, Vandenberghe R, Schaeverbeke J, Martinez-Lage P, Tainta M, Teunissen CE, Popp J, Peyratout G, Tsolaki M, Freund-Levi Y, Lovestone S, Streffer J, Barkhof F, Bertram L, Blennow K, Zetterberg H, Visser PJ, Vos SJB. Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiology. Brain Commun. 2025 Jun 20;7(4):fcaf253.

doi: 10.1093/braincomms/fcaf253. eCollection 2025. IF=4,5, Q1

 

570. 6188. Vasileiou D, Moraitou D, Diamantaras K, Papaliagkas V, Pezirkianidis C, Tsolaki M.
Positive Psychology Interventions in Early-Stage Cognitive Decline Related to Dementia: A Systematic Review of Cognitive and Brain Functioning Outcomes of Mindfulness Interventions. Brain Sci. 2025 May 28;15(6):580.

doi: 10.3390/brainsci15060580 IF=2,8

569. 6186. Kountoura A, Tegos T, Arnaoutoglou M, Tsolaki M.

 Online Occupational Therapy as a Rehabilitation Intervention for Parkinson's Disease: A Systematized Review.

 Clin Pract. 2025 May 23;15(6):98. doi: 10.3390/clinpract15060098.ΙF=2,2

 

568. 6184. Delaby C, Ladang A, Martinez-Yriarte J, Zecca C, Logroscino G, Körtvelyessy P, Tumani H, Parchi P, Quadrio I, Hart M, Olsen DA, Alcolea D, Blennow K, Fortea J, Lleo A, Algeciras-Schimnich A, Ayrignac X, Bedel A, Santos GAA, Borelli W, Bouaziz-Amar E, Baldeiras I, Bigot-Corbel E, Bjerke M, Carretero Perez M, Casoli T, Chabrashvili T, Chapman MD, Cusato J, Dursun E, Fourier A, Galimberti D, Gezen-Ak D, Gordon BA, Gouju J, de Las Heras Florez S, Hernandez Sanchez J, Herwerth M, Imperiale D, Kaczorowski F, Kasuga K, Keshavan A, Khalil M, Kuhle J, Leithner C, Lewczuk P, Letournel F, Tsolaki M, Giuffrè GM, Blanc MC, Mroczko B, Martínez Rodríguez JE, Musso G, Kulczynska-Przybik A, Nogueira L, Paquet C, Baiardi S, Gaetani L, Parnetti L, Perez Garay R, Poesen K, Quillard-Muraine M, Rodriguez Borja E, Schraen S, Terracciano D, Bachhuber F, Halbgebauer S, Tzartos S, Tzartos J, Unterwalder N, Vermunt L, Wellington CL, Zetterberg H, Teunissen C, Lehmann S. Clinical use and reporting of neurofilament quantification in neurological disorders:

Alzheimers Dement. 2025 Jun;21(6):e70343. doi: 10.1002/alz.70343. IF=13

 

567. 6180. Makri M, Palasidou A, Moraitou D, Tegos T, Fidani L, Tsolaki M. A preliminary adaptation and validation of the genetic counseling outcome scale (GCOS-24) for use in Greece. J Genet Couns. 2025 Jun;34(3):e70068.

doi: 10.1002/jgc4.70068 IF=1,9

 

566. 6178. Nicolas A, Sherva R, Grenier-Boley B, Kim Y, Kikuchi M, Timsina J, de Rojas I, Dalmasso MC, Zhou X, Le Guen Y, Arboleda-Bustos CE, Camargos Bicalho MA, Guerchet M, van der Lee S, Goss M, Castillo A, Bellenguez C, Küçükali F, Satizabal CL, Fongang B, Yang Q, Peters O, Schneider A, Dichgans M, Rujescu D, Scherbaum N, Deckert J, Riedel-Heller S, Hausner L, Molina-Porcel L, Düzel E, Grimmer T, Wiltfang J, Heilmann-Heimbach S, Moebus S, Tegos T, Scarmeas N, Dols-Icardo O, Moreno F, Pérez-Tur J, Bullido MJ, Pastor P, Sánchez-Valle R, Álvarez V, Cao H, Ip NY, Fu AKY, Ip FCF, Olivar N, Muchnik C, Cuesta C, Campanelli L, Solis P, Politis DG, Kochen S, Brusco LI, Boada M, García-González P, Puerta R, Mir P, Real LM, Piñol-Ripoll G, García-Alberca JM, Royo JL, Rodriguez-Rodriguez E, Soininen H, Heikkinen S, de Mendonça A, Mehrabian S, Traykov L, Hort J, Vyhnalek M, Rasmussen KL, Thomassen JQ, Pijnenburg YAL, Holstege H, van Swieten JC, Seelaar H, Claassen JAHR, Jansen WJ, Ramakers I, Verhey F, van der Lugt A, Scheltens P, Ortega-Rojas J, Concha Mera AG, Mahecha MF, Pardo R, Arboleda G, Bahrami S, Fominykh V, Selbæk G, Graff C, Papenberg G, Giedraitis V, Boland A, Deleuze JF, de Marco LA, de …See abstract for full author list ➔Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations.Nat Genet. 2025 Jun 18. doi: 10.1038/s41588-025-02227. IF=31,8

 

 

565. 6129. Tzekaki EE, Katsipis G, Chatzikostopoulos A, Koutoupa A, Lavrentiadou SN, Tsolaki M, Pantazaki AA
Neuroprotective, Antioxidant and Anti-Inflammatory Effect of Greek Pomegranate Seed Oil on N2a Neuroblastoma Cells and Mild Cognitive Impairment Patients.

Biology (Basel). 2025 May 15;14(5):548. doi: 10.3390/biology14050548. IF= 3,8

 

564. 6127. Ioannidou S, Tsolaki M, Ginoudis A, Tamvakis A, Tsolaki A, Makedou K, Lymperaki E.
Oxidative Stress Biomarkers as Preclinical Markers of Mild Cognitive Impairment: The Impact of Age and Sex.

J Pers Med. 2025 Apr 26;15(5):171. doi: 10.3390/jpm15050171. IF=3,8

 

  1. 6126. Cesana BM, Poptsi E, Tsolaki M, Bergh S, Fabbo A, Frölich L, Jori MC, Defanti CA. A Confirmatory Factor Analysis of the Dementia Attitude Scale (DAS) in a European Case Series of Caregivers of People with Dementia Enrolled in the RECage Study.

NeuroSci. 2025 May 20;6(2):45. IF=1,6

 

  1. 6162. Cerami C, Boccardi M, Meli C, Panzavolta A, Funghi G, Festari C, Cappa SF, Chatzikostopoulos T, Chicherio C, Clarens F, de Oliveira FF, Di Lorenzo F, Filardi M, Ibanez A, Girtler N, Lebouvier T, Logroscino G, Luca A, MacPherson SE, Matias-Guiu JA, Piccoli T, Piguet O, Pomati S, Russo M, Sacco L, Schild AK, Sensi SL, Shirk SD, Sollberger M, Tábuas-Pereira M, Tsolaki M, van den Berg E, Bertoux M, Kumfor F, Van den Stock J, Welsh-Bohmer KA, Dodich A; SIGNATURE initiative. Understanding barriers and optimizing socio-cognitive assessment in the diagnosis of neurocognitive disorders. J Neuropsychol. 2025 May 14. doi: 10.1111/jnp.12431. Online ahead of print ΙF=2
  2. 6160. Chatzikostopoulos A, Moraitou D, Papaliagkas V, Tsolaki M. Mapping the Neuropsychiatric Symptoms in Alzheimer's Disease Using Biomarkers, Cognitive Abilities, and Personality Traits: A Systematic Review. Diagnostics (Basel). 2025 Apr 24;15(9):1082. doi: 10.3390/diagnostics15091082 IF=3,6
  3. 6142. Ioannidou S, Ginoudis A, Makedou K, Tsolaki M, Lymperaki E. Serum and Cerebrospinal Fluid Malondialdehyde Levels in Patients with Mild Cognitive Impairment. J Xenobiot. 2025 Mar 30;15(2):50. doi: 10.3390/jox15020050.IF=6

 

  1. 6137. Marina Makri, Akylina Despoti, Mara Gkioka, Magda Tsolaki.

Caregivers and non-caregivers attitudes regarding pre-symptomatic Alzheimer’s disease testing. Alzheimer’s Dement. 2023;19(Suppl. 19):e077383.  https://doi.org/10.1002/alz.077383. IF=13 

 

  1. 6136. Panayiota Manola, Marina Makri, Magda Tsolaki. Remote Caring Guidelines: An innovative protocol fordementia caregivers. Alzheimer’s Dement. 2023;19(Suppl. 20):e076137. IF=13

https://doi.org/10.1002/alz.076137

 

  1. 6119. Ivain P, Baksh A, Saini F, Idris M, Tamayo-Elizalde M, Wells J, Benejam B, Loosli SV, Sandkühler K, Wlasich E, Wagemann O, Levin J, Martet D, Sacco S, Falquero S, Clert M, Rebillat AS, Khoo WM, Smith MA, Beresford-Webb J, Zaman S, Carmona-Iragui M, Videla L, Fortea J, Langballe EM, Medbøen IT, Larsen FK, Baldimtsi E, Paradisi R, Ntailakis P, Tsolaki M, Papantoniou G, McGlinchey E, McCarron M, Kennelly S, Strydom A. Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study. Alzheimers Dement. 2025 Mar;21(3):e70071. IF=13

 

  1. 6121. Tsatali M, Eleftheriadou D, Palla N, Tsolaki M, Moraitou D.
    Normative Data for the D-KEFS Tower Test in Greek Adult Population Between 20 and 85 Years Old.     Brain Sci. 2025 Mar 6;15(3):278. IF=2,7
  2. 6110. Wesenhagen KEJ, de Leeuw DM, Tomassen J, Gobom J, Bos I, Vos SJB, Martinez-Lage P, Tainta M, Popp J, Peyratout G, Tsolaki M, Vandenberghe R, Freund-Levi Y, Verhey F, Lovestone S, Streffer J, Dobricic V, Blennow K, Scheltens P, Smit AB, Bertram L, Teunissen CE, Zetterberg H, Tijms BM, Visser PJ; Alzheimer’s Disease Neuroimaging Initiative. Synaptic protein CSF levels relate to memory scores in individuals without dementia. Alzheimers Res Ther. 2025 Mar 3;17(1):56. doi: 10.1186/s13195-025-01703-z. IF=7,9
  3. 6103. Tsigkou E, Tsironi KA, Papantoniou G, Sofologi M, Kougioumtzis G, Katsouri IG, Moraitou D, Tsolaki M. Τhe Greek Version of the Marwit-Meuser Caregiver Grief Inventory (MM-CGI) and MM-CGI Short Form (MM-CGI-SF): An Examination of Their Psychometric Properties in Family Caregivers of Persons with Dementia Before Death. Behav Sci (Basel). 2025 Feb 15;15(2):219. doi: 10.3390/bs15020219. IF=2,7
  4. 6099. Tzekaki E, Bekiari C, Pantazaki A, Tsantarliotou M, Tsolaki M, Lavrentiadou SN. A new protocol for the development of organoids based on molecular mechanisms in the developing newborn rat brain: Prospective applications in the study of Alzheimer's disease. J Neurosci Methods. 2025 Feb 18:110404. doi: 10.1016/j.jneumeth.2025.110404. IF=2,7
  5. 6082. Batzikosta A, Moraitou D, Steiropoulos P, Papantoniou G, Kougioumtzis GA, Katsouri IG, Sofologi M, Tsolaki M. Examining Specific Theory-of-Mind Aspects in Amnestic and Non-Amnestic Mild Cognitive Impairment: Their Relationships with Sleep Duration and Cognitive Planning. Brain Sci. 2025 Jan 10;15(1):57. doi: 10.3390/brainsci15010057. IF=2,7
  6. 6072. Delaby C, Teunissen C, Olsen DA, Alcolea D, Lleo A, Algeciras-Schimnich A, Santos GAA, Amar EB, Ayrignac X, Baldeiras I, Bigot-Corbel E, Bjerke M, Perez MC, Casoli T, Chabrashvili T, Chapman MD, Cusato J, Dursun E, Fourier A, Galimberti D, Gezen-Ak D, Gordon BA, Hart M, Herwerth M, Kaczorowski F, Kasuga K, Keshavan A, Khalil M, Koertvelyessy P, Kuhle J, Ladang A, Lewczuk P, Logroscino G, Tsolaki M, Giuffrè GM, Blanc MC, Mroszko B, Musso G, Kulczynska-Przybik A, Nogueira L, Paquet C, Parchi P, Parnetti L, Garay RP, Poesen K, Quadrio I, Quillard-Muraine M, Borja ER, Schraen S, Terracciano D, Tumani H, Tzartos SAJ, Unterwalder N, Vermunt L, Wellington CL, Yriarte J, Blennow K, Zetterberg H, Lehmann S. Biomarkers. Alzheimers Dement. 2024 Dec;20 Suppl 2(Suppl 2):e090643. doi: 10.1002/alz.090643. IF=13

 

  1. 4681. Marizzoni M, Ferrari C, Babiloni C, Albani D, Barkhof F, Cavaliere L, Didic M, Forloni G, Fusco F, Galluzzi S, Hensch T, Jovicich J, Marra C, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ranjeva JP, Ribaldi F, Rolandi E, Rossini PM, Salvatore M, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB. CSF cutoffs for MCI due to AD depend on APOEε4 carrier status. Neurobiol Aging. 2020 May; 89:55-62. doi: 10.1016/j.neurobiolaging.2019.12.019. IF=5,133

 

  1. 4680. Westwood S, Baird AL, Anand SN, Nevado-Holgado AJ, Kormilitzin A, Shi L, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Baker S, Buckley NJ, Ten Kate M, Scheltens P, Teunissen CE, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lléo A, Sala I, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Legido-Quigley C, Bertram L, Barkhof F, Zetterberg H, Morgan BP, Streffer J, Visser PJ, Lovestone S. Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.

J Alzheimers Dis. 2020;74(1):213-225. doi: 10.3233/JAD-190434.PMID: 31985466, IF=3,4 

 

  1. 4679. Giannouli V, Tsolaki M. Depression and financial capacity assessment in Parkinson's disease with dementia: Overlooking an important factor?

Psychiatriki. 2019 Jan-Mar;30(1):66-70. doi: 10.22365/jpsych.2019.301.66. IF=1,494

 

  1. 6068. Poptsi E, Moraitou D, Tsardoulias E, Symeonidis AL, Tsolaki M. R4Alz-R: a cutting-edge tool for spotting the very first and subtle signs of aging-related cognitive impairment with high accuracy. Geroscience. 2024 Dec 27. IF=6,5
  2. 6066. Le Borgne J, Gomez L, Heikkinen S, Amin N, Ahmad S, Choi SH, Bis J, Grenier-Boley B, Rodriguez OG, Kleineidam L, Young J, Tripathi KP, Wang L, Varma A, Campos-Martin R, van der Lee S, Damotte V, de Rojas I, Palmal S; EADB, GR@ACE, DEGESCO, EADI, GERAD, DemGene, FinnGen, ADGC, CHARGE; Lipton R, Reiman E, McKee A, De Jager P, Bush W, Small S, Levey A, Saykin A, Foroud T, Albert M, Hyman B, Petersen R, Younkin S, Sano M, Wisniewski T, Vassar R, Schneider J, Henderson V, Roberson E, DeCarli C, LaFerla F, Brewer J, Swerdlow R, Van Eldik L, Hamilton-Nelson K, Paulson H, Naj A, Lopez O, Chui H, Crane P, Grabowski T, Kukull W, Asthana S, Craft S, Strittmatter S, Cruchaga C, Leverenz J, Goate A, Kamboh MI, George-Hyslop PS, Valladares O, Kuzma A, Cantwell L, Riemenschneider M, Morris J, Slifer S, Dalmasso C, Castillo A, Küçükali F, Peters O, Schneider A, Dichgans M, Rujescu D, Scherbaum N, Deckert J, Riedel-Heller S, Hausner L, Molina-Porcel L, Düzel E, Grimmer T, Wiltfang J, Heilmann-Heimbach S, Moebus S, Tegos T, Scarmeas N, Dols-Icardo O, Moreno F, Pérez-Tur J, Bullido MJ, Pastor P, Sánchez-Valle R, Álvarez V, Boada M, García-González P, Puerta R, Mir P, Real LM, Piñol-Ripoll G, García-X-chromosome-wide association study for Alzheimer's disease. …See abstract for full author list ➔Mol Psychiatry. 2024 Dec 4. doi: 10.1038/s41380-024-02838-5. Online ahead of print.PMID: 39633006. IF=9,6
  3. 6065. Tseriotis VS, Vavougios G, Tsolaki M, Spilioti M, Kosmidis EK.Electroencephalogram criticality in cognitive impairment: a monitoring biomarker? Cogn Neurodyn. 2024 Dec;18(6):3679-3689. doi: 10.1007/s11571-024-10155-4. Epub 2024 Jul 26.PMID: 39712107. IF= 3,1
  4. 6057. Mendes A, Herrmann FR, Bergh S, Cesana BM, Handels R, Ciccone A, Cognat E, Fabbo A, Fascendini S, Frisoni GB, Froelich L, Jori MC, Mecocci P, Merlo P, Peters O, Tsolaki M, Defanti CA. Clinical Predictors of Mortality in People With Severe Behavioral and Psychological Symptoms of Dementia.

J Am Med Dir Assoc. 2024 Nov 25:105374. doi: 10.1016/j.jamda.2024.105374. ΙF=7.802

  1. 6049. Loukou S, Papantoniou G, Pantazaki A, Tsolaki M.
    The Role of Greek Olive Leaf Extract in Patients with Mild Alzheimer's Disease (the GOLDEN Study): A Randomized Controlled Clinical Trial.     Neurol Int. 2024 Oct 29;16(6):1247-1265. IF=2,117

 

  1. 6028. Giannouli V, Tsolaki M. Can cerebrospinal fluid biomarkers tell us something about financial capacity in Alzheimer's disease patients? A preliminary study.

Neuropsychiatr. 2024 Sep 11. doi: 10.1007/s40211-024-00509-z. IF=2,19

 

  1. 6009. Koetsier J, Cavill R, Reijnders R, Harvey J, Homann J, Kouhsar M, Deckers K, Köhler S, Eijssen LMT, van den Hove DLA, Demuth I, Düzel S; Alzheimer's Disease Neuroimaging Initiative; Smith RG, Smith AR, Burrage J, Walker EM, Shireby G, Hannon E, Dempster E, Frayling T, Mill J, Dobricic V, Johannsen P, Wittig M, Franke A, Vandenberghe R, Schaeverbeke J, Freund-Levi Y, Frölich L, Scheltens P, Teunissen CE, Frisoni G, Blin O, Richardson JC, Bordet R, Engelborghs S, de Roeck E, Martinez-Lage P, Tainta M, Lleó A, Sala I, Popp J, Peyratout G, Verhey F, Tsolaki M, Andreasson U, Blennow K, Zetterberg H, Streffer J, Vos SJB, Lovestone S, Visser PJ, Lill CM, Bertram L, Lunnon K, Pishva E Blood-based multivariate methylation risk score for cognitive impairment and dementia.. Alzheimers Dement. 2024 Aug 28. doi: 10.1002/alz.14061. IF=13`

 

  1. 6011.  Smith RG, Pishva E, Kouhsar M, Imm J, Dobricic V, Johannsen P, Wittig M, Franke A, Vandenberghe R, Schaeverbeke J, Freund-Levi Y, Frölich L, Scheltens P, Teunissen CE, Frisoni G, Blin O, Richardson JC, Bordet R, Engelborghs S, de Roeck E, Martinez-Lage P, Altuna M, Tainta M, Lleó A, Sala I, Popp J, Peyratout G, Winchester L, Nevado-Holgado A, Verhey F, Tsolaki M, Andreasson U, Blennow K, Zetterberg H, Streffer J, Vos SJB, Lovestone S, Visser PJ, Bertram L, Lunnon K. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study. Alzheimers Dement. 2024 Aug 28. doi: 10.1002/alz.14098. IF=13

 

  1. 6013. Georgoudas M, Moraitou D, Poptsi E, Tsardoulias E, Kesanli D, Papaliagkas V, Tsolaki M. The Mixed Role of Sleep and Time of Day in Working Memory Performance of Older Adults with Mild Cognitive Impairment. Healthcare (Basel). 2024 Aug 14;12(16):1622. doi: 10.3390/healthcare12161622.PMID: 39201180Free PMC article. IF=2,8

 

  1. 6014. Batzikosta A, Moraitou D, Steiropoulos P, Papantoniou G, Kougioumtzis GA, Katsouri IG, Sofologi M, Tsolaki M. The Relationships of Specific Cognitive Control Abilities with Objective and Subjective Sleep Parameters in Mild Cognitive Impairment: Revealing the Association between Cognitive Planning and Sleep Duration. Brain Sci. 2024 Aug 14;14(8):813. doi: 10.3390/brainsci14080813.PMID: 39199504Free PMC articleIF=3,3

 

 

  1. 6002. Kaltsa M, Tsolaki A, Lazarou I, Mittas I, Papageorgiou M, Papadopoulou D, Tsimpli IM, Tsolaki M. Assessing the Linguistic Capacity Across Alzheimer's Disease and Its Preclinical Stages: Evidence from Narrative Macrostructure in Elderly Speakers of Greek. J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240496. IF=13

 

  1. 6001. Wesenhagen KEJ, de Leeuw DM, Tomassen J, Gobom J, Bos I, Vos SJB, Martinez-Lage P, Tainta M, Popp J, Peyratout G, Tsolaki M, Vandenberghe R, Freund-Levi Y, Verhey F, Lovestone S, Streffer J, Dobricic V, Blennow K, Scheltens P, Smit AB, Bertram L, Teunissen CE, Zetterberg H, Tijms BM, Visser PJ, Initiative TADN   Synaptic protein CSF levels relate to memory scores in individuals without dementia..Res Sq [Preprint]. 2024 Jul 23:rs.3.rs-4607202. doi: 10.21203/rs.3.rs-4607202/v1.
  2. 5999. van Setten A, Uleman JF, Melis RJF, Lawlor B, Riksen NP, Claassen JAHR, de Heus RAA; NILVAD Study Group. No association between markers of systemic inflammation and endothelial dysfunction with Alzheimer's disease progression: a longitudinal study. Geroscience. 2024 Jul 31. doi: 10.1007/s11357-024-01294- IF=5,6

 

  1. 5787. Delvenne A, Vandendriessche C, Gobom J, Burgelman M, Dujardin P, De Nolf C, Tijms BM, Teunissen CE, Schindler SE, Verhey F, Ramakers I, Martinez-Lage P, Tainta M, Vandenberghe R, Schaeverbeke J, Engelborghs S, De Roeck E, Popp J, Peyratout G, Tsolaki M, Freund-Levi Y, Lovestone S, Streffer J, Bertram L, Blennow K, Zetterberg H, Visser PJ, Vandenbroucke RE, Vos SJB. Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studies. Fluids Barriers CNS. 2024 Jul 18;21(1):58. doi: 10.1186/s12987-024-00555-3. IF=5,9

 

 

  1. 5783. Tsatali M, Gaspar De Almeida Santos A, Makri M, Santokhie RT, Boccaletti L, Caciula I, Caciula R, Trogu G, Tsolaki M, Johansen KJ. Peer Support Workers as an Innovative Force in Advocacy in Dementia Care: A Transnational Project Delivered in Norway, Greece, Italy, and Romania. J Multidiscip Healthc. 2024 Jul 8;17:3155-3165. doi: 10.2147/JMDH.S464195. IF=3,3

 

  1. 5778. Delvenne A, Gobom J, Schindler SE, Kate MT, Reus LM, Dobricic V, Tijms BM, Benzinger TLS, Cruchaga C, Teunissen CE, Ramakers I, Martinez-Lage P, Tainta M, Vandenberghe R, Schaeverbeke J, Engelborghs S, Roeck E, Popp J, Peyratout G, Tsolaki M, Freund-Levi Y, Lovestone S, Streffer J, Barkhof F, Bertram L, Blennow K, Zetterberg H, Visser PJ, Vos SJB. CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease. Alzheimers Dement. 2024 Jul 6. Impact factor=13  doi: 10.1002/alz.14103.

 

  1. 5768. Kaltsa, M., Tsolaki, A., Lazarou, I., Mittas, I., Papageorgiou, M., Papadopoulou, D., Tsimpli, I. M. & Tsolaki, M. (2024/to appear). Language markers of dementia and their role in early diagnosis of Alzheimer’s disease: exploring grammatical and syntactic competence via sentence repetition. Journal of Alzheimer’s Disease Reports. [Journal Impact Factor: 3.2, H-index: 19, Open Access]

 

  1. 5771. Kaltsa, M., Tsolaki, A., Lazarou, I., Mittas, I., Papageorgiou, M., Papadopoulou, D., Tsimpli, I.M., Tsangalidis, A. & Tsolaki, M. (2023). Eliciting evidence on linguistic perspectives for Subjective Cognitive Impairment, Mild Cognitive Impairment and Alzheimer’s Disease: A cross‐sectional study. Alzheimer's & Dementia:https://doi.org/10.1002/alz.076053 [Journal Impact Factor: 13, H-index: 162, Open Access]

 

  1. 5776. Poptsi E, Moraitou D, Tsardoulias E, Symeonidis AL, Tsolaki M. Subjective Cognitive Impairment Can Be Detected from the Decline of Complex Cognition: Findings from the Examination of Remedes 4 Alzheimer's (R4Alz) Structural Validity. Brain Sci. 2024 May 27;14(6):548. doi: 10.3390/brainsci14060548.PMID: 38928548 Impact Factor 3,3

 

  1. 5777. Tsouvala A, Katsouri IG, Moraitou D, Papantoniou G, Sofologi M, Nikova A, Vlotinou P, Tsiakiri A, Tsolaki M.Metacognitive Awareness of Older Adult Drivers with Mild Cognitive Impairment: Relationships with Demographics, Subjective Evaluation of Cognition, and Driving Self-Efficacy. Behav Sci (Basel). 2024 Jun 6;14(6):483. doi: 10.3390/bs14060483.PMID: 38920815Free article. IF=2,5.

 

  1. 5752. Bampa G, Moraitou D, Metallidou P, Masoura E, Papantoniou G, Sofologi M, Kougioumtzis GA, Tsolaki M. The Efficacy of a Metacognitive Training Program in Amnestic Mild Cognitive Impairment: A 6-Month Follow-Up Clinical Study. Healthcare (Basel). 2024 May 14;12(10):1019.

 doi:10.3390/healthcare12101019  . IF=2,8

 

  1. 5741. Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamujić-Čomi…See abstract for full author list ➔Nat Genet. 2019 Sep;51(9):1423-1424. doi: 10.1038/s41588-019-0495-7.

 

  1. 5730. Thanos G. Stavropoulos1 Lampros Mpaltadoros1 Ioulietta Lazarou1 Margarita Grammatikopoulou1 Marijn Muurling2 Casper de Boer2 Jelena Curcic3 Rouba Kouzak4 Herman Verheij5 Vera J.M. Nies5 Andre Durudas6 Kristin Hannesdottir7 Chris Hinds8 Yoanna Daskalova5 Andrew P. Owens9 Yuhao Wu8 Gul Erdemli7 Pieter Stolk5 Federica Lucivero8 Vaibhav A. Narayan10 Dag Aarsland9 Spiros Nikolopoulos1 Magda Tsolaki11,12 Pieter Jelle Visser, Ioannis Kompatsiaris

An app to measure functional decline in managing finances in Alzheimer’s disease: Preliminary results of the RADAR-AD study. Alzheimer’s Dement. 2021;17(Suppl. 5):e053645. © 2021 the Alzheimer’s Association wileyonlinelibrary.com/journal/alz 1 of 5 https://doi.org/10.1002/alz.053645 

 

  1. 5692. Grammatikopoulou M, Lazarou I, Alepopoulos V, Mpaltadoros L, Oikonomou VP, Stavropoulos TG, Nikolopoulos S, Kompatsiaris I, Tsolaki M. Assessing the cognitive decline of people in the spectrum of AD by monitoring their activities of daily living in an IoT-enabled smart home environment: a cross-sectional pilot study. Front Aging Neurosci. 2024 Mar 28;16:1375131. doi: 10.3389/fnagi.2024.1375131. eCollection 2024. IF=4,8

 

  1. 5710. Tsatali M, Moraitou D, Gialaouzidis M, Bakoglidou E, Psaltis V, Bertzes N, Hassanin HI, Emmanouilidou E, Totonidis M, Frantzi N, Avdikou K, Gavra A, Diamantidou A, Kapsali N, Kouroundi E, Tsolaki M. Discriminant Potential of the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in Greek Older Adults with Subjective Cognitive Decline and Mild Cognitive Impairment. J Alzheimers Dis Rep. 2024 Mar 19;8(1):543-554. doi: 10.3233/ADR-230151. eCollection 2024.IF=3,2

 

  1. 5696. Cesana BM, Bergh S, Ciccone A, Cognat E, Fabbo A, Fascendini S, Frisoni GB, Froelich L, Handels R, Jori MC, Mecocci P, Merlo P, Peters O, Tsolaki M, Defanti CA. Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study. J Alzheimers Dis. 2024 Mar 12. IF=4,0

 

  1. 5690. Bampa G, Moraitou D, Metallidou P, Masoura E, Papantoniou G, Sofologi M, Kougioumtzis G, Papatzikis E, Tsolaki M. Metacognitive beliefs of efficacy about daily life situations and use of cognitive strategies in amnestic mild cognitive impairment: a cross-sectional study.

Front Psychol. 2024 Feb 13;15:1275678. doi: 10.3389/fpsyg.2024.1275678. eCollection 2024. IF=3.8

 

  1. 5687. Giannios G, Mpaltadoros L, Alepopoulos V, Grammatikopoulou M, Stavropoulos TG, Nikolopoulos S, Lazarou I, Tsolaki M, Kompatsiaris I. A Semantic Framework to Detect Problems in Activities of Daily Living Monitored through Smart Home Sensors.

Sensors (Basel). 2024 Feb 8;24(4):1107. doi: 10.3390/s24041107. IF=4,050

 

  1. 5685. Tilkeridou M, Moraitou D, Papaliagkas V, Frantzi N, Emmanouilidou E, Tsolaki M. An Examination of the Motives for Attributing and Interpreting Deception in People with Amnestic Mild Cognitive Impairment.

J Intell. 2024 Jan 24;12(2):12. doi: 10.3390/jintelligence12020012. IF=3,5

 

  1. 5664. Chatzikostopoulos T, Gialaouzidis M, Koutoupa A, Tsolaki M. The Effects of Pomegranate Seed Oil on Mild Cognitive Impairment.

J Alzheimers Dis. 2024; 97(4):1961-1970. doi: 10.3233/JAD-231100. IF=4,16

 

  1. 5665. Tsatali M, Angelidou IA, Tsolaki M, Teichmann B. The Dementia Knowledge Assessment Scale, the Knowledge in Dementia Scale, and the Dementia Knowledge Assessment Tool 2: Which Is the Best Tool to Measure Dementia Knowledge in Greece? J Alzheimers Dis Rep. 2023 Dec 29;7(1):1377-1393. doi: 10.3233/ADR-230161. IF=3,2

 

  1. 5666. Baldimtsi E, Mouzakidis C, Karathanasi EM, Verykouki E, Hassandra M, Galanis E, Hatzigeorgiadis A, Goudas M, Zikas P, Evangelou G, Papagiannakis G, Bellis G, Kokkotis C, Tsatalas T, Giakas G, Theodorakis Y, Tsolaki M. Effects of Virtual Reality Physical and Cognitive Training Intervention On Cognitive Abilities of Elders with Mild Cognitive Impairment.

J Alzheimers Dis Rep. 2023 Dec 29;7(1):1475-1490. doi: 10.3233/ADR-230099. IF=3,2

----------

  1. 5652. Dyer AH, Murphy C, Dolphin H, Morrison L, Briggs R, Lawlor B, Kennelly SP; NILVAD Study Group. Long-term antipsychotic use, orthostatic hypotension and falls in older adults with Alzheimer's disease. Eur Geriatr Med. 2024 Jan 2. doi: 10.1007/s41999-023-00910-x. IF=3.269

 

  1. 5647. Angelidou IA, Makri M, Beyreuther K, Boada Rovira M, Despoti A, Engelborghs S, Miguel A, Rodríguez I, Stocker H, Temmerman J, Tsolaki M, Yener G, Yerlikaya D, Teichmann B. Attitudes toward pre-symptomatic screening for Alzheimer's dementia in five European countries: a comparison of family members of people with Alzheimer's dementia versusnon-family members.

Front Genet. 2023 Dec 15; 14:1305107. doi: 10.3389/fgene.2023.1305107 IF=4.772

(515) 5641. What goes wrong with the perceptions of elder financial abuse? Data from older adults, healthcare professionals and students from Greece.

Giannouli V, Tsolaki M. J Elder Abuse Negl. 2023 Dec 3:1-8. doi: 10.1080/08946566.2023.2291050. IF=1,78

(514). 5639. Le Borgne J; EADB, GR@ACE, Degesco, EADI, GERAD, DemGene; Amouyel P, Andreassen O, Frikke-Schmidt R, Hiltunen M, Ingelsson M, Ramirez A, Rossi G, Ruiz A, Sanchez-Juan P, Sims R, Sleegers K, Tsolaki M, van der Lee SJ, Williams J, Lambert JC, Bellenguez C. Association of MGMT and BIN1 genes with Alzheimer's disease risk across sex and APOE ε4 status.  Alzheimers Dement. 2023 Dec 2. doi: 10.1002/alz.13550. IF=8,25 

(513) 5625. Mendes A, Bergh S, Cesana BM, Handels R, Ciccone A, Cognat E, Fabbo A, Fascendini S, Frisoni GB, Froelich L, Jori MC, Mecocci P, Merlo P, Peters O, Tsolaki M, Defanti CA. Respectful Caring for the Agitated Elderly (ReCAGE): A Multicentre, Prospective, Observational Study to Evaluate the Effectiveness of Special Care Units for People with Dementia. J Alzheimers Dis. 2023 Nov 1. doi: 10.3233/JAD-230708. IF=4,16

(512) 5626. Alopoudi A, Makri M, Alişoğlu B, Doğan A, Imbesi A, Karakoyun M, Lacapelle A, Navarro Roux MA, Pissa A, Tsolaki M. A Protocol for the Development and Assessment of a Non-Pharmacological Intervention Designed to Improve Cognitive Skills of Adults with Intellectual Disabilities: A Mixed Method Design. J Multidiscip Healthc. 2023 Nov 1;16:3215-3226. doi: 10.2147/JMDH.S422859. eCollection 2023. ΙF=2,919

(511) 5615.  Tsormpatzoudi SO, Moraitou D, Papaliagkas V, Pezirkianidis C, Tsolaki M. Resilience in Mild Cognitive Impairment (MCI): Examining the Level and the Associations of Resilience with Subjective Wellbeing and Negative Affect in Early and Late-Stage MCI. Behav Sci (Basel). 2023 Sep 23;13(10):792. doi: 10.3390/bs13100792.IF+2,98

(510) 5616. Tsiflikioti K, Moraitou D, Pezirkianidis C, Papantoniou G, Sofologi M, Kougioumtzis GA, Tsolaki M Enhancing Subjective Wellbeing in Older Individuals with Amnestic Mild Cognitive Impairment: A Randomized Trial of a Positive Psychology Intervention..Behav Sci (Basel). 2023 Oct 13;13(10):838. doi: 10.3390/bs13100838.PMID: 37887488. IF+2,98

(509) 5590. Li Y, Saul A, Taylor B, Ponsonby AL, Simpson-Yap S, Blizzard L, Broadley S, Lechner-Scott J; Ausimmune/AusLong Investigators Group; Karabudak R, Patti F, Eichau S, Onofrj M, Ozakbas S, Horakova D, Kubala Havrdova E, Grand'Maison F, Alroughani R, Gerlach O, Amato MP, Altintas A, Girard M, Duquette P, Blanco Y, Ramo-Tello C, Laureys G, Kalincik T, Khoury SJ, Shaygannejad V, Etemadifar M, Singhal B, Mrabet S, Foschi M, Habek M, John N, Hughes S, McCombe P, Ampapa R, van der Walt A, Butzkueven H, de Gans K, McGuigan C, Oreja-Guevara C, Sa MJ, Petersen T, Al-Harbi T, Sempere AP, Van Wijmeersch B, Grigoriadis N, Prevost J, Gray O, Castillo-Triviño T, Macdonell R, Lugaresi A, Sajedi SA; MSBase; van der Mei I.  Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.

J Neurol. 2023 Sep 28. IF=6,682

(508) 5585. Bampa G, Tsolaki M, Moraitou D, Metallidou P, Masoura E, Mintziviri M, Paparis K, Tsourou D, Papantoniou G, Sofologi M, Papaliagkas V, Kougioumtzis G, Papatzikis E. Metacognitive Differences in Amnestic Mild Cognitive Impairment and Healthy Cognition: A Cross-Sectional Study Employing Online Measures. J Intell. 2023 Sep 19;11(9):184. doi: 10.3390/jintelligence11090184.PMID: 37754914. IF=3,5

(507) (508) 5586. Pikouli FA, Moraitou D, Papantoniou G, Sofologi M, Papaliagkas V, Kougioumtzis G, Poptsi E, Tsolaki M. Metacognitive Strategy Training Improves Decision-Making Abilities in Amnestic Mild Cognitive Impairment. J Intell. 2023 Sep 11;11(9):182. doi: 10.3390/jintelligence11090182.PMID: 37754911. IF=3,5

  1. 5587. Sofologi M, Foutsitzi E, Papantoniou A, Kougioumtzis G, Zaragas H, Tsolaki M, Moraitou D, Papantoniou G. The Effect of Secondary Education Teachers' Metacognitive Knowledge and Professional Development on Their Tacit Knowledge Strategies. J Intell. 2023 Sep 6;11(9):179. IF=3,5

  2. 5452. Makri M, Gkioka M, Moraitou D, Fidani L, Tegos T, Tsolaki M. Attitudes, Motivations, and Barriers to Pre-Symptomatic Alzheimer's Disease Screening: Development and Validation of the 'Perceptions regarding pRE-symptomatic Alzheimer's Disease Screening' (PRE-ADS) Questionnaire.

J Alzheimers Dis. 2023 Sep 1. doi: 10.3233/JAD-220954. IF= 4,16

  1. 5451. Le Guen Y, Luo G, Ambati A, Damotte V, Jansen I, Yu E, Nicolas A, de Rojas I, Peixoto Leal T, Miyashita A, Bellenguez C, Lian MM, Parveen K, Morizono T, Park H, Grenier-Boley B, Naito T, Küçükali F, Talyansky SD, Yogeshwar SM, Sempere V, Satake W, Alvarez V, Arosio B, Belloy ME, Benussi L, Boland A, Borroni B, Bullido MJ, Caffarra P, Clarimon J, Daniele A, Darling D, Debette S, Deleuze JF, Dichgans M, Dufouil C, During E, Düzel E, Galimberti D, Garcia-Ribas G, García-Alberca JM, García-González P, Giedraitis V, Goldhardt O, Graff C, Grünblatt E, Hanon O, Hausner L, Heilmann-Heimbach S, Holstege H, Hort J, Jung YJ, Jürgen D, Kern S, Kuulasmaa T, Lee KH, Lin L, Masullo C, Mecocci P, Mehrabian S, de Mendonça A, Boada M, Mir P, Moebus S, Moreno F, Nacmias B, Nicolas G, Niida S, Nordestgaard BG, Papenberg G, Papma J, Parnetti L, Pasquier F, Pastor P, Peters O, Pijnenburg YAL, Piñol-Ripoll G, Popp J, Porcel LM, Puerta R, Pérez-Tur J, Rainero I, Ramakers I, Real LM, Riedel-Heller S, Rodriguez-Rodriguez E, Ross OA, Luís Royo J, Rujescu D, Scarmeas N, Scheltens P, Scherbaum N, Schneider A, Seripa D, Skoog I, Solfrizzi V, Spalletta G, Squassina A, van Swieten J, Sánchez-Valle R, Tan EK, Teg…See abstract for full author list ➔ Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04subtypes. Proc Natl Acad Sci U S A 2023 Sep 5;120(36):e2302720120.  doi: 10.1073/pnas.2302720120. Epub 2023 Aug 29.

  2. 5448. Tsolaki M, Makri M, Tsatali M, Teichmann Β. European Projects for Patients with Dementia and Their Caregivers.

Adv Exp Med Biol. 2023;1425:609-618.IF=3,65

502.5443. Tsatali M, Moraitou D, Boza ES, Tsolaki M.  Cognition and Functionality Were Not Affected Due to the COVID-19 Pandemic in People with Mild Cognitive Impairment and AD Dementia Attending Digital Non-Pharmacologic Interventions.

Brain Sci. 2023 Jul 8;13(7):1044. IF=3,17 

  1. 5442. Cesana BM, Poptsi E, Tsolaki M, Bergh S, Ciccone A, Cognat E, Fabbo A, Fascendini S, Frisoni GB, Frölich L, Jori MC, Mecocci P, Merlo P, Peters O, Defanti CA. A Confirmatory and an Exploratory Factor Analysis of the Cohen-Mansfield Agitation Inventory (CMAI) in a European Case Series of Patients with Dementia: Results from the RECage Study.

Brain Sci. 2023 Jul 3;13(7):1025. IF=3,17

  1. 5540. Tarnanas I, Tsolaki M. Making Pre-screening for Alzheimer's Disease (AD) and Postoperative Delirium Among Post-Acute COVID-19 Syndrome (PACS) a National Priority: The Deep Neuro Study.

Adv Exp Med Biol. 2023; 1424:41-47. doi: 10.1007/978-3-031-31982-2_4. IF=3,65

  1. 5536. Giannouli V, Tsolaki M.In the Hands of Hypnos: Associations between Sleep, Cognitive Performance and Financial Capacity in aMCI and Mild AD. Sleep Sci. 2023 Jul 6;16(2):231-236. IF=0,608

  2. 5534. Muurling M, Pasmooij AMG, Koychev I, Roik D, Froelich L, Schwertner E, Religa D, Abdelnour C, Boada M, Almici M, Galluzzi S, Cardoso S, de Mendonça A, Owens AP, Kuruppu S, Gjestsen MT, Lazarou I, Gkioka M, Tsolaki M, Diaz A, Gove D, Visser PJ, Aarsland D, Lucivero F, de Boer C; RADAR-AD Consortium. Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.

PLoS One. 2023 Jul 7;18(7):e0285807. IF-3.752

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0285807

  1. 5528. Lazarou I, Oikonomou VP, Mpaltadoros L, Grammatikopoulou M, Alepopoulos V, Stavropoulos TG, Bezerianos A, Nikolopoulos S, Kompatsiaris I, Tsolaki M; RADAR-AD Consortium. Eliciting brain waves of people with cognitive impairment during meditation exercises using portable electroencephalography in a smart-home environment: a pilot study.

Front Aging Neurosci. 2023 May 30;15:1167410. IF= 5.702

  1. 5523. Giannouli V, Tsolaki M. What Do Arithmetic Errors in the Financial Context Reveal? A Preliminary Study of Individuals with Neurocognitive Disorders. Neurol Int. 2023 Jun 1;15(2):743-749. IF=0,448
  2. 5505. European Alzheimer’s & Dementia Biobank Mendelian Randomization (EADB-MR) Collaboration; Luo J, Thomassen JQ, Bellenguez C, Grenier-Boley B, de Rojas I, Castillo A, Parveen K, Küçükali F, Nicolas A, Peters O, Schneider A, Dichgans M, Rujescu D, Scherbaum N, Jürgen D, Riedel-Heller S, Hausner L, Porcel LM, Düzel E, Grimmer T, Wiltfang J, Heilmann-Heimbach S, Moebus S, Tegos T, Scarmeas N, Clarimon J, Moreno F, Pérez-Tur J, Bullido MJ, Pastor P, Sánchez-Valle R, Álvarez V, Boada M, García-González P, Puerta R, Mir P, Real LM, Piñol-Ripoll G, García-Alberca JM, Royo JL, Rodriguez-Rodriguez E, Soininen H, Kuulasmaa T, de Mendonça A, Mehrabian S, Hort J, Vyhnalek M, van der Lee S, Graff C, Papenberg G, Giedraitis V, Boland A, Bacq-Daian D, Deleuze JF, Nicolas G, Dufouil C, Pasquier F, Hanon O, Debette S, Grünblatt E, Popp J, Benussi L, Galimberti D, Arosio B, Mecocci P, Solfrizzi V, Parnetti L, Squassina A, Tremolizzo L, Borroni B, Nacmias B, Sorbi S, Caffarra P, Seripa D, Rainero I, Daniele A, Masullo C, Spalletta G, Williams J, Amouyel P, Jessen F, Kehoe P, Tsolaki M, Rossi G, Sánchez-Juan P, Sleegers K, Ingelsson M, Andreassen OA, Hiltunen M, Van Duijn C, Sims R, van der …Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease. See abstract for full author list ➔JAMA Netw Open. 2023 May 1;6(5):e2313734. doi: 10.1001/jamanetworkopen.2023.13734. IF=13,37

  3. 5480. Cognat E, Sabia S, Fayel A, Lilamand M, Handels R, Fascendini S, Bergh S, Frisoni GB, Fabbo A, Tsolaki M, Frölich L, Peters O, Merlo P, Ciccone A, Mecocci P, Dumurgier J, Defanti CA, Hugon J, Paquet C. BPSD Patterns in Patients With Severe Neuropsychiatric Disturbances: Insight From the RECAGE Study. Am J Geriatr Psychiatry. 2023 Apr 23:S1064-7481(23)00265-8. doi: 10.1016/j.jagp.2023.03.014. IF=7.796

  4. 5476. Alexandri F, Papadopoulou L, Tsolaki A, Papantoniou G, Athanasiadis L, Tsolaki M.

The Effect of Cannabidiol 3% on Neuropsychiatric Symptoms in Dementia - Six-Month Follow-Up. Clin Gerontol. 2023 May 8:1-8. IF=2.871

 

  1. 5456. Tsolaki M, Arcan C, Zahid S. Editorial: The role of natural products in neurological disorders.

Front Neurol. 2023 Apr 13;14:1163282.IF= 4.086

  1. 5419. Dubois B, López-Arrieta J, Lipschitz S, Triantafyllos D, Spiru L, Moroz S, Venger O, Vermersch P, Moussy A, Mansfield CD, Hermine O, Tsolaki M; AB09004 Study Group Investigators. Alzheimers Res Ther. Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial. Alzheimers Res Ther. 2023 Feb 28;15(1):39. doi: 10.1186/s13195-023-01169-x. IF=6,42

 

  1. 5417. Giannouli V, Tsolaki M.Beneath the Top of the Iceberg: Financial Capacity Deficits in Mixed Dementia with and without Depression. Healthcare (Basel). 2023 Feb 9;11(4):505. doi: 10.3390/healthcare11040505. IF= 2.194

 

  1. 5416. Giannouli V, Tsolaki M. Brain Volumes and Metacognitive Deficits in Knowledge of Self, Task and Strategies in Mathematics: A Preliminary Pilot One-Year Longitudinal Study in aMCI Patients Compared to Healthy Controls.

Diagnostics (Basel). 2023 Feb 11;13(4):680. doi: 10.3390/diagnostics13040680. IF=3. 992

 

  1. 5409. Makri M, Christakidou A, Tsolaki M.A Novel Method of Teaching English to People with Mild Cognitive Impairment Using Songs: A Randomized Controlled Trial Protocol. J Alzheimer’s Dis. 2023 Feb 10. doi: 10.3233/JAD-220184. IF=4.160

 

  1. 5407. Poptsi E, Moraitou D, Tsardoulias E, Symeonidis AL, Papaliagkas V, Tsolaki M. R4Alz-Revised: A Tool Able to Strongly Discriminate 'Subjective Cognitive Decline' from Healthy Cognition and 'Minor Neurocognitive Disorder'.

Diagnostics (Basel). 2023 Jan 17;13(3):338. doi: 10.3390/diagnostics13030338. IF=3. 992

 

  1. 5347. Giannouli V, Tsolaki M. Is there a specific order of appearance of financial capacity deficits across neurocognitive disorders? What comes first and what should be treated. Int J Geriatr Psychiatry. 2023 Feb;38(2):e5880 IF= 3.485

 

  1. 5343. Devranis P, Vassilopoulou Ε, Tsironis V, Sotiriadis PM, Chourdakis M, Aivaliotis M, Tsolaki M. Mediterranean Diet, Ketogenic Diet or MIND Diet for Aging Populations with Cognitive Decline: A Systematic Review. Life (Basel). 2023 Jan 6;13(1):173. doi: 10.3390/life13010173. I.F=3.13

 

  1. 5345. Giannouli V, Tsolaki M. Stressful life events, general cognitive performance, and financial capacity in healthy older adults and Alzheimer's disease patients. Neuropsychiatr. 2023 Jan 4. doi: 10.1007/s40211-022-00451-y. IF= 1.456

 

  1. 5336. Tsentidou G, Moraitou D, Tsolaki M, Masoura E, Papaliagkas V. Trajectories of Cognitive Impairment in Adults Bearing Vascular Risk Factors, with or without Diagnosis of Mild Cognitive Impairment: Findings from a Longitudinal Study Assessing Executive Functions, Memory, and Social Cognition. Diagnostics (Basel). 2022 Dec 2;12(12):3017. doi: 10.3390/diagnostics12123017. IF=3992

 

  1. 5337. Poptsi E, Moraitou D, Tsatali M, Papaliagkas V, Tzanakaki-Melissari M, Kyriakoulaki E, Kounti F, Markou N, Liapi D, Batsila G, Ouzouni F, Vasiloglou M, Tsolaki M. Examining Voting Capacity in Older Adults with and without Cognitive Decline. Brain Sci. 2022 Nov 25;12(12):1614. doi: 10.3390/brainsci12121614. IF= 3.333

 

  1. 5334. Ioulietta Lazarou, Margarita Grammatikopoulou, Lampros Mpaltadoros, Ioanna Provata, Thanos G. Stavropoulos, Spiros Nikolopoulos, Chrysostomos Bourlis, Angelos Konstantinidis, Voula Ganosi, Ioannis Kompatsiaris, and Magda Tsolaki. The Effects of Playing the “We are Family” Brain Games in People with Mild Cognitive Impairment: A Feasibility Study. The Effects of Playing The “We are Family” Brain Games in People with Mild Cognitive Impairment and Alzheimer’s Disease: A Feasibility Study. J Alzheimers Dis Parkinsonism 13: 554. Impact Factor =2,18

 

  1. Küçükali F, Neumann A, Van Dongen J, De Pooter T, Joris G, De Rijk P, Ohlei O, Dobricic V, Bos I, Vos SJB, Engelborghs S, De Roeck E, Vandenberghe R, Gabel S, Meersmans K, Tsolaki M, Verhey F, Martinez-Lage P, Tainta M, Frisoni G, Blin O, Richardson JC, Bordet R; Alzheimer's Disease Neuroimaging Initiative (ADNI), Scheltens P, Popp J, Peyratout G, Johannsen P, Frölich L, Freund-Levi Y, Streffer J, Lovestone S, Legido-Quigley C, Kate MT, Barkhof F, Zetterberg H, Bertram L, Strazisar M, Visser PJ, Van Broeckhoven C, Sleegers K; EMIF-AD Study Group.Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits. Alzheimers Dement. 2022 Dec 4. doi: 10.1002/alz.12842. Online ahead of print. IF=21.566
  2. 5309. Tsentidou G, Moraitou D, Tsolaki M. Emotion Recognition in a Health Continuum: Comparison of Healthy Adults of Advancing Age, Community Dwelling Adults Bearing Vascular Risk Factors and People Diagnosed with Mild Cognitive Impairment.Int J Environ Res Public Health. 2022 Oct 16;19(20):13366.. IF=3.364

 

  1. 5310. Bampa G, Kouroglou D, Metallidou P, Tsolaki M, Kougioumtzis G, Papantoniou G, Sofologi M, Moraitou D.Metacognitive Scales: Assessing Metacognitive Knowledge in Older Adults Using Everyday Life Scenarios. Diagnostics (Basel). 2022 Oct 5;12(10):2410. doi: 10.3390/diagnostics12102410. IF=3.992

 

  1. 5302. Giannouli V, Tsolaki M. Neurocognitive disorders and financial altruism: A few or many steps away for financial generosity and self-justification statements to be used in the diagnosis of brain pathology in old age? Psychiatry Clin Neurosci. 2022 Oct 18. doi: 10.1111/pcn.13493. IF= 12.145

 

  1. 5287. Vassilopoulou E, Koumbi L, Karastogiannidou C, Sotiriadis PM, Felicia PC, Tsolaki M. Adjustment of the MIND diet tool for discriminating Greek patients with dementia: A confirmatory factor analysis.

Front Neurol. 2022 Sep 7;13:811314. doi: 10.3389/fneur.2022.811314. eCollection 2022. IF=3552

 

  1. 5286. Giannouli V, Tsolaki M. What Biological Factors, Social Determinants, and Psychological and Behavioral Symptoms of Patients with Mild Alzheimer's Disease Correlate with Caregiver Estimations of Financial Capacity? Bringing Biases Against Older Women Into Focus. J Alzheimers Dis Rep. 2022 Aug 5;6(1):503-507. If=3,1

  2. 5282. Tatiana-Danai D, John P, Anastasia K, Dimitrios K, Loukas A, Panagiotis I, Efrosini K, Thomas T, Magda T Non-Pharmacological Interventions for the Hallucinations in Patients with Dementia. A Cross-Over Randomized Controlled Trial.

.J Clin Cases Rep. 2022;5(4):139-148. Epub 2022 Jan 31. IF=0,532

  1.   Jansen IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, Dalmasso MC, Grenier-Boley B, Zettergren A, Mishra A, Ali M, Andrade V, Bellenguez C, Kleineidam L, Küçükali F, Sung YJ, Tesí N, Vromen EM, Wightman DP, Alcolea D, Alegret M, Alvarez I, Amouyel P, Athanasiu L, Bahrami S, Bailly H, Belbin O, Bergh S, Bertram L, Biessels GJ, Blennow K, Blesa R, Boada M, Boland A, Buerger K, Carracedo Á, Cervera-Carles L, Chene G, Claassen JAHR, Debette S, Deleuze JF, de Deyn PP, Diehl-Schmid J, Djurovic S, Dols-Icardo O, Dufouil C, Duron E, Düzel E; EADB consortium, Fladby T, Fortea J, Frölich L, García-González P, Garcia-Martinez M, Giegling I, Goldhardt O, Gobom J, Grimmer T, Haapasalo A, Hampel H, Hanon O, Hausner L, Heilmann-Heimbach S, Helisalmi S, Heneka MT, Hernández I, Herukka SK, Holstege H, Jarholm J, Kern S, Knapskog AB, Koivisto AM, Kornhuber J, Kuulasmaa T, Lage C, Laske C, Leinonen V, Lewczuk P, Lleó A, de Munain AL, Lopez-Garcia S, Maier W, Marquié M, Mol MO, Montrreal L, Moreno F, Moreno-Grau S, Nicolas G, Nöthen MM, Orellana A, Pålhaugen L, Papma JM, Pasquier F, Perneczky R, Peters O, Pijnenburg YAL, Popp J, Posthuma D, Pozueta A, Priller J, Puerta R, Quintela I, Ramakers I, Rodriguez-Rodriguez E, Rujescu D, Saltvedt I, Sanchez-Juan P, Scheltens P, Scherbaum N, Schmid M, Schneider A, Selbæk G, Selnes P, Shadrin A, Skoog I, Soininen H, Tárraga L, Teipel S; GR@ACE study group, Tijms B, Tsolaki M, Van Broeckhoven C, Van Dongen J, van Swieten JC, Vandenberghe R, Vidal JS, Visser PJ, Vogelgsang J, Waern M, Wagner M, Wiltfang J, Wittens MMJ, Zetterberg H, Zulaica M, van Duijn CM, Bjerke M, Engelborghs S, Jessen F, Teunissen CE, Pastor P, Hiltunen M, Ingelsson M, Andreassen OA, Clarimón J, Sleegers K, Ruiz A, Ramirez A, Cruchaga C, Lambert JC, van der Flier W. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.

Acta Neuropathol. 2022 Sep 6. IF= 15.887

 

  1. Giannouli V, Tsolaki M. Neuropsychological Performance and Engagement in Estate Planning and Advance Care Planning Preparation of Patients With Neurocognitive Disorders and Healthy Older Adults: Is the Situation Alarming or Reassuring in Greece?

Gerontol Geriatr Med. 2022 Aug 25;8:23337214221119053.IF=1470

 

  1. Giannouli V, Tsolaki M. Elder financial abuse and the COVID-19 pandemic: A call to action through training programmes?

Psychiatriki. 2022 Aug 30.IF=1.113 

  1. Stamovlasis D, Giannouli V, Vaiopoulou J, Tsolaki MCatastrophe Theory Applied to Neuropsychological Data: Nonlinear Effects of Depression on Financial Capacity in Amnestic Mild Cognitive Impairment and Dementia. Entropy (Basel). 2022 Aug 7;24(8):1089.IF= 2.524

 

  1. Giannouli V, Tsolaki M. Self-Awareness of Cognitive Efficiency, Cognitive Status, Insight, and Financial Capacity in Patients with Mild AD, aMCI, and Healthy Controls: An Intriguing Liaison with Clinical Implications? Neurol Int. 2022 Jul 30;14(3):628-637.IF=1,1

 

  1. Tsolaki M, Sia E, Giannouli V.Anesthesia and dementia: an up-to-date review of the existing literature. Appl Neuropsychol Adult. 2022 Aug 18:1-10. 2.248. IF=1.10

 

  1. 5246. Chatzikostopoulos A, Moraitou D, Tsolaki M, Masoura E, Papantoniou G, Sofologi M, Papaliagkas V, Kougioumtzis G, Papatzikis E. Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's Disease Dementia (ADD): Using the "Doors and People" Tool to Differentiate between Early aMCI-Late aMCI-Mild ADD Diagnostic Groups.

Diagnostics (Basel). 2022 Jul 21;12(7):1768. IF=3992

 

  1. Dimitriou T, Papatriantafyllou J, Konsta A, Kazis D, Athanasiadis L, Ioannidis P, Koutsouraki E, Tegos T, Tsolaki M. Assess of Combinations of Non-Pharmacological Interventions for the Reduction of Irritability in Patients with Dementia and their Caregivers: A Cross-Over RCT. Brain Sci. 2022 May 26;12(6):691. IF= 3.333

 

  1. 5233. Teichmann B, Gkioka M, Kruse A, Tsolaki M. Informal Caregivers' Attitude Toward Dementia: The Impact of Dementia Knowledge, Confidence in Dementia Care, and the Behavioral and Psychological Symptoms of the Person with Dementia. A Cross-Sectional Study. J Alzheimers Dis. 2022 Jun 13. doi: 10.3233/JAD-215731. IF= 4.472

 

  1. 5231. Zygouris S, Segkouli S, Triantafyllidis A, Giakoumis D, Tsolaki M, Votis K, Tzovaras D. Usability of the Virtual Supermarket Test for Older Adults with and without Cognitive Impairment. J Alzheimers Dis Rep. 2022 May 13;6(1):229-234. IF= 4.472

 

  1. 5226. Delvenne A, Gobom J, Tijms B, Bos I, Reus LM, Dobricic V, Kate MT, Verhey F, Ramakers I, Scheltens P, Teunissen CE, Vandenberghe R, Schaeverbeke J, Gabel S, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Tsolaki M, Freund-Levi Y, Lovestone S, Streffer J, Barkhof F, Bertram L, Blennow K, Zetterberg H, Visser PJ, Vos SJB. Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.

Alzheimers Dement. 2022 Jun 14. doi: 10.1002/alz.12713 ΙF= 21.566

 

  1. 5214. Le Guen Y, Belloy ME, Grenier-Boley B, de Rojas I, Castillo-Morales A, Jansen I, Nicolas A, Bellenguez C, Dalmasso C, Küçükali F, Eger SJ, Rasmussen KL, Thomassen JQ, Deleuze JF, He Z, Napolioni V, Amouyel P, Jessen F, Kehoe PG, van Duijn C, Tsolaki M, Sánchez-Juan P, Sleegers K, Ingelsson M, Rossi G, Hiltunen M, Sims R, van der Flier WM, Ramirez A, Andreassen OA, Frikke-Schmidt R, Williams J, Ruiz A, Lambert JC, Greicius MD; Members of the EADB, GR@ACE, DEGESCO, DemGene, GERAD, and EADI Groups, Arosio B, Benussi L, Boland A, Borroni B, Caffarra P, Daian D, Daniele A, Debette S, Dufouil C, Düzel E, Galimberti D, Giedraitis V, Grimmer T, Graff C, Grünblatt E, Hanon O, Hausner L, Heilmann-Heimbach S, Holstege H, Hort J, Jürgen D, Kuulasmaa T, van der Lugt A, Masullo C, Mecocci P, Mehrabian S, de Mendonça A, Moebus S, Nacmias B, Nicolas G, Olaso R, Papenberg G, Parnetti L, Pasquier F, Peters O, Pijnenburg YAL, Popp J, Rainero I, Ramakers I, Riedel-Heller S, Scarmeas N, Scheltens P, Scherbaum N, Schneider A, Seripa D, Soininen H, Solfrizzi V, Spalletta G, Squassina A, van Swieten J, Tegos TJ, Tremolizzo L, Verhey F, Vyhnalek M, Wiltfang J, Boada M, García-González P, Puerta R, Real LM, Álvarez V, Bullido MJ, Clarimon J, García-Alberca JM, Mir P, Moreno F, Pastor P, Piñol-Ripoll G, Molina-Porcel L, Pérez-Tur J, Rodríguez-Rodríguez E, Royo JL, Sánchez-Valle R, Dichgans M, Rujescu D.Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.

JAMA Neurol. 2022 May 31. IF=11,5

 

  1. 5207. Wesenhagen KEJ, Gobom J, Bos I, Vos SJB, Martinez-Lage P, Popp J, Tsolaki M, Vandenberghe R, Freund-Levi Y, Verhey F, Lovestone S, Streffer J, Dobricic V, Bertram L; Alzheimer's Disease Neuroimaging Initiative, Blennow K, Pikkarainen M, Hallikainen M, Kuusisto J, Laakso M, Soininen H, Scheltens P, Zetterberg H, Teunissen CE, Visser PJ, Tijms BM. Effects of age, amyloid, sex, and APOEε4 on the CSF proteome in normal cognition.

Alzheimers Dement (Amst). 2022 May 6;14(1):e12286. IF= 2.497

 

  1. 5206. Visser PJ, Reus LM, Gobom J, Jansen I, Dicks E, van der Lee SJ, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Freund-Levi Y, Froelich L, Sleegers K, Dobricic V, Lovestone S, Streffer J, Vos SJB, Bos I; ADNI, Smit AB, Blennow K, Scheltens P, Teunissen CE, Bertram L, Zetterberg H, Tijms BMCorrection: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease.

.Mol Neurodegener. 2022 May 13;17(1):37. doi: 10.1186/s13024-022-00540-0. IF=14.195

 

  1. 5191. Bellenguez C, Küçükali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, Holmans PA, Boland A, Damotte V, van der Lee SJ, Costa MR, Kuulasmaa T, Yang Q, de Rojas I, Bis JC, Yaqub A, Prokic I, Chapuis J, Ahmad S, Giedraitis V, Aarsland D, Garcia-Gonzalez P, Abdelnour C, Alarcón-Martín E, Alcolea D, Alegret M, Alvarez I, Álvarez V, Armstrong NJ, Tsolaki A, Antúnez C, Appollonio I, Arcaro M, Archetti S, Pastor AA, Arosio B, Athanasiu L, Bailly H, Banaj N, Baquero M, Barral S, Beiser A, Pastor AB, Below JE, Benchek P, Benussi L, Berr C, Besse C, Bessi V, Binetti G, Bizarro A, Blesa R, Boada M, Boerwinkle E, Borroni B, Boschi S, Bossù P, Bråthen G, Bressler J, Bresner C, Brodaty H, Brookes KJ, Brusco LI, Buiza-Rueda D, Bûrger K, Burholt V, Bush WS, Calero M, Cantwell LB, Chene G, Chung J, Cuccaro ML, Carracedo Á, Cecchetti R, Cervera-Carles L, Charbonnier C, Chen HH, Chillotti C, Ciccone S, Claassen JAHR, Clark C, Conti E, Corma-Gómez A, Costantini E, Custodero C, Daian D, Dalmasso MC, Daniele A, Dardiotis E, Dartigues JF, de Deyn PP, de Paiva Lopes K, de Witte LD, Debette S, Deckert J, Del Ser T, Denning N, DeStefano A, Dichgans M, Diehl-Schmid J, Diez-Fairen M, Rossi PD, Djurovic S, Duron E, Düzel E, Dufouil C, Eiriksdottir G, Engelborghs S, Escott-Price V, Espinosa A, Ewers M, Faber KM, Fabrizio T, Nielsen SF, Fardo DW, Farotti L, Fenoglio C, Fernández-Fuertes M, Ferrari R, Ferreira CB, Ferri E, Fin B, Fischer P, Fladby T, Fließbach K, Fongang B, Fornage M, Fortea J, Foroud TM, Fostinelli S, Fox NC, Franco-Macías E, Bullido MJ, Frank-García A, Froelich L, Fulton-Howard B, Galimberti D, García-Alberca JM, García-González P, Garcia-Madrona S, Garcia-Ribas G, Ghidoni R, Giegling I, Giorgio G, Goate AM, Goldhardt O, Gomez-Fonseca D, González-Pérez A, Graff C, Grande G, Green E, Grimmer T, Grünblatt E, Grunin M, Gudnason V, Guetta-Baranes T, Haapasalo A, Hadjigeorgiou G, Haines JL, Hamilton-Nelson KL, Hampel H, Hanon O, Hardy J, Hartmann AM, Hausner L, Harwood J, Heilmann-Heimbach S, Helisalmi S, Heneka MT, Hernández I, Herrmann MJ, Hoffmann P, Holmes C, Holstege H, Vilas RH, Hulsman M, Humphrey J, Biessels GJ, Jian X, Johansson C, Jun GR, Kastumata Y, Kauwe J, Kehoe PG, Kilander L, Ståhlbom AK, Kivipelto M, Koivisto A, Kornhuber J, Kosmidis MH, Kukull WA, Kuksa PP, Kunkle BW, Kuzma AB, Lage C, Laukka EJ, Launer L, Lauria A, Lee CY, Lehtisalo J, Lerch O, Lleó A, Longstreth W Jr, Lopez O, de Munain AL, Love S, Löwemark M, Luckcuck L, Lunetta KL, Ma Y, Macías J, MacLeod CA, Maier W, Mangialasche F, Spallazzi M, Marquié M, Marshall R, Martin ER, Montes AM, Rodríguez CM, Masullo C, Mayeux R, Mead S, Mecocci P, Medina M, Meggy A, Mehrabian S, Mendoza S, Menéndez-González M, Mir P, Moebus S, Mol M, Molina-Porcel L, Montrreal L, Morelli L, Moreno F, Morgan K, Mosley T, Nöthen MM, Muchnik C, Mukherjee S, Nacmias B, Ngandu T, Nicolas G, Nordestgaard BG, Olaso R, Orellana A, Orsini M, Ortega G, Padovani A, Paolo C, Papenberg G, Parnetti L, Pasquier F, Pastor P, Peloso G, Pérez-Cordón A, Pérez-Tur J, Pericard P, Peters O, Pijnenburg YAL, Pineda JA, Piñol-Ripoll G, Pisanu C, Polak T, Popp J, Posthuma D, Priller J, Puerta R, Quenez O, Quintela I, Thomassen JQ, Rábano A, Rainero I, Rajabli F, Ramakers I, Real LM, Reinders MJT, Reitz C, Reyes-Dumeyer D, Ridge P, Riedel-Heller S, Riederer P, Roberto N, Rodriguez-Rodriguez E, Rongve A, Allende IR, Rosende-Roca M, Royo JL, Rubino E, Rujescu D, Sáez ME, Sakka P, Saltvedt I, Sanabria Á, Sánchez-Arjona MB, Sanchez-Garcia F, Juan PS, Sánchez-Valle R, Sando SB, Sarnowski C, Satizabal CL, Scamosci M, Scarmeas N, Scarpini E, Scheltens P, Scherbaum N, Scherer M, Schmid M, Schneider A, Schott JM, Selbæk G, Seripa D, Serrano M, Sha J, Shadrin AA, Skrobot O, Slifer S, Snijders GJL, Soininen H, Solfrizzi V, Solomon A, Song Y, Sorbi S, Sotolongo-Grau O, Spalletta G, Spottke A, Squassina A, Stordal E, Tartan JP, Tárraga L, Tesí N, Thalamuthu A, Thomas T, Tosto G, Traykov L, Tremolizzo L, Tybjærg-Hansen A, Uitterlinden A, Ullgren A, Ulstein I, Valero S, Valladares O, Broeckhoven CV, Vance J, Vardarajan BN, van der Lugt A, Dongen JV, van Rooij J, van Swieten J, Vandenberghe R, Verhey F, Vidal JS, Vogelgsang J, Vyhnalek M, Wagner M, Wallon D, Wang LS, Wang R, Weinhold L, Wiltfang J, Windle G, Woods B, Yannakoulia M, Zare H, Zhao Y, Zhang X, Zhu C, Zulaica M; EADB; GR@ACE; DEGESCO; EADI; GERAD; Demgene; FinnGen; ADGC; CHARGE, Farrer LA, Psaty BM, Ghanbari M, Raj T, Sachdev P, Mather K, Jessen F, Ikram MA, de Mendonça A, Hort J, Tsolaki M, Pericak-Vance MA, Amouyel P, Williams J, Frikke-Schmidt R, Clarimon J, Deleuze JF, Rossi G, Seshadri S, Andreassen OA, Ingelsson M, Hiltunen M, Sleegers K, Schellenberg GD, van Duijn CM, Sims R, van der Flier WM, Ruiz A, Ramirez A, Lambert JC.New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022 Apr 4. doi: 10.1038/s41588-022-01024-z. Online ahead of print. PMID: 35379992. IF= 38.333

 

  1. 5189. Lazarou I, Georgiadis K, Nikolopoulos S, Oikonomou VP, Stavropoulos TG, Tsolaki A, Kompatsiaris I, Tsolaki M; and the RADAR-AD Consortiume. Exploring Network Properties Across Preclinical Stages of Alzheimer's Disease Using a Visual Short-Term Memory and Attention Task with High-Density Electroencephalography: A Brain-Connectome Neurophysiological Study. J Alzheimers Dis. 2022 Apr 1. doi: 10.3233/JAD-215421. IF= 4,472

 

  1. 5187. Nikolaidou E, Tsatali M, Eleftheriou M, Wang H, Karagiozi K, Margaritidou P, Tsolaki M. Emotional Function, Negative Thoughts about the Pandemic, and Adaptability Skills among Dementia Caregivers during the COVID-19 Pandemic. Brain Sci. 2022 Mar 29;12(4):459. IF= 3.114

 

  1. 5182. 457. Visser PJ, Reus LM, Gobom J, Jansen I, Dicks E, van der Lee SJ, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Freund-Levi Y, Froelich L, Sleegers K, Dobricic V, Lovestone S, Streffer J, Vos SJB, Bos I; ADNI, Smit AB, Blennow K, Scheltens P, Teunissen CE, Bertram L, Zetterberg H, Tijms BM. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease. Mol Neurodegener. 2022 Mar 28;17(1):27. IF= 14.195

 

  1. 5173. Giannouli V, Tsolaki M. Liberating older adults from the bonds of vascular risk factors: What is their impact on financial capacity in aMCI? Psychiatry Clin Neurosci. 2022 Mar 9. IF=5.188

 

  1. 5165. Dimitriou T, Papatriantafyllou J, Konsta A, Kazis D, Athanasiadis L, Ioannidis P, Koutsouraki E, Tegos T, Tsolaki M.Non-Pharmacological Interventions for Wandering/Aberrant Motor Behavior in Patients with Dementia. Brain Sci. 2022 Jan 19;12(2):130. IF=3.394

 

  1. 5164. Tsatali M, Avdikou K, Gialaouzidis M, Minopoulou D, Emmanouel A, Kouroundi E, Tsolaki M. The discriminant validity of Rey Complex Figure Test (RCFT) in subjective cognitive decline, mild cognitive impairment (multiple domain) and Alzheimer's disease dementia (ADD; mild stage) in Greek older adults. Appl Neuropsychol Adult. 2022 Feb 21:1. IF= 2,248

 

  1. 5161. Sexton C, Solis M, Aharon-Peretz J, Alexopoulos P, Apostolova LG, Bayen E, Birkenhager B, Cappa S, Constantinidou F, Fortea J, Gerritsen DL, Hassanin HI, Ibanez A, Ioannidis P, Karageorgiou E, Korczyn A, Leroi I, Lichtwarck B, Logroscino G, Lynch C, Mecocci P, Molinuevo JL, Papatriantafyllou J, Papegeorgiou S, Politis A, Raman R, Ritchie K, Sanchez-Juan P, Sano M, Scarmeas N, Spiru L, Stathi A, Tsolaki M, Yener G, Zaganas I, Zygouris S, Carrillo M. Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium. Alzheimers Dement. 2022 Feb 20. ΙF= 21.566

 

  1. 5147. Giannouli V, Tsolaki M. Financial Incapacity of Patients with Mild Alzheimer's Disease: What Neurologists Need to Know about Where the Impairment Lies. Neurol Int. 2022 Jan 11;14(1):90-98. IF=1,22

 

  1. 5139. Giannouli V, Stamovlasis D, Tsolaki M.Longitudinal Study of Depression on Amnestic Mild Cognitive Impairment and Financial Capacity. Clin Gerontol. 2022 Jan 5:1-7. IF=2.24

 

  1. 5101. Ntracha A, Iakovakis D, Hadjidimitriou S, Charisis VS, Tsolaki M, Hadjileontiadis LJ. Detection of Mild Cognitive Impairment Through Natural Language and Touchscreen Typing Processing. Front Digit Health. 2020 Oct 8;2:567158. doi: 10.3389/fdgth.2020.567158. IF=5.175.

 

  1. 5133. Delaby C, Teunissen CE, Blennow K, Alcolea D, Arisi I, Amar EB, Beaume A, Bedel A, Bellomo G, Bigot-Corbel E, Bjerke M, Blanc-Quintin MC, Boada M, Bousiges O, Chapman MD, DeMarco ML, D'Onofrio M, Dumurgier J, Dufour-Rainfray D, Engelborghs S, Esselmann H, Fogli A, Gabelle A, Galloni E, Gondolf C, Grandhomme F, Grau-Rivera O, Hart M, Ikeuchi T, Jeromin A, Kasuga K, Keshavan A, Khalil M, Körtvelyessy P, Kulczynska-Przybik A, Laplanche JL, Lewczuk P, Li QX, Lleó A, Malaplate C, Marquié M, Masters CL, Mroczko B, Nogueira L, Orellana A, Otto M, Oudart JB, Paquet C, Paoletti FP, Parnetti L, Perret-Liaudet A, Peoc'h K, Poesen K, Puig-Pijoan A, Quadrio I, Quillard-Muraine M, Rucheton B, Schraen S, Schott JM, Shaw LM, Suárez-Calvet M, Tsolaki M, Tumani H, Udeh-Momoh CT, Vaudran L, Verbeek MM, Verde F, Vermunt L, Vogelgsang J, Wiltfang J, Zetterberg H, Lehmann S. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview. Alzheimers Dement. 2021 Dec 22. IF= 21.566

 

  1. 4780. Makri M, Christakidou A, Tsolaki M. English Lessons with the Use of Songs for People with Mild Cognitive Impairment. Alzheimers Dement. 2021 Dec;17 Suppl 12:e058651. ΙF=21.566

 

  1. 5126. Janssen O, Jansen WJ, Vos SJB, Boada M, Parnetti L, Gabryelewicz T, Fladby T, Molinuevo JL, Villeneuve S, Hort J, Epelbaum S, Lleó A, Engelborghs S, van der Flier WM, Landau S, Popp J, Wallin A, Scheltens P, Rikkert MO, Snyder PJ, Rowe C, Chételat G, Ruíz A, Marquié M, Chipi E, Wolfsgruber S, Heneka M, Boecker H, Peters O, Jarholm J, Rami L, Tort-Merino A, Binette AP, Poirier J, Rosa-Neto P, Cerman J, Dubois B, Teichmann M, Alcolea D, Fortea J, Sánchez-Saudinós MB, Ebenau J, Pocnet C, Eckerström M, Thompson L, Villemagne V, Buckley R, Burnham S, Delarue M, Freund-Levi Y, Wallin ÅK, Ramakers I, Tsolaki M, Soininen H, Hampel H, Spiru L; Alzheimer's Disease Neuroimaging Initiative; FACEHBI study group; PREVENT-AD research group, Tijms B, Ossenkoppele R, Verhey FRJ, Jessen F, Visser PJ. Characteristics of subjective cognitive decline associated with amyloid positivity. Alzheimers Dement. 2021 Dec 8. ΙF= 21.566

 

  1. 5121. Xu J, Green R, Kim M, Lord J, Ebshiana A, Westwood S, Baird AL, Nevado-Holgado AJ, Shi L, Hye A, Snowden SG, Bos I, Vos SJB, Vandenberghe R, Teunissen CE, Kate MT, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck EE, Engelborghs S, Sleegers K, Bordet R, Rami L, Kettunen P, Tsolaki M, Verhey FRJ, Alcolea D, Lleó A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Proitsi P, Legido-Quigley C, On Behalf Of The European Medical Information Framework Consortium. Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort.Biomedicines. 2021 Nov 3;9(11):1610. ΙF=5.612

 

  1. 5111. Giannouli V, Tsolaki M. Financial Capacity and Illiteracy: Does Education Matter in Amnestic Mild Cognitive Impairment? J Alzheimers Dis Rep. 2021 Sep 6;5(1):715-719.IF= 4.472

 

  1. 5107. Tzekaki EE, Tsolaki M, Geromichalos GD, Pantazaki ΑA. Extra Virgin Olive Oil consumption from Mild Cognitive Impairment patients attenuates oxidative and nitrative stress reflecting on the reduction of the PARP levels and DNA damage. Exp Gerontol. 2021 Dec:156:111621. doi: 10.1016/j.exger.2021.111621.IF= 3,376

 

  1. 5093. Lazarou I, Moraitou D, Papatheodorou M, Vavouras I, Lokantidou C, Agogiatou C, Gialaoutzis M, Nikolopoulos S, Stavropoulos TG, Kompatsiaris IY, Tsolaki M. Adaptation and Validation of the Memory Alteration Test (M@T) in Greek Middle-Aged, Older, and Older-Old Population with Subjective Cognitive Decline and Mild Cognitive Impairment. J Alzheimers Dis. 2021 Oct 10. doi: 10.3233/JAD-210558. IF= 4.472

 

  1. 5091. Katsipis G, Tzekaki EE, Tsolaki M, Pantazaki AA. Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis. J Neuroimmunol. 2021 Oct 9;361:577744. doi: 10.1016/j.jneuroim.2021.577744. IF=3.478

 

  1. 4709. Dimitriadis SI, Tarnanas I, Wiederhold M, Wiederhold B, Tsolaki M, Fleisch E.Mnemonic strategy training of the elderly at risk for dementia enhances integration of information processing via cross-frequency coupling. Alzheimers Dement (N Y). 2016 Sep 15;2(4):241-249. doi: 10.1016/j.trci.2016.08.004. eCollection 2016 IF=17,127

 

  1. 5051. Simrén J, Leuzy A, Karikari TK, Hye A, Benedet AL, Lantero-Rodriguez J, Mattsson-Carlgren N, Schöll M, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Aarsland D; AddNeuroMed consortium, Hansson O, Rosa-Neto P, Westman E, Blennow K, Zetterberg H, Ashton NJ.The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease. Alzheimers Dement. 2021 Jul;17(7):1145-1156. doi: 10.1002/alz.12283. IF=17,127

 

  1. 5071. Tsatali M, Moraitou D, Poptsi E, Sia E, Agogiatou C, Gialaouzidis M, Tabakis IM, Avdikou K, Bakoglidou E, Batsila G, Bekiaridis-Moschou D, Chatziroumpi O, Diamantidou A, Gavra A, Kouroundi E, Liapi D, Markou N, Ouzouni F, Papasozomenou C, Soumpourou A, Tsolaki M. Are There Any Cognitive and Behavioral Changes Potentially Related to Quarantine Due to the COVID-19 Pandemic in People with Mild Cognitive Impairment and AD Dementia? A Longitudinal Study. Brain Sci. 2021 Aug 31;11(9):1165. IF= 3.578

 

  1. 5058. Stavropoulos TG, Meditskos G, Lazarou I, Mpaltadoros L, Papagiannopoulos S, Tsolaki M, Kompatsiaris I. Detection of Health-Related Events and Behaviours from Wearable Sensor Lifestyle Data Using Symbolic Intelligence: A Proof-of-Concept Application in the Care of Multiple Sclerosis. Sensors (Basel). 2021 Sep 17;21(18):6230. IF=3,576

 

  1. 5068. Tsolaki M, Tsatali M, Gkioka M, Poptsi E, Tsolaki A, Papaliagkas V, Tabakis IM, Lazarou I, Makri M, Kazis D, Papagiannopoulos S, Kiryttopoulos A, Koutsouraki E, Tegos T. Memory Clinics and Day Care Centers in Thessaloniki, Northern Greece: 30 Years of Clinical Practice and Experience. Front Neurol. 2021 Aug 25;12:683131. IF=3,62
  2. 5070. Tijms BM, Gobom J, Teunissen C, Dobricic V, Tsolaki M, Verhey F, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuévo JL, Engelborghs S, Freund-Levi Y, Froelich L, Bertram L, Lovestone S, Streffer J, Vos S, Adni, Blennow K, Scheltens P, Zetterberg H, Visser PJ.CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals. Proteomes. 2021 Aug 2;9(3):36. doi: 10.3390/proteomes9030036. IF=2,91

 

  1. 5069. Tsatali M, Moraitou D, Papantoniou G, Foutsitzi E, Bonti E, Kougioumtzis G, Ntritsos G, Sofologi M, Tsolaki M. Measuring Impulsivity in Greek Adults: Psychometric Properties of the Barratt Impulsiveness Scale (BIS-11) and Impulsive Behavior Scale (Short Version of UPPS-P). Brain Sci. 2021 Jul 29;11(8):1007. IF=3.110

 

  1. 5063. Lazarou I, Stavropoulos TG, Mpaltadoros L, Nikolopoulos S, Koumanakos G, Tsolaki M, Kompatsiaris IY. Human Factors and Requirements of People with Cognitive Impairment, Their Caregivers, and Healthcare Professionals for mHealth Apps Including Reminders, Games, and Geolocation Tracking: A Survey-Questionnaire Study. J Alzheimers Dis Rep. 2021 Jun 11;5(1):497-513. IF=4.472.

 

  1. 5061. Lazarev VF, Tsolaki M, Mikhaylova ER, Benken KA, Shevtsov MA, Nikotina AD, Lechpammer M, Mitkevich VA, Makarov AA, Moskalev AA, Kozin SA, Margulis BA, Guzhova IV, Nudler E.Extracellular GAPDH Promotes Alzheimer Disease Progression by Enhancing Amyloid-β Aggregation and Cytotoxicity. Aging Dis. 2021 Aug 1;12(5):1223-1237. IF=6.745

 

  1. 5052. Dimitriadis SI, Lyssoudis C, Tsolaki AC, Lazarou E, Kozori M, Tsolaki M.Greek High Phenolic Early Harvest Extra Virgin Olive Oil Reduces the Over-Excitation of Information-Flow Based on Dominant Coupling Mode Model in Patients with Mild Cognitive Impairment: An EEG Resting-State Validation Approach. J Alzheimers Dis. 2021 Jul 19. doi: 10.3233/JAD-210454. ΙF=3.909

 

  1. 5046. Karagiozi K, Margaritidou P, Tsatali M, Marina M, Dimitriou T, Apostolidis H, Tsiatsos T, Tsolaki M.Comparison of on Site versus Online Psycho Education Groups and Reducing Caregiver Burden. Clin Gerontol. 2021 Jul 5:1-11. IF=1,375

 

  1. 5045. Giannouli V, Tsolaki M.Is Depression or Apathy Playing a Key Role in Predicting Financial Capacity in Parkinson's Disease with Dementia and Frontotemporal Dementia? Brain Sci. 2021 Jun 14;11(6):785. IF=3.110

 

  1. 5044. Tsatali M, Poptsi E, Moraitou D, Agogiatou C, Bakoglidou E, Gialaouzidis M, Papasozomenou C, Soumpourou A, Tsolaki M. Discriminant Validity of the WAIS-R Digit Symbol Substitution Test in Subjective Cognitive Decline, Mild Cognitive Impairment (Amnestic Subtype) and Alzheimer's Disease Dementia (ADD) in Greece. Brain Sci. 2021 Jun 30;11(7):881. IF=3.110

 

  1. 5036. Kladi A, Iliadou P, Tsolaki M, Moraitou D. Age-related Differences in Mu rhythm during Emotional Destination Memory. Curr Aging Sci. 2021 Jun 7. IF=1,78

 

  1. 5031. de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, Pedersen NL, Stringa N, Zettergren A, Hernández I, Montrreal L, Antúnez C, Antonell A, Tankard RM, Bis JC, Sims R, Bellenguez C, Quintela I, González-Perez A, Calero M, Franco-Macías E, Macías J, Blesa R, Cervera-Carles L, Menéndez-González M, Frank-García A, Royo JL, Moreno F, Huerto Vilas R, Baquero M, Diez-Fairen M, Lage C, García-Madrona S, García-González P, Alarcón-Martín E, Valero S, Sotolongo-Grau O, Ullgren A, Naj AC, Lemstra AW, Benaque A, Pérez-Cordón A, Benussi A, Rábano A, Padovani A, Squassina A, de Mendonça A, Arias Pastor A, Kok AAL, Meggy A, Pastor AB, Espinosa A, Corma-Gómez A, Martín Montes A, Sanabria Á, DeStefano AL, Schneider A, Haapasalo A, Kinhult Ståhlbom A, Tybjærg-Hansen A, Hartmann AM, Spottke A, Corbatón-Anchuelo A, Rongve A, Borroni B, Arosio B, Nacmias B, Nordestgaard BG, Kunkle BW, Charbonnier C, Abdelnour C, Masullo C, Martínez Rodríguez C, Muñoz-Fernandez C, Dufouil C, Graff C, Ferreira CB, Chillotti C, Reynolds CA, Fenoglio C, Van Broeckhoven C, Clark C, Pisanu C, Satizabal CL, Holmes C, Buiza-Rueda D, Aarsland D, Rujescu D, Alcolea D, Galimberti D, Wallon D, Seripa D, Grünblatt E, Dardiotis E, Düzel E, Scarpini E, Conti E, Rubino E, Gelpi E, Rodriguez-Rodriguez E, Duron E, Boerwinkle E, Ferri E, Tagliavini F, Küçükali F, Pasquier F, Sanchez-Garcia F, Mangialasche F, Jessen F, Nicolas G, Selbæk G, Ortega G, Chêne G, Hadjigeorgiou G, Rossi G, Spalletta G, Giaccone G, Grande G, Binetti G, Papenberg G, Hampel H, Bailly H, Zetterberg H, Soininen H, Karlsson IK, Alvarez I, Appollonio I, Giegling I, Skoog I, Saltvedt I, Rainero I, Rosas Allende I, Hort J, Diehl-Schmid J, Van Dongen J, Vidal JS, Lehtisalo J, Wiltfang J, Thomassen JQ, Kornhuber J, Haines JL, Vogelgsang J, Pineda JA, Fortea J, Popp J, Deckert J, Buerger K, Morgan K, Fließbach K, Sleegers K, Molina-Porcel L, Kilander L, Weinhold L, Farrer LA, Wang LS, Kleineidam L, Farotti L, Parnetti L, Tremolizzo L, Hausner L, Benussi L, Froelich L, Ikram MA, Deniz-Naranjo MC, Tsolaki M, Rosende-Roca M, Löwenmark M, Hulsman M, Spallazzi M, Pericak-Vance MA, Esiri M, Bernal Sánchez-Arjona M, Dalmasso MC, Martínez-Larrad MT, Arcaro M, Nöthen MM, Fernández-Fuertes M, Dichgans M, Ingelsson M, Herrmann MJ, Scherer M, Vyhnalek M, Kosmidis MH, Yannakoulia M, Schmid M, Ewers M, Heneka MT, Wagner M, Scamosci M, Kivipelto M, Hiltunen M, Zulaica M, Alegret M, Fornage M, Roberto N, van Schoor NM, Seidu NM, Banaj N, Armstrong NJ, Scarmeas N, Scherbaum N, Goldhardt O, Hanon O, Peters O, Skrobot OA, Quenez O, Lerch O, Bossù P, Caffarra P, Dionigi Rossi P, Sakka P, Hoffmann P, Holmans PA, Fischer P, Riederer P, Yang Q, Marshall R, Kalaria RN, Mayeux R, Vandenberghe R, Cecchetti R, Ghidoni R, Frikke-Schmidt R, Sorbi S, Hägg S, Engelborghs S, Helisalmi S, Botne Sando S, Kern S, Archetti S, Boschi S, Fostinelli S, Gil S, Mendoza S, Mead S, Ciccone S, Djurovic S, Heilmann-Heimbach S, Riedel-Heller S, Kuulasmaa T, Del Ser T, Lebouvier T, Polak T, Ngandu T, Grimmer T, Bessi V, Escott-Price V, Giedraitis V, Deramecourt V, Maier W, Jian X, Pijnenburg YAL; EADB contributors; GR@ACE study group; DEGESCO consortium; IGAP (ADGC, CHARGE, EADI, GERAD); PGC-ALZ consortia, Kehoe PG, Garcia-Ribas G, Sánchez-Juan P, Pastor P, Pérez-Tur J, Piñol-Ripoll G, Lopez de Munain A, García-Alberca JM, Bullido MJ, Álvarez V, Lleó A, Real LM, Mir P, Medina M, Scheltens P, Holstege H, Marquié M, Sáez ME, Carracedo Á, Amouyel P, Schellenberg GD, Williams J, Seshadri S, van Duijn CM, Mather KA, Sánchez-Valle R, Serrano-Ríos M, Orellana A, Tárraga L, Blennow K, Huisman M, Andreassen OA, Posthuma D, Clarimón J, Boada M, van der Flier WM, Ramirez A, Lambert JC, van der Lee SJ, Ruiz A.Common variants in Alzheimer's disease and risk stratification by polygenic risk scores. Nat Commun. 2021 Jun 7;12(1):3417. doi: 10.1038/s41467-021-22491-8. IF=14.919.
  2. 5027.Andreadou EG, Katsipis G, Tsolaki M, Pantazaki AA. Involvement and relationship of bacterial lipopolysaccharides and cyclooxygenases levels in Alzheimer's Disease and Mild Cognitive Impairment patients. J Neuroimmunol. 2021 Mar 30;357:577561. doi: 10.1016/j.jneuroim.2021.577561.ΙF=3,125

 

  1. 5013. Tsentidou G, Moraitou D, Tsolaki M. Similar Theory of Mind Deficits in Community Dwelling Older Adults with Vascular Risk Profile and Patients with Mild Cognitive Impairment: The Case of Paradoxical Sarcasm Comprehension.

Brain Sci. 2021 May 13;11(5):627. IF=3,110

 

  1. 5024.Poptsi E, Tsatali M, Agogiatou C, Bakoglidou E, Batsila G, Dellaporta D, Kounti-Zafeiropoulou F, Liapi D, Lysitsas K, Markou N, Mouzakidis C, Ouzouni F, Papasozomenou C, Soumpourou A, Vasiloglou M, Zafeiropoulos S, Tsolaki M. Longitudinal Cognitive and Physical Training Effectiveness in MCI, Based on the Experience of the Alzheimer's Hellas Day Care Centre. J Geriatr Psychiatry Neurol. 2021 Jun 1:8919887211016057. doi: 10.1177/08919887211016057. IF=2.125

 

  1. 5015. Chalkias IN, Tegos T, Topouzis F, Tsolaki M. . Ocular biomarkers and their role in the early diagnosis of neurocognitive disorders. Eur J Ophthalmol. 2021 May 17:11206721211016311. IF= 1.642

 

  1. 5008. Limoncu H, Boz HE, Zygouris S, Tsolaki M, Giakoumis D, Votis K, Tzovaras D, Öztürk V, Yener GG A Virtual Reality-Based Screening Test for Cognitive Impairment in Small Vessel Disease. J Alzheimers Dis Rep. 2021 Mar 8;5(1):161-169. IF= 3.909

 

  1. 4782. Stavropoulos TG, Lazarou I, Diaz A, Gove D, Georges J, Manyakov NV, Pich EM, Hinds C, Tsolaki M, Nikolopoulos S, Kompatsiaris I; Wearable Devices for Assessing Function in Alzheimer's Disease: A European Public Involvement Activity About the Features and Preferences of Patients and Caregivers. RADAR-AD Consortium. Front Aging Neurosci. 2021 Apr 12; IF=4,504

 

  1. 4776. Schneider J, Gkioka M, Papagiannopoulos S, Moraitou D, Metz B, Tsolaki M, Kruse A, Teichmann B. Expectations of nursing personnel and physicians on dementia training : A descriptive survey in general hospitals in Germany and Greece. Z Gerontol Geriatr. 2021 Apr 21. IF= 0.919

 

  1. 4762. Tzekaki EE, Tsolaki M, Pantazaki ΑA, Geromichalos G, Lazarou E, Kozori M, Sinakos Z. The pleiotropic beneficial intervention of olive oil intake on the Alzheimer's disease onset via fibrinolytic system. Exp Gerontol. 2021 Jul 15:150:111344.

 doi: 10.1016/j.exger.2021.111344.: IF= 3,376

 

  1. 4756. Giannouli V, Tsolaki M. Frontotemporal dementia and financial capacity: facing the Cerberus of overestimation or underestimation? Australas Psychiatry. 2021 Apr 5: IF=0,943

 

  1. 5071. Tsatali M, Moraitou D, Poptsi E, Sia E, Agogiatou C, Gialaouzidis M, Tabakis IM, Avdikou K, Bakoglidou E, Batsila G, Bekiaridis-Moschou D, Chatziroumpi O, Diamantidou A, Gavra A, Kouroundi E, Liapi D, Markou N, Ouzouni F, Papasozomenou C, Soumpourou A, Tsolaki M.Are There Any Cognitive and Behavioral Changes Potentially Related to Quarantine Due to the COVID-19 Pandemic in People with Mild Cognitive Impairment and AD Dementia? A Longitudinal Study. Brain Sci. 2021 Aug 31;11(9):1165. IF=3.110

 

  1. 4754. Shi L, Winchester LM, Westwood S, Baird AL, Anand SN, Buckley NJ, Hye A, Ashton NJ, Bos I, Vos SJB, Kate MT, Scheltens P, Teunissen CE, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lléo A, Sala I, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Legido-Quigley C, Barkhof F, Andreasson U, Blennow K, Zetterberg H, Streffer J, Lill CM, Bertram L, Visser PJ, Kolb HC, Narayan VA, Lovestone S, Nevado-Holgado AJ. Replication study of plasma proteins relating to Alzheimer's pathology. Alzheimers Dement. 2021 Mar 31 IF= 17.127

 

  1. 4752. Nabais MF, Laws SM, Lin T, Vallerga CL, Armstrong NJ, Blair IP, Kwok JB, Mather KA, Mellick GD, Sachdev PS, Wallace L, Henders AK, Zwamborn RAJ, Hop PJ, Lunnon K, Pishva E, Roubroeks JAY, Soininen H, Tsolaki M, Mecocci P, Lovestone S, Kłoszewska I, Vellas B; Australian Imaging Biomarkers and Lifestyle study; Alzheimer’s Disease Neuroimaging Initiative, Furlong S, Garton FC, Henderson RD, Mathers S, McCombe PA, Needham M, Ngo ST, Nicholson G, Pamphlett R, Rowe DB, Steyn FJ, Williams KL, Anderson TJ, Bentley SR, Dalrymple-Alford J, Fowder J, Gratten J, Halliday G, Hickie IB, Kennedy M, Lewis SJG, Montgomery GW, Pearson J, Pitcher TL, Silburn P, Zhang F, Visscher PM, Yang J, Stevenson AJ, Hillary RF, Marioni RE, Harris SE, Deary IJ, Jones AR, Shatunov A, Iacoangeli A, van Rheenen W, van den Berg LH, Shaw PJ, Shaw CE, Morrison KE, Al-Chalabi A, Veldink JH, Hannon E, Mill J, Wray NR, McRae AF. Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders. Genome Biol. 2021 Mar 26;22(1):90. IF= 10.806

 

  1. 4749. Giannouli V, Tsolaki M.APOE ɛ4 Allele and Financial Capacity Performance in Mild Alzheimer's Disease: A Pilot Study. J Alzheimers Dis Rep. 2021 Jan 29;5(1):93-97. doi: 10.3233/ADR-200254 IF= 3.909

 

  1. 4748. Hassandra M, Galanis E, Hatzigeorgiadis A, Goudas M, Mouzakidis C, Karathanasi EM, Petridou N, Tsolaki M, Zikas P, Evangelou G, Papagiannakis G, Bellis G, Kokkotis C, Panagiotopoulos SR, Giakas G, Theodorakis Y. Α Virtual Reality App for Physical and Cognitive Training of Older People With Mild Cognitive Impairment: Mixed Methods Feasibility Study. JMIR Serious Games. 2021 Mar 24;9(1):e24170. doi: 10.2196/24170. IF=3.530

 

  1. 4742. Poptsi E, Tsolaki M, Bergh S, Cesana BM, Ciccone A, Fabbo A, Frisoni GB, Frölich L, Lavolpe S, Guazzarini AG, Hugon J, Fascendini S, Mecocci P, Defanti CA. Rationale, Design, and Methodology of a Prospective Cohort Study for Coping with Behavioral and Psychological Symptoms of Dementia: The RECage Project. J Alzheimers Dis. 2021 Mar 10. doi: 10.3233/JAD-201215. ΙF=3.909

 

  1. 4709. Nifli AP, Tsolaki M, Tournoy J, Ide K. Editorial: Cognitive Impairment: Therapy Momentum in the Continuum of Life. Front Pharmacol. 2021 Jan 29;11:618344. IF=4.225

 

  1. 4704. Chalkias E, Topouzis F, Tegos T, Tsolaki M. The Contribution of Ocular Biomarkers in the Differential Diagnosis of Alzheimer's Disease versus Other Types of Dementia and Future Prospects. J Alzheimers Dis. 2021 Feb 1. ΙF=3.909

Τέλος φόρμας

Αρχή φόρμας

Τέλος φόρμας

 

  1. 4755. Eleni G. Andreadou, Georgios Katsipis, Magda Tsolaki , and Anastasia A. Pantazaki. Bacterial rhamnolipids (RLs) in saliva of Alzheimer's disease and Mild Cognitive Impairment patients and correlation with neuroinflammation and cognitive state.  GSC Advanced Research and Reviews, 2021, 06(03), 209–219  

 

  1. 4634. Iliadou P, Paliokas I, Zygouris S, Lazarou E, Votis K, Tzovaras D, Tsolaki M.A Comparison of Traditional and Serious Game-Based Digital Markers of Cognition in Older Adults with Mild Cognitive Impairment and Healthy Controls. J Alzheimers Dis. 2021 Jan 14. ΙF=3.909

 

  1. 4633. Hassanin HI, Tawfik HM, Zygouris S, Tsatali M, Sweed HS, Tsolaki M.Setting Up a Cognitive Training Service for Egyptian Older Adults. J Alzheimers Dis. 2021 Jan 8. doi: 10.3233/JAD-201278 IF=3.909

 

  1. 4631. Giannouli V, Tsolaki M. Mild Alzheimer Disease, Financial Capacity, and the Role of Depression: Eyes Wide Shut? Alzheimer Dis Assoc Disord. 2021 Jan 11 IF=2,44
  2. 4629. Tijms BM, Gobom J, Reus L, Jansen I, Hong S, Dobricic V, Kilpert F, Ten Kate M, Barkhof F, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Bertram L, Lovestone S, Streffer J, Vos S, Bos I; Alzheimer’s Disease Neuroimaging Initiative (ADNI), Blennow K, Scheltens P, Teunissen CE, Zetterberg H, Visser PJ. Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics. Brain. 2020 Dec 1;143(12):3776-3792. IF=11.337
  3. 4626. Whiley L, Chappell KE, D'Hondt E, Lewis MR, Jiménez B, Snowden SG, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Swann JR, Hye A, Lovestone S, Legido-Quigley C, Holmes E; AddNeuroMed consortium. Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease. Alzheimers Res Ther. 2021 Jan 9;13(1):20. doi: 10.1186/s13195-020-00741-z. ΙF=5.015

 

  1. 4613. Gkioka M, Teichmann B, Moraitou D, Papagiannopoulos S, Tsolaki M. Effects of a Person Centered Dementia Training Program in Greek Hospital Staff-Implementation and Evaluation. Brain Sci. 2020 Dec 12;10(12):E976. ΙF= 3.332

 

  1. 4612. Kurbatova N, Garg M, Whiley L, Chekmeneva E, Jiménez B, Gómez-Romero M, Pearce J, Kimhofer T, D'Hondt E, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Aarsland D, Nevado-Holgado A, Liu B, Snowden S, Proitsi P, Ashton NJ, Hye A, Legido-Quigley C, Lewis MR, Nicholson JK, Holmes E, Brazma A, Lovestone S. Urinary metabolic phenotyping for Alzheimer's disease. Sci Rep. 2020 Dec 10;10(1):21745. IF= 3.998

 

  1. 4610. Tzekaki EE, Papaspyropoulos A, Tsolaki M, Lazarou E, Kozori M, Pantazaki ΑA. Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease. Exp Gerontol. 2020 Dec 5:111178.IF= 3.376

 

  1. 4599. Ribaldi F, Altomare D, Jovicich J, Ferrari C, Picco A, Pizzini FB, Soricelli A, Mega A, Ferretti A, Drevelegas A, Bosch B, Müller BW, Marra C, Cavaliere C, Bartrés-Faz D, Nobili F, Alessandrini F, Barkhof F, Gros-Dagnac H, Ranjeva JP, Wiltfang J, Kuijer J, Sein J, Hoffmann KT, Roccatagliata L, Parnetti L, Tsolaki M, Constantinidis M, Aiello M, Salvatore M, Montalti M, Caulo M, Didic M, Bargallo N, Blin O, Rossini P, Schonknecht P, Floridi P, Payoux P, Visser PJ, Bordet R, Lopes R, Tarducci R, Bombois S, Hensch T, Fiedler U, Richardson JC, Frisoni GB, Marizzoni M. Accuracy and reproducibility of automated white matter hyper-intensities segmentation with lesion segmentation tool: A European multi-site 3T study. Magn Reson Imaging. 2020 Nov 18:S0730-725X(20)30643-3. doi: 10.1016/j.mri.2020.11.008. ΙF=2.053

 

  1. 4641. Zygouris S, Gkioka M, Moraitou D, Teichmann B, Tsiatsos T, Papagianopoulos S, Tsolaki M. Assessing the Attitudes of Greek Nurses Toward Computerized Dementia Screening. J Alzheimers Dis. 2020 Nov 8. ΙF=3.909

 

  1. 4594. Visser PJ, Reus LM, Gobom J, Jansen I, Dicks E, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Freund-Levi Y, Froelich L, Sleegers K, Dobricic V, Hong S, Lovestone S, Streffer J, Vos SJB, Bos I, Smit AB, Blennow K, Scheltens P, Teunissen CE, Bertram L, Zetterberg H, Tijms BM. Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's disease. medRxiv. 2020 Nov 3:2020.10.29.20211920.

 

  1. 4589. Giannouli V, Tsolaki M. Unraveling Ariadne's Thread Into the Labyrinth of aMCI: Depression and Financial Capacity. Alzheimer Dis Assoc Disord. 2020 Oct 30. IF= 2.098

 

  1. 4586. Gkioka M, Schneider J, Kruse A, Tsolaki M, Moraitou D, Teichmann B. Evaluation and Effectiveness of Dementia Staff Training Programs in General Hospital Settings: A Narrative Synthesis with Holton's Three-Level Model Applied. J Alzheimers Dis. 2020 Oct 20. doi: 10.3233/JAD-200741. Online ahead of print. ΙF=3.909

 

  1. 4576. Tsolaki M, Lazarou E, Kozori M, Petridou N, Tabakis I, Lazarou I, Karakota M, Saoulidis I, Melliou E, Magiatis P. A Randomized Clinical Trial of Greek High Phenolic Early Harvest Extra Virgin Olive Oil in Mild Cognitive Impairment: The MICOIL Pilot Study. J Alzheimers Dis. 2020; 78(2):801-817. doi: 10.3233/JAD-200405. ΙF=3.909

 

https://ygeia50plus.gr/clinical-studies/apu-kliniki-meleth-micoil-elaiolado-to-framako-gia-to-alzheimer/

 

 

  1. 4574. Tsatali M, Emmanouel A, Gialaouzidis M, Avdikou K, Stefanatos C, Diamantidou A, Kouroundi E, Messini C, Tsolaki M. Rey Complex Figure Test (RCFT): Norms for the Greek older adult population. Appl Neuropsychol Adult. 2020 Oct 12:1-9.IF=1.350

 

  1. 4566. Mårtensson G, Ferreira D, Granberg T, Cavallin L, Oppedal K, Padovani A, Rektorova I, Bonanni L, Pardini M, Kramberger MG, Taylor JP, Hort J, Snædal J, Kulisevsky J, Blanc F, Antonini A, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Aarsland D, Westman E.The reliability of a deep learning model in clinical out-of-distribution MRI data: A multicohort study. Med Image Anal. 2020 May 1;66:101714. IF= 15.583

 

  1. 4565. Zygouris S, Iliadou P, Lazarou E, Giakoumis D, Votis K, Alexiadis A, Triantafyllidis A, Segkouli S, Tzovaras D, Tsiatsos T, Papagianopoulos S, Tsolaki M.Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy? J Alzheimers Dis. 2020 Sep 25. ΙF=3.909

 

  1. 4547. Dyer AH, Murphy C, Lawlor B, Kennelly SP; NILVAD StudyGroup. Sedative Load in Community-Dwelling Older Adults with Mild-Moderate Alzheimer's Disease: Longitudinal Relationships with Adverse Events, Delirium and Falls. Drugs Aging. 2020 Sep 14. IF= 2.925

 

  1. 4528. Buegler M, Harms R, Balasa M, Meier IB, Exarchos T, Rai L, Boyle R, Tort A, Kozori M, Lazarou E, Rampini M, Cavaliere C, Vlamos P, Tsolaki M, Babiloni C, Soricelli A, Frisoni G, Sanchez-Valle R, Whelan R, Merlo-Pich E, Tarnanas I. Digital biomarker-based individualized prognosis for people at risk of dementia. Alzheimers Dement (Amst). 2020 Aug 19;12(1):e12073. doi: 10.1002/dad2.12073. eCollection 2020. PMID: 32832589 Free PMC article. IF=

 

  1. 4529. Shi L, Winchester LM, Liu BY, Killick R, Ribe EM, Westwood S, Baird AL, Buckley NJ, Hong S, Dobricic V, Kilpert F, Franke A, Kiddle S, Sattlecker M, Dobson R, Cuadrado A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Ten Kate M, Scheltens P, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lleó A, Alcolea D, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Teunissen CE, Freund-Levi Y, Frölich L, Legido-Quigley C, Barkhof F, Blennow K, Rasmussen KL, Nordestgaard BG, Frikke-Schmidt R, Nielsen SF, Soininen H, Vellas B, Kloszewska I, Mecocci P, Zetterberg H, Morgan BP, Streffer J, Visser PJ, Bertram L, Nevado-Holgado AJ, Lovestone S. Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology. J Alzheimers Dis. 2020 Aug 20. doi: 10.3233/JAD-200208. ΙF=3.909

 

  1. 4517. Karakostas A, König A, Crispim-Junior CF, Bremond F, Derreumaux A, Lazarou I, Kompatsiaris I, Tsolaki M, Robert P. A French-Greek Cross-Site Comparison Study of the Use of Automatic Video Analyses for the Assessment of Autonomy in Dementia Patients. Biosensors (Basel). 2020 Aug 21;10(9):E103. doi: 10.3390/bios10090103. IF= 3.240
  2. 4510. Gkioka M, Tsolaki M, Papagianopoulos S, Teichmann B, Moraitou D. Psychometric properties of dementia attitudes scale, dementia knowledge assessment tool 2 and confidence in dementia scale in a Greek sample. Nurs Open. 2020 Jul 3;7(5):1623-1633. doi: 10.1002/nop2.546. IF= 1.363

 

  1. 4511. Roubroeks JAY, Smith AR, Smith RG, Pishva E, Ibrahim Z, Sattlecker M, Hannon EJ, Kłoszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Wahlund LO, Aarsland D, Proitsi P, Hodges A, Lovestone S, Newhouse SJ, Dobson RJB, Mill J, van den Hove DLA, Lunnon K. An epigenome-wide association study of Alzheimer's disease blood highlights robust DNA hypermethylation in the HOXB6 gene. Neurobiol Aging. 2020 Jul 3;95:26-45. doi: 10.1016/j.neurobiolaging.2020.06.023. IF=4.398

 

  1. 4509. Elvsåshagen T, Bahrami S, van der Meer D, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Beyer MK, Blasi G, Borgwardt S, Boye B, Buitelaar J, Bøen E, Celius EG, Cervenka S, Conzelmann A, Coynel D, Di Carlo P, Djurovic S, Eisenacher S, Espeseth T, Fatouros-Bergman H, Flyckt L, Franke B, Frei O, Gelao B, Harbo HF, Hartman CA, Håberg A, Heslenfeld D, Hoekstra PJ, Høgestøl EA, Jonassen R, Jönsson EG; Karolinska Schizophrenia Project (KaSP) consortium, Kirsch P, Kłoszewska I, Lagerberg TV, Landrø NI, Le Hellard S, Lesch KP, Maglanoc LA, Malt UF, Mecocci P, Melle I, Meyer-Lindenberg A, Moberget T, Nordvik JE, Nyberg L, Connell KSO, Oosterlaan J, Papalino M, Papassotiropoulos A, Pauli P, Pergola G, Persson K, de Quervain D, Reif A, Rokicki J, van Rooij D, Shadrin AA, Schmidt A, Schwarz E, Selbæk G, Soininen H, Sowa P, Steen VM, Tsolaki M, Vellas B, Wang L, Westman E, Ziegler GC, Zink M, Andreassen OA, Westlye LT, Kaufmann T.The genetic architecture of human brainstem structures and their involvement in common brain disorders. Nat Commun. 2020 Aug 11;11(1):4016. IF=12,121

 

  1. 4504. Poptsi E, Moraitou D, Tsardoulias E, Symeonidis AL, Tsolaki M. Is the Discrimination of Subjective Cognitive Decline from Cognitively Healthy Adulthood and Mild Cognitive Impairment Possible? A Pilot Study Utilizing the R4Alz Battery.

J Alzheimers Dis. 2020 Jul 24. doi: 10.3233/JAD-200562. ΙF=3.909

 

  1. 4494. Dyer AH, Murphy C, Briggs R, Lawlor B, Kennelly SP; NILVAD Study Group, Lawlor B, Segurado R, Kennelly S, Marcel GM, Howard R, Pasquier F, Borjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, Senechal O, Devendeville A, Calais G, Crawford F, Mullan M, Aalten P, Berglund MA, Claassen JA, De Heus RA, De Jong DLK, Godefroy O, Hutchinson S, Ioannou A, Jonsson M, Kent A, Kern J, Nemtsas P, Panidou MK, Abdullah L, Paris D, Santoso AM, van Spijker GJ, Spiliotou M, Thomoglou G, Wallin A. Antidepressant Use and Orthostatic Hypotension in Older Adults Living with Mild-to-Moderate Alzheimer Disease. Int J Geriatr Psychiatry. 2020 Jul 15. doi: 10.1002/gps.5377. ΙF= 3.141
  2. 4473. Lazarou I, Georgiadis K, Nikolopoulos S, Oikonomou VP, Tsolaki A, Kompatsiaris I, Tsolaki M, Kugiumtzis D. A Novel Connectome-Based Electrophysiological Study of Subjective Cognitive Decline Related to Alzheimer's Disease by Using Resting-State High-Density EEG EGI GES 300. Brain Sci. 2020 Jun 19;10(6):E392. doi: 10.3390/brainsci10060392. IF=2.786
  3. 4460. Konijnenberg E, Tijms BM, Gobom J, Dobricic V, Bos I, Vos S, Tsolaki M, Verhey F, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Frölich L, Lovestone S, Streffer J, Bertram L, Blennow K, Teunissen CE, Veerhuis R, Smit AB, Scheltens P, Zetterberg H, Visser PJ. APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease. Alzheimers Res Ther. 2020 May 27;12(1):65. IF= 5.015
  4. 4453. Dimitriou TD, Verykouki E, Papatriantafyllou J, Konsta A, Kazis D, Tsolaki M. Non-Pharmacological interventions for the anxiety in patients with dementia. A cross-over randomised controlled trial. Behav Brain Res. 2020 May 16;390:112617. IF= 2.770
  5. 4445. Quattrini G, Pievani M, Jovicich J, Aiello M, Bargalló N, Barkhof F, Bartres-Faz D, Beltramello A, Pizzini FB, Blin O, Bordet R, Caulo M, Constantinides M, Didic M, Drevelegas A, Ferretti A, Fiedler U, Floridi P, Gros-Dagnac H, Hensch T, Hoffmann KT, Kuijer JP, Lopes R, Marra C, Müller BW, Nobili F, Parnetti L, Payoux P, Picco A, Ranjeva JP, Roccatagliata L, Rossini PM, Salvatore M, Schonknecht P, Schott BH, Sein J, Soricelli A, Tarducci R, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Frisoni GB, Marizzoni M; PharmaCog Consortium. Amygdalar nuclei and hippocampal subfields on MRI: test-retest reliability of automated volumetry across different MRI sites and vendors. Neuroimage. 2020 May 13:116932. IF=5812.
  6. 4443. Giannouli V, Tsolaki M. Vascular Dementia, Depression, and Financial Capacity Assessment. Alzheimer Dis Assoc Disord. 2020 May 1 IF= 1.16
  7. 4436. Papaspyropoulos A, Tsolaki M, Foroglou N, Pantazaki AA. Modeling and Targeting Alzheimer's Disease With Organoids. Front Pharmacol. 2020 Mar 31;11:396. doi: 10.3389/fphar.2020.00396. eCollection 2020. PMID: 32300301 Free PMC article. Review. IF= 3.845
  8. 4419. Dyer AH, Lawlor B, Kennelly SP; NILVAD Study Group. Gait speed, cognition and falls in people living with mild-to-moderate Alzheimer disease: data from NILVAD. BMC Geriatr. 2020 Mar 30;20(1):117. IF=2.818
  9. 4417. Abdullah L, Crawford F, Tsolaki M, Börjesson-Hanson A, Olde Rikkert M, Pasquier F, Wallin A, Kennelly S, Ait-Ghezala G, Paris D, Hendrix S, Blennow K, Lawlor B, Mullan M. The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial. Front Neurol. 2020 Mar 6;11:149.IF=3,552
  10. 4411. Tsolaki AC, Tsolaki M, Pandria N, Lazarou E, Gkatzima O, Zilidou V, Karagianni M, Iakovidou-Kritsi Z, Kimiskidis VK, Bamidis PD. Web-Based Intervention Effects on Mild Cognitive Impairment Based on Apolipoprotein E Genotype: Quasi-Experimental Study. J Med Internet Res. 2020 May 7;22(5):e14617. doi: 10.2196/14617 ΙF=4.945
  11. 4404. Koutsouraki E, Michmizos D, Patsi O, Tzartos J, Spilioti M, Arnaoutoglou M, Tsolaki M. A probable role of copper in the comorbidity in Wilson's and Creutzfeldt-Jakob's Diseases: a case report. Virol J. 2020 Mar 13;17(1):35. IF= 2.464
  12. 4401. Papagiannis I, Tsolaki M, Kiryttopoulos A, Antoniadi E, Kyriakogianni C, Fotiou D, Notas K, Liougka E, Myrou A, Hatzitolios A, Haloudis P, Papaioannou M, Spilioti M, Papa A, Tegos T.West Nile neuroinvasive disease. Report of four cases in Northern Greece, 2018. J Med Virol. 2020 Mar 1. IF= 2.373
  13. 4387. Lim B, Tsolaki M, Batruch I, Anastasiou A, Frontistis A, Prassas I, Diamandis EP. Putative autoantibodies in the cerebrospinal fluid of Alzheimer's disease patients.. F1000Res. 2019 Nov 11;8:1900. doi: 10.12688/f1000research.21140.1. eCollection 2019. IF= 2.64
  14. 4380. Brzezińska A, Bourke J, Rivera-Hernández R, Tsolaki M, Woźniak J, Kaźmierski J. Depression in Dementia or Dementia in Depression? Systematic Review of Studies and Hypotheses. Curr Alzheimer Res. 2020 Feb 16. doi: 10.2174/1567205017666200217104114. [Epub ahead of print] IF= 3.289
  15. 5159. Neumann A, Küçükali F, Bos I, Vos SJB, Engelborghs S, De Pooter T, Joris G, De Rijk P, De Roeck E, Tsolaki M, Verhey F, Martinez-Lage P, Tainta M, Frisoni G, Blin O, Richardson J, Bordet R, Scheltens P, Popp J, Peyratout G, Johannsen P, Frölich L, Vandenberghe R, Freund-Levi Y, Streffer J, Lovestone S, Legido-Quigley C, Ten Kate M, Barkhof F, Strazisar M, Zetterberg H, Bertram L, Visser PJ, van Broeckhoven C, Sleegers K; EMIF-AD study group. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation. Mol Psychiatry. 2022 Feb 16. IF=12.384
  16. 4322. Stamate D, Kim M, Proitsi P, Westwood S, Baird A, Nevado-Holgado A, Hye A, Bos I, Vos SJB, Vandenberghe R, Teunissen CE, Kate MT, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck E, Engelborghs S, Sleegers K, Bordet R, Ramit L, Kettunen P, Tsolaki M, Verhey F, Alcolea D, Lléo A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Legido-Quigley C. A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort. Alzheimers Dement (N Y). 2019 Dec 18;5:933-938. IF= 14.423
  17. 4301. Balestrino R, Hurtado-Gonzalez CA, Stocchi F, Radicati FG, Chaudhuri KR, Rodriguez-Blazquez C, Martinez-Martin P; PDCS European Study Group. Applications of the European Parkinson's Disease Association sponsored Parkinson's Disease Composite Scale (PDCS). NPJ Parkinsons Dis. 2019 Nov 27;5:26. doi: 10.1038/s41531-019-0097-1. eCollection 2019. IF=1.529
  18. 4302. Sofologi M, Koutsouraki E, Tsolaki M, Tsolaki A, Koukoulidis T, Theofilidis A, Papantoniou G, Moraitou D. Analyzing social cognition and understanding of social inferences in patients with multiple sclerosis. A comparative study. Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:15-26. IF=1,008

364.4303.  Giannouli V, Tegos T, Zilakaki M, Tsolaki M. Elders and mental capacity: Using a qualitative approach to examine views on independence and protection across the Balkans. Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:122-139. IF=1,008

  1. 4304. Tzekaki EE, Tsolaki M, Pantazaki AA, Geromichalos G, Lazarou E, Kozori M, Sinakos Z. Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease.AD. Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:181. IF=1,008
  2. 4274. Tsatali M, Egkiazarova M, Toumpalidou M, Karagiozi K, Margaritidou P, Tsolaki M. Greek Adaptation of the Positive Aspects of Caregiving (PAC) Scale in Dementia Caregivers. Clin Gerontol. 2019 Nov 5:1-10. IF= 1.01
  3. 4372. Marizzoni M, Ferrari C, Babiloni C, Albani D, Barkhof F, Cavaliere L, Didic M, Forloni G, Fusco F, Galluzzi S, Hensch T, Jovicich J, Marra C, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ranjeva JP, Ribaldi F, Rolandi E, Rossini PM, Salvatore M, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB. CSF cutoffs for MCI due to AD depend on APOEε4 carrier status. Neurobiol Aging. 2019 Dec 30. IF=4398
  4. 4261. Zygouris S, Gkioka M, Moraitou D, Teichmann B, Tsiatsos T, Papagianopoulos S, Tsolaki M. Views of nursing staff on computerized dementia screening : A validation and pilot study in a general hospital. Z Gerontol Geriatr. 2019 Oct 22. IF= 0.919
  5. 4260. Poptsi E, Tsardoulias E, Moraitou D, Symeonidis AL, Tsolaki M. REMEDES for Alzheimer-R4Alz Battery: Design and Development of a New Tool of Cognitive Control Assessment for the Diagnosis of Minor and Major Neurocognitive Disorders. J Alzheimers Dis. 2019 Oct 18. IF=3.517
  6. 4257. Satizabal CL, Adams HHH, Hibar DP, White CC, Knol MJ, Stein JL, Scholz M, Sargurupremraj M, Jahanshad N, Roshchupkin GV, Smith AV, Bis JC, Jian X, Luciano M, Hofer E, Teumer A, van der Lee SJ, Yang J, Yanek LR, Lee TV, Li S, Hu Y, Koh JY, Eicher JD, Desrivières S, Arias-Vasquez A, Chauhan G, Athanasiu L, Rentería ME, Kim S, Hoehn D, Armstrong NJ, Chen Q, Holmes AJ, den Braber A, Kloszewska I, Andersson M, Espeseth T, Grimm O, Abramovic L, Alhusaini S, Milaneschi Y, Papmeyer M, Axelsson T, Ehrlich S, Roiz-Santiañez R, Kraemer B, Håberg AK, Jones HJ, Pike GB, Stein DJ, Stevens A, Bralten J, Vernooij MW, Harris TB, Filippi I, Witte AV, Guadalupe T, Wittfeld K, Mosley TH, Becker JT, Doan NT, Hagenaars SP, Saba Y, Cuellar-Partida G, Amin N, Hilal S, Nho K, Mirza-Schreiber N, Arfanakis K, Becker DM, Ames D, Goldman AL, Lee PH, Boomsma DI, Lovestone S, Giddaluru S, Le Hellard S, Mattheisen M, Bohlken MM, Kasperaviciute D, Schmaal L, Lawrie SM, Agartz I, Walton E, Tordesillas-Gutierrez D, Davies GE, Shin J, Ipser JC, Vinke LN, Hoogman M, Jia T, Burkhardt R, Klein M, Crivello F, Janowitz D, Carmichael O, Haukvik UK, Aribisala BS, Schmidt H, Strike LT, Cheng CY, Risacher SL, Pütz B, Fleischman DA, Assareh AA, Mattay VS, Buckner RL, Mecocci P, Dale AM, Cichon S, Boks MP, Matarin M, Penninx BWJH, Calhoun VD, Chakravarty MM, Marquand AF, Macare C, Kharabian Masouleh S, Oosterlaan J, Amouyel P, Hegenscheid K, Rotter JI, Schork AJ, Liewald DCM, de Zubicaray GI, Wong TY, Shen L, Sämann PG, Brodaty H, Roffman JL, de Geus EJC, Tsolaki M, Erk S, van Eijk KR, Cavalleri GL, van der Wee NJA, McIntosh AM, Gollub RL, Bulayeva KB, Bernard M, Richards JS, Himali JJ, Loeffler M, Rommelse N, Hoffmann W, Westlye LT, Valdés Hernández MC, Hansell NK, van Erp TGM, Wolf C, Kwok JBJ, Vellas B, Heinz A, Olde Loohuis LM, Delanty N, Ho BC, Ching CRK, Shumskaya E, Singh B, Hofman A, van der Meer D, Homuth G, Psaty BM, Bastin ME, Montgomery GW, Foroud TM, Reppermund S, Hottenga JJ, Simmons A, Meyer-Lindenberg A, Cahn W, Whelan CD, van Donkelaar MMJ, Yang Q, Hosten N, Green RC, Thalamuthu A, Mohnke S, Hulshoff Pol HE, Lin H, Jack CR Jr, Schofield PR, Mühleisen TW, Maillard P, Potkin SG, Wen W, Fletcher E, Toga AW, Gruber O, Huentelman M, Davey Smith G, Launer LJ, Nyberg L, Jönsson EG, Crespo-Facorro B, Koen N, Greve DN, Uitterlinden AG, Weinberger DR, Steen VM, Fedko IO, Groenewold NA, Niessen WJ, Toro R, Tzourio C, Longstreth WT Jr, Ikram MK, Smoller JW, van Tol MJ, Sussmann JE, Paus T, Lemaître H, Schroeter ML, Mazoyer B, Andreassen OA, Holsboer F, Depondt C, Veltman DJ, Turner JA, Pausova Z, Schumann G, van Rooij D, Djurovic S, Deary IJ, McMahon KL, Müller-Myhsok B, Brouwer RM, Soininen H, Pandolfo M, Wassink TH, Cheung JW, Wolfers T, Martinot JL, Zwiers MP, Nauck M, Melle I, Martin NG, Kanai R, Westman E, Kahn RS, Sisodiya SM, White T, Saremi A, van Bokhoven H, Brunner HG, Völzke H, Wright MJ, van 't Ent D, Nöthen MM, Ophoff RA, Buitelaar JK, Fernández G, Sachdev PS, Rietschel M, van Haren NEM, Fisher SE, Beiser AS, Francks C, Saykin AJ, Mather KA, Romanczuk-Seiferth N, Hartman CA, DeStefano AL, Heslenfeld DJ, Weiner MW, Walter H, Hoekstra PJ, Nyquist PA, Franke B, Bennett DA, Grabe HJ, Johnson AD, Chen C, van Duijn CM, Lopez OL, Fornage M, Wardlaw JM, Schmidt R, DeCarli C, De Jager PL, Villringer A, Debette S, Gudnason V, Medland SE, Shulman JM, Thompson PM, Seshadri S, Ikram MA. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat Genet. 2019 Oct 21. IF= 25.455
  7. 4353. Westwood S, Baird AL, Anand SN, Nevado-Holgado AJ, Kormilitzin A, Shi L, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Baker S, Buckley NJ, Ten Kate M, Scheltens P, Teunissen CE, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lléo A, Sala I, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Legido-Quigley C, Bertram L, Barkhof F, Zetterberg H, Morgan BP, Streffer J, Visser PJ, Lovestone S. Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort. J Alzheimers Dis. 2020 Jan 22. doi: 10.3233/JAD-190434.
  8. 4244. Dyer AH, Murphy C, Lawlor B, Kennelly SP; NILVAD Study Group. Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD. J Am Med Dir Assoc. 2019 Oct 8. pii: S1525-8610(19)30615-2. doi: 10.1016/j.jamda.2019.08.006, ΙF= 5.775
  9. 4221. Tsentidou G, Moraitou D, Tsolaki M. Cognition in Vascular Aging and Mild Cognitive Impairment. J Alzheimers Dis. 2019 Sep 23. IF=3.517
  10. 4204. Lazarou I, Nikolopoulos S, Dimitriadis SI, Yiannis Kompatsiaris I, Spilioti M, Tsolaki M. Is brain connectome research the future frontier for subjective cognitive decline? A systematic review. Clin Neurophysiol. 2019 Oct;130(10):1762-1780. doi: 10.1016/j.clinph.2019.07.004. Epub 2019 Jul 19. IF=3.675
  11. 4203. Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, Buitelaar J, Celius EG, Cervenka S, Conzelmann A, Córdova-Palomera A, Dale AM, de Quervain DJF, Carlo P, Djurovic S, Dørum ES, Eisenacher S, Elvsåshagen T, Espeseth T, Fatouros-Bergman H, Flyckt L, Franke B, Frei O, Haatveit B, Håberg AK, Harbo HF, Hartman CA, Heslenfeld D, Hoekstra PJ, Høgestøl EA, Jernigan TL, Jonassen R, Jönsson EG; Karolinska Schizophrenia Project (KaSP), Kirsch P, Kłoszewska I, Kolskår KK, Landrø NI, Hellard S, Lesch KP, Lovestone S, Lundervold A, Lundervold AJ, Maglanoc LA, Malt UF, Mecocci P, Melle I, Meyer-Lindenberg A, Moberget T, Norbom LB, Nordvik JE, Nyberg L, Oosterlaan J, Papalino M, Papassotiropoulos A, Pauli P, Pergola G, Persson K, Richard G, Rokicki J, Sanders AM, Selbæk G, Shadrin AA, Smeland OB, Soininen H, Sowa P, Steen VM, Tsolaki M, Ulrichsen KM, Vellas B, Wang L, Westman E, Ziegler GC, Zink M, Andreassen OA, Westlye LT. Common brain disorders are associated with heritable patterns of apparent aging of the brain. Nat Neurosci. 2019 Oct;22(10):1617-1623. doi: 10.1038/s41593-019-0471-7. Epub 2019 Sep 24. IF=21.403
  12. 4200. van Maurik IS, Vos SJ, Bos I, Bouwman FH, Teunissen CE, Scheltens P, Barkhof F, Frolich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Frisoni GB, Spiru L, Freund-Levi Y, Wallin AK, Hampel H, Soininen H, Tsolaki M, Verhey F, Kłoszewska I, Mecocci P, Vellas B, Lovestone S, Galluzzi S, Herukka SK, Santana I, Baldeiras I, de Mendonça A, Silva D, Chetelat G, Egret S, Palmqvist S, Hansson O, Visser PJ, Berkhof J, van der Flier WM; Alzheimer's Disease Neuroimaging Initiative. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. Lancet Neurol. 2019 Sep 13. pii: S1474-4422(19)30283-2. doi: 10.1016/S1474-4422(19)30283-2. IF=27,138
  13. 4201. Shi L, Westwood S, Baird AL, Winchester L, Dobricic V, Kilpert F, Hong S, Franke A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Buckley NJ, Kate MT, Scheltens P, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lleó A, Alcolea D, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Teunissen CE, Freund-Levi Y, Frölich L, Legido-Quigley C, Barkhof F, Blennow K, Zetterberg H, Baker S, Morgan BP, Streffer J, Visser PJ, Bertram L, Lovestone S, Nevado-Holgado AJ. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. Alzheimers Dement. 2019 Sep 5. IF= 14.423
  14. 5148. Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, Van Berckel B, Binette AP, Blennow K, Boada M, Boecker H, Bottlaender M, den Braber A, Brooks DJ, Van Buchem MA, Camus V, Carill JM, Cerman J, Chen K, Chételat G, Chipi E, Cohen AD, Daniels A, Delarue M, Didic M, Drzezga A, Dubois B, Eckerström M, Ekblad LL, Engelborghs S, Epelbaum S, Fagan AM, Fan Y, Fladby T, Fleisher AS, Van der Flier WM, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Frings L, Frisoni GB, Fröhlich L, Gabryelewicz T, Gertz HJ, Gill KD, Gkatzima O, Gómez-Tortosa E, Grimmer T, Guedj E, Habeck CG, Hampel H, Handels R, Hansson O, Hausner L, Hellwig S, Heneka MT, Herukka SK, Hildebrandt H, Hodges J, Hort J, Huang CC, Iriondo AJ, Itoh Y, Ivanoiu A, Jagust WJ, Jessen F, Johannsen P, Johnson KA, Kandimalla R, Kapaki EN, Kern S, Kilander L, Klimkowicz-Mrowiec A, Klunk WE, Koglin N, Kornhuber J, Kramberger MG, Kuo HC, Van Laere K, Landau SM, Landeau B, Lee DY, de Leon M, Leyton CE, Lin KJ, Lleó A, Löwenmark M, Madsen K, Maier W, Marcusson J, Marquié M, Martinez-Lage P, Maserejian N, Mattsson N, de Mendonça A, Meyer PT, Miller BL, Minatani S, Mintun MA, Mok VCT, Molinuevo JL, Morbelli SD, Morris JC, Mroczko B, Na DL, Newberg A, Nobili F, Nordberg A, Olde Rikkert MGM, de Oliveira CR, Olivieri P, Orellana A, Paraskevas G, Parchi P, Pardini M, Parnetti L, Peters O, Poirier J, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Reiman EM, Rinne JO, Rodrigue KM, Rodríguez-Rodriguez E, Roe CM, Rosa-Neto P, Rosen HJ, Rot U, Rowe CC, Rüther E, Ruiz A, Sabri O, Sakhardande J, Sánchez-Juan P, Sando SB, Santana I, Sarazin M, Scheltens P, Schröder J, Selnes P, Seo SW, Silva D, Skoog I, Snyder PJ, Soininen H, Sollberger M, Sperling RA, Spiru L, Stern Y, Stomrud E, Takeda A, Teichmann M, Teunissen CE, Thompson LI, Tomassen J, Tsolaki M, Vandenberghe R, Verbeek MM, Verhey FRJ, Villemagne V, Villeneuve S, Vogelgsang J, Waldemar G, Wallin A, Wallin ÅK, Wiltfang J, Wolk DA, Yen TC, Zboch M, Zetterberg H.Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol. 2022 Jan 31. ΙF=18,3
  15. 4195. Eraslan Boz H, Limoncu H, Zygouris S, Tsolaki M, Giakoumis D, Votis K, Tzovaras D, Öztürk V, Yener GG. A new tool to assess amnestic mild cognitive impairment in Turkish older adults: virtual supermarket (VSM). Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2019 Sep 4:1-15. IF= 1,919
  16. 3844. Lim B, Tsolaki M, Soosaipillai A, Brown M, Zilakaki M, Tagaraki F, Fotiou D, Koutsouraki E, Grosi E, Prassas I, Diamandis EP. Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer's disease. Clin Chem Lab Med. 2019 Aug 15. IF= 3.638
  17. 4435. Tsatali M, Fotiadou F, Giaglis G, Tsolaki M. The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly. Aging Clin Exp Res. 2019 Sep;31(9):1305-1312. doi: 10.1007/s40520-018-1076-9. Epub 2018 Nov 23. IF=2.331
  18. 4164. Manolopoulos A, Andreadis P, Malandris K, Avgerinos I, Karagiannis T, Kapogiannis D, Tsolaki M, Tsapas A, Bekiari E. Intravenous Immunoglobulin for Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis. Am J Alzheimers Dis Other Demen. 2019 Aug;34(5):281-289. IF=1.774
  19. 4149. Lazarou I, Stavropoulos TG, Meditskos G, Andreadis S, Kompatsiaris IY, Tsolaki M. Long-Term Impact of Intelligent Monitoring Technology on People with Cognitive Impairment: An Observational Study. J Alzheimers Dis. 2019 Jun 24. IF=3,920
  20. 4150. Nielsen TR, Segers K, Vanderaspoilden V, Beinhoff U, Minthon L, Pissiota A, Bekkhus-Wetterberg P, Bjørkløf GH, Tsolaki M, Gkioka M, Waldemar G. Validation of a brief Multicultural Cognitive Examination (MCE) for evaluation of dementia. Int J Geriatr Psychiatry. 2019 Jul;34(7):982-989. IF= 3.141
  21. 4131. Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, Kern S, Ousset PJ, Maruff P, Skoog I, Verhey FRJ, Freund-Levi Y, Tsolaki M, Wallin ÅK, Olde Rikkert M, Soininen H, Spiru L, Zetterberg H, Blennow K, Scheltens P, Muniz-Terrera G, Visser PJ; Alzheimer Disease Neuroimaging Initiative; AIBL Research Group; ICTUS/DSA study groups. Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype. Alzheimers Dement. 2019 Jun 1. IF=12.740
  22. 4122. Poptsi E, Moraitou D, Eleftheriou M, Kounti-Zafeiropoulou F, Papasozomenou C, Agogiatou C, Bakoglidou E, Batsila G, Liapi D, Markou N, Nikolaidou E, Ouzouni F, Soumpourou A, Vasiloglou M, Tsolaki M. Normative Data for the Montreal Cognitive Assessment in Greek Older Adults With Subjective Cognitive Decline, Mild Cognitive Impairment and Dementia. J Geriatr Psychiatry Neurol. 2019 Sep;32(5):265-274. IF=2.109
  23. 4109. Kim M, Snowden S, Suvitaival T, Ali A, Merkler DJ, Ahmad T, Westwood S, Baird A, Proitsi P, Nevado-Holgado A, Hye A, Bos I, Vos S, Vandenberghe R, Teunissen C, Ten Kate M, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck E, Sleegers K, Bordet R, Rami L, Kettunen P, Tsolaki M, Verhey F, Sala I, Lléo A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Engelborghs S, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Barkhof F, Ashton N, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Legido-Quigley C. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort. Alzheimers Dement. 2019 Apr 28. pii: S1552-5260(19)30074-3. doi: 10.1016/j.jalz.2019.03.004. IF=12.740
  24. 4010. Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleó A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum. Alzheimers Dement. 2019 May;15(5):644-654. IF=12.740
  25. 4077. Morgan AR, Touchard S, Leckey C, O'Hagan C, Nevado-Holgado AJ; NIMA Consortium, Barkhof F, Bertram L, Blin O, Bos I, Dobricic V, Engelborghs S, Frisoni G, Frölich L, Gabel S, Johannsen P, Kettunen P, Kłoszewska I, Legido-Quigley C, Lleó A, Martinez-Lage P, Mecocci P, Meersmans K, Molinuevo JL, Peyratout G, Popp J, Richardson J, Sala I, Scheltens P, Streffer J, Soininen H, Tainta-Cuezva M, Teunissen C, Tsolaki M, Vandenberghe R, Visser PJ, Vos S, Wahlund LO, Wallin A, Westwood S, Zetterberg H, Lovestone S, Morgan BP; Annex: NIMA–Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer's Disease. Inflammatory biomarkers in Alzheimer's disease plasma. Alzheimers Dement. 2019 Apr 29. pii: S1552-5260(19)30078-0. IF=12.740
  26. 4075. Martinez-Martin P, Radicati FG, Rodriguez Blazquez C, Wetmore J, Kovacs N, Ray Chaudhuri K, Stocchi F; PDCS European Study Group. Extensive validation study of the Parkinson's Disease Composite Scale. Eur J Neurol. 2019 Oct;26(10):1281-1288. IF= 4.387
  27. 2192. Canevelli M, Adali N, Cantet C, Andrieu S, Bruno G, Cesari M, Vellas B; ICTUS/DSA Group. Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study. J Neurol. 2013 Jul;260(7):1859-65. doi: 10.1007/s00415-013-6893-3. Epub 2013 Mar 17.

 

  1. 4059. Poptsi E, Lazarou I, Markou N, Vassiloglou M, Nikolaidou E, Diamantidou A, Siatra V, Karathanassi E, Karakostas A, Zafeiropoulou FK, Tsiatsos T, Tsolaki M. A Comparative Single-Blind Randomized Controlled Trial With Language Training in People With Mild Cognitive Impairment. Am J Alzheimers Dis Other Demen. 2019 May;34(3):176-187. IF= 1.16
  2. 4057. Lleó A, Alcolea D, Martínez-Lage P, Scheltens P, Parnetti L, Poirier J, Simonsen AH, Verbeek MM, Rosa-Neto P, Slot RER, Tainta M, Izaguirre A, Reijs BLR, Farotti L, Tsolaki M, Vandenbergue R, Freund-Levi Y, Verhey FRJ, Clarimón J, Fortea J, Frolich L, Santana I, Molinuevo JL, Lehmann S, Visser PJ, Teunissen CE, Zetterberg H, Blennow K. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study. Alzheimers Dement. 2019 Apr 6. IF=12.740
  3. 4055. Marizzoni M, Ferrari C, Macis A, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Pizzini F, Rossini PM, Salvatore M, Schönknecht P, Soricelli A, Del Percio C, Hensch T, Hegerl U, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium. Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease. J Alzheimers Dis. 2019 Apr 1. IF=3,920
  4. 4023. Kountouras J, Doulberis M, Polyzos SA, Katsinelos T, Vardaka E, Kountouras C, Arapoglou S, Exadaktylos AK, Deretzi G, Tsolaki M, Boziki M, Katsinelos P. Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on incidence of all-cause and Alzheimer's dementia. Alzheimers Dement. 2019 Mar 11. pii: S1552-5260(19)30029-9. doi: 10.1016/j.jalz.2019.01.008. IF=12.740
  5. 4024. Lougiaki P, Tsolaki M, Pantazaki A. [Bioinks and in vitro neurovascular unit production - New prospects in Alzheimer's disease research]. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:209-222. Greek, Modern. IF=1,008
  6. 4025. Tzekaki E, Tsolaki M, Pantazaki A.[Technical characteristics of Alzheimer model based on organ technology (organoid)]. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:195-208. Greek, Modern. IF=1,008
  7. 4026. Kalogiannis G, Chassapis G, Tsolaki M. Removing muscle artifacts from EEG data of people with cognitive impairment using high order statistic methods. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:165-173. IF=1,008
  8. 4027. Giannouli V, Tsolaki M. Are left angular gyrus and amygdala volumes important for financial capacity in mild cognitive impairment? Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:160-164. IF=1,008
  9. 4028. Messinis L, Apostolopoulos D, Spiridonidis T, Nasios G, Giazkoulidou A, Tsolaki M, Panagiotopoulos V. Robust regional cerebral blood flow perfusion deficits in relapsing-remitting multiple sclerosis patients with executive function impairment. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:147-159. IF=1,008
  10. 4029. Solias AA, Chaldogeridis AE, Batzikosta AV, Tsolaki M. Comparison of two electronic screening tests (culturally neutral & culturally customized) for major and minor neurocognitive disorders. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:111-122. IF=1,008
  11. 4030. Tsolaki M. Future strategies of management of Alzheimer's Disease. The role of homotaurine. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:82-94. IF=1,008
  12. 4031. Karypidou E, Megagiannis P, Papaoikonomou D, Pelteki N, Gkatzima O, Tsolaki M. Callosal Angle and Evans Index predict beta amyloid and tau protein in patients with dementia. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:51-58. IF=1,008
  13. 4032. Katsouri I, Athanasiadis L, Bekiaris E, Tsolaki M. Differences between professional and non-professional drivers with cognitive disorders. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:17-31. IF=1,008
  14. 4033. Triantafyllidou E, Moraitou D, Kaklamanaki E, Georgiadou T, Athanasaki M, Malliopoulou E, Schina C, Hamoli M, Moschou S, Petropoulou Z, Mpoulakis P, Douli E, Pagoni K, Nikolaidou S, Nouli CD, Masoura E, Tsolaki M, Papantoniou Retrogenetic models of working memory: Preliminary multi-group analysis. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:4-1. IF=1,008
  15. 4010. Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleó A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum. Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30018-4. doi: 10.1016/j.jalz.2019.01.004. [Epub ahead of print]. IF=12.740
  16. 3998. Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, Dardiotis E, Guillo-Benarous F, Hampel H, Kochan NA, Lista S, Luck T, Maruff P, Molinuevo JL, Kornhuber J, Reisberg B, Riedel-Heller SG, Risacher SL, Roehr S, Sachdev PS, Scarmeas N, Scheltens P, Shulman MB, Saykin AJ, Verfaillie SCJ, Visser PJ, Vos SJB, Wagner M, Wolfsgruber S, Jessen F; Alzheimer's Disease Neuroimaging Initiative; DESCRIPA working group; INSIGHT-preAD study group; SCD-I working group, van der Flier WM. Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia. Alzheimers Dement. 2019 Mar;15(3):465-476. doi: 10.1016/j.jalz.2018.10.003. Epub 2018 Dec 13. IF=12.740
  17. 3990. Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamujić-Čomić H, Frosch MP, Thonberg H, Maier W, Roschupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hernández I, Kamboh MI, Brundin R, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT Jr, Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Andre Uitterlinden AG, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, George-Hyslop PS, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu CK, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo Á, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Frölich L, Barral S, McGuinness B, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, McQuillin A, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, DeCarli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, Kölsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, Hüll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin LW, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, LaFerla FM, Jöckel KH, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann HE, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, Nöthen MM, Masliah E, Hooper NM, McCormick WC, Daniele A, McCurry SM, Bayer A, McDavid AN, Gallacher J, McKee AC, van den Bussche H, Mesulam M, Brayne C, Miller BL, Riedel-Heller S, Miller CA, Miller JW, Al-Chalabi A, Morris JC, Shaw CE, Myers AJ, Wiltfang J, O'Bryant S, Olichney JM, Alvarez V, Parisi JE, Singleton AB, Paulson HL, Collinge J, Perry WR, Mead S, Peskind E, Cribbs DH, Rossor M, Pierce A, Ryan NS, Poon WW, Nacmias B, Potter H, Sorbi S, Quinn JF, Sacchinelli E, Raj A, Spalletta G, Raskind M, Caltagirone C, Bossù P, Orfei MD, Reisberg B, Clarke R, Reitz C, Smith AD, Ringman JM, Warden D, Roberson ED, Wilcock G, Rogaeva E, Bruni AC, Rosen HJ, Gallo M, Rosenberg RN, Ben-Shlomo Y, Sager MA, Mecocci P, Saykin AJ, Pastor P, Cuccaro ML, Vance JM, Schneider JA, Schneider LS, Slifer S, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tang M, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu CE, Yu L, Saba Y; Alzheimer Disease Genetics Consortium (ADGC),; European Alzheimer’s Disease Initiative (EADI),; Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE),; Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES),, Pilotto A, Bullido MJ, Peters O, Crane PK, Bennett D, Bosco P, Coto E, Boccardi V, De Jager PL, Lleo A, Warner N, Lopez OL, Ingelsson M, Deloukas P, Cruchaga C, Graff C, Gwilliam R, Fornage M, Goate AM, Sanchez-Juan P, Kehoe PG, Amin N, Ertekin-Taner N, Berr C, Debette S, Love S, Launer LJ, Younkin SG, Dartigues JF, Corcoran C, Ikram MA, Dickson DW, Nicolas G, Campion D, Tschanz J, Schmidt H, Hakonarson H, Clarimon J, Munger R, Schmidt R, Farrer LA, Van Broeckhoven C, C O'Donovan M, DeStefano AL, Jones L, Haines JL, Deleuze JF, Owen MJ, Gudnason V, Mayeux R, Escott-Price V, Psaty BM, Ramirez A, Wang LS, Ruiz A, van Duijn CM, Holmans PA, Seshadri S, Williams J, Amouyel P, Schellenberg GD, Lambert JC, Pericak-Vance MA. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet. 2019 Mar;51(3):414-430. doi: 10.1038/s41588-019-0358-2. Epub 2019 Feb 28. IF=27.125
  18. 3988. Ashraf A, Stosnach H, Parkes HG, Hye A, Powell J; AddNeuroMed consortium, So PW. Pattern of Altered Plasma Elemental Phosphorus, Calcium, Selenium, Iron and Copper in Alzheimer's Disease. Sci Rep. 2019 Feb 28;9(1):3147. doi: 10.1038/s41598-018-37431-8. IF=4.609.
  19. 3949. Douka S, Zilidou VI, Lilou O, Tsolaki M. Greek Traditional Dances: A Way to Support Intellectual, Psychological, and Motor Functions in Senior Citizens at Risk of Neurodegeneration. Front Aging Neurosci. 2019 Jan 25;11:6. ΙF= 3.582
  20. 3935. Boccardi V, Westman E, Pelini L, Lindberg O, Muehlboeck JS, Simmons A, Tarducci R, Floridi P, Chiarini P, Soininen H, Kloszewska I, Tsolaki M, Vellas B, Spenger C, Wahlund LO, Lovestone S, Mecocci P. Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer's Disease. Front Aging Neurosci. 2019 Jan 17;10:439. doi: 10.3389/fnagi.2018.00439. eCollection 2018. ΙF= 3.582
  21. 3890. Vivas AB, Ypsilanti A, Ladas AI, Kounti F, Tsolaki M, Estévez AF.Enhancement of Visuospatial Working Memory by the Differential Outcomes Procedure in Mild Cognitive Impairment and Alzheimer's Disease. Front Aging Neurosci. 2018 Nov 13;10:364. doi: 10.3389/fnagi.2018.00364. eCollection 2018. IF= 3.582
  22. 3882. Poptsi E, Lazarou L, Markou N, Vassiloglou M, Nikolaidou E, Diamantidou A, Siatra V, Karathanassi E, Karakostas A, Zafeiropoulou FK, Tsiatsos T, Tsolaki M. A Comparative Single-Blind Randomized Controlled Trial With Language Training in People With Mild Cognitive Impairment. Am J Alzheimers Dis Other Demen. 2018 Dec 5:IF=1,602
  23. 3873. Kazmierski J, Messini-Zachou C, Gkioka M, Tsolaki M. The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2018 Sep;33(6):385-393 IF=1,602
  24. 3872. Tsatali M, Fotiadou F, Giaglis G, Tsolaki M. The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly. Aging Clin Exp Res. 2018 Nov 23. ΙF= 2.121
  25. 3865. Dimitriou TD, Verykouki E, Papatriantafyllou J, Konsta A, Kazis D, Tsolaki M. Non-pharmacological interventions for agitation/aggressive behaviour in patients with dementia: a randomized controlled crossover trial. Funct Neurol. 2018 Jul/Sept;33(3):143-147. IF=0,77
  26. 3860. Peloso GM, van der Lee SJ; International Genomics of Alzheimer's Project (IGAP), Destefano AL, Seshardi S. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. Alzheimers Dement (Amst). 2018 Sep 22;10:595-598. doi: 10.1016/j.dadm.2018.08.008. eCollection 2018.IF=12, 74
  27. 3859. Jovicich J, Babiloni C, Ferrari C, Marizzoni M, Moretti DV, Del Percio C, Lizio R, Lopez S, Galluzzi S, Albani D, Cavaliere L, Minati L, Didic M, Fiedler U, Forloni G, Hensch T, Molinuevo JL, Bartrés Faz D, Nobili F, Orlandi D, Parnetti L, Farotti L, Costa C, Payoux P, Rossini PM, Marra C, Schönknecht P, Soricelli A, Noce G, Salvatore M, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Frisoni GB. Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity. J Alzheimers Dis. 2018 Oct 29. doi: 10.3233/JAD-180158. [Epub ahead of print] IF=3,920
  28. 3825. de Matos MR, Ferreira C, Herukka SK, Soininen H, Janeiro A, Santana I, Baldeiras I, Almeida MR, Lleó A, Dols-Icardo O, Alcolea D, Benussi L, Binetti G, Paterlini A, Ghidoni R, Nacmias B, Meulenbroek O, van Waalwijk van Doorn LJC, Kuiperij HB, Hausner L, Waldemar G, Simonsen AH, Tsolaki M, Gkatzima O, de Oliveira CR, Verbeek MM, Clarimon J, Hiltunen M, de Mendonça A, Martins M. Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers. J Alzheimers Dis. 2018 Oct 9. IF=3,920
  29. 3815. Avdikou K, Stefanatos C, Tsatali M, Gouva M, Tsolaki M. The Role of Gender in Shame, Hostility, and Aggression Experienced by Caregivers for Patients With Dementia. Am J Alzheimers Dis Other Demen. 2018 Oct 7:1533317518802458. doi: 10.1177/1533317518802458. [Epub ahead of print] IF=1,602
  30. 3806. Ten Kate M, Redolfi A, Peira E, Bos I, Vos SJ, Vandenberghe R, Gabel S, Schaeverbeke J, Scheltens P, Blin O, Richardson JC, Bordet R, Wallin A, Eckerstrom C, Molinuevo JL, Engelborghs S, Van Broeckhoven C, Martinez-Lage P, Popp J, Tsolaki M, Verhey FRJ, Baird AL, Legido-Quigley C, Bertram L, Dobricic V, Zetterberg H, Lovestone S, Streffer J, Bianchetti S, Novak GP, Revillard J, Gordon MF, Xie Z, Wottschel V, Frisoni G, Visser PJ, Barkhof F. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study. Alzheimers Res Ther. 2018 Sep 27;10(1):100. doi: 10.1186/s13195-018-0428-1. IF= 6.206
  31. 3799. Nielsen TR, Segers K, Vanderaspoilden V, Beinhoff U, Minthon L, Pissiota A, Bekkhus-Wetterberg P, Bjørkløf GH, Tsolaki M, Gkioka M, Waldemar G. Validation of a European Cross-Cultural Neuropsychological Test Battery (CNTB) for evaluation of dementia. Int J Geriatr Psychiatry. 2019 Jan;34(1):144-152.IF=2,94
  32. 3801. Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial. PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep.IF=11.675
  33. 3781. Tsolaki AC, Gatzima O, Daniilidou M, Lazarou E, Bamidis PD, Verykouki E, Iakovidou-Kritsi Z, Tsolaki M. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study. Neurodegener Dis. 2018 Sep 11;18(4):216-224. doi: 10.1159/000491764. [Epub ahead of print] IF= 2.785
  34. 3778. Begcevic I, Tsolaki M, Brinc D, Brown M, Martinez-Morillo E, Lazarou I, Kozori M, Tagaraki F, Nenopoulou S, Gkioka M, Lazarou E, Lim B, Batruch I, Diamandis EP.Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progression. F1000Res. 2018 Jul 5;7:1012. doi: 10.12688/f1000research.15095.1. eCollection 2018.
  35. 3771. Albani D Marizzoni M, Ferrari C, Fusco F, Boeri L, Raimondi I, Jovicich J, Babiloni C, Soricelli A, Lizio R, Galluzzi S, Cavaliere L, Didic M, Schönknecht P, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Bocchio L, Salvatore M, Rossini PM, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Forloni G, Frisoni GB, Consortium P. Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study., J Alzheimers Dis. 2018 Aug 20. IF=3,920
  36. 3764. Lazarou I, Adam K, Georgiadis K, Tsolaki A, Nikolopoulos S, Yiannis Kompatsiaris I, Tsolaki M. Can a Novel High-Density EEG Approach Disentangle the Differences of Visual Event Related Potential (N170), Elicited by Negative Facial Stimuli, in People with Subjective Cognitive Impairment? J Alzheimers Dis. 2018 Jul 28. doi: 10.3233/JAD-180223. [Epub ahead of print] IF=3,920
  37. 3758. Mårtensson G, Pereira JB, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Volpe G, Westman E. Stability of graph theoretical measures in structural brain networks in Alzheimer's disease. Sci Rep. 2018 Aug 2;8(1):11592. doi: 10.1038/s41598-018-29927-0. IF= 4.259
  38. 3720. Nielsen TR, Segers K, Vanderaspoilden V, Bekkhus-Wetterberg P, Bjørkløf GH, Beinhoff U, Minthon L, Pissiota A, Tsolaki M, Gkioka M, Waldemar G. Validation of the Rowland Universal Dementia Assessment Scale (RUDAS) in a multicultural sample across five Western European countries: diagnostic accuracy and normative data. Int Psychogeriatr. 2018 Jul 18:1-10. doi: 10.1017/S1041610218000832. IF=2,261
  39. 3714. Bos I, Vos SJB, Jansen WJ, Vandenberghe R, Gabel S, Estanga A, Ecay-Torres M, Tomassen J, den Braber A, Lleó A, Sala I, Wallin A, Kettunen P, Molinuevo JL, Rami L, Chetelat G, de la Sayette V, Tsolaki M, Freund-Levi Y, Johannsen P; Alzheimer's Disease Neuroimaging Initiative, Novak GP, Ramakers I, Verhey FR, Visser PJ. Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data. Front Aging Neurosci. 2018 Jun 25;10:193. doi: 10.3389/fnagi.2018.00193. eCollection 2018. IF= 4.504
  40. 3688. Brainstorm Consortium, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, Duncan L, Escott-Price V, Falcone GJ, Gormley P, Malik R, Patsopoulos NA, Ripke S, Wei Z, Yu D, Lee PH, Turley P, Grenier-Boley B, Chouraki V, Kamatani Y, Berr C, Letenneur L, Hannequin D, Amouyel P, Boland A, Deleuze JF, Duron E, Vardarajan BN, Reitz C, Goate AM, Huentelman MJ, Kamboh MI, Larson EB, Rogaeva E, St George-Hyslop P, Hakonarson H, Kukull WA, Farrer LA, Barnes LL, Beach TG, Demirci FY, Head E, Hulette CM, Jicha GA, Kauwe JSK, Kaye JA, Leverenz JB, Levey AI, Lieberman AP, Pankratz VS, Poon WW, Quinn JF, Saykin AJ, Schneider LS, Smith AG, Sonnen JA, Stern RA, Van Deerlin VM, Van Eldik LJ, Harold D, Russo G, Rubinsztein DC, Bayer A, Tsolaki M, Proitsi P, Fox NC, Hampel H, Owen MJ, Mead S, Passmore P, Morgan K, Nöthen MM, Rossor M, Lupton MK, Hoffmann P, Kornhuber J, Lawlor B, McQuillin A, Al-Chalabi A, Bis JC, Ruiz A, Boada M, Seshadri S, Beiser A, Rice K, van der Lee SJ, De Jager PL, Geschwind DH, Riemenschneider M, Riedel-Heller S, Rotter JI, Ransmayr G, Hyman BT, Cruchaga C, Alegret M, Winsvold B, Palta P, Farh KH, Cuenca-Leon E, Furlotte N, Kurth T, Ligthart L, Terwindt GM, Freilinger T, Ran C, Gordon SD, Borck G, Adams HHH, Lehtimäki T, Wedenoja J, Buring JE, Schürks M, Hrafnsdottir M, Hottenga JJ, Penninx B, Artto V, Kaunisto M, Vepsäläinen S, Martin NG, Montgomery GW, Kurki MI, Hämäläinen E, Huang H, Huang J, Sandor C, Webber C, Muller-Myhsok B, Schreiber S, Salomaa V, Loehrer E, Göbel H, Macaya A, Pozo-Rosich P, Hansen T, Werge T, Kaprio J, Metspalu A, Kubisch C, Ferrari MD, Belin AC, van den Maagdenberg AMJM, Zwart JA, Boomsma D, Eriksson N, Olesen J, Chasman DI, Nyholt DR, Avbersek A, Baum L, Berkovic S, Bradfield J, Buono R, Catarino CB, Cossette P, De Jonghe P, Depondt C, Dlugos D, Ferraro TN, French J, Hjalgrim H, Jamnadas-Khoda J, Kälviäinen R, Kunz WS, Lerche H, Leu C, Lindhout D, Lo W, Lowenstein D, McCormack M, Møller RS, Molloy A, Ng PW, Oliver K, Privitera M, Radtke R, Ruppert AK, Sander T, Schachter S, Schankin C, Scheffer I, Schoch S, Sisodiya SM, Smith P, Sperling M, Striano P, Surges R, Thomas GN, Visscher F, Whelan CD, Zara F, Heinzen EL, Marson A, Becker F, Stroink H, Zimprich F, Gasser T, Gibbs R, Heutink P, Martinez M, Morris HR, Sharma M, Ryten M, Mok KY, Pulit S, Bevan S, Holliday E, Attia J, Battey T, Boncoraglio G, Thijs V, Chen WM, Mitchell B, Rothwell P, Sharma P, Sudlow C, Vicente A, Markus H, Kourkoulis C, Pera J, Raffeld M, Silliman S, Boraska Perica V, Thornton LM, Huckins LM, William Rayner N, Lewis CM, Gratacos M, Rybakowski F, Keski-Rahkonen A, Raevuori A, Hudson JI, Reichborn-Kjennerud T, Monteleone P, Karwautz A, Mannik K, Baker JH, O'Toole JK, Trace SE, Davis OSP, Helder SG, Ehrlich S, Herpertz-Dahlmann B, Danner UN, van Elburg AA, Clementi M, Forzan M, Docampo E, Lissowska J, Hauser J, Tortorella A, Maj M, Gonidakis F, Tziouvas K, Papezova H, Yilmaz Z, Wagner G, Cohen-Woods S, Herms S, Julià A, Rabionet R, Dick DM, Ripatti S, Andreassen OA, Espeseth T, Lundervold AJ, Steen VM, Pinto D, Scherer SW, Aschauer H, Schosser A, Alfredsson L, Padyukov L, Halmi KA, Mitchell J, Strober M, Bergen AW, Kaye W, Szatkiewicz JP, Cormand B, Ramos-Quiroga JA, Sánchez-Mora C, Ribasés M, Casas M, Hervas A, Arranz MJ, Haavik J, Zayats T, Johansson S, Williams N, Dempfle A, Rothenberger A, Kuntsi J, Oades RD, Banaschewski T, Franke B, Buitelaar JK, Arias Vasquez A, Doyle AE, Reif A, Lesch KP, Freitag C, Rivero O, Palmason H, Romanos M, Langley K, Rietschel M, Witt SH, Dalsgaard S, Børglum AD, Waldman I, Wilmot B, Molly N, Bau CHD, Crosbie J, Schachar R, Loo SK, McGough JJ, Grevet EH, Medland SE, Robinson E, Weiss LA, Bacchelli E, Bailey A, Bal V, Battaglia A, Betancur C, Bolton P, Cantor R, Celestino-Soper P, Dawson G, De Rubeis S, Duque F, Green A, Klauck SM, Leboyer M, Levitt P, Maestrini E, Mane S, De-Luca DM, Parr J, Regan R, Reichenberg A, Sandin S, Vorstman J, Wassink T, Wijsman E, Cook E, Santangelo S, Delorme R, Rogé B, Magalhaes T, Arking D, Schulze TG, Thompson RC, Strohmaier J, Matthews K, Melle I, Morris D, Blackwood D, McIntosh A, Bergen SE, Schalling M, Jamain S, Maaser A, Fischer SB, Reinbold CS, Fullerton JM, Guzman-Parra J, Mayoral F, Schofield PR, Cichon S, Mühleisen TW, Degenhardt F, Schumacher J, Bauer M, Mitchell PB, Gershon ES, Rice J, Potash JB, Zandi PP, Craddock N, Ferrier IN, Alda M, Rouleau GA, Turecki G, Ophoff R, Pato C, Anjorin A, Stahl E, Leber M, Czerski PM, Cruceanu C, Jones IR, Posthuma D, Andlauer TFM, Forstner AJ, Streit F, Baune BT, Air T, Sinnamon G, Wray NR, MacIntyre DJ, Porteous D, Homuth G, Rivera M, Grove J, Middeldorp CM, Hickie I, Pergadia M, Mehta D, Smit JH, Jansen R, de Geus E, Dunn E, Li QS, Nauck M, Schoevers RA, Beekman AT, Knowles JA, Viktorin A, Arnold P, Barr CL, Bedoya-Berrio G, Bienvenu OJ, Brentani H, Burton C, Camarena B, Cappi C, Cath D, Cavallini M, Cusi D, Darrow S, Denys D, Derks EM, Dietrich A, Fernandez T, Figee M, Freimer N, Gerber G, Grados M, Greenberg E, Hanna GL, Hartmann A, Hirschtritt ME, Hoekstra PJ, Huang A, Huyser C, Illmann C, Jenike M, Kuperman S, Leventhal B, Lochner C, Lyon GJ, Macciardi F, Madruga-Garrido M, Malaty IA, Maras A, McGrath L, Miguel EC, Mir P, Nestadt G, Nicolini H, Okun MS, Pakstis A, Paschou P, Piacentini J, Pittenger C, Plessen K, Ramensky V, Ramos EM, Reus V, Richter MA, Riddle MA, Robertson MM, Roessner V, Rosário M, Samuels JF, Sandor P, Stein DJ, Tsetsos F, Van Nieuwerburgh F, Weatherall S, Wendland JR, Wolanczyk T, Worbe Y, Zai G, Goes FS, McLaughlin N, Nestadt PS, Grabe HJ, Depienne C, Konkashbaev A, Lanzagorta N, Valencia-Duarte A, Bramon E, Buccola N, Cahn W, Cairns M, Chong SA, Cohen D, Crespo-Facorro B, Crowley J, Davidson M, DeLisi L, Dinan T, Donohoe G, Drapeau E, Duan J, Haan L, Hougaard D, Karachanak-Yankova S, Khrunin A, Klovins J, Kučinskas V, Lee Chee Keong J, Limborska S, Loughland C, Lönnqvist J, Maher B, Mattheisen M, McDonald C, Murphy KC, Nenadic I, van Os J, Pantelis C, Pato M, Petryshen T, Quested D, Roussos P, Sanders AR, Schall U, Schwab SG, Sim K, So HC, Stögmann E, Subramaniam M, Toncheva D, Waddington J, Walters J, Weiser M, Cheng W, Cloninger R, Curtis D, Gejman PV, Henskens F, Mattingsdal M, Oh SY, Scott R, Webb B, Breen G, Churchhouse C, Bulik CM, Daly M, Dichgans M, Faraone SV, Guerreiro R, Holmans P, Kendler KS, Koeleman B, Mathews CA, Price A, Scharf J, Sklar P, Williams J, Wood NW, Cotsapas C, Palotie A, Smoller JW, Sullivan P, Rosand J, Corvin A, Neale BM. Analysis of shared heritability in common disorders of the brain. Science. 2018 Jun 22;360(6395). pii: eaap8757. doi: 10.1126/science.aap8757. IF=37,205
  41. 3686. Bos I, Verhey FR, Ramakers IHGB, Jacobs HIL, Soininen H, Freund-Levi Y, Hampel H, Tsolaki M, Wallin ÅK, van Buchem MA, Oleksik A, Verbeek MM, Rikkert MO, van der Flier WM, Scheltens P, Aalten P, Visser PJ, Vos SJB. Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline. Alzheimers Res Ther. 2018 Jun 20;10(1):56. doi: 10.1186/s13195-018-0391-x. IF=6,154
  42. 3687. Marizzoni M, Ferrari C, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ribaldi F, Rossini PM, Schönknecht P, Soricelli A, Hensch T, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium. Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers. J Alzheimers Dis. 2018 Jun 9. doi: 10.3233/JAD-180152. IF=3,920
  43. 3619. Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimella R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka SK, Johannsen P, van Laere K, de Leon M, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimers Dement. 2018 Mar 27 ΙF=9.478
  44. 3592. Giannouli V, Stamovlasis D, Tsolaki M. Exploring the Role of Cognitive Factors in a New Instrument for Elders' Financial Capacity Assessment. J Alzheimers Dis. 2018 Mar 1. doi: 10.3233/JAD-170812 IF=3,920
  45. 3568. Lazarou I, Nikolopoulos S, Petrantonakis PC, Kompatsiaris I, Tsolaki M. EEG-Based Brain-Computer Interfaces for Communication and Rehabilitation of People with Motor Impairment: A Novel Approach of the 21 st Century. Front Hum Neurosci. 2018 Jan 31;12:14. ΙF=3,209
  46. 3563. Poulakis K, Pereira JB, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E. Heterogeneous patterns of brain atrophy in Alzheimer's disease. Neurobiol Aging. 2018 Jan 31;65:98-108. IF=5,117
  47. 3537. Nielsen TR, Segers K, Vanderaspoilden V, Bekkhus-Wetterberg P, Minthon L, Pissiota A, Bjørkløf GH, Beinhoff U, Tsolaki M, Gkioka M, Waldemar G. Performance of middle-aged and elderly European minority and majority populations on a Cross-Cultural Neuropsychological Test Battery (CNTB). Clin Neuropsychol. 2018 Jan 24:1-20. doi: 10.1080/13854046.2018.1430256. IF=1.564
  48. 3526. Kalafatakis F, Bekiaridis-Moschou D, Gkioka E, Tsolaki M. Mobile phone use for 5 minutes can cause significant memory impairment in humans. Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:146-154. ΙF=1.048
  49. 3527. Papasozomenou C, Poptsi E, Tabaki EM, Tsolaki M. The operation of the Day Care Centre of Alzheimer Hellas "Saint Helen" and of the Memory Clinic of Papanikolaou General Hospital from 2007 to 2017. Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:136-145. ΙF=1.048
  50. 3528, Papaoikonomou D, Karypidou E, Megagiannis P, Tsolaki-Tagaraki F, Nenopoulou S, Gkatzima O, Tsolaki M. The correlation of Evans index with CSF protein levels and ventriculomegaly. Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:123-130. ΙF=1.048
  51. 3529. Papaliagkas V, Papantoniou G, Tsolaki M, Moraitou D. Self-report instruments of cognitive failures as screening tools for Subjective Cognitive Impairment in older adults. Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:58-70. ΙF=1.048
  52. 3530. Papageorgakopoulos TN, Moraitou D, Papanikolaou M, Tsolaki M. The association between Alzheimer's disease and cancer: Systematic review - Meta-analysis. Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:45-57. ΙF=1.048
  53. 3513. Bos I, Verhey FR, Ramakers IHGB, Jacobs HIL, Soininen H, Freund-Levi Y, Hampel H, Tsolaki M, Wallin ÅK, van Buchem MA, Oleksik A, Verbeek MM, Olde Rikkert M, van der Flier WM, Scheltens P, Aalten P, Visser PJ, Vos SJB. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline. Alzheimers Res Ther. 2017 Dec 29;9(1):101. doi: 10.1186/s13195-017-30328-9. IF=6.154
  54. 3507. Dimitriadis SI, Liparas D, Tsolaki MN; Alzheimer's Disease Neuroimaging Initiative. Random Forest Feature Selection, Fusion and Ensemble Strategy: Combining Multiple Morphological MRI Measures to Discriminate among healhy elderly, MCI, cMCI and Alzheimer's disease patients: from the Alzheimer's disease neuroimaging initiative (ADNI) database. J Neurosci Methods. 2017 Dec 18. IF=2,15

282. 3487. Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Köhler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodríguez-Rodríguez E, Roe CM, Rot U, Rüther E, Santana I, Schröder J, Seo SW, Sorininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Zetterberg H. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry. 2017 Nov 29. doi: 10.1001/jamapsychiatry.2017.3391.IF= 15.307

  1. 3484. Verheijen J, van der Zee J, Gijselinck I, Van den Bossche T, Dillen L, Heeman B, Gómez-Tortosa E, Lladó A, Sanchez-Valle R, Graff C, Pastor P, Pastor MA, Benussi L, Ghidoni R, Binetti G, Clarimon J, de Mendonça A, Gelpi E, Tsolaki M, Diehl-Schmid J, Nacmias B, Almeida MR, Borroni B, Matej R, Ruiz A, Engelborghs S, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, Sleegers K; BELNEU Consortium; EU EOD Consortium. Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort. Neurobiol Aging. 2017 Oct 25. IF=5.153
  2. 3448. Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, O'Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG.Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2017 Oct 19. IF=3,920
  3. 3427. Reijs BLR, Vos SJB, Soininen H, Lötjonen J, Koikkalainen J, Pikkarainen M, Hall A, Vanninen R, Liu Y, Herukka SK, Freund-Levi Y, Frisoni GB, Frölich L, Nobili F, Rikkert MO, Spiru L, Tsolaki M, Wallin ÅK, Scheltens P, Verhey F, Visser PJ. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study. J Alzheimers Dis. 2017 Oct 11. doi: 10.3233/JAD-170039. IF=3,920
  4. 3433.Reijs BLR, Ramakers IHGB, Köhler S, Teunissen CE, Koel-Simmelink M, Nathan PJ, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Vandenberghe R, Johannsen P, Blackwell A, Vanderstichele H, Verhey F, Visser PJ. Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study. J Alzheimers Dis. 2017;60(3):1119-1128. doi: 10.3233/JAD-160766. IF=3,920
  5. 3434. Reijs BLR, Ramakers IHGB, Elias-Sonnenschein L, Teunissen CE, Koel-Simmelink M, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Johannsen P, Vanderstichele H, Verhey F, Devanand DP, Visser PJ. Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition. J Alzheimers Dis. 2017;60(3):1025-1034. doi: 10.3233/JAD-170564. IF=3,920
  6. 3393. Segkouli S, Paliokas I, Tzovaras D, Lazarou I, Karagiannidis C, Vlachos F, Tsolaki M. A computerized test for the assessment of mild cognitive impairment subtypes in sentence processing. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Sep 15:1-23. doi: IF=1,763
  7. 3385. Lazarou I, Parastatidis T, Tsolaki A, Gkioka M, Karakostas A, Douka S, Tsolaki M. International Ballroom Dancing Against Neurodegeneration: A Randomized Controlled Trial in Greek Community-Dwelling Elders With Mild Cognitive impairment. Am J Alzheimers Dis Other Demen. 2017 Dec;32(8):489-499.. doi: 10.1177/1533317517725813. IF=1,614

http://journals.sagepub.com/doi/pdf/10.1177/1533317517725813

  1. 3367. Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, Sleegers K, Vronskaya M, Ruiz A, Graham RR, Olaso R, Hoffmann P, Grove ML, Vardarajan BN, Hiltunen M, Nöthen MM, White CC, Hamilton-Nelson KL, Epelbaum J, Maier W, Choi SH, Beecham GW, Dulary C, Herms S, Smith AV, Funk CC, Derbois C, Forstner AJ, Ahmad S, Li H, Bacq D, Harold D, Satizabal CL, Valladares O, Squassina A, Thomas R, Brody JA, Qu L, Sánchez-Juan P, Morgan T, Wolters FJ, Zhao Y, Garcia FS, Denning N, Fornage M, Malamon J, Naranjo MCD, Majounie E, Mosley TH, Dombroski B, Wallon D, Lupton MK, Dupuis J, Whitehead P, Fratiglioni L, Medway C, Jian X, Mukherjee S, Keller L, Brown K, Lin H, Cantwell LB, Panza F, McGuinness B, Moreno-Grau S, Burgess JD, Solfrizzi V, Proitsi P, Adams HH, Allen M, Seripa D, Pastor P, Cupples LA, Price ND, Hannequin D, Frank-García A, Levy D, Chakrabarty P, Caffarra P, Giegling I, Beiser AS, Giedraitis V, Hampel H, Garcia ME, Wang X, Lannfelt L, Mecocci P, Eiriksdottir G, Crane PK, Pasquier F, Boccardi V, Henández I, Barber RC, Scherer M, Tarraga L, Adams PM, Leber M, Chen Y, Albert MS, Riedel-Heller S, Emilsson V, Beekly D, Braae A, Schmidt R, Blacker D, Masullo C, Schmidt H, Doody RS, Spalletta G, Jr WTL, Fairchild TJ, Bossù P, Lopez OL, Frosch MP, Sacchinelli E, Ghetti B, Yang Q, Huebinger RM, Jessen F, Li S, Kamboh MI, Morris J, Sotolongo-Grau O, Katz MJ, Corcoran C, Dunstan M, Braddel A, Thomas C, Meggy A, Marshall R, Gerrish A, Chapman J, Aguilar M, Taylor S, Hill M, Fairén MD, Hodges A, Vellas B, Soininen H, Kloszewska I, Daniilidou M, Uphill J, Patel Y, Hughes JT, Lord J, Turton J, Hartmann AM, Cecchetti R, Fenoglio C, Serpente M, Arcaro M, Caltagirone C, Orfei MD, Ciaramella A, Pichler S, Mayhaus M, Gu W, Lleó A, Fortea J, Blesa R, Barber IS, Brookes K, Cupidi C, Maletta RG, Carrell D, Sorbi S, Moebus S, Urbano M, Pilotto A, Kornhuber J, Bosco P, Todd S, Craig D, Johnston J, Gill M, Lawlor B, Lynch A, Fox NC, Hardy J; ARUK Consortium, Albin RL, Apostolova LG, Arnold SE, Asthana S, Atwood CS, Baldwin CT, Barnes LL, Barral S, Beach TG, Becker JT, Bigio EH, Bird TD, Boeve BF, Bowen JD, Boxer A, Burke JR, Burns JM, Buxbaum JD, Cairns NJ, Cao C, Carlson CS, Carlsson CM, Carney RM, Carrasquillo MM, Carroll SL, Diaz CC, Chui HC, Clark DG, Cribbs DH, Crocco EA, DeCarli C, Dick M, Duara R, Evans DA, Faber KM, Fallon KB, Fardo DW, Farlow MR, Ferris S, Foroud TM, Galasko DR, Gearing M, Geschwind DH, Gilbert JR, Graff-Radford NR, Green RC, Growdon JH, Hamilton RL, Harrell LE, Honig LS, Huentelman MJ, Hulette CM, Hyman BT, Jarvik GP, Abner E, Jin LW, Jun G, Karydas A, Kaye JA, Kim R, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lunetta KL, Lyketsos CG, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Morris JC, Murrell JR, Myers AJ, O'Bryant S, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Perry W, Peskind E, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rogaeva E, Rosen HJ, Rosenberg RN, Sager MA, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu CE, Yu L, Garzia F, Golamaully F, Septier G, Engelborghs S, Vandenberghe R, De Deyn PP, Fernadez CM, Benito YA, Thonberg H, Forsell C, Lilius L, Kinhult-Stählbom A, Kilander L, Brundin R, Concari L, Helisalmi S, Koivisto AM, Haapasalo A, Dermecourt V, Fievet N, Hanon O, Dufouil C, Brice A, Ritchie K, Dubois B, Himali JJ, Keene CD, Tschanz J, Fitzpatrick AL, Kukull WA, Norton M, Aspelund T, Larson EB, Munger R, Rotter JI, Lipton RB, Bullido MJ, Hofman A, Montine TJ, Coto E, Boerwinkle E, Petersen RC, Alvarez V, Rivadeneira F, Reiman EM, Gallo M, O'Donnell CJ, Reisch JS, Bruni AC, Royall DR, Dichgans M, Sano M, Galimberti D, St George-Hyslop P, Scarpini E, Tsuang DW, Mancuso M, Bonuccelli U, Winslow AR, Daniele A, Wu CK; GERAD/PERADES, CHARGE, ADGC, EADI, Peters O, Nacmias B, Riemenschneider M, Heun R, Brayne C, Rubinsztein DC, Bras J, Guerreiro R, Al-Chalabi A, Shaw CE, Collinge J, Mann D, Tsolaki M, Clarimón J, Sussams R, Lovestone S, O'Donovan MC, Owen MJ, Behrens TW, Mead S, Goate AM, Uitterlinden AG, Holmes C, Cruchaga C, Ingelsson M, Bennett DA, Powell J, Golde TE, Graff C, De Jager PL, Morgan K, Ertekin-Taner N, Combarros O, Psaty BM, Passmore P, Younkin SG, Berr C, Gudnason V, Rujescu D, Dickson DW, Dartigues JF, DeStefano AL, Ortega-Cubero S, Hakonarson H, Campion D, Boada M, Kauwe JK, Farrer LA, Van Broeckhoven C, Ikram MA, Jones L, Haines JL, Tzourio C, Launer LJ, Escott-Price V, Mayeux R, Deleuze JF, Amin N, Holmans PA, Pericak-Vance MA, Amouyel P, van Duijn CM, Ramirez A, Wang LS, Lambert JC, Seshadri S, Williams J, Schellenberg GD. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 Jul 17. doi: 10.1038/ng.3916. [Epub ahead of print] (IF=31.694)
  2. 3346. Andreadou E, Pantazaki AA, Daniilidou M, Tsolaki M. Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease. J Alzheimers Dis. 2017; 59 (1) :209-222. doi: 10.3233/JAD-161020. IF=3,920
  3. 3345. Lupton MK, Benyamin B, Proitsi P, Nyholt DR, Ferreira MA, Montgomery GW, Heath AC, Madden PA, Medland SE, Gordon SD; GERAD1 Consortium; Alzheimer’s Disease Neuroimaging Initiative, Lovestone S, Tsolaki M, Kloszewska I, Soininen H, Mecocci P, Vellas B, Powell JF, Bush AI, Wright MJ, Martin NG, Whitfield JB. No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease. J Alzheimers Dis. 2017 May 30. IF=3,920
  4. 3342. Meiland F, Innes A, Mountain G, Robinson L, van der Roest H, García-Casal JA, Gove D, Thyrian JR, Evans S, Dröes RM, Kelly F, Kurz A, Casey D, Szcześniak D, Dening T, Craven MP, Span M, Felzmann H, Tsolaki M, Franco-Martin M. Technologies to Support Community-Dwelling Persons With Dementia: A Position Paper on Issues Regarding Development, Usability, Effectiveness and Cost-Effectiveness, Deployment, and Ethics. JMIR Rehabil Assist Technol. 2017 Jan 16;4(1):e1. doi: 10.2196/rehab.6376. ΙF=3,4
  5. 3336. Iliadou VV, Bamiou DE, Sidiras C, Moschopoulos NP, Tsolaki M, Nimatoudis I, Chermak GD. The Use of the Gaps-In-Noise Test as an Index of the Enhanced Left Temporal Cortical Thinning Associated with the Transition between Mild Cognitive Impairment and Alzheimer's Disease. J Am Acad Audiol. 2017 May;28(5):463-471. doi: 10.3766/jaaa.16075. IF= 1.344
  6. 3329. Bos I, Vos SJ, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Engelborghs S, Niemantsverdriet E, De Roeck EE, Tsolaki M, Freund-Levi Y, Johannsen P, Vandenberghe R, Lleó A, Alcolea D, Frisoni GB, Galluzzi S, Nobili F, Morbelli S, Drzezga A, Didic M, van Berckel BN, Salmon E, Bastin C, Dauby S, Santana I, Baldeiras I, de Mendonça A, Silva D, Wallin A, Nordlund A, Coloma PM, Wientzek A, Alexander M, Novak GP, Gordon MF; Alzheimer's Disease Neuroimaging Initiative., Wallin ÅK, Hampel H, Soininen H, Herukka SK, Scheltens P, Verhey FR, Visser PJ. The frequency and influence of dementia risk factors in prodromal Alzheimer's disease. Neurobiol Aging. 2017 Apr 8;56:33-40. IF=5.153
  7. 3323.Tsolaki M., Gkioka M, Verykouki E, Galoutzi N, Kavalou E, Pattakou-Parasyri V. Prevalence of Dementia, Depression, and Mild Cognitive Impairment in a Rural Area of the Island of Crete, Greece. Am J Alzheimers Dis Other Demen. 2017 Aug;32(5):252-264. doi: 10.1177/1533317517698789. IF=1,614
  8. 3325. Tsolaki AC, Kosmidou V, Kompatsiaris IY, Papadaniil C, Hadjileontiadis L, Adam A, Tsolaki M. Brain source localization of MMN and P300 ERPs in mild cognitive impairment and Alzheimer's disease: a high-density EEG approach. Neurobiol Aging. 2017 Jul;55:190-201. doi: 10.1016/j.neurobiolaging.2017.03.025.. IF=5.153
  9. 3308. De Roeck A, Van den Bossche T, van der Zee J, Verheijen J, De Coster W, Van Dongen J, Dillen L, Baradaran-Heravi Y, Heeman B, Sanchez-Valle R, Lladó A, Nacmias B, Sorbi S, Gelpi E, Grau-Rivera O, Gómez-Tortosa E, Pastor P, Ortega-Cubero S, Pastor MA, Graff C, Thonberg H, Benussi L, Ghidoni R, Binetti G, de Mendonça A, Martins M, Borroni B, Padovani A, Almeida MR, Santana I, Diehl-Schmid J, Alexopoulos P, Clarimon J, Lleó A, Fortea J, Tsolaki M, Koutroumani M, Matěj R, Rohan Z, De Deyn P, Engelborghs S, Cras P, Van Broeckhoven C, Sleegers K; European Early-Onset Dementia (EU EOD) consortium.. "Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's disease. Acta Neuropathol. 2017 Apr 27. doi: 10.1007/s00401-017-1714-x. ΙF= 11.360
  10. 3304. Ferreira D, Hansson O, Barroso J, Molina Y, Machado A, Hernández-Cabrera JA, Muehlboeck JS, Stomrud E, Nägga K, Lindberg O, Ames D, Kalpouzos G, Fratiglioni L, Bäckman L, Graff C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Ahlström H, Lind L, Larsson EM, Wahlund LO, Simmons A, Westman E; and for the AddNeuroMed consortium, for the Alzheimer's Disease Neuroimaging Initiative (ADNI).; Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) research group..The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals. Hippocampus. 2017 Feb 28. IF=4.074

 

  1. 3260. Dimitriou TD, Tsolaki M. Evaluation of the efficacy of randomized controlled trials of sensory stimulation interventions for sleeping disturbances in patients with dementia: a systematic review. Clin Interv Aging. 2017 Mar 17;12:543-548. IF= 2.314.
  2. 3266. Bosco P, Redolfi A, Bocchetta M, Ferrari C, Mega A, Galluzzi S, Austin M, Chincarini A, Collins DL, Duchesne S, Maréchal B, Roche A, Sensi F, Wolz R, Alegret M, Assal F, Balasa M, Bastin C, Bougea A, Emek-Savaş DD, Engelborghs S, Grimmer T, Grosu G, Kramberger MG, Lawlor B, Mandic Stojmenovic G, Marinescu M, Mecocci P, Molinuevo JL, Morais R, Niemantsverdriet E, Nobili F, Ntovas K, O'Dwyer S, Paraskevas GP, Pelini L, Picco A, Salmon E, Santana I, Sotolongo-Grau O, Spiru L, Stefanova E, Popovic KS, Tsolaki M, Yener GG, Zekry D, Frisoni GB. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study. Alzheimers Dement. 2017 Mar 2. IF= 12.407
  3. 3252. Handels RL, Vos SJ, Kramberger MG, Jelic V, Blennow K, van Buchem M, van der Flier W, Freund-Levi Y, Hampel H, Olde Rikkert M, Oleksik A, Pirtosek Z, Scheltens P, Soininen H, Teunissen C, Tsolaki M, Wallin AK, Winblad B, Verhey FR, Visser PJ. Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers. Alzheimers Dement. 2017 Aug;13(8):903-912. doi: 10.1016/j.jalz.2016.12.015.IF= 12.407
  4. 3243. Lunnon K, Keohane A, Pidsley R, Newhouse S, Riddoch-Contreras J, Thubron EB, Devall M, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Schalkwyk L, Dobson R, Malik AN, Powell J, Lovestone S, Hodges A; AddNeuroMed Consortium. Mitochondrial genes are altered in blood early in Alzheimer's disease. Neurobiol Aging. 2017 Jan 7; 53: 36-47. Doi : 10.1016/j.neurobiolaging.2016.12.029. ΙF=5.153
  5. 3245. Nathan PJ, Lim YY, Abbott R, Galluzzi S, Marizzoni M, Babiloni C, Albani D, Bartres-Faz D, Didic M, Farotti L, Parnetti L, Salvadori N, Müller BW, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Payoux P, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI). Neurobiol Aging. 2017 Jan 18;53:1-10. doi: 10.1016/j.neurobiolaging.2017.01.013. ΙF=5.153
  6. 3148. Khan W, Giampietro V, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaître H, Nees F, Paus T, Pausova Z, Rietschel M, Smolka MN, Ströhle A, Gallinat J, Vellas B, Soininen H, Kloszewska I, Tsolaki M, Mecocci P, Spenger C, Villemagne VL, Masters CL, Muehlboeck JS, Bäckman L, Fratiglioni L, Kalpouzos G, Wahlund LO, Schumann G, Lovestone S, Williams SC, Westman E, Simmons A; Alzheimer–s Disease Neuroimaging Initiative.; AddNeuroMed Consortium, Australian, Imaging, Biomarkers, and Lifestyle Study Research Group.; IMAGEN consortium. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease. J Alzheimers Dis. 2017;56(3):1159-1174. doi: 10.3233/JAD-161097. IF=3,920
  7. 3130. Hibar DP, Adams HH, Jahanshad N, Chauhan G, Stein JL, Hofer E, Renteria ME, Bis JC, Arias-Vasquez A, Ikram MK, Desrivières S, Vernooij MW, Abramovic L, Alhusaini S, Amin N, Andersson M, Arfanakis K, Aribisala BS, Armstrong NJ, Athanasiu L, Axelsson T, Beecham AH, Beiser A, Bernard M, Blanton SH, Bohlken MM, Boks MP, Bralten J, Brickman AM, Carmichael O, Chakravarty MM, Chen Q, Ching CR, Chouraki V, Cuellar-Partida G, Crivello F, Den Braber A, Doan NT, Ehrlich S, Giddaluru S, Goldman AL, Gottesman RF, Grimm O, Griswold ME, Guadalupe T, Gutman BA, Hass J, Haukvik UK, Hoehn D, Holmes AJ, Hoogman M, Janowitz D, Jia T, Jørgensen KN, Karbalai N, Kasperaviciute D, Kim S, Klein M, Kraemer B, Lee PH, Liewald DC, Lopez LM, Luciano M, Macare C, Marquand AF, Matarin M, Mather KA, Mattheisen M, McKay DR, Milaneschi Y, Muñoz Maniega S, Nho K, Nugent AC, Nyquist P, Loohuis LM, Oosterlaan J, Papmeyer M, Pirpamer L, Pütz B, Ramasamy A, Richards JS, Risacher SL, Roiz-Santiañez R, Rommelse N, Ropele S, Rose EJ, Royle NA, Rundek T, Sämann PG, Saremi A, Satizabal CL, Schmaal L, Schork AJ, Shen L, Shin J, Shumskaya E, Smith AV, Sprooten E, Strike LT, Teumer A, Tordesillas-Gutierrez D, Toro R, Trabzuni D, Trompet S, Vaidya D, Van der Grond J, Van der Lee SJ, Van der Meer D, Van Donkelaar MM, Van Eijk KR, Van Erp TG, Van Rooij D, Walton E, Westlye LT, Whelan CD, Windham BG, Winkler AM, Wittfeld K, Woldehawariat G, Wolf C, Wolfers T, Yanek LR, Yang J, Zijdenbos A, Zwiers MP, Agartz I, Almasy L, Ames D, Amouyel P, Andreassen OA, Arepalli S, Assareh AA, Barral S, Bastin ME, Becker DM, Becker JT, Bennett DA, Blangero J, van Bokhoven H, Boomsma DI, Brodaty H, Brouwer RM, Brunner HG, Buckner RL, Buitelaar JK, Bulayeva KB, Cahn W, Calhoun VD, Cannon DM, Cavalleri GL, Cheng CY, Cichon S, Cookson MR, Corvin A, Crespo-Facorro B, Curran JE, Czisch M, Dale AM, Davies GE, De Craen AJ, De Geus EJ, De Jager PL, De Zubicaray GI, Deary IJ, Debette S, DeCarli C, Delanty N, Depondt C, DeStefano A, Dillman A, Djurovic S, Donohoe G, Drevets WC, Duggirala R, Dyer TD, Enzinger C, Erk S, Espeseth T, Fedko IO, Fernández G, Ferrucci L, Fisher SE, Fleischman DA, Ford I, Fornage M, Foroud TM, Fox PT, Francks C, Fukunaga M, Gibbs JR, Glahn DC, Gollub RL, Göring HH, Green RC, Gruber O, Gudnason V, Guelfi S, Håberg AK, Hansell NK, Hardy J, Hartman CA, Hashimoto R, Hegenscheid K, Heinz A, Le Hellard S, Hernandez DG, Heslenfeld DJ, Ho BC, Hoekstra PJ, Hoffmann W, Hofman A, Holsboer F, Homuth G, Hosten N, Hottenga JJ, Huentelman M, Pol HE, Ikeda M, Jack CR Jr, Jenkinson M, Johnson R, Jönsson EG, Jukema JW, Kahn RS, Kanai R, Kloszewska I, Knopman DS, Kochunov P, Kwok JB, Lawrie SM, Lemaître H, Liu X, Longo DL, Lopez OL, Lovestone S, Martinez O, Martinot JL, Mattay VS, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Mecocci P, Melle I, Meyer-Lindenberg A, Mohnke S, Montgomery GW, Morris DW, Mosley TH, Mühleisen TW, Müller-Myhsok B, Nalls MA, Nauck M, Nichols TE, Niessen WJ, Nöthen MM, Nyberg L, Ohi K, Olvera RL, Ophoff RA, Pandolfo M, Paus T, Pausova Z, Penninx BW, Pike GB, Potkin SG, Psaty BM, Reppermund S, Rietschel M, Roffman JL, Romanczuk-Seiferth N, Rotter JI, Ryten M, Sacco RL, Sachdev PS, Saykin AJ, Schmidt R, Schmidt H, Schofield PR, Sigursson S, Simmons A, Singleton A, Sisodiya SM, Smith C, Smoller JW, Soininen H, Steen VM, Stott DJ, Sussmann JE, Thalamuthu A, Toga AW, Traynor BJ, Troncoso J, Tsolaki M, Tzourio C, Uitterlinden AG, Hernández MC, Van der Brug M, van der Lugt A, van der Wee NJ, Van Haren NE, van 't Ent D, Van Tol MJ, Vardarajan BN, Vellas B, Veltman DJ, Völzke H, Walter H, Wardlaw JM, Wassink TH, Weale ME, Weinberger DR, Weiner MW, Wen W, Westman E, White T, Wong TY, Wright CB, Zielke RH, Zonderman AB, Martin NG, Van Duijn CM, Wright MJ, Longstreth WT, Schumann G, Grabe HJ, Franke B, Launer LJ, Medland SE, Seshadri S, Thompson PM, Ikram MA. Novel genetic loci associated with hippocampal volume. Nat Commun. 2017 Jan 18;8:13624. doi: 10.1038/ncomms13624.ΙF= 11.470
  8. 3115. van Waalwijk van Doorn LJ, Gispert JD, Kuiperij HB, Claassen JA, Arighi A, Baldeiras I, Blennow K, Bozzali M, Castelo-Branco M, Cavedo E, Emek-Savaş DD, Eren E, Eusebi P, Farotti L, Fenoglio C, Ormaechea JF, Freund-Levi Y, Frisoni GB, Galimberti D, Genc S, Greco V, Hampel H, Herukka SK, Liu Y, Lladó A, Lleó A, Nobili FM, Oguz KK, Parnetti L, Pereira J, Picco A, Pikkarainen M, de Oliveira CR, Saka E, Salvadori N, Sanchez-Valle R, Santana I, Scarpini E, Scheltens P, Soininen H, Tarducci R, Teunissen C, Tsolaki M, Urbani A, Martinez EV, Visser PJ, Wallin AK, Yener G, Molinuevo JL, Meulenbroek O, Verbeek MM. Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes. J Alzheimers Dis. 2017;56(2):543-555. doi: 10.3233/JAD-160668.IF=3,920
  9. 3113. Zygouris S, Ntovas K, Giakoumis D, Votis K, Doumpoulakis S, Segkouli S, Karagiannidis C, Tzovaras D, Tsolaki M. A Preliminary Study on the Feasibility of Using a Virtual Reality Cognitive Training Application for Remote Detection of Mild Cognitive Impairment. J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160518. IF= 3,920
  10. 3100. Skrobot OA, O'Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group., Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. The Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2016 Dec 10. pii: S1552-5260(16)33073-4. doi: 10.1016/j.jalz.2016.10.007. [Epub ahead of print] ΙF= ΙF= 11.619
  11. 3082. Kim M, Nevado-Holgado A, Whiley L, Snowden SG, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Thambisetty M, Dobson RJ, Powell JF, Lupton MK, Simmons A, Velayudhan L, Lovestone S, Proitsi P, Legido-Quigley C. Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease. J Alzheimers Dis. 2017;60(3):809-817. doi: 10.3233/JAD-160645.IF= 3,920
  12. 3059. Tsolaki AC, Kosmidou VE, Yiannis Kompatsiaris I, Papadaniil C, Hadjileontiadis L, Tsolaki M. Age-induced differences in brain neural activation elicited by visual emotional stimuli: A High-Density EEG study. Neuroscience. 2017 Jan 6;340:268-278. doi: 10.1016/j.neuroscience.2016.10.059. Epub 2016 Nov 1. ΙF=3.23
  13. 3027. Proitsi P, Kim M, Whiley L, Simmons A, Sattlecker M, Velayudhan L, Lupton MK, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Powell JF, Dobson RJ, Legido-Quigley C. Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis. Alzheimers Dement. 2017 Feb;13(2):140-151. doi: 10.1016/j.jalz.2016.08.003. Epub 2016 Sep 28.ΙF= 11.619
  14. 3018. Athanasopoulos D, Karagiannis G, Tsolaki M. Recent Findings in Alzheimer Disease and Nutrition Focusing on Epigenetics. Adv Nutr. 2016 Sep 15;7(5):917-27. doi: 10.3945/an.116.012229. Print 2016 Sep. Review. IF= 5.386

 

  1. 2929. Lazarou I, Karakostas A, Stavropoulos TG, Tsompanidis T, Meditskos G, Kompatsiaris I, Tsolaki M. A Novel and Intelligent Home Monitoring System for Care Support of Elders with Cognitive Impairment. J Alzheimers Dis. 2016 Oct 18;54(4):1561-1591. IF= 3,920

http://www.voria.gr/article/apth-exipno-sistima-ex-apostaseos-parakolouthisis-ilikiomenon-me-ania

http://techit.gr/2016/11/eks-apostaseos-parakolouthisi/

  1. 2961. Albi A, Pasternak O, Minati L, Marizzoni M, Bartrés-Faz D, Bargalló N, Bosch B, Rossini PM, Marra C, Müller B, Fiedler U, Wiltfang J, Roccatagliata L, Picco A, Nobili FM, Blin O, Sein J, Ranjeva JP, Didic M, Bombois S, Lopes R, Bordet R, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Frisoni G, Jovicich J; PharmaCog Consortium. Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects. Hum Brain Mapp. 2016 Aug 13. doi: 10.1002/hbm.23350. IF= 4.962
  2. 2987. Papadaniil CD, Kosmidou VE, Tsolaki A, Tsolaki M, Kompatsiaris IY, Hadjileontiadis LJ. Cognitive MMN and P300 in Mild Cognitive Impairment and Alzheimer's Disease: A High Density EEG-3D Vector Field Tomography Approach. Brain Res. 2016 Oct 1;1648(Pt A):425-433. doi: 10.1016/j.brainres.2016.07.043. ΙF= 2.843
  3. 2984. Kalincik T, Kuhle J, Pucci E, Rojas JI, Tsolaki M, Sirbu CA, Slee M, Butzkueven H; MSBase Scientific Leadership Group and MSBase Study Group. Data quality evaluation for observational multiple sclerosis registries. Mult Scler. 2016 Aug 1. pii: 1352458516662728. IF=4.822
  4. 2929. Tsolaki M, Karathanasi E, Lazarou I, Dovas K, Verykouki E, Karakosta A, Georgiadis K, Tsolaki A, Adam K, Kompatsiaris I, Sinakos Z. Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial. J Alzheimers Dis. 2016 Jul 27 54, issue 1 (August 2016). IF=3,920

http://www.j-alz.com/ 

http://www.j-alz.com/content/efficacy-and-safety-crocus-sativus-patients-mild-cognitive-impairment

  1. 2973. Meulenbroek O, O'Dwyer S, de Jong D, van Spijker G, Kennelly S, Cregg F, Olde Rikkert M, Abdullah L, Wallin A, Walsh C, Coen R, Kenny RA, Daly L, Segurado R, Borjesson-Hanson A, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Molloy W, Tsolaki M, Howard R, Adams J, Gaynor S, Lawlor B.European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer’s disease—the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow. BMJ Open 2016;6:e011584. doi:10.1136/bmjopen-2016-011584. IF=2.562

http://bmjopen.bmj.com/cgi/content/full/bmjopen-2016-011584?ijkey=KGKWhmV3rvHRtaU&keytype=ref

  1. 2966. Tarnanas I, Tsolaki M, Nef T, M Müri R, Mosimann UP. Can a novel computerized cognitive screening test provide additional information for early detection of Alzheimer's disease? Alzheimers Dement. 2014 Nov;10(6):790-8. doi: 10.1016/j.jalz.2014.01.002. IF=14.483
  2. 2940. Pierrakos C, Attou R, Decorte L, Velissaris D, Cudia A, Gottignies P, Devriendt J, Tsolaki M, De Bels D. Cerebral perfusion alterations and cognitive decline in critically ill sepsis survivors. Acta Clin Belg. 2016 Jun 3:1-6. IF=0,683
  3. 2932. Coley N, Gallini A, Garès V, Gardette V, Andrieu S; ICTUS/DSA group. A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort. J Am Med Dir Assoc. 2015 Dec;16(12):1104.e1. doi: 10.1016/j.jamda.2015.09.010  IF=4.939.

 (242) 2933. Grotz C, Letenneur L, Bonsang E, Amieva H, Meillon C, Quertemont E, Salmon E, Adam S; ICTUS/DSA group. Retirement age and the age of onset of Alzheimer's disease: results from the ICTUS study. PLoS One. 2015 Feb 25;10(2):e0115056. doi: 10.1371/journal.pone.0115056. eCollection 2015.IF= 3.234.

Vellas B, Reynish E, Ousset PJ, Andrieu S, Burns A, Pasquier F, Frisoni G, Salmon E, Michel JP, Zekry DS, Boada M, Dartigues JF, Olde-Rikkert MG, Rigaud AS, Winblad B, Malick A, Sinclair A, Frölich L, Scheltens P, Ribera C, Touchon J, Robert P, Salva A, Waldmar G, Bullock R, Costa-Tsolaki M, Rodriguez G, Spiru L, Jones RW, Stiens G, Stoppe G, Eriksdotter Jönhagen M, Cherubini A, Lage PM, Gomez-Isla T, Camus V, Aguüera-Morales E, Lopez F, Andrieu S, Savy S, Cantet C, Coley N.

(241) 2934. Canevelli M, Adali N, Kelaiditi E, Cantet C, Ousset PJ, Cesari M; ICTUS/DSA Group. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study. Phytomedicine. 2014 May 15;21(6):888-92. doi: 10.1016/j.phymed.2014.01.003. Epub 2014 Feb 16. IF= 3.126

Vellas B, Reynish E, Ousset PJ, Andrieu S, Burns A, Pasquier F, Frisoni G, Salmon E, Michel JP, Zekry DS, Boada M, Dartigues JF, Olde-Rikkert MG, Rigaud AS, Winblad B, Malick A, Sinclair A, Frölich L, Scheltens P, Ribera C, Touchon J, Robert P, Salva A, Waldmar G, Bullock R, Costa-Tsolaki M, Rodriguez G, Spiru L, Jones RW, Stiens G, Stoppe G, Eriksdotter Jönhagen M, Cherubini A, Lage PM, Gomez-Isla T, Camus V, Aguüera-Morales E, Lopez F, Andrieu S, Savy S, Cantet C, Coley N.

(240) 2935. Gardette V, Lapeyre-Mestre M, Piau A, Gallini A, Cantet C, Montastruc JL, Vellas B, Andrieu S; ICTUS Group. A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study. CNS Drugs. 2014 Feb;28(2):157-70. doi: 10.1007/s40263-013-0133-3ν. IF= 5.113.

Vellas B, Jones RW, Burns A, Bullock R, Malick A, Salmon E, Waldemar G, Dartigues JF, Pasquier F, Touchon J, Robert P, Rigaud AS, Camus V, Stiens G, Frölich L, Costa-Tsolaki M, Frisoni G, Rodriguez G, Cherubini A, Spiru L, Boada M, Salva A, Agüera-Morales E, Ribera-Casado JM, Lage PM, Winblad B, Jönhagen ME, Michel JP, Scheltens P, Olde-Rikkert M.

(239) 2936. Canevelli M, Adali N, Cantet C, Andrieu S, Bruno G, Cesari M, Vellas B; ICTUS/DSA Group. Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study. J Neurol. 2013 Jul;260(7):1859-65. doi: 10.1016/j.phymed.2014.01.003.  IF=3.841

Vellas B, Reynish E, Ousset PJ, Andrieu S, Burns A, Pasquier F, Frisoni G, Salmon E, Michel JP, Zekry DS, Boada M, Dartigues JF, Olde-Rikkert MG, Rigaud AS, Winblad B, Malick A, Sinclair A, Frölich L, Scheltens P, Ribera C, Touchon J, Robert P, Salva A, Waldmar G, Bullock R, Costa-Tsolaki M, Rodriguez G, Spiru L, Jones RW, Stiens G, Stoppe G, Eriksdotter Jönhagen M, Cherubini A, Lage PM, Gomez-Isla T, Camus V, Aguüera-Morales E, Lopez F, Andrieu S, Savy S, Cantet C, Coley N.

(238) 2928. Tsolaki M, Papaliagkas V, Frisoni G, Jones R, Touchon J, Spiru L, Vellaz B, Verhey F, Winblad B, Visser PJ. MCI patients in Europe: Medication and comorbidities. The DESCRIPA study. Curr Alzheimer Res. 2016 Jun 2. ΙF=3.889

(237) 2917. Korakas Ν., Tsolaki M. Cognitive Impairment in Multiple Sclerosis: What tests could help us to detect it. A review. Cogn Behav Neurol. 2016 Jun;29(2):55-67.  doi: 10.1097/WNN.0000000000000097. IF= 0,946

(236) 2906. Pereira JB, Mijalkov M, Kakaei E, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO, Volpe G, Westman E; AddNeuroMed consortium, for the Alzheimer's Disease Neuroimaging Initiative. Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease. Cereb Cortex. 2016 Aug;26(8):3476-3493. doi: 10.1093/cercor/bhw128.IF= 8.665

(235) 2739. Lupton MK, Strike L, Hansell NK, Wen W, Mather KA, Armstrong NJ, Thalamuthu A, McMahon KL, de Zubicaray GI, Assareh AA, Simmons A, Proitsi P, Powell JF, Montgomery GW, Hibar DP, Westman E, Tsolaki M, Kloszewska I, Soininen H, Mecocci P, Velas B, Lovestone S; Alzheimer's Disease Neuroimaging Initiative, Brodaty H, Ames D, Trollor JN, Martin NG, Thompson PM, Sachdev PS, Wright MJ. The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume. Neurobiol Aging. 2016 Apr;40:68-77. doi: 10.1016/j.neurobiolaging.2015.12.023. Epub 2016 Jan 11. IF= 4.853

(234) 2740. Theofilou P, Giannouli V, Kolias S, Tsolaki M. Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol. Health Psychol Res. 2015 Apr 13;3(1):1556. doi: 10.4081/hpr.2015.1556ν. eCollection 2015 Apr 13.

(233) 2741. Marchitelli R, Minati L, Marizzoni M, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Schönknecht P, Hensch T, Hoffmann KT, Kuijer JP, Visser PJ, Barkhof F, Frisoni GB, Jovicich J. Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques. Hum Brain Mapp. 2016 Jun;37(6):2114-32. doi: 10.1002/hbm.23157. [Epub ahead of print] IF= 5.969

(232) 2720. Galluzzi S, Marizzoni M, Babiloni C, Albani D, Antelmi L, Bagnoli C, Bartres-Faz D, Cordone S, Didic M, Farotti L, Fiedler U, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Parnetti L, Payoux P, Del Percio C, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium. Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'. J Intern Med. 2016 Jun;279(6):576-91. doi: 10.1111/joim.12482. [Epub ahead of print]. IF=6,063

(231) 2684. Papadaniil CD, Kosmidou VE, Tsolaki A, Tsolaki M, Kompatsiaris I, Hadjileontiadis LJ. Phase-amplitude cross-frequency coupling in EEG-derived cortical time series upon an auditory perception task. Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:4150-4153. doi: 10.1109/EMBC.2015.7319308.

(230) 2685. Kosmidou VE, Adam A, Papadaniil CD, Tsolaki M, Hadjileontiadis LJ, Kompatsiaris I. Gender effect in human brain responses to bottom-up and top-down attention using the EEG 3D-Vector Field Tomography. Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:7574-7577. doi: 10.1109/EMBC.2015.7320145. 

(229) 2683. Orellana C, Ferreira D, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; AddNeuronMed consortium and for the Alzheimer''s Disease Neuroimaging Initiative. Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations. Neurodegener Dis. 2016;16(1-2):77-86. doi: 10.1159/000442443. IF= 3,511

 (228) 279. 2673. Tsolaki M, Zygouris S, Lazarou I, Kompatsiaris I, Chatzileontiadis L, Votis C, Tzovaras D, Karakostas A, Karagkiozi C, Dimitriou T, Tsiatsios T, Dimitriadis S, Tarnanas I, Dranidis D, Bamidis P. Our experience with informative and communication technologies (ICT) in dementia. Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:131-139. IF=0,957

(227) 2664. Sattlecker M, Khondoker M, Proitsi P, Williams S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Dobson RJ. Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease. J Alzheimers Dis. 2015;49(4):1105-14. doi: 10.3233/JAD-140669. IF=4.151

(226) 2660. Ferreira D, Cavallin L, Granberg T, Lindberg O, Aguilar C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging Initiative*. Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition. doi: 10.1007/s00330-015-4101-9. Eur Radiol. 2016 Aug;26(8):2597-610.  IF=4.014

 (225) 2655. Dimitriadis SI, Laskaris NA, Bitzidou MP, Tarnanas I, Tsolaki MN. A novel biomarker of amnestic MCI based on dynamic cross-frequency coupling patterns during cognitive brain responses. Front Neurosci. 2015 Oct 20;9:350. doi: 10.3389/fnins.2015.00350. eCollection 2015. IF=3,7

(224) 2653. Reijs BL, Teunissen CE, Goncharenko N, Betsou F, Blennow K, Baldeiras I, Brosseron F, Cavedo E, Fladby T, Froelich L, Gabryelewicz T, Gurvit H, Kapaki E, Koson P, Kulic L, Lehmann S, Lewczuk P, Lleó A, Maetzler W, de Mendonça A, Miller AM, Molinuevo JL, Mollenhauer B, Parnetti L, Rot U, Schneider A, Simonsen AH, Tagliavini F, Tsolaki M, Verbeek MM, Verhey FR, Zboch M, Winblad B, Scheltens P, Zetterberg H, Visser PJ. The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases. Front Neurol. 2015 Oct 15;6:216. doi: 10.3389/fneur.2015.00216.

(223) 2648. Voyle N, Keohane A, Newhouse S, Lunnon K, Johnston C, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Hodges A, Kiddle S, Dobson RJ. A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.  J Alzheimers Dis. 2015;49(3):659-69.  doi: 10.3233/JAD-150440. IF=4.151

(222) 2630. Falahati F, Ferreira D, Soininen H, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Lovestone S, Eriksdotter M, Wahlund LO, Simmons A, Westman E; AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative. The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects. Brain Topogr. 2016 Mar;29(2):296-307. doi: 10.1007/s10548-015-0455-1. ΙF=3,468

http://link.springer.com/article/10.1007/s10548-015-0455-1 

(221) 2625. Cacace R, Van den Bossche T, Engelborghs S, Geerts N, Laureys A, Dillen L, Graff C, Thonberg H, Chiang HH, Pastor P, Ortega-Cubero S, Pastor MA, Diehl-Schmid J, Alexopoulos P, Benussi L, Ghidoni R, Binetti G, Nacmias B, Sorbi S, Sanchez-Valle R, Lladó A, Gelpi E, Almeida MR, Santana I, Tsolaki M, Koutroumani M, Clarimon J, Lleó A, Fortea J, de Mendonça A, Martins M, Borroni B, Padovani A, Matej R, Rohan Z, Vandenbulcke M, Vandenberghe R, De Deyn PP, Cras P, van der Zee J, Sleegers K, Van Broeckhoven C; Belgium Neurology (BELNEU) Consortium and the European Early-Onset Dementia (EU EOD) Consortium.  Rare Variants in PLD3 do not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort. Hum Mutat. 2015 Dec;36(12):1226-35. doi: 10.1002/humu.22908. IF= 5.34

(220) (271) 2614. Chiam JT, Lunnon K, Voyle N, Proitsi P, Coppola G, Geschwind D, Nelson S, Johnston C, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Hodges A, Lovestone S, Newhouse S, Dobson RJ, Kiddle SJ, Sattlecker M. No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease. J Alzheimers Dis. 2015 Aug 3;47(3):741-750. doi: 10.3233/JAD-150289. IF=4.151

(219) (272). 2615. Travassos M, Santana I, Baldeiras I, Tsolaki M, Gkatzima O, Sermin G, Yener GG, Simonsen A, Hasselbalch SG, Kapaki E, Mara B, Cunha RA, Agostinho P, Blennow K, Zetterberg H, Mendes VM, Manadas B, de Mendon A. Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease? J Alzheimers Dis. 2015 Aug 11;47(4):1069-1078. doi: 10.3233/JAD-150374. IF=4.151

(218) 2603. Duits FH, Martinez-Lage P, Paquet C, Engelborghs S, Lleó A, Hausner L, Molinuevo JL, Stomrud E, Farotti L, Ramakers IH, Tsolaki M, Skarsgård C, Åstrand R, Wallin A, Vyhnalek M, Holmber-Clausen M, Forlenza OV, Ghezzi L, Ingelsson M, Hoff EI, Roks G, de Mendonça A, Papma JM, Izagirre A, Taga M, Struyfs H, Alcolea DA, Frölich L, Balasa M, Minthon L, Twisk JW, Persson S, Zetterberg H, van der Flier WM, Teunissen CE, Scheltens P, Blennow K. Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study. Alzheimers Dement. 2016 Feb;12(2):154-63. doi: 10.1016/j.jalz.2015.08.003. ΙF=12.407

(217) 2579. Segkouli S, Paliokas I, Tzovaras D, Tsakiris T, Tsolaki M, Karagiannidis C. Novel Virtual User Models of Mild Cognitive Impairment for Simulating Dementia.Comput Math Methods Med. 2015;2015:358638. doi: 10.1155/2015/358638. Epub 2015 Aug 3. http://dx.doi.org/10.1155/2015/358638. http://www.hindawi.com/journals/cmmm/2015/358638/ IF= 0.766

(216) 2590. Bamidis PD, Fissler P, Papageorgiou SG, Zilidou V, Konstantinidis EI, Billis AS, Romanopoulou E, Karagianni M, Beratis I, Tsapanou A, Tsilikopoulou G, Grigoriadou E, Ladas A, Kyrillidou A, Tsolaki A, Frantzidis C, Sidiropoulos E, Siountas A, Matsi S, Papatriantafyllou J, Margioti E, Nika A, Schlee W, Elbert T, Tsolaki M, Vivas AB, Kolassa IT. Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorder. Front Aging Neurosci. 2015 Aug 7;7:152. doi: 10.3389/fnagi.2015.00152. IF= 4.000

(215) 2532. Jovicich J, Minati L, Marizzoni M, Marchitelli R, Sala-Llonch R, Bartrés-Faz D, Arnold J, Benninghoff J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Schönknecht P, Hensch T, Hoffmann KT, Kuijer JP, Visser PJ, Scheltens P, Frisoni GB; PharmaCog Consortium. Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study. Neuroimage. 2016 Jan 1;124(Pt A):442-54. doi: 10.1016/j.neuroimage.2015.07.010. IF=6.357

(214) 2494. Chouliaras L, Kenis G, Visser PJ, Scheltens P, Tsolaki M, Jones RW, Kehoe PG, Graff C, Girtler NG, Wallin ÅK, Rikkert MO, Spiru L, Elias-Sonnenschein LS, Ramakers IH, Pishva E, Os JV, Steinbusch HW, Verhey FR, van den Hove D, Rutten BP. DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts. Epigenomics. 2015 Jun;7(4):533-537. doi: 10.2217/epi.15.22. ΙF= 4.649

(213) 2488. Kruse N, Persson S, Alcolea D, Bahl JM, Baldeiras I, Capello E, Chiasserini D, Bocchio Chiavetto L, Emersic A, Engelborghs S, Eren E, Fladby T, Frisoni G, García-Ayllón MS, Genc S, Gkatzima O, Heegaard NH, Janeiro AM, Kováčech B, Kuiperij HB, Leitão MJ, Lleó A, Martins M, Matos M, Mollergard HM, Nobili F, Öhrfelt A, Parnetti L, de Oliveira CR, Rot U, Sáez-Valero J, Struyfs H, Tanassi JT, Taylor P, Tsolaki M, Vanmechelen E, Verbeek MM, Zilka N, Blennow K, Zetterberg H, Mollenhauer B. Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study. Neurobiol Aging. 2015 May 15. pii: S0197-4580(15)00250-X. doi: 10.1016/j.neurobiolaging.2015.05.003. IF= 4.853

(212) 2489. Kiddle SJ, Steves CJ, Mehta M, Simmons A, Xu X, Newhouse S, Sattlecker M, Ashton NJ, Bazenet C, Killick R, Adnan J, Westman E, Nelson S, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Curtis C, Breen G, Williams SC, Lovestone S, Spector TD, Dobson RJ. Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes. Transl Psychiatry. 2015 Jun 16;5:e584. doi: 10.1038/tp.2015.78. IF=5.620

 (211) 2469. Marizzoni M, Antelmi L, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Salvadori N, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Hoffmann KT, Hensch T, Schönknecht P, Kuijer JP, Visser PJ, Barkhof F, Bordet R, Frisoni GB, Jovicich J; Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly. PharmaCog Consortium. Hum Brain Mapp. 2015 Sep;36(9):3516-27. doi: 10.1002/hbm.22859. IF= 6.924

(210) 2452. Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ; and the Amyloid Biomarker Study Group, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BN, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, Förster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, Gómez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, Köhler S, Koglin N, Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lleó A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendonça A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, Møllergård HM, Morris JC, Mroczko B, Van der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Resende de Oliveira C, Rinne JO, Rodrigue KM, Rodríguez-Rodríguez E, Roe CM, Rot U, Rowe CC, Rüther E, Sabri O, Sanchez-Juan P, Santana I, Sarazin M, Schröder J, Schütte C, Seo SW, Soetewey F, Soininen H, Spiru L, Struyfs H, Teunissen CE, Tsolaki M, Vandenberghe R, Verbeek MM, Villemagne VL, Vos SJ, van Waalwijk van Doorn LJ, Waldemar G, Wallin A, Wallin ÅK, Wiltfang J, Wolk DA, Zboch M, Zetterberg H. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis. JAMA. 2015 May 19;313(19):1924-1938. doi: 10.1001/jama.2015.4668. IF= 30.387

 (209) 2432. Tarnanas I, Papagiannopoulos S, Kazis D, Wiederhold M, Widerhold B, Tsolaki M. Reliability of a novel serious game using dual-task gait profiles to early characterize aMCI. Front Aging Neurosci. 2015 Apr 22;7:50. doi: 10.3389/fnagi.2015.00050. eCollection 2015. IF=2,8

(208) 2426. Kountouras J, Tsolaki F, Tsolaki M, Gavalas E, Zavos C, Polyzos SA, Boziki M, Katsinelos P, Kountouras C, Vardaka E, Tagarakis GI, Deretzi G. Helicobacter pylori-related ApoE 4 polymorphism may be associated with dysphagic symptoms in older adults. Dis Esophagus. 2015 Apr 15. doi: 10.1111/dote.12364. IF=2.057

 (207) 2415. Jekel K, Damian M, Wattmo C, Hausner L, Bullock R, Connelly PJ, Dubois B, Eriksdotter M, Ewers M, Graessel E, Kramberger MG, Law E, Mecocci P, Molinuevo JL, Nygård L, Olde-Rikkert MG, Orgogozo JM, Pasquier F, Peres K, Salmon E, Sikkes SA, Sobow T, Spiegel R, Tsolaki M, Winblad B, Frölich L. Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review. Alzheimers Res Ther. 2015 Mar 18;7(1):17. eCollection 2015. doi: 10.1186/s13195-015-0099-0. IF=3,5

 (206) 2403. Tsolaki F, Kountouras J, Topouzis F, Tsolaki M. Helicobacter pylori infection, dementia and primary open-angle glaucoma: are they connected? BMC Ophthalmol. 2015 Dec;15(1):6. doi: 10.1186/s12886-015-0006-2. IF=1.08

(205) 2404. Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC, Kunkle BW, Wang LS, Bis JC, Bellenguez C, Harold D, Lunetta KL, Destefano AL, Grenier-Boley B, Sims R, Beecham GW, Smith AV, Chouraki V, Hamilton-Nelson KL, Ikram MA, Fievet N, Denning N, Martin ER, Schmidt H, Kamatani Y, Dunstan ML, Valladares O, Laza AR, Zelenika D, Ramirez A, Foroud TM, Choi SH, Boland A, Becker T, Kukull WA, van der Lee SJ, Pasquier F, Cruchaga C, Beekly D, Fitzpatrick AL, Hanon O, Gill M, Barber R, Gudnason V, Campion D, Love S, Bennett DA, Amin N, Berr C, Tsolaki M, Buxbaum JD, Lopez OL, Deramecourt V, Fox NC, Cantwell LB, Tárraga L, Dufouil C, Hardy J, Crane PK, Eiriksdottir G, Hannequin D, Clarke R, Evans D, Mosley TH Jr, Letenneur L, Brayne C, Maier W, De Jager P, Emilsson V, Dartigues JF, Hampel H, Kamboh MI, de Bruijn RF, Tzourio C, Pastor P, Larson EB, Rotter JI, O'Donovan MC, Montine TJ, Nalls MA, Mead S, Reiman EM, Jonsson PV, Holmes C, St George-Hyslop PH, Boada M, Passmore P, Wendland JR, Schmidt R, Morgan K, Winslow AR, Powell JF, Carasquillo M, Younkin SG, Jakobsdóttir J, Kauwe JS, Wilhelmsen KC, Rujescu D, Nöthen MM, Hofman A, Jones L; IGAP Consortium, Haines JL, Psaty BM, Van Broeckhoven C, Holmans P, Launer LJ, Mayeux R, Lathrop M, Goate AM, Escott-Price V, Seshadri S, Pericak-Vance MA, Amouyel P, Williams J, van Duijn CM, Schellenberg GD, Farrer LA. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. 2016 Jan;21(1):108-17. doi: 10.1038/mp.2015.23.  IF= 15.147

(204) 2398. Ferreira D, Cavallin L, Larsson EM, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; The AddNeuroMed consortium, the Alzheimer's Disease Neuroimaging, Initiative.Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment. J Intern Med. 2015 Sep;278(3):277-90. doi: 10.1111/joim.12358. IF=5.785

 (203) 2395. Gross AL, Sherva R, Mukherjee S, Newhouse S, Kauwe JS, Munsie LM, Waterston LB, Bennett DA, Jones RN, Green RC, Crane PK; Alzheimer's Disease Neuroimaging Initiative; GENAROAD Consortium; AD Genetics Consortium. Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets. Neuroepidemiology. 2014;43(3-4):194-205. IF=2.476

 

(202) 2379. Vos SJ, Verhey F, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Morbelli S, Frisoni GB, Drzezga A, Didic M, van Berckel BN, Simmons A, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Muscio C, Herukka SK, Salmon E, Bastin C, Wallin A, Nordlund A, de Mendonça A, Silva D, Santana I, Lemos R, Engelborghs S, Van der Mussele S; The Alzheimer’s Disease Neuroimaging Initiative, Freund-Levi Y, Wallin ÅK, Hampel H, van der Flier W, Scheltens P, Visser PJ. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. Brain. 2015 May;138(Pt 5):1327-38. doi: 10.1093/brain/awv029. IF= 10.226

(201) 2374. Tarnanas I, Schlee W, Tsolaki M, Müri R, Mosimann U, Nef T. Ecological validity of virtual reality daily living activities screening for early dementia: longitudinal study. JMIR Serious Games. 2013 Aug 6;1(1):e1. doi: 10.2196/games.2778. ΙF=4.7

(200) 2364. Khondoker M, Newhouse S, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Dobson R, Simmons A. Linking Genetics of Brain Changes to Alzheimer's Disease: Sparse Whole Genome Association Scan of Regional MRI Volumes in the ADNI and AddNeuroMed Cohorts. J Alzheimers Dis. 2015;45(3):851-64. doi: 10.3233/JAD-142214. IF=4,17

(199) 2352. Proitsi P, Kim M, Whiley L, Pritchard M, Leung R, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Sham P, Lovestone S, Powell JF, Dobson RJ, Legido-Quigley C. Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease. Transl Psychiatry. 2015 Jan 13;5:e494. doi: 10.1038/tp.2014.127. IF= 4.044

(198) 2347. Nho K, Kim S, Risacher SL, Shen L, Corneveaux JJ, Swaminathan S, Lin H, Ramanan VK, Liu Y, Foroud TM, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta KL, Farrer LA, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, McDonald BC, Farlow MR, Ghetti B, Huentelman MJ, Saykin AJ; for the Indiana Memory, Aging Study; for the Alzheimer's Disease Neuroimaging Initiative (ADNI); for the Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study; for the AddNeuroMed Consortium. Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol. 2015 Jan 5. doi: 10.1002/ana.24349. IF=11.91

(197) 2344. Jones L, Lambert JC, Wang LS, Choi SH, Harold D, Vedernikov A, Escott-Price V, Stone T, Richards A, Bellenguez C, Ibrahim-Verbaas CA, Naj AC, Sims R, Gerrish A, Jun G, DeStefano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Schmidt H, Kunkle BW, Dunstan ML, Ruiz A, Bihoreau MT, Reitz C, Pasquier F, Hollingworth P, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letteneur L, Kornhuber J, Tárraga L, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Emilsson V, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Kehoe P, Rogaeva E, Gallacher J, St George-Hyslop P, Clarimon J, Lleò A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Sanchez Garcia F, Fox N, Hardy J, Deniz Naranjo MC, Razquin C, Bosco P, Clarke R, Brayne C, Galimberti D, Mancuso M, Moebus S, Mecocci P, Del Zompo M, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, Nacmias B, Gilbert JR, Mayhaus M, Jessen F, Dichgans M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alavarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O'Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH Jr, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Pastor P, Schmidt R, Rujescu D, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Haines JL, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Ramirez A, Schellenberg GD, Seshadri S, Amouyel P, Williams J, Holmans PA. Convergent genetic and expression data implicate immunity in Alzheimer's disease. International Genomics of Alzheimer's Disease Consortium (IGAP); Alzheimers Dement. 2015 Jun;11(6):658-71. doi: 10.1016/j.jalz.2014.05.1757. IF=17.472

(196) 2342. Hall A, Mattila J, Koikkalainen J, Lötjonen J, Wolz R, Scheltens P, Frisoni G, Tsolaki M, Nobili F, Freund-Levi Y, Minthon L, Frölich L, Hampel H, Visser PT, Soininen H. Predicting Progression from Cognitive Impairment to Alzheimer's Disease with the Disease State Index. Curr Curr Alzheimer Res. 2015;12(1):69-79. IF=3,796

(195) 2339. Lleó A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, Ghidoni R, Lewczuk P, Jeromin A, Winblad B, Tsolaki M, Mroczko B, Visser PJ, Santana I, Svenningsson P, Blennow K, Aarsland D, Molinuevo JL, Zetterberg H, Mollenhauer B. Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases. Nat Rev Neurol. 2014 Dec 16. doi: 10.1038/nrneurol.2014.232. IF=14.103

(194) 2301. Tsolaki A, Kosmidou V, Hadjileontiadis L, Kompatsiaris IY, Tsolaki M. Brain source localization of MMN, P300 and N400: Aging and gender differences. Brain Res. 2015 Apr 7;1603:32-49. doi: 10.1016/j.brainres.2014.10.004. IF= 2.957

(193) (238) 2327. Tarnanas I, Laskaris N, Tsolaki M, Muri R, Nef T, Mosimann UP. On the comparison of a novel serious game and electroencephalography biomarkers for early dementia screening.Adv Exp Med Biol. 2015;821:63-77. doi: 10.1007/978-3-319-08939-3_11. IF= 1.953

(192) (239) 2329. Zygouris S, Giakoumis D, Votis K, Doumpoulakis S, Konstantinos N, Segkouli S, Charalampos K, Tzovaras D, Tsolaki M. Can a Virtual Reality Cognitive Training Application Fulfill a Dual Role? Using the Virtual Supermarket Cognitive Training Application as a Screening Tool for Mild Cognitive Impairment. J Alzheimers Dis. 2015;44(4):1333-47. doi: 10.3233/JAD-141260. IF=4,17

https://www.auth.gr/news/press/18225 και το αγγλικό εδώ: http://www.j-alz.com/content/virtual-reality-brain-training-game-can-detect-mild-cognitive-impairment-condition-often

 

- Le Courrier de Russie: http://www.lecourrierderussie.com/2015/06/virtual-supermarket/

- Ta Nea: http://www.tanea.gr/impact-journalism-day/article/5250394/to-eikoniko-soypermarket/

- The Daily Star: http://www.thedailystar.net/impact-journalism-day/virtual-supermarket-game-detect-memory-problems-older-adults-100078

- La Regione Ticino: http://www.laregione.ch/articolo/il-videogioco-che-salva-dallalzheimer/10427

(191) 2319. Ramanan VK, Nho K, Shen L, Risacher SL, Kim S, McDonald BC, Farlow MR, Foroud TM, Gao S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Aisen PS, Petersen RC, Jack CR Jr, Shaw LM, Trojanowski JQ, Weiner MW, Green RC, Toga AW, De Jager PL, Yu L, Bennett DA, Saykin AJ. FASTKD2 is associated with memory and hippocampal structure in older adults. Mol Psychiatry. 2015 Oct;20(10):1197-204. doi: 10.1038/mp.2014.142. IF= 15.147

(190) 2312.  Lebedev AV, Westman E, Van Westen GJ, Kramberger MG, Lundervold A, Aarsland D, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Simmons A; Alzheimer's Disease Neuroimaging Initiative and the AddNeuroMed consortium. Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness. Neuroimage Clin. 2014 Aug 28;6:115-25. doi: 10.1016/j.nicl.2014.08.023. eCollection 2014. IF=

(189) 2315. Khan W, Westman E, Jones N, Wahlund LO, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Muehlboeck JS, Simmons A; for the AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging Initiative. Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts. Brain Topogr. 2015 Sep;28(5):746-59. doi: 10.1007/s10548-014-0415-1. ΙF= 2.519

(188). 2284. Lawlor B, Kennelly S, O'Dwyer S, Cregg F, Walsh C, Coen R, Kenny RA, Howard R, Murphy C, Adams J, Daly L, Segurado R, Gaynor S, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Wallin A, Borjesson A, Molloy W, Tsolaki M, Olde Rikkert M. NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease. BMJ Open. 2014 Oct 9;4(10):e006364. doi: 10.1136/bmjopen-2014-006364. IF=2,063

(187). 2283. Tsolaki M. Clinical workout for the early detection of cognitive decline and dementia. Eur J Clin Nutr. 2014 Nov;68(11):1186-91. doi: 10.1038/ejcn.2014.189. IF=2,95

(186). 2254. Proitsi P, Lupton MK, Velayudhan L, Newhouse S, Fogh I, Tsolaki M, Daniilidou M, Pritchard M, Kloszewska I, Soininen H, Mecocci P, Vellas B; Alzheimer's Disease Neuroimaging Initiative, Williams J; GERAD1 Consortium, Stewart R, Sham P, Lovestone S, Powell JF. Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a mendelian randomization analysis. PLoS Med. 2014 Sep 16;11(9):e1001713. doi: 10.1371/journal.pmed.1001713. e1001713. IF= 4.24

(185). 2251. Frantzidis CA, Vivas AB, Tsolaki A, Klados MA, Tsolaki M, Bamidis PD. Functional disorganization of small-world brain networks in mild Alzheimer's Disease and amnestic Mild Cognitive Impairment: an EEG study using Relative Wavelet Entropy (RWE). Front Aging Neurosci. 2014 Aug 26;6:224. doi: 10.3389/fnagi.2014.00224. eCollection 2014. IF= 5.2

(184). 2249. Hall A, Muñoz-Ruiz M, Mattila J, Koikkalainen J, Tsolaki M, Mecocci P, Kloszewska I, Vellas B, Lovestone S, Visser PJ, Lötjonen J, Soininen H. Generalizability of the Disease State Index Prediction Model for Identifying Patients Progressing from Mild Cognitive Impairment to Alzheimer's Disease. J Alzheimers Dis. 2015;44(1):79-92. doi: 10.3233/JAD-140942. IF=4,17

(183). 2244. Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, Hasselbalch SG, Hausner L, Heuser I, Jessen F, Jones RW, Kurz A, Lawlor B, Lleo A, Martinez-Lage P, Mecocci P, Mehrabian S, Monsch A, Nobili F, Nordberg A, Olde Rikkert M, Orgogozo JM, Pasquier F, Peters O, Salmon E, Sánchez-Castellano C, Santana I, Sarazin M, Traykov L, Tsolaki M, Visser PJ, Wallin AK, Wilcock G, Wilkinson D, Wolf H, Yener G, Zekry D, Frisoni GB. The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey. Alzheimers Dement. 2015 Feb;11(2):195-206.e1. doi: 10.1016/j.jalz.2014.06.006.  IF= 14.483.

(182). 2245. Proitsi P, Lupton MK, Velayudhan L, Hunter G, Newhouse S, Lin K, Fogh I, Tsolaki M, Daniilidou M, Pritchard M, Craig D, Todd S, Johnston JA, McGuinness B, Kloszewska I, Soininen H, Mecocci P, Vellas B, Passmore PA, Sims R, Williams J, Brayne C; for the Alzheimer's Disease Neuroimaging Initiative; for the GERAD1 Consortium, Stewart R, Sham P, Lovestone S, Powell JF. Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer's disease. Neurobiol Aging. 2014 Jul 24. pii: S0197-4580(14)00492-8. doi: 10.1016/j.neurobiolaging.2014.07.023. Ι.F. =6,634

(181). 2246. Doyle OM, Westman E, Marquand AF, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Williams SC, Simmons A.Predicting progression of Alzheimer's disease using ordinal regression. PLoS One. 2014 Aug 20;9(8):e105542. doi: 10.1371/journal.pone.0105542.:e105542. IF= 4.24

(180). 2240. Menni C, Kiddle SJ, Mangino M, Viñuela A, Psatha M, Steves C, Sattlecker M, Buil A, Newhouse S, Nelson S, Williams S, Voyle N, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Spector TD, Dobson R, Valdes AM.Circulating Proteomic Signatures of Chronological Age. J Gerontol A Biol Sci Med Sci. 2015 Jul;70(7):809-16. doi: 10.1093/gerona/glu121. IF= 4.984

(179). (223) 2227. Jovicich J, Marizzoni M, Bosch B, Bartrés-Faz D, Arnold J, Benninghoff J, Wiltfang J, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Chanoine V, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Ragucci M, Soricelli A, Salvadori N, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini P, Marra C, Otto J, Reiss-Zimmermann M, Hoffmann KT, Galluzzi S, Frisoni GB; The PharmaCog Consortium. Multisite Longitudinal Reliability of Tract-Based Spatial Statistics in Diffusion Tensor Imaging of Healthy Elderly Subjects. Neuroimage. 2014 Nov 1;101:390-403. doi: 10.1016/j.neuroimage.2014.06.075. IF=7.063

(178). (221). 2223. Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, Westman E, Simmons A, Dobson R, Sattlecker M, Lupton M, Lunnon K, Keohane A, Ward M, Pike I, Zucht HD, Pepin D, Zheng W, Tunnicliffe A, Richardson J, Gauthier S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement. 2014 Nov;10(6):799-807.e2. doi: 10.1016/j.jalz.2014.05.1749. IF= 14.483.

(177). (222). 2224. Aguilar C, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Wahlund LO, Simmons A, Westman E; AddNeuroMed Consortium. Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort. Front. Aging Neurosci., 2014 Jul 14;6:145.| doi: 10.3389/fnagi.2014.00145.  IF=5,2.

http://www.frontiersin.org/Journal/Abstract.aspx?s=18&name=aging_neuroscience&ART_DOI=10.3389/fnagi.2014.00145&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&journalName=Frontiers_in_Aging_Neuroscience&id=93619

(176). (219). 2219. Tsatali M, Papaliagkas V, Damigos D, Mavreas V, Gouva M, Tsolaki M. Depression and Anxiety Levels Increase Chronic Musculoskeletal Pain in Patients with Alzheimer's Disease. Curr Alzheimer Res. 2014 Jun 17.  IF= 4.953.

(175). (218). 2214. Escott-Price V, Bellenguez C, Wang LS, Choi SH, Harold D, Jones L, Holmans P, Gerrish A, Vedernikov A, Richards A, DeStefano AL, Lambert JC, Ibrahim-Verbaas CA, Naj AC, Sims R, Jun G, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Denning N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Schmidt H, Kunkle B, Dunstan ML, Vronskaya M; the United Kingdom Brain Expression Consortium, Johnson AD, Ruiz A, Bihoreau MT, Reitz C, Pasquier F, Hollingworth P, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Baldwin C, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Hernández I, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, George-Hyslop PS, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Garcia FS, Fox NC, Hardy J, Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Scarpini E, Bonuccelli U, Mancuso M, Siciliano G, Moebus S, Mecocci P, Zompo MD, Maier W, Hampel H, Pilotto A, Frank-García A, Panza F, Solfrizzi V, Caffarra P, Nacmias B, Perry W, Mayhaus M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O'Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH Jr, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Schmidt R, Rujescu D, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Haines JL, Lathrop M, Pericak-Vance MA, Launer LJ, Van Broeckhoven C, Farrer LA, van Duijn CM, Ramirez A, Seshadri S, Schellenberg GD, Amouyel P, Williams J. Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease. PLoS One. 2014 Jun 12;9(6):e94661. doi: 10.1371/journal.pone.0094661. eCollection 2014. IF= 4.24

(174) 2173. Tsolaki A, Kazis D, Kompatsiaris I, Kosmidou V, Tsolaki M. Electroencephalogram and Alzheimer's Disease: Clinical and Research Approaches. Int J Alzheimers Dis. 2014;2014:349249. doi: 10.1155/2014/349249. Epub 2014 Apr 24. Review. IF=4,17

(173)  2184. Mukaetova-Ladinska EB, Krsteska R, Vaskova O, Makazlieva T, Tsolaki M. Dementia and Depression in Older Adults: A Southeast European Perspective: Summary of a Dementia Psychogeriatric Symposium held in Ohrid, 23 May 2013. J Alzheimers Dis. 2014;41(4):1251-60. doi: 10.3233/JAD-131640. IF=4,17

(172) 2175. Sattlecker M, Kiddle SJ, Newhouse S, Proitsi P, Nelson S, Williams S, Johnston C, Killick R, Simmons A, Westman E, Hodges A, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S; the AddNeuroMed Consortium, Dobson RJ.Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimers Dement. 2014 Nov;10(6):724-34. doi: 10.1016/j.jalz.2013.09.016. ΙF= 14.483

(171) 2170. Duits FH, Teunissen CE, Bouwman FH, Visser PJ, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N, Marcusson J, Wallin A, Rikkert MO, Tsolaki M, Parnetti L, Herukka SK, Hampel H, De Leon MJ, Schröder J, Aarsland D, Blankenstein MA, Scheltens P, van der Flier WM. The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean? Alzheimers Dement. 2014 Nov;10(6):713-723.e2. doi: 10.1016/j.jalz.2013.12.023. ΙF= 14.483

(170) 2166. Tarnanas I, Tsolaki A, Wiederhold M, Wiederhold B, Tsolaki M. Five-year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps? Alzheimers Dement (Amst). 2015 Nov 14;1(4):521-32. doi: 10.1016/j.dadm.2015.10.005ν eCollection 2015 Dec. IF=2,706

(169) 2145. Zygouris S, Tsolaki M. Computerized Cognitive Testing for Older Adults: A review. Am J Alzheimers Dis Other Demen. 2015 Feb;30(1):13-28. doi: 10.1177/1533317514522852. ΙF=1,518

http://aja.sagepub.com/cgi/reprint/30/1/13.pdf?ijkey=EcNpCqJZHR7OiSb&keytype=finite

(168) 2140. Paajanen T, Hänninen T, Aitken A, Hallikainen M, Westman E, Wahlund LO, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Spenger C, Lovestone S, Simmons A, Soininen H; AddNeuroMed Consortium.CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease. Dement Geriatr Cogn Dis Extra. 2013 Nov 30;3(1):446-58.IF= 2.787

  1. 2133. Frantzidis CA, Ladas AK, Vivas AB, Tsolaki M, Bamidis PD.Cognitive and physical training for the elderly: evaluating outcome efficacy by means of neurophysiological synchronization. Int J Psychophysiol. 2014 Jul;93(1):1-11. doi: 10.1016/j.ijpsycho.2014.01.007. IF=2,661
  2. 2123. Giannouli V, Tsolaki M. Legal capacity of the elderly in Greece.Hell J Nucl Med. 2014 Jan-Apr;17 Suppl 1:2-6. IF= 0.86

(165) 1120. Papapostolou P, Goutsaridou F, Arvaniti M, Emmanouilidou M, Tezapsidis G, Tsolaki M, Tsitouridis I. Is total brain volume correlated to cognitive function and education in patients with Alzheimer disease? Neuroradiol J. 2008 Oct 1;21(4):500-4.IF= 0.522.

(164). 1147. Papapostolou P, Arvaniti M, Goutsaridou F, Emmanouilidou M, Tezapsidis G, Chondromatidou S, Tsolaki M, Tsitouridis I. 3D MR Models and Volumetric Measurements of the Brain in Patients with Alzheimer's Disease. Neuroradiol J. 2008 Dec 17;21(5):611-7. IF= 0.522.

(163). 2097. Paajanen T, Hänninen T, Tunnard C, Hallikainen M, Mecocci P, Sobow T, Tsolaki M, Vellas B, Lovestone S, Soininen H. CERAD Neuropsychological Compound Scores are Accurate in Detecting Prodromal Alzheimer's Disease: A Prospective AddNeuroMed Study. Dement Geriatr Cogn Dis Extra. 2013 Nov 30;3(1):446-58. doi: 10.1159/000356725. IF=4,261

(162) 2073. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, Jun G, Destefano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Gerrish A, Schmidt H, Kunkle B, Dunstan ML, Ruiz A, Bihoreau MT, Choi SH, Reitz C, Pasquier F, Hollingworth P, Ramirez A, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Baldwin C, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Morón FJ, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Green R, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, St George-Hyslop P, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Sanchez-Garcia F, Fox NC, Hardy J, Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Mancuso M, Matthews F; European Alzheimer's Disease Initiative (EADI); Genetic and Environmental Risk in Alzheimer's Disease (GERAD); Alzheimer's Disease Genetic Consortium (ADGC); Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE), Moebus S, Mecocci P, Del Zompo M, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, Nacmias B, Gilbert JR, Mayhaus M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O'Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH Jr, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Schmidt R, Rujescu D, Wang LS, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013 Dec;45(12):1452-8. doi: 10.1038/ng.2802.  IF= 35.209

 

Ελεύθερος τύπος 30/10/2013

 

(161). 2064. Kiddle SJ, Sattlecker M, Proitsi P, Simmons A, Westman E, Bazenet C, Nelson SK, Williams S, Hodges A, Johnston C, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Newhouse S, Lovestone S, Dobson R.Candidate Blood Proteome Markers of Alzheimer's Disease Onset and Progression: A Systematic Review and Replication Study. J Alzheimers Dis. 2014;38(3):515-31. doi: 10.3233/JAD-130380. ΙF. =4,261

 

(160). 2065. Pereira JB, Cavallin L, Spulber G, Aguilar C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Aarsland D, Lovestone S, Simmons A, Wahlund LO, Westman E; The AddNeuroMed consortium for the Alzheimer's Disease Neuroimaging Initiative.Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs. J Intern Med. 2014 Mar;275(3):317-30. doi: 10.1111/joim.12148. IF.= 6,455

 

 (159) 2050. Proitsi P, Lee SH, Lunnon K, Keohane A, Powell J, Troakes C, Al-Sarraj S, Furney S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Hodges A; AddNeuroMed Consortium. Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood. Neurobiol Aging. 2014 Feb;35(2):279-90. doi: 10.1016/j.neurobiolaging.2013.08.002. Ι.F. =6,634

 

(158) 2051. Lupton MK, Proitsi P, Lin K, Hamilton G, Daniilidou M, Tsolaki M, Powell JF. The Role of ABCA1 Gene Sequence Variants on Risk of Alzheimer's Disease. J Alzheimers Dis. 2014;38(4):897-906. doi: 10.3233/JAD-131121. IF=4,261

(157) 2052. Whiley L, Sen A, Heaton J, Proitsi P, García-Gómez D, Leung R, Smith N, Thambisetty M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Lovestone S, Legido-Quigley C; AddNeuroMed Consortium. Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.Neurobiol Aging. 2013 Sep 13. Ι.F. =6,634

 (156) 2026. Nho K, Corneveaux JJ, Kim S, Lin H, Risacher SL, Shen L, Swaminathan S, Ramanan VK, Liu Y, Foroud T, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta K, Farrer LA; Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H; AddNeuroMed Consortium, McDonald BC, Farlow MR, Ghetti B; Indiana Memory and Aging Study, Huentelman MJ, Saykin AJ. Identification of functional  variants from whole-exome sequencing, combined with neuroimaging genetics. Mol Psychiatry. 2013 Jul;18(7):739. ΙF= 13.668

(155) 2027. Leung R, Proitsi P, Simmons A, Lunnon K, Güntert A, Kronenberg D, Pritchard M, Tsolaki M, Mecocci P, Kloszewska I, Vellas B, Soininen H, Wahlund LO, Lovestone S. Inflammatory proteins in plasma are associated with severity of Alzheimer's disease. PLoS One. 2013 Jun 10;8(6). IF= 4.09

(154) 2009. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, Heun R, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2013 May 29;45(6):712. ΙF=35.532

(153) 1984. Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, Boada M, Bullock R, De Deyn PP, Frisoni GB, Hampel H, Jones RW, Kehoe P, Lenoir H, Minthon L, Olde Rikkert MG, Rodriguez G, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Verhey FR, Winblad B, Wahlund LO, Wilcock G, Visser PJ. Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study. Dement Geriatr Cogn Disord. 2013 May 3;36(1-2):1-19. IF= 3.142

(152) 1981. Tsantali E, Economidis D, Tsolaki M. Could language deficits really differentiate Mild Cognitive Impairment (MCI) from mild Alzheimer's disease? Arch Gerontol Geriatr. 2013 2013 Nov-Dec;57(3):263-70. IF=1,496

(151) 1978. Nho K, Corneveaux JJ, Kim S, Lin H, Risacher SL, Shen L, Swaminathan S, Ramanan VK, Liu Y, Foroud T, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta K, Farrer LA; for the Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H; for the AddNeuroMed Consortium, McDonald BC, Farlow MR, Ghetti B; for the Indiana Memory and Aging Study, Huentelman MJ, Saykin AJ. Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry. 2013 Apr 23. ΙF=13,668

(150) 1966. Aguilar C, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Spenger C, Simmons A, Wahlund LO. Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment. Psychiatry Res. 2013 Mar 29. ΙF=2.768

(149) 1964.  Clerx L, van Rossum IA, Burns L, Knol DL, Scheltens P, Verhey F, Aalten P, Lapuerta P, van de Pol L, van Schijndel R, de Jong R, Barkhof F, Wolz R, Rueckert D, Bocchetta M, Tsolaki M, Nobili F, Wahlund LO, Minthon L, Frölich L, Hampel H, Soininen H, Visser PJ. Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment. Neurobiol Aging. 2013 Mar 26. ΙF=6,634

(148) 1939. Vos SJ, van Rossum IA, Verhey F, Knol DL, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Frisoni GB, Froelich L, Nobili F, van der Flier W, Blennow K, Wolz R, Scheltens P, Visser PJ. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology. 2013 Feb 27. IF=8,31

(147) 1916. Koutroumani M, Daniilidou M, Giannakouros T, Proitsi P, Liapi D, Germanou A, Nikolakaki E, Tsolaki M. The deletion variant of a2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment. J Neurol Sci. 2013 Mar 15. IF=2.441

 (146) 1914. Vermeiren AP, Bosma H, Visser PJ, Zeegers MP, Graff C, Ewers M, Frisoni GB, Frölich L, Hampel H, Jones RW, Kehoe PG, Lenoir H, Minthon L, Nobili FM, Olde Rikkert M, Rigaud AS, Scheltens P, Soininen H, Spiru L, Tsolaki M, Wahlund LO, Vellas B, Wilcock G, Elias-Sonnenschein LS, Verhey FR.The Association Between APOE ε4 and Alzheimer-type Dementia among Memory Clinic Patients is Confined to those with a Higher Education. The DESCRIPA Study. J Alzheimers Dis. 2013 Feb 4.  ΙF:4,261

(145) 1909. Mangialasche F, Westman E, Kivipelto M, Muehlboeck JS, Cecchetti R, Baglioni M, Tarducci R, Gobbi G, Floridi P, Soininen H, Kłoszewska I, Tsolaki M, Vellas B, Spenger C, Lovestone S, Wahlund LO, Simmons A, Mecocci P; The AddNeuroMed consortium. Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol. J Intern Med. 2013 Jan 24. ΙF: 5.483

(144) 1900. Spulber G, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Wahlund LO, Westman E; The AddNeuroMed consortium for the Alzheimer Disease Neuroimaging Initiative. An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment. J Intern Med. 2012 Dec 27. ΙF: 5.483

(143) 1901. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J; Alzheimer Genetic Analysis Group. TREM2 variants in Alzheimer's disease. N Engl J Med. 2013 Jan 10;368(2):117-27. Free Article ΙF:53.298

(142) Laskaris NA, Tarnanas I, Tsolaki MN, Vlaikidis N, Karlovasitou AK. Improved detection of amnestic MCI by means of discriminative vector quantization of single-trial cognitive ERP responses. J Neurosci Methods. 2012 Nov 9;212(2):344-354. ΙF:2,4

(141) 1854. Greco I, Day N, Riddoch-Contreras J, Reed J, Soininen H, K 322 Oszewska I, Tsolaki M, Vellas B, Spenger C, Mecocci P, Wahlund LO, Simmons A, Barnes J, Lovestone SS. Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation. J Transl Med. 2012 Oct 31;10(1):217. ΙF: 3.47

(140) 1824. Kiddle SJ, Thambisetty M, Simmons A, Riddoch-Contreras J, Hye A, Westman E, Pike I, Ward M, Johnston C, Lupton MK, Lunnon K, Soininen H, Kloszewska I, Tsolaki M, Vellas B, Mecocci P, Lovestone S, Newhouse S, Dobson R; for the Alzheimer’s Disease Neuroimaging Initiative. Plasma Based Markers of [(11)C] PiB-PET Brain Amyloid Burden. PLoS One. 2012;7(9):e44260. ΙF: 4,411

 (139) 1826. Lunnon K, Sattlecker M, Furney SJ, Coppola G, Simmons A, Proitsi P, Lupton MK, Lourdusamy A, Johnston C, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Geschwind D, Lovestone S, Dobson R, Hodges A. A Blood Gene Expression Marker of Early Alzheimer's Disease. J Alzheimers Dis. 2012 Oct 5. ΙF =4,261

(138) 1827. Velayudhan L, Proitsi P, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Hodges A, Powell J, Lovestone S, Simmons A. Entorhinal Cortex Thickness Predicts Cognitive Decline in Alzheimer's Disease. J Alzheimers Dis. 2012 Oct 9. Ι.F. =4,261

(137) (181) 1821. van Rossum IA, Vos SJ, Burns L, Knol DL, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, L'italien G, van der Flier WM, Teunissen CE, Blennow K, Barkhof F, Rueckert D, Wolz R, Verhey F, Visser PJ. Injury markers predict time to dementia in subjects with MCI and amyloid pathology.  Neurology. 2012 Sep 26. IF=8,31

(136) (180) 1815. Tarnanas I, Laskaris N, Tsolaki M. On The Comparison of VR-Responses, as Performance Measures in Prospective Memory, with Auditory P300 Responses in MCI Detection. Stud Health Technol Inform. 2012;181:156-61. IF=4,08

(135) (179) 1805. Vellas B, Hausner L, Frölich L, Cantet C, Gardette V, Reynish E, Gillette S, Ag Era-Morales E, Auriacombe S, Boada-Rovira M, Bullock R, Byrne J, Cherubini A, Eriksdotter-J Nhagen M, Frisoni G, Hasselbalch S, Jones R, Martinez-Lage P, Rikkert M, Tsolaki M, Ousset PJ, Pasquier F, Ribera-Casado JM, Rigaud AS, Robert P, Rodriguez G, Salmon E, A S, Scheltens P, Schneider A, Spiru L, Touchon J, Zekry D, Winblad B, Andrieu S. Progression of Alzheimer disease in Europe: Data from the European ICTUS study. Curr Alzheimer Res. 2012 Jun 26. IF=4,97

(134). (174) 1779. Tagarakis GI, Voucharas C, Tsolaki F, Daskalopoulos ME, Papaliagkas V, Parisis C, Gogaki E, Tsagalas I, Sataitidis I, Tsolaki M, Tsilimingas NB. Ondasetron versus haloperidol for the treatment of postcardiotomy delirium: a prospective, randomized, double-blinded study. J Cardiothorac Surg. 2012 Mar 21;7(1):25. Ι.F. =0,91

(133). (175) 1780. Proitsi P, Lupton MK, Dudbridge F, Tsolaki M, Hamilton G, Daniilidou M, Pritchard M, Lord K, Martin BM, Craig D, Todd S, McGuinness B, Hollingworth P, Harold D, Kloszewska I, Soininen H, Mecocci P, Velas B, Gill M, Lawlor B, Rubinsztein DC, Brayne C, Passmore PA, Williams J, Lovestone S, Powell JF. Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation. Neurobiol Aging. 2012 Jan 31. Ι.F. =6,634

(132). (176) 1781. Mattsson N, Rosén E, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek MM, Olde Rikkert M, Tsolaki M, Mulugeta E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Wallin A, Eriksdotter-Jönhagen M, Minthon L, Winblad B, Blennow K, Zetterberg H. Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology. 2012 Feb 14;78(7):468-76.  Ι.F. =8,17

(131). (177) 1782. Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, Sattlecker M, Furney S, Saleem M, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Coppola G, Geschwind D, Simmons A, Lovestone S, Dobson R, Hodges A. Mitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood. J Alzheimers Dis. 2012 Mar 30. ΙF =4,261

(130). (178) 1783. Lourdusamy A, Newhouse S, Lunnon K, Proitsi P, Powell J, Hodges A, Nelson SK, Stewart A, Williams S, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Lovestone S; on behalf of the AddNeuroMed Consortium, Dobson R; for the Alzheimer’s Disease Neuroimaging Initiative. Identification of cis- regulatory variation influencing protein abundance levels in human plasma. Hum Mol Genet. 2012 May 16. IF.= 8,058

(129) 1714. Vos S, van Rossum I, Burns L, Knol D, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Handels R, L'italien G, van der Flier W, Aalten P, Teunissen C, Barkhof F, Blennow K, Wolz R, Rueckert D, Verhey F, Visser PJ. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol Aging. 2012 Jan 19. IF=5,559

(128) 1715.Tsolaki F, Gogaki E, Sakkias F, Skatharoudi C, Lopatatzidi C, Tsoulopoulos V, Lampoura S, Topouzis F, Tsolaki M, Kountouras J. Helicobacter pylori infection and primary open-angle glaucoma: is there a connection? Clin Ophthalmol. 2012;6:45-7. IF= 1.755


URL:https://www.dovepress.com/articles.php?article_id=9009&l=PrNOEuiFKQ6oOjxs8SoNZbYY67447

(127) 1716. Bamidis PD, Konstantinidis EI, Billis A, Frantzidis C, Tsolaki M, Hlauschek W, Kyriacou E,  A Web services-based exergaming platform for senior citizens: The long lasting memories project approach to e-health care.  Conf Proc IEEE Eng Med Biol Soc. 2011 Aug;2011:2505-9. IF=3,673

(126) 1717. Liu Y, Julkunen V, Paajanen T, Westman E, Wahlund LO, Aitken A, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Spenger C, Lovestone S, Simmons A, Soininen H; AddNeuroMed Consortium.Education increases reserve against Alzheimer's disease-evidence from structural MRI analysis. Neuroradiology. 2012 Jan 14. IF=2,87

(125) 1718. Thambisetty M, Simmons A, Hye A, Campbell J, Westman E, Zhang Y, Wahlund LO, Kinsey A, Causevic M, Killick R, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S; for the AddNeuroMed consortium. Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease. PLoS One. 2011;6(12):e28527. ΙF: 4,411

(124) 1719. Mangialasche F, Xu W, Kivipelto M, Costanzi E, Ercolani S, Pigliautile M, Cecchetti R, Baglioni M, Simmons A, Soininen H, Tsolaki M, Kloszewska I, Vellas B, Lovestone S, Mecocci P; AddNeuroMed Consortium. Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol Aging. 2011 Dec 20. IF=5,559

(123) 1720. Sikkes SA, Visser PJ, Knol DL, de Lange-de Klerk ES, Tsolaki M, Frisoni GB, Nobili F, Spiru L, Rigaud AS, Frölich L, Rikkert MO, Soininen H, Touchon J, Wilcock G, Boada M, Hampel H, Bullock R, Vellas B, Pijnenburg YA, Scheltens P, Verhey FR, Uitdehaag BM. Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the development of screening guidelines and diagnostic criteria for predementia Alzheimer's disease study. J Am Geriatr Soc. 2011 Dec;59(12):2273-81.IF=3,913

(122)1721. Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RC, Griffith P, Obisesan TO, Shatz R, Borenstein A, Cupples LA, Lunetta KL, Fallin MD, Baldwin CT, Farrer LA; Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study Group.A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol. 2011 Dec;68(12):1569-79. ΙF=6,31

(121) 1722. Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO; AddNeuroMed consortium; Alzheimer's Disease Neuroimaging Initiative. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage. 2011 Oct 1;58(3):818-28. . ΙF : 6,817

 (120) 1691. Furney SJ, Kronenberg D, Simmons A, Güntert A, Dobson RJ, Proitsi P, Wahlund LO, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S. Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression. J Alzheimers Dis. 2011;26 Suppl 3:395-405. ΙF:3,82

(119) 1692. Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Johnston JA, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Kölsch H, Heun R, Schürmann B, Bussche HV, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Davies G, Harris SE, Starr JM, Deary IJ, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Jones L, Holmans PA, O'Donovan MC, Owen MJ, Williams J. The Role of Variation at AβPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease. J Alzheimers Dis. 2011 Oct 25. ΙF:3,82

(118) 1693. Koliaki CC, Messini C, Tsolaki M. Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study*. CNS Neurosci Ther. 2011 Feb 26. ΙF:3,492

(117) 1676.Logue MW, Posner H, Green RC, Moline M, Cupples LA, Lunetta KL, Zou H, Hurt SW, Farrer LA, Decarli C; MIRAGE Study Group. Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients. Alzheimers Dement. 2011 Sep;7(5):493-500. ΙF:4,55

(116) 1662. Norberg J, Graff C, Almkvist O, Ewers M, Frisoni GB, Frölich L, Hampel H, Jones RW, Kehoe PG, Lenoir H, Minthon L, Nobili F, Olde Rikkert M, Rigaud AS, Scheltens P, Soininen H, Spiru L, Tsolaki M, Wahlund LO, Vellas B, Wilcock G, Elias-Sonnenschein LS, Verhey FR, Visser PJ. Regional Differences in Effects of APOE ε4 on Cognitive Impairment in Non-Demented Subjects. Dement Geriatr Cogn Disord. 2011 Sep 22;32(2):135-142. ΙF:2,58

(115) 1638. Westman E, Cavallin L, Muehlboeck JS, Zhang Y, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO; AddNeuroMed consortium. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One. 2011;6(7):e22506.  ΙF: 4,411

(114) 1639. Daniilidou M, Tsolaki M, Giannakouros T, Nikolakaki E. Detection of elevated antibodies against SR protein kinase 1 in the serum of Alzheimer's disease patients. J Neuroimmunol. 2011 Sep 15;238(1-2):67-72. Epub 2011 Jul 27. ΙF: 2,942

 (113) 1625. Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO; for the AddNeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative.  AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage. 2011 Jul 1. ΙF: 6,817

(112)  1626. Tsolaki F, Gogaki E, Tiganita S, Skatharoudi C, Lopatatzidi C, Topouzis F, Tsolaki M. Alzheimer's disease and primary open-angle glaucoma: is there a connection? Clin Ophthalmol. 2011;5:887-90. Epub 2011 Jun 28. ΙF = 1.755

(111)1627. Whitehead D, Tunnard C, Hurt C, Wahlund LO, Mecocci P, Tsolaki M, Vellas B, Spenger C, Kłoszewska I, Soininen H, Cromb D, Lovestone S, Simmons A.  Frontotemporal atrophy associated with paranoid delusions in women with Alzheimer's disease. Int Psychogeriatr. 2011 Jul 11:1-9. ΙF = 2.478.

(110) 1628. Fountoulakis KN, Pavlidis I, Tsolaki M. Life events and dementia: What is the nature of their relationship? Psychiatry Res. 2011 Nov 30;190(1):156-8ΙF: 2.344

(109) 1567. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Rüther E, Schürmann B, Heun R, Kölsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Gallacher J, Hüll M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC; the Alzheimer's Disease Neuroimaging Initiative, van Duijn CM, Breteler MM, Ikram MA, Destefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S; CHARGE consortium, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alpérovitch A, Lathrop M; EADI1 consortium, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snædal J, Björnsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossù P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P, Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011 May;43(5):429-35.. IF=24,176.

(108) 1568. Daniilidou M, Koutroumani M, Tsolaki M. Epigenetic Mechanisms in Alzheimer's Disease. Curr Med Chem. 2011 Apr 5. Curr Med Chem. 2011;18(12):1751-6. IF=4,708

(107). 1549. Lupton MK, Proitsi P, Danillidou M, Tsolaki M, Hamilton G, Wroe R, Pritchard M, Lord K, Martin BM, Kloszewska I, Soininen H, Mecocci P, Vellas B, Harold D, Hollingworth P, Lovestone S, Powell JF. Deep sequencing of the nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease. PLoS One. 2011 Feb 25;6(2):e17298.  ΙF =4,411

(106). 1544. Costafreda SG, Dinov ID, Tu Z, Shi Y, Liu CY, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Wahlund LO, Spenger C, Toga AW, Lovestone S, Simmons A. Automated hippocampal shape analysis predicts the onset of dementia in Mild Cognitive Impairment. Neuroimage. 2011 Jan 24. IF=5.739

(105) 1540. Papaliagkas VT, Kimiskidis VK, Tsolaki MN, Anogianakis G. Cognitive event-related potentials: Longitudinal changes in mild cognitive impairment. Clin Neurophysiol. 2011 Jan 10. ΙF=3.122

(104) 1529. Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C.

The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. Int J Geriatr Psychiatry. 2011 Jan;26(1):75-82. ΙF=1,981

 

(103) 1519. Tsolaki M, Kounti F, Agogiatou C, Poptsi E, Bakoglidou E, Zafeiropoulou M, Soumbourou A, Nikolaidou E, Batsila G, Siambani A, Nakou S, Mouzakidis C, Tsiakiri A, Zafeiropoulos S, Karagiozi K, Messini C, Diamantidou A, Vasiloglou M. Effectiveness of Nonpharmacological Approaches in Patients with Mild Cognitive Impairment. Neurodegener Dis. 2011;8(3):138-45. IF=3,496.

 

(102) 1520.Badiavas K, Molyvda E, Iakovou I, Tsolaki M, Psarrakos K, Karatzas N. SPECT imaging evaluation in movement disorders: far beyond visual assessment. Med Mol Imaging. 2010 Dec 2. IF=2,525 Eur J Nucl Medicine 12/2010; 38(4):764-73 IF=4.53

 

(101) 1521. Furney SJ, Simmons A, Breen G, Pedroso I, Lunnon K, Proitsi P, Hodges A, Powell J, Wahlund LO, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lathrop M, Shen L, Kim S, Saykin AJ, Weiner MW, Lovestone S. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol Psychiatry. 2010 Nov 30. IF=15,049

(100) 1491. Paajanen T, Hänninen T, Tunnard C, Mecocci P, Sobow T, Tsolaki M, Vellas B, Lovestone S, Soininen H, For The Addneuromed Consortium. CERAD Neuropsychological Battery Total Score in Multinational Mild Cognitive Impairment and Control Populations: The AddNeuroMed Study. J Alzheimers Dis. 2010 Oct 7. IF=5,101

(99) 1492. Gustavsson A, Jonsson L, Rapp T, Reynish E, Ousset PJ, Andrieu S, Cantet C, Winblad B, Vellas B, Wimo A; ICTUS Study Group. Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study. J Nutr Health Aging. 2010 Aug;14(8):648-54. IF=2,321

(98) 1493. Tunnard C, Whitehead D, Hurt C, Wahlund L, Mecocci P, Tsolaki M, Vellas B, Spenger C, Kłoszewska I, Soininen H, Lovestone S, Simmons A; on behalf of the AddNeuroMed Consortium.Apathy and cortical atrophy in Alzheimer's disease. Int J Geriatr Psychiatry. 2010 Sep 27. ΙF=1,981

(97) 1494. Liu Y, Paajanen T, Westman E, Zhang Y, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium. APOE ε2 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord. 2010;30(3):229-37. IF=3,142

(96) 1495. Westman E, Simmons A, Zhang Y, Muehlboeck JS, Tunnard C, Liu Y, Collins L, Evans A, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Spenger C, Wahlund LO; for the AddNeuroMed consortium. Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage. 2010 Aug 25. IF=5.739

(95) 1496. Jacobs HI, Visser PJ, Van Boxtel MP, Frisoni GB, Tsolaki M, Papapostolou P, Nobili F, Wahlund LO, Minthon L, Frölich L, Hampel H, Soininen H, van de Pol L, Scheltens P, Tan FE, Jolles J, Verhey FR.The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol Aging. 2010 Aug 23. IF=5,559

(94)  1497. Emre M, Tsolaki M, Bonuccelli U, Destée A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladström A, Jones R; 11018 Study Investigators. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010 Oct;9(10):969-77. IF=18,13

(93) 1481. Liu Y, Paajanen T, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen For The Addneuromed Consortium H. Effect of APOE epsilon4 Allele on Cortical Thicknesses and Volumes: The AddNeuroMed Study. J Alzheimers Dis. 2010 Aug 6. IF=5,101

(92) 1482. Perneczky R, Wagenpfeil S, Lunetta KL, Cupples LA, Green RC, Decarli C, Farrer LA, Kurz A; MIRAGE Study Group. Head circumference, atrophy, and cognition: implications for brain reserve in Alzheimer disease. Neurology. 2010 Jul 13;75(2):137-42.  IF=5,690

(91) 1483. Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, Wahlund LO, Westman E, Kinsey A, Güntert A, Proitsi P, Powell J, Causevic M, Killick R, Lunnon K, Lynham S, Broadstock M, Choudhry F, Howlett DR, Williams RJ, Sharp SI, Mitchelmore C, Tunnard C, Leung R, Foy C, O'Brien D, Breen G, Furney SJ, Ward M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Hodges A, Murphy DG, Parkins S, Richardson JC, Resnick SM, Ferrucci L, Wong DF, Zhou Y, Muehlboeck S, Evans A, Francis PT, Spenger C, Lovestone S. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry. 2010 Jul;67(7):739-48. IF=14.27

(90) 1484. Lindesay J, Bullock R, Daniels H, Emre M, Förstl H, Frölich L, Gabryelewicz T, Martínez-Lage P, Monsch AU, Tsolaki M, van Laar T. Turning principles into practice in Alzheimer's disease. Int J Clin Pract. 2010 Aug;64(9):1198-209. IF= 2.245

(89) 1485. Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging. 2010 Aug;31(8):1375-85. IF=5,559

(88) 1475. Papaliagkas VT, Tsolaki M, Anogianakis G. Cerebrospinal Fluid Proteins in the Diagnosis of Alzheimer's Disease. Recent Pat CNS Drug Discov. 2010 Mar 19.

(87) 1474. Emre M, Bernabei R, Blesa R, Bullock R, Cunha L, Daniëls H, Dziadulewicz E, Förstl H, Frölich L, Gabryelewicz T, Levin O, Lindesay J, Martínez-Lage P, Monsch A, Tsolaki M, van Laar T. Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease. CNS Neurosci Ther. 2010 Mar 29. IF=4.432

(86) Tsolaki M, Messini CZ, Siapera M, Fotiadou F, Delaporta D, Karatolias A. Depression, extrapyramidal symptoms, dementia and an unexpected outcome: a case report. Cases J. 2010 Feb 2;3(1):47.

(85) Papaliagkas VT, Anogianakis G, Tsolaki M, Koliakos G, Kimiskidis VK. Combination of P300 and CSF beta-Amyloid(1-42) Assays may Provide a Potential Tool in the Early Diagnosis of Alzheimer's Disease. Curr Alzheimer Res. 2009 Nov 26. ΙF=4.132

(84) Tsolaki M, Papaliagkas V, Anogianakis G, Bernabei R, Emre M, Frolich L, Visser PJ, Michel JP, Pirttila T, Olde Rikkert M, Soininen H, Sobow T, Vellas B, Verhey F, Winblad B. Consensus statement on dementia education and training in europe. J Nutr Health Aging. 2010;14(2):131-5. IF=2,321

(83) 1343. Tsolaki  M.,  Papaliagkas V.,  Kounti F.,  Messini C.,  Boziki M.,   Anogianakis G.,  Vlaikidis V.. Severe stress events and dementia: A study of an elderly Greek demented population. Psychiatry Research 2010; 176 (1) :51-4  IF=2,666

 

(82) 1368. Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C; for the AddNeuroMed Consortium. MRI Measures of Alzheimer's Disease and the AddNeuroMed Study. Ann N Y Acad Sci. 2009 Oct;1180:47-55. IF=1,93

 

(81) 1369. Lovestone S, Francis P, Kloszewska I, Mecocci P, Simmons A, Soininen H, Spenger C, Tsolaki M, Vellas B, Wahlund LO, Ward M; on behalf of the AddNeuroMed Consortium. AddNeuroMed-The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease. Ann N Y Acad Sci. 2009 Oct;1180:36-46. IF=1,93

 

(80). 1367. Froelich L, Andreasen N, Tsolaki M, Foucher A, Kavanagh S, Bart Van Baelen, Schwalen S. Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey. Curr Med Res Opin. 2009 Oct 26. IF=3,062

 

(79) 1280.  Papaliagkas VT, Tsolaki MN, Kimiskidis VK, Anogianakis G. Male patient with mild cognitive impairment and extremely high P300 and Slow-wave latencies: a case report.

Cases J. 2009 Jul 1;2:6157.

 

(78) 1365. Hurt CS, Banerjee S, Tunnard C, Whitehead D, Tsolaki M, Mecocci P, Kloszewska I, Soininen H, Vellas B, Lovestone S. Insight, Cognition and Quality of Life in Alzheimer's Disease.

J Neurol Neurosurg Psychiatry. 2009 Oct 13. IF=3,630

 

(77) 1319. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schόrmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frφlich L, Hampel H, Hόll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mόhleisen TW, Nφthen MM, Moebus S, Jφckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.  Nat Genet. 2009 Oct;41(10):1088-93. IF=24,176.

 

(76) 1311. Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; for the AddNeuroMed Consortium. Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups-The AddNeuroMed study. Neurobiol Aging. 2009 Aug 13. IF=5,559

 

(75) 1281. van de Pol L, Verhey F, Frisoni G, Tsolaki M, Papapostoulou P, Nobili F, Wahlund LO, Minthon L, Frolich L, Hampel H, Soininen H, Knol D, Barkhof F, Scheltens P, Verhey PJ. White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study.  J Neurol Neurosurg Psychiatry. 2009 Jun 18. IF=3,630

 

(74) 1288. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosιn E, Aarsland D, Visser PJ, Schrφder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilδ T, Wallin A, Jφnhagen ME, Minthon L, Winblad B, Blennow K. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009 Jul 22;302(4):385-93, IF=31,7

 

(73) 1289. Papaliagkas VT, Anogianakis G, Tsolaki MN, Koliakos G, Kimiskidis VK. Progression of Mild Cognitive Impairment to Alzheimer's Disease: Improved Diagnostic Value of the Combined Use of N200 Latency and beta-Amyloid(1-42) Levels. Dement Geriatr Cogn Disord. 2009 Jul 23;28(1):30-35. IF=3,142

 

(72) 1276. Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund-Levi Y, Tsolaki M, Minthon L, Wallin AK, Hampel H, Bόrger K, Pirttila T, Soininen H, Rikkert MO, Verbeek MM, Spiru L, Blennow K. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.  Lancet Neurol. 2009 Jun 10. IF=18,13

 

(71) 1277. Papaliagkas VT, Anogianakis G, Tsolaki MN, Koliakos G, Kimiskidis VK. Prediction of conversion from mild cognitive impairment to Alzheimer's disease by CSF cytochrome c levels and N200 latency.  Curr Alzheimer Res. 2009 Jun;6(3):279-84, IF=4,132

 

(70). 1266. Proitsi P, Hamilton G, Tsolaki M, Lupton M, Daniilidou M, Hollingworth P, Archer N, Foy C, Stylios F, McGuinness B, Todd S, Lawlor B, Gill M, Brayne C, Rubinsztein DC, Owen M, Williams J, Craig D, Passmore P, Lovestone S, Powell JF. A Multiple Indicators Multiple Causes (MIMIC) model of Behavioural and Psychological Symptoms in Dementia (BPSD).

Neurobiol Aging. 2009 Apr 20; IF= 5,559

 

(69). 1239. Birks J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE. Rivastigmine for Alzheimer's disease.  Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001191. IF=5.653

 

(68). 1240. Tsolaki M, Eleftheriou M, Karavida N. Alzheimer's dementia and post-traumatic stress disorder differences and similarities in neuroimaging.

Hell J Nucl Med. 2009 Jan-Apr;12(1):41-6. IF=0,71

(67). Cuenco KT, Friedland R, Baldwin CT, Guo J, Vardarajan B, Lunetta KL, Cupples LA, Green RC, DeCarli C, Farrer LA; MIRAGE Study Group. Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families. Neurobiol Aging. 2011 Feb;32(2):249-56. IF=5,559       

(66).1241. Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Grigoriadis N, Tsolaki M, Chatzopoulos D, Katsinelos P, Tzilves D, Zabouri A, Michailidou I. Increased cerebrospinal fluid helicobacter pylori antibody in Alzheimer's disease.

Int J Neurosci. 2009;119(6):765-77. IF=0,831

 

(65). 1222. Kountouras J, Boziki M, Gavalas E, Zavos C, Grigoriadis N, Deretzi G, Tzilves D, Katsinelos P, Tsolaki M, Chatzopoulos D, Venizelos I. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.  J Neurol. 2009 Feb 25. IF=2,984

 

(64). 1193.Tsolaki M, Kounti F, Karamavrou S. Severe Psychological Stress in Elderly Individuals: A Proposed Model of Neurodegeneration and Its Implications.

Am J Alzheimers Dis Other Demen. 2009 Apr-May;24(2):85-94. IF=3.142

 

(63). 1205. T Cuenco K, Lunetta KL, Baldwin CT, McKee AC, Guo J, Cupples LA, Green RC, St George-Hyslop PH, Chui H, DeCarli C, Farrer LA; MIRAGE Study Group.Farrer LA, Green RC, Baldwin CT, Cupples LA, Lunetta KL, Cuenco KT, Auerbach S, Logue M, Akomolafe A, Ashley A, Freedman L, Ofili E, Chui H, DeCarli C, Duara R, Foroud T, Farlow M, Friedland R, Go R, Kurz A, Obisesan T, Petrovitch H, White L, Sabbagh M, Sadovnick D, Tsolaki M. Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. Arch Neurol. 2008 Dec;65(12):1640-8. IF=5,204

 

(62). (1172) Tsolaki M, Paraskevi S, Karamavrou S, Degleris N. Attitudes and Perceptions Regarding Alzheimer's Disease in Greece.

Am J Alzheimers Dis Other Demen. 2009;24:21-26. IF=3.142

 

(61). 1197.Nieoullon A, Bentuι-Ferrer D, Bordet R, Tsolaki M, Fφrstl H. Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine. Curr Med Res Opin. 2008 Dec;24(12):3357-67. IF=3,062

 

(60). Papaliagkas V, Kimiskidis V, Tsolaki M, Anogianakis G. Usefulness of event-related potentials in the assessment of mild cognitive impairment.

BMC Neurosci. 2008 Nov 5;9(1):107. IF=2,85

 

(59). 1179. Maiovis P, Gavopoulou E, Eleftheriou M, Tsokanari I, Tsolaki M. Diagnostic uncertainty in a severely demented male patient: a case report. Cases J. 2008 Oct 19;1(1):250.

 

(58). Cuenco KT, Green RC, Zhang J, Lunetta K, Erlich PM, Cupples LA, Farrer LA, DeCarli C; MIRAGE Study Group. Baldwin CT, Auerbach S, Akomolafe A, Freedman L, Ofili E, Chui H, DeCarli C, Duara R, Foroud T, Farlow M, Friedland R, Go R, Kurz A, Obisesan T, Petrovitch H, White L, Relkin N, Sabbagh M, Sadovnick D, Tsolaki M, Morey P, Adamiak B, Ade-Okanlami A, Cowden L, Cramer B, Dandiilidou M, Dwosh E, Grady E, Humphrey S, Imamura C, Kolody H, Long N, Luis M, Martelli K, Wainwright J, Farrell J, Huyck M, Johnson D. Magnetic resonance imaging traits in siblings discordant for Alzheimer disease.  J Neuroimaging. 2008 Jul;18(3):268-75. IF=1,811

 

(57). Hurt C, Bhattacharyya S, Burns A, Camus V, Liperoti R, Marriott A, Nobili F, Robert P, Tsolaki M, Vellas B, Verhey F, Byrne EJ. Patient and Caregiver Perspectives of Quality of Life in Dementia. An Investigation of the Relationship to Behavioural and Psychological Symptoms in Dementia. Dement Geriatr Cogn Disord. 2008 Aug 4;26(2):138-146. IF=2,511

 

(56)-78- 1137. Visser PJ, Verhey FR, Boada M, Bullock R, De Deyn PP, Frisoni GB, Frolich L, Hampel H, Jolles J, Jones R, Minthon L, Nobili F, Olde Rikkert M, Ousset PJ, Rigaud AS, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Wahlund LO, Wilcock G, Winblad B. Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology. 2008;30(4):254-65. IF=2,352

 

(55). Tagarakis GI, Tsolaki-Tagaraki F, Tsolaki M, Diegeler A, Stylianakis GE, Kazis D, Tsilimingas NB, Papassotiropoulos A. Are genetic components related to cognitive decline after coronary artery surgery? Genetics and brain function after bypass heart surgery. J Card Surg. 2008 May-Jun;23(3):280-1. IF=0,709

 

(54). Petrovic M, Hurt C, Collins D, Burns A, Camus V, Liperoti R, Marriott A, Nobili F, Robert P, Tsolaki M, Vellas B, Verhey F, Byrne EJ. Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer's disease consortium (EADC) study.

Acta Clin Belg. 2007 Nov-Dec;62(6):426-32. IF=0,637

 

(53). Castro-Costa E, Dewey M, Stewart R, Banerjee S, Huppert F, Mendonca-Lima C, Bula C, Reisches F, Wancata J, Ritchie K, Tsolaki M, Mateos R, Prince M.

Ascertaining late-life depressive symptoms in Europe: an evaluation of the survey version of the EURO-D scale in 10 nations. The SHARE project.

Int J Methods Psychiatr Res. 2008;17(1):12-29. IF=1,979

 

(52). Aalten P, Verhey FR, Boziki M, Brugnolo A, Bullock R, Byrne EJ, Camus V, Caputo M, Collins D, De Deyn PP, Elina K, Frisoni G, Holmes C, Hurt C, Marriott A, Mecocci P, Nobili F, Ousset PJ, Reynish E, Salmon E, Tsolaki M, Vellas B, Robert PH. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II.

Dement Geriatr Cogn Disord. 2008;25(1):1-8. Review. IF=2,511

 

(51). Sakka P, Tsolaki M, Hort J, Hager K, Soininen H, Lσpez Pousa S, Li C, Schwam E. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy. Curr Med Res Opin. 2007 Dec;23(12):3153-65. IF=3,062

 

(50). Aalten P, Verhey FR, Boziki M, Bullock R, Byrne EJ, Camus V, Caputo M, Collins D, De Deyn PP, Elina K, Frisoni G, Girtler N, Holmes C, Hurt C, Marriott A, Mecocci P, Nobili F, Ousset PJ, Reynish E, Salmon E, Tsolaki M, Vellas B, Robert PH. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.

Dement Geriatr Cogn Disord. 2007;24(6):457-63. IF=2,511

 

(49). Castro-Costa E, Dewey M, Stewart R, Banerjee S, Huppert F, Mendonca-Lima C, Bula C, Reisches F, Wancata J, Ritchie K, Tsolaki M, Mateos R, Prince M.

Prevalence of depressive symptoms and syndromes in later life in ten European countries: the SHARE study.  Br J Psychiatry. 2007 Nov;191:393-401. IF=5,436

 

(48). Kountouras J, Tsolaki M, Boziki M, Gavalas E, Zavos C, Stergiopoulos C, Kapetanakis N, Chatzopoulos D, Venizelos I. Association between Helicobacter pylori infection and mild cognitive impairment. Eur J Neurol. 2007 Sep;14(9):976-82. IF=2,437

 

(47). Tagarakis GI, Tsolaki-Tagaraki F, Tsolaki M, Diegeler A, Tsilimingas NB, Papassotiropoulos A. The role of apolipoprotein E in cognitive decline and delirium after bypass heart operations.

Am J Alzheimers Dis Other Demen. 2007 Jun-Jul;22(3):223-8. IF=3.142

 

(46). Tagarakis GI, Tsolaki-Tagaraki F, Tsolaki M, Diegeler A, Kazis D, Rouska E, Papassotiropoulos A. The role of SOAT-1 polymorphisms in cognitive decline and delirium after bypass heart surgery. Clin Res Cardiol. 2007 Sep;96(9):600-3. IF=2.958

 

(45). Wollmer MA, Sleegers K, Ingelsson M, Zekanowski C, Brouwers N, Maruszak A, Brunner F, Huynh KD, Kilander L, Brundin RM, Hedlund M, Giedraitis V, Glaser A, Engelborghs S, De Deyn PP, Kapaki E, Tsolaki M, Daniilidou M, Molyva D, Paraskevas GP, Thal DR, Barcikowska M, Kuznicki J, Lannfelt L, Van Broeckhoven C, Nitsch RM, Hock C, Papassotiropoulos A.Association study of cholesterol-related genes in Alzheimer's disease. Neurogenetics. 2007 Aug;8(3):179-88. IF=4,250

 

(44). 67-943. Pearson JV, Huentelman MJ, Halperin RF, Tembe WD, Melquist S, Homer N, Brun M, Szelinger S, Coon KD, Zismann VL, Webster JA, Beach T, Sando SB, Aasly JO, Heun R, Jessen F, Kolsch H, Tsolaki M, Daniilidou M, Reiman EM, Papassotiropoulos A, Hutton ML, Stephan DA, Craig DW. Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies.

Am J Hum Genet. 2007 Jan;80(1):126-39. IF=12,629

 

(43). (862) Tsolaki M, Alexiadou A, Kiosseoglou G, Kounti F. Correlations between the Functional-Cognitive Assessment Scale and the Alzheimer's Disease Assessment Scale when administered to patients with dementia residing in long-term care.

Am J Alzheimers Dis Other Demen. 2006 Aug-Sep;21(4):274-80. IF= 3,142

 

(42). Papassotiropoulos A, Lambert JC, Wavrant-De Vriθze F, Wollmer MA, von der Kammer H, Streffer JR, Maddalena A, Huynh KD, Wolleb S, Lutjohann D, Schneider B, Thal DR, Grimaldi LM, Tsolaki M, Kapaki E, Ravid R, Konietzko U, Hegi T, Pasch T, Jung H, Braak H, Amouyel P, Rogaev EI, Hardy J, Hock C, Nitsch RM.

Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease. Neurodegener Dis. 2005;2(5):233-41. IF=3,496

 

(41). 291. Kounti F, Tsolaki M, Kiosseoglou G. Functional cognitive assessment scale (FUCAS): a new scale to assess executive cognitive function in daily life activities in patients with dementia and mild cognitive impairment. Hum Psychopharmacol. 2006 Jul;21(5):305-11. IF=2,386

 

(40). Wollmer MA, Kapaki E, Hersberger M, Muntwyler J, Brunner F, Tsolaki M, Akatsu H, Kosaka K, Michikawa M, Molyva D, Paraskevas GP, Lόtjohann D, von Eckardstein A, Hock C, Nitsch RM, Papassotiropoulos A. Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2006 Jul 5;141B(5):534-6. IF=4,463

 

(39). Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I. Relationship between Helicobacter pylori infection and Alzheimer disease.

Neurology. 2006 Mar 28;66(6):938-40. IF=5,690

 

(38). Tsolaki M, Trontzos C, Kazis A. [The contribution of nuclear medicine procedures in the diagnosis of dementia of Alzheimer's type. Imaging beta amyloid plaques]. Hell J Nucl Med. 2005 Sep-Dec;8(3):187-90. Review. Greek, Modern. IF-0,71

 

(37). Robert PH, Verhey FR, Byrne EJ, Hurt C, De Deyn PP, Nobili F, Riello R, Rodriguez G, Frisoni GB, Tsolaki M, Kyriazopoulou N, Bullock R, Burns A, Vellas B. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry. 2005 Nov;20(7):490-6. Epub 2005 Jan 27.IF=1,463

 

(36). Gerasimou G, Tsolaki M, Bostanjopoulou S, Liaros G, Papanastasiou E, Balaris V, Katsarou Z, Fotiou F, Dedousi E, Baloyannis S, Milonas I. [Findings from molecular imaging with SPET camera and 123I-ioflupane in the differential diagnosis of Parkinsonism and essential tremor]  Hell J Nucl Med. 2005 May-Aug;8(2):81-5. Greek, Modern. IF-0,71

 

(35). 674. Papassotiropoulos A, Wollmer MA, Tsolaki M, Brunner F, Molyva D, Lόtjohann D, Nitsch RM, Hock C. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease.

J Clin Psychiatry. 2005 Jul;66(7):940-7. IF=5,553

 

(34). Tsolaki M, Grammaticos P, Karanasou C, Balaris V, Kapoukranidou D, Kalpidis I, Petsanis K, Dedousi E. Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer's dementia. Hell J Nucl Med. 2005 Jan-Apr;8(1):39-42. IF=0,71

 

(33). Papassotiropoulos A, Tsolaki M, Wollmer MA, Molyva D, Thal DR, Huynh KD, Tracy J, Staehelin HB, Monsch AU, Nitsch RM, Hock C. No association of a non-synonymous PLAU polymorphism with Alzheimer's disease and disease-related traits. Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):21-3. IF=4,463

 

(32). Chen F, Wollmer MA, Hoerndli F, Mόnch G, Kuhla B, Rogaev EI, Tsolaki M, Papassotiropoulos A, Gφtz J. Role for glyoxalase I in Alzheimer's disease. Proc Natl Acad Sci U S A. 2004 May 18;101(20):7687-92. IF=10,452

 

(31). de Quervain DJ, Poirier R, Wollmer MA, Grimaldi LM, Tsolaki M, Streffer JR, Hock C, Nitsch RM, Mohajeri MH, Papassotiropoulos A. Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Hum Mol Genet. 2004 Jan 1;13(1):47-52. IF=8,099

 

(30). Wollmer MA, Streffer JR, Tsolaki M, Grimaldi LM, Lόtjohann D, Thal D, von Bergmann K, Nitsch RM, Hock C, Papassotiropoulos A. Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease. Mol Psychiatry. 2003 Jun;8(6):635-8. IF=11,804

 

(29). Kapinas K, Kimiskidis VK, Kazis AD, Kokkas B, Tsolaki M, Georgiadis G. Myasthenia gravis: correlation of age with clinical course and anti-AChr antibody levels.

Int J Immunopathol Pharmacol. 1999 Sep;12(3):127-131. IF=3,213

 

(28). Wollmer MA, Streffer JR, Lόtjohann D, Tsolaki M, Iakovidou V, Hegi T, Pasch T, Jung HH, Bergmann K, Nitsch RM, Hock C, Papassotiropoulos A. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease.

Neurobiol Aging. 2003 May-Jun;24(3):421-6. IF=5,599

 

(27). Streffer JR, Papassotiropoulos A, Kurosinski P, Signorell A, Wollmer MA, Tsolaki M, Iakovidou V, Horndli F, Bosset J, Gφtz J, Nitsch RM, Hock C. Saitohin gene is not associated with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):362-3. IF=3,630

 

(26). Tsolaki M, Kartali N. Folic acid and Alzheimer's disease.

Int J Geriatr Psychiatry. 2003 Feb;18(2):187-8. No abstract available. IF=1,930

 

(25). Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, Iakovidou V, Maddalena A, Lόtjohann D, Ghebremedhin E, Hegi T, Pasch T, Trδxler M, Brόhl A, Benussi L, Binetti G, Braak H, Nitsch RM, Hock C. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.

Arch Neurol. 2003 Jan;60(1):29-35. IF=5,204

 

(24). Bozikas VP, Kosmidis MH, Kourtis A, Gamvrula K, Melissidis P, Tsolaki M, Karavatos A.

Clock drawing test in institutionalized patients with schizophrenia compared with Alzheimer's disease patients. Schizophr Res. 2003 Feb 1;59(2-3):173-9. IF= 4,264

 

(23). Tsolaki M. Evaluation of tiapride in agitated elderly outpatients: an open study.

Hum Psychopharmacol. 2001 Jul;16(5):417-422. IF=2,386

 

(22). Tsolaki M, Iakovidou V, Papadopoulou E, Aminta M, Nakopoulou E, Pantazi T, Kazis A.

Greek validation of the seven-minute screening battery for Alzheimer's disease in the elderly.

Am J Alzheimers Dis Other Demen. 2002 May-Jun;17(3):139-48. IF=3,142

 

(21). Tsolaki M, Kokarida K, Iakovidou V, Stilopoulos E, Meimaris J, Kazis A.

Extrapyramidal symptoms and signs in Alzheimer's disease: prevalence and correlation with the first symptom. Am J Alzheimers Dis Other Demen. 2001 Sep-Oct;16(5):268-78. IF=3,142

 

(20). Tsolaki M, Sakka V, Gerasimou G, Dimacopoulos N, Chatzizisi O, Fountoulakis KN, Kyriazis G, Papanastasiou J, Kazis A. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects.

Am J Alzheimers Dis Other Demen. 2001 Jan-Feb;16(1):21-31. IF=3,142

 

(19). Tsolaki M, Pantazi T, Kazis A. Efficacy of acetylcholinesterase inhibitors versus nootropics in Alzheimer's disease: a retrospective, longitudinal study.

J Int Med Res. 2001 Jan-Feb;29(1):28-36. IF=0,665

 

(18). Birks J, Grimley Evans J, Iakovidou V, Tsolaki M. Rivastigmine for Alzheimer's disease.

Cochrane Database Syst Rev. 2000;(4):CD001191. Review. IF=5,653

 

(17). Fountoulakis KN, Tsolaki M, Paulopoulos H, Kazis A.

Validation of the epidemiological dementia index in geriatric outpatients.

Int Psychogeriatr. 2000 Jun;12(2):195-208. IF=1,745

 

(16). Tsolaki M, Iakovidou V, Navrozidou H, Aminta M, Pantazi T, Kazis A.

Hindi Mental State Examination (HMSE) as a screening test for illiterate demented patients.

Int J Geriatr Psychiatry. 2000 Jul;15(7):662-4. IF=2.525

 

(15). Fotiou F, Fountoulakis KN, Tsolaki M, Goulas A, Palikaras A.

Changes in pupil reaction to light in Alzheimer's disease patients: a preliminary report.

Int J Psychophysiol. 2000 Jul;37(1):111-20. IF=2,247

 

(14). Birks J, Iakovidou V, Tsolaki M.

Rivastigmine for Alzheimer's disease.

Cochrane Database Syst Rev. 2000;(2):CD001191. Review. Update in: Cochrane Database Syst Rev. 2000;(4):CD001191.

 

(13). Fountoulakis KN, Tsolaki M, Iacovides A, Yesavage J, O'Hara R, Kazis A, Ierodiakonou C.

The validation of the short form of the Geriatric Depression Scale (GDS) in Greece.

Aging (Milano). 1999 Dec;11(6):367-72. IF=1,068

 

(12). Fountoulakis K, Fotiou F, Iacovides A, Tsiptsios J, Goulas A, Tsolaki M, Ierodiakonou C. Changes in pupil reaction to light in melancholic patients.

Int J Psychophysiol. 1999 Jan;31(2):121-8. IF=2,247

 

(11). Fountoulakis KN, Tsolaki M, Mohs RC, Kazis A.

Epidemiological dementia index: a screening instrument for Alzheimer's disease and other types of dementia suitable for use in populations with low education level.

Dement Geriatr Cogn Disord. 1998 Nov-Dec;9(6):329-38. IF=2,511

 

(10). Tsolaki M, Fountoulakis K, Chantzi E, Kazis A.

Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of a Greek population. Int Psychogeriatr. 1997 Sep;9(3):327-41. IF=1,745

 

(9). Tsolaki M, Fountoulakis K, Nakopoulou E, Kazis A, Mohs RC. Alzheimer's Disease Assessment Scale: the validation of the scale in Greece in elderly demented patients and normal subjects. Dement Geriatr Cogn Disord. 1997 Sep-Oct;8(5):273-80. IF=2,511

(8). Lehfeld H, Reisberg B, Finkel S, Kanowski S, Wied V, Pittas J, Tsolaki M, Informant-rated activities-of-daily-living (ADL) assessments: results of a study of 141 items in the U.S.A., Germany, Russia, and Greece from the International ADL Scale Development Project.Alzheimer Dis Assoc Disord. 1997;11 Suppl 4:S39-44. IF=3,142

(7). Gorgias N, Maidatsi P, Tsolaki M, Alvanou A, Kiriazis G, Kaidoglou K, Giala M.

Hypoxic pretreatment protects against neuronal damage of the rat hippocampus induced by severe hypoxia.

Brain Res. 1996 Apr 1;714(1-2):215-25. ΙF=2,341

 

(6). Tsolaki M, Drevelegas A, Karachristianou S, Kapinas K, Divanoglou D, Routsonis K.

Correlation of dementia, neuropsychological and MRI findings in multiple sclerosis.

Dementia. 1994 Jan-Feb;5(1):48-52. IF=2,511

 

(5). Botsios D, Economou L, Manthos A, Tsolaki M, Sioga A, Agelopoulos S, Dadoukis I, Foroglou C. Ultrastructural alterations of the rat intestinal epithelium fed with polymeric, oligopeptidic or elementary full diet, following starvation.

Histol Histopathol. 1993 Jul;8(3):527-35. IF=2,182

 

(4). Drevelengas A, Kalaitzoglou I, Tsolaki M.

Tolosa-Hunt syndrome with sellar erosion: case report.

Neuroradiology. 1993;35(6):451-3. IF=1,625

 

(3). Petridou M, Mourelatos D, Tsolaki M, Kazis A, Kourakis A, Routsonis K.

Cytogenetic damage by melphalan and hyperthermia in patients with an initial epileptic attack. Mutat Res. 1992 Aug;280(2):143-8. IF=4,111

 

(2). Manthos A, Tsolaki M, Kaidoglou K, Alvanou A, Hatjinikolaou K, Hatjiagorakis A, Giala M, Foroglou C.

Ultrastructure of the rat hippocampus after isobaric respirative hyperoxia.

Histol Histopathol. 1991 Jan;6(1):73-8. IF=2,182

 

(1). Tsolaki M, Yannacou-Peftoulidou M, Grammaticos P, Sofianos E, Foroglou G.

Phenytoin plasma levels after intraoperative administration, for the prevention of post-craniotomy seizures.

Acta Neurochir (Wien). 1987;84(1-2):36-8. IF=1,212

 

 

ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΤΟ PUBMED   515. Άθροισμα Impact Factor=30824,943

 

Tsolaki M., 510  + Costa-Tsolaki M. 5=515

 

(515) 5641. What goes wrong with the perceptions of elder financial abuse? Data from older adults, healthcare professionals and students from Greece.

Giannouli V, Tsolaki M. J Elder Abuse Negl. 2023 Dec 3:1-8. doi: 10.1080/08946566.2023.2291050. IF=1,78

 

(514). 5639. Le Borgne J; EADB, GR@ACE, Degesco, EADI, GERAD, DemGene; Amouyel P, Andreassen O, Frikke-Schmidt R, Hiltunen M, Ingelsson M, Ramirez A, Rossi G, Ruiz A, Sanchez-Juan P, Sims R, Sleegers K, Tsolaki M, van der Lee SJ, Williams J, Lambert JC, Bellenguez C. Association of MGMT and BIN1 genes with Alzheimer's disease risk across sex and APOE ε4 status.  Alzheimers Dement. 2023 Dec 2. doi: 10.1002/alz.13550. IF=8,25

 

(513) 5625. Mendes A, Bergh S, Cesana BM, Handels R, Ciccone A, Cognat E, Fabbo A, Fascendini S, Frisoni GB, Froelich L, Jori MC, Mecocci P, Merlo P, Peters O, Tsolaki M, Defanti CA. Respectful Caring for the Agitated Elderly (ReCAGE): A Multicentre, Prospective, Observational Study to Evaluate the Effectiveness of Special Care Units for People with Dementia. J Alzheimers Dis. 2023 Nov 1. doi: 10.3233/JAD-230708. IF=4,16

 

(512) 5626. Alopoudi A, Makri M, Alişoğlu B, Doğan A, Imbesi A, Karakoyun M, Lacapelle A, Navarro Roux MA, Pissa A, Tsolaki M. A Protocol for the Development and Assessment of a Non-Pharmacological Intervention Designed to Improve Cognitive Skills of Adults with Intellectual Disabilities: A Mixed Method Design. J Multidiscip Healthc. 2023 Nov 1;16:3215-3226. doi: 10.2147/JMDH.S422859. eCollection 2023. ΙF=2,919

 

(511) 5615.  Tsormpatzoudi SO, Moraitou D, Papaliagkas V, Pezirkianidis C, Tsolaki M. Resilience in Mild Cognitive Impairment (MCI): Examining the Level and the Associations of Resilience with Subjective Wellbeing and Negative Affect in Early and Late-Stage MCI. Behav Sci (Basel). 2023 Sep 23;13(10):792. doi: 10.3390/bs13100792.IF+2,98

 

(510) 5616. Tsiflikioti K, Moraitou D, Pezirkianidis C, Papantoniou G, Sofologi M, Kougioumtzis GA, Tsolaki M Enhancing Subjective Wellbeing in Older Individuals with Amnestic Mild Cognitive Impairment: A Randomized Trial of a Positive Psychology Intervention..Behav Sci (Basel). 2023 Oct 13;13(10):838. doi: 10.3390/bs13100838.PMID: 37887488. IF+2,98

 

(509) 5590. Li Y, Saul A, Taylor B, Ponsonby AL, Simpson-Yap S, Blizzard L, Broadley S, Lechner-Scott J; Ausimmune/AusLong Investigators Group; Karabudak R, Patti F, Eichau S, Onofrj M, Ozakbas S, Horakova D, Kubala Havrdova E, Grand'Maison F, Alroughani R, Gerlach O, Amato MP, Altintas A, Girard M, Duquette P, Blanco Y, Ramo-Tello C, Laureys G, Kalincik T, Khoury SJ, Shaygannejad V, Etemadifar M, Singhal B, Mrabet S, Foschi M, Habek M, John N, Hughes S, McCombe P, Ampapa R, van der Walt A, Butzkueven H, de Gans K, McGuigan C, Oreja-Guevara C, Sa MJ, Petersen T, Al-Harbi T, Sempere AP, Van Wijmeersch B, Grigoriadis N, Prevost J, Gray O, Castillo-Triviño T, Macdonell R, Lugaresi A, Sajedi SA; MSBase; van der Mei I.  Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.

J Neurol. 2023 Sep 28. IF=6,682

 

(508) 5585. Bampa G, Tsolaki M, Moraitou D, Metallidou P, Masoura E, Mintziviri M, Paparis K, Tsourou D, Papantoniou G, Sofologi M, Papaliagkas V, Kougioumtzis G, Papatzikis E. Metacognitive Differences in Amnestic Mild Cognitive Impairment and Healthy Cognition: A Cross-Sectional Study Employing Online Measures. J Intell. 2023 Sep 19;11(9):184. doi: 10.3390/jintelligence11090184.PMID: 37754914. IF=3,5

 

(507) (508) 5586. Pikouli FA, Moraitou D, Papantoniou G, Sofologi M, Papaliagkas V, Kougioumtzis G, Poptsi E, Tsolaki M. Metacognitive Strategy Training Improves Decision-Making Abilities in Amnestic Mild Cognitive Impairment. J Intell. 2023 Sep 11;11(9):182. doi: 10.3390/jintelligence11090182.PMID: 37754911. IF=3,5

 

  1. 5587. Sofologi M, Foutsitzi E, Papantoniou A, Kougioumtzis G, Zaragas H, Tsolaki M, Moraitou D, Papantoniou G. The Effect of Secondary Education Teachers' Metacognitive Knowledge and Professional Development on Their Tacit Knowledge Strategies. J Intell. 2023 Sep 6;11(9):179. IF=3,5

 

 

  1. 5452. Makri M, Gkioka M, Moraitou D, Fidani L, Tegos T, Tsolaki M. Attitudes, Motivations, and Barriers to Pre-Symptomatic Alzheimer's Disease Screening: Development and Validation of the 'Perceptions regarding pRE-symptomatic Alzheimer's Disease Screening' (PRE-ADS) Questionnaire.

J Alzheimers Dis. 2023 Sep 1. doi: 10.3233/JAD-220954. IF= 4,16

 

  1. 5451. Le Guen Y, Luo G, Ambati A, Damotte V, Jansen I, Yu E, Nicolas A, de Rojas I, Peixoto Leal T, Miyashita A, Bellenguez C, Lian MM, Parveen K, Morizono T, Park H, Grenier-Boley B, Naito T, Küçükali F, Talyansky SD, Yogeshwar SM, Sempere V, Satake W, Alvarez V, Arosio B, Belloy ME, Benussi L, Boland A, Borroni B, Bullido MJ, Caffarra P, Clarimon J, Daniele A, Darling D, Debette S, Deleuze JF, Dichgans M, Dufouil C, During E, Düzel E, Galimberti D, Garcia-Ribas G, García-Alberca JM, García-González P, Giedraitis V, Goldhardt O, Graff C, Grünblatt E, Hanon O, Hausner L, Heilmann-Heimbach S, Holstege H, Hort J, Jung YJ, Jürgen D, Kern S, Kuulasmaa T, Lee KH, Lin L, Masullo C, Mecocci P, Mehrabian S, de Mendonça A, Boada M, Mir P, Moebus S, Moreno F, Nacmias B, Nicolas G, Niida S, Nordestgaard BG, Papenberg G, Papma J, Parnetti L, Pasquier F, Pastor P, Peters O, Pijnenburg YAL, Piñol-Ripoll G, Popp J, Porcel LM, Puerta R, Pérez-Tur J, Rainero I, Ramakers I, Real LM, Riedel-Heller S, Rodriguez-Rodriguez E, Ross OA, Luís Royo J, Rujescu D, Scarmeas N, Scheltens P, Scherbaum N, Schneider A, Seripa D, Skoog I, Solfrizzi V, Spalletta G, Squassina A, van Swieten J, Sánchez-Valle R, Tan EK, Teg…See abstract for full author list ➔ Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04subtypes. Proc Natl Acad Sci U S A 2023 Sep 5;120(36):e2302720120.  doi: 10.1073/pnas.2302720120. Epub 2023 Aug 29.

 

  1. 5448. Tsolaki M, Makri M, Tsatali M, Teichmann Β. European Projects for Patients with Dementia and Their Caregivers.

Adv Exp Med Biol. 2023;1425:609-618.IF=3,65

 

502.5443. Tsatali M, Moraitou D, Boza ES, Tsolaki M.  Cognition and Functionality Were Not Affected Due to the COVID-19 Pandemic in People with Mild Cognitive Impairment and AD Dementia Attending Digital Non-Pharmacologic Interventions.

Brain Sci. 2023 Jul 8;13(7):1044. IF=3,17

 

  1. 5442. Cesana BM, Poptsi E, Tsolaki M, Bergh S, Ciccone A, Cognat E, Fabbo A, Fascendini S, Frisoni GB, Frölich L, Jori MC, Mecocci P, Merlo P, Peters O, Defanti CA. A Confirmatory and an Exploratory Factor Analysis of the Cohen-Mansfield Agitation Inventory (CMAI) in a European Case Series of Patients with Dementia: Results from the RECage Study.

Brain Sci. 2023 Jul 3;13(7):1025. IF=3,17

 

  1. 5540. Tarnanas I, Tsolaki M. Making Pre-screening for Alzheimer's Disease (AD) and Postoperative Delirium Among Post-Acute COVID-19 Syndrome (PACS) a National Priority: The Deep Neuro Study.

Adv Exp Med Biol. 2023; 1424:41-47. doi: 10.1007/978-3-031-31982-2_4. IF=3,65

 

  1. 5536. Giannouli V, Tsolaki M.In the Hands of Hypnos: Associations between Sleep, Cognitive Performance and Financial Capacity in aMCI and Mild AD. Sleep Sci. 2023 Jul 6;16(2):231-236. IF=0,608

 

  1. 5534. Muurling M, Pasmooij AMG, Koychev I, Roik D, Froelich L, Schwertner E, Religa D, Abdelnour C, Boada M, Almici M, Galluzzi S, Cardoso S, de Mendonça A, Owens AP, Kuruppu S, Gjestsen MT, Lazarou I, Gkioka M, Tsolaki M, Diaz A, Gove D, Visser PJ, Aarsland D, Lucivero F, de Boer C; RADAR-AD Consortium. Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.

PLoS One. 2023 Jul 7;18(7):e0285807. IF-3.752

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0285807

 

  1. 5528. Lazarou I, Oikonomou VP, Mpaltadoros L, Grammatikopoulou M, Alepopoulos V, Stavropoulos TG, Bezerianos A, Nikolopoulos S, Kompatsiaris I, Tsolaki M; RADAR-AD Consortium. Eliciting brain waves of people with cognitive impairment during meditation exercises using portable electroencephalography in a smart-home environment: a pilot study.

Front Aging Neurosci. 2023 May 30;15:1167410. IF= 5.702

 

  1. 5523. Giannouli V, Tsolaki M. What Do Arithmetic Errors in the Financial Context Reveal? A Preliminary Study of Individuals with Neurocognitive Disorders. Neurol Int. 2023 Jun 1;15(2):743-749. IF=0,448

 

  1. 5505. European Alzheimer’s & Dementia Biobank Mendelian Randomization (EADB-MR) Collaboration; Luo J, Thomassen JQ, Bellenguez C, Grenier-Boley B, de Rojas I, Castillo A, Parveen K, Küçükali F, Nicolas A, Peters O, Schneider A, Dichgans M, Rujescu D, Scherbaum N, Jürgen D, Riedel-Heller S, Hausner L, Porcel LM, Düzel E, Grimmer T, Wiltfang J, Heilmann-Heimbach S, Moebus S, Tegos T, Scarmeas N, Clarimon J, Moreno F, Pérez-Tur J, Bullido MJ, Pastor P, Sánchez-Valle R, Álvarez V, Boada M, García-González P, Puerta R, Mir P, Real LM, Piñol-Ripoll G, García-Alberca JM, Royo JL, Rodriguez-Rodriguez E, Soininen H, Kuulasmaa T, de Mendonça A, Mehrabian S, Hort J, Vyhnalek M, van der Lee S, Graff C, Papenberg G, Giedraitis V, Boland A, Bacq-Daian D, Deleuze JF, Nicolas G, Dufouil C, Pasquier F, Hanon O, Debette S, Grünblatt E, Popp J, Benussi L, Galimberti D, Arosio B, Mecocci P, Solfrizzi V, Parnetti L, Squassina A, Tremolizzo L, Borroni B, Nacmias B, Sorbi S, Caffarra P, Seripa D, Rainero I, Daniele A, Masullo C, Spalletta G, Williams J, Amouyel P, Jessen F, Kehoe P, Tsolaki M, Rossi G, Sánchez-Juan P, Sleegers K, Ingelsson M, Andreassen OA, Hiltunen M, Van Duijn C, Sims R, van der …Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease. See abstract for full author list ➔JAMA Netw Open. 2023 May 1;6(5):e2313734. doi: 10.1001/jamanetworkopen.2023.13734. IF=13,37

 

  1. 5480. Cognat E, Sabia S, Fayel A, Lilamand M, Handels R, Fascendini S, Bergh S, Frisoni GB, Fabbo A, Tsolaki M, Frölich L, Peters O, Merlo P, Ciccone A, Mecocci P, Dumurgier J, Defanti CA, Hugon J, Paquet C. BPSD Patterns in Patients With Severe Neuropsychiatric Disturbances: Insight From the RECAGE Study. Am J Geriatr Psychiatry. 2023 Apr 23:S1064-7481(23)00265-8. doi: 10.1016/j.jagp.2023.03.014. IF=7.796

 

  1. 5476. Alexandri F, Papadopoulou L, Tsolaki A, Papantoniou G, Athanasiadis L, Tsolaki M.

The Effect of Cannabidiol 3% on Neuropsychiatric Symptoms in Dementia - Six-Month Follow-Up. Clin Gerontol. 2023 May 8:1-8. IF=2.871

 

  1. 5456. Tsolaki M, Arcan C, Zahid S. Editorial: The role of natural products in neurological disorders.

Front Neurol. 2023 Apr 13;14:1163282.IF= 4.086

 

  1. 5419. Dubois B, López-Arrieta J, Lipschitz S, Triantafyllos D, Spiru L, Moroz S, Venger O, Vermersch P, Moussy A, Mansfield CD, Hermine O, Tsolaki M; AB09004 Study Group Investigators. Alzheimers Res Ther. Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial. Alzheimers Res Ther. 2023 Feb 28;15(1):39. doi: 10.1186/s13195-023-01169-x. IF=6,42

 

  1. 5417. Giannouli V, Tsolaki M.Beneath the Top of the Iceberg: Financial Capacity Deficits in Mixed Dementia with and without Depression. Healthcare (Basel). 2023 Feb 9;11(4):505. doi: 10.3390/healthcare11040505. IF= 2.194

 

  1. 5416. Giannouli V, Tsolaki M. Brain Volumes and Metacognitive Deficits in Knowledge of Self, Task and Strategies in Mathematics: A Preliminary Pilot One-Year Longitudinal Study in aMCI Patients Compared to Healthy Controls.

Diagnostics (Basel). 2023 Feb 11;13(4):680. doi: 10.3390/diagnostics13040680. IF=3. 992

 

  1. 5409. Makri M, Christakidou A, Tsolaki M.A Novel Method of Teaching English to People with Mild Cognitive Impairment Using Songs: A Randomized Controlled Trial Protocol. J Alzheimer’s Dis. 2023 Feb 10. doi: 10.3233/JAD-220184. IF=4.160

 

  1. 5407. Poptsi E, Moraitou D, Tsardoulias E, Symeonidis AL, Papaliagkas V, Tsolaki M. R4Alz-Revised: A Tool Able to Strongly Discriminate 'Subjective Cognitive Decline' from Healthy Cognition and 'Minor Neurocognitive Disorder'.

Diagnostics (Basel). 2023 Jan 17;13(3):338. doi: 10.3390/diagnostics13030338. IF=3. 992

 

  1. 5347. Giannouli V, Tsolaki M. Is there a specific order of appearance of financial capacity deficits across neurocognitive disorders? What comes first and what should be treated. Int J Geriatr Psychiatry. 2023 Feb;38(2):e5880 IF= 3.485

 

  1. 5343. Devranis P, Vassilopoulou Ε, Tsironis V, Sotiriadis PM, Chourdakis M, Aivaliotis M, Tsolaki M. Mediterranean Diet, Ketogenic Diet or MIND Diet for Aging Populations with Cognitive Decline: A Systematic Review. Life (Basel). 2023 Jan 6;13(1):173. doi: 10.3390/life13010173. I.F=3.13

 

  1. 5345. Giannouli V, Tsolaki M. Stressful life events, general cognitive performance, and financial capacity in healthy older adults and Alzheimer's disease patients. Neuropsychiatr. 2023 Jan 4. doi: 10.1007/s40211-022-00451-y. IF= 1.456

 

  1. 5336. Tsentidou G, Moraitou D, Tsolaki M, Masoura E, Papaliagkas V. Trajectories of Cognitive Impairment in Adults Bearing Vascular Risk Factors, with or without Diagnosis of Mild Cognitive Impairment: Findings from a Longitudinal Study Assessing Executive Functions, Memory, and Social Cognition. Diagnostics (Basel). 2022 Dec 2;12(12):3017. doi: 10.3390/diagnostics12123017. IF=3992

 

  1. 5337. Poptsi E, Moraitou D, Tsatali M, Papaliagkas V, Tzanakaki-Melissari M, Kyriakoulaki E, Kounti F, Markou N, Liapi D, Batsila G, Ouzouni F, Vasiloglou M, Tsolaki M. Examining Voting Capacity in Older Adults with and without Cognitive Decline. Brain Sci. 2022 Nov 25;12(12):1614. doi: 10.3390/brainsci12121614. IF= 3.333

 

  1. 5334. Ioulietta Lazarou, Margarita Grammatikopoulou, Lampros Mpaltadoros, Ioanna Provata, Thanos G. Stavropoulos, Spiros Nikolopoulos, Chrysostomos Bourlis, Angelos Konstantinidis, Voula Ganosi, Ioannis Kompatsiaris, and Magda Tsolaki. The Effects of Playing the “We are Family” Brain Games in People with Mild Cognitive Impairment: A Feasibility Study. The Effects of Playing The “We are Family” Brain Games in People with Mild Cognitive Impairment and Alzheimer’s Disease: A Feasibility Study. J Alzheimers Dis Parkinsonism 13: 554. Impact Factor =2,18

 

  1. Küçükali F, Neumann A, Van Dongen J, De Pooter T, Joris G, De Rijk P, Ohlei O, Dobricic V, Bos I, Vos SJB, Engelborghs S, De Roeck E, Vandenberghe R, Gabel S, Meersmans K, Tsolaki M, Verhey F, Martinez-Lage P, Tainta M, Frisoni G, Blin O, Richardson JC, Bordet R; Alzheimer's Disease Neuroimaging Initiative (ADNI), Scheltens P, Popp J, Peyratout G, Johannsen P, Frölich L, Freund-Levi Y, Streffer J, Lovestone S, Legido-Quigley C, Kate MT, Barkhof F, Zetterberg H, Bertram L, Strazisar M, Visser PJ, Van Broeckhoven C, Sleegers K; EMIF-AD Study Group.Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits. Alzheimers Dement. 2022 Dec 4. doi: 10.1002/alz.12842. Online ahead of print. IF=21.566
  2. 5309. Tsentidou G, Moraitou D, Tsolaki M. Emotion Recognition in a Health Continuum: Comparison of Healthy Adults of Advancing Age, Community Dwelling Adults Bearing Vascular Risk Factors and People Diagnosed with Mild Cognitive Impairment.Int J Environ Res Public Health. 2022 Oct 16;19(20):13366.. IF=3.364

 

  1. 5310. Bampa G, Kouroglou D, Metallidou P, Tsolaki M, Kougioumtzis G, Papantoniou G, Sofologi M, Moraitou D.Metacognitive Scales: Assessing Metacognitive Knowledge in Older Adults Using Everyday Life Scenarios. Diagnostics (Basel). 2022 Oct 5;12(10):2410. doi: 10.3390/diagnostics12102410. IF=3.992

 

  1. 5302. Giannouli V, Tsolaki M. Neurocognitive disorders and financial altruism: A few or many steps away for financial generosity and self-justification statements to be used in the diagnosis of brain pathology in old age? Psychiatry Clin Neurosci. 2022 Oct 18. doi: 10.1111/pcn.13493. IF= 12.145

 

  1. 5287. Vassilopoulou E, Koumbi L, Karastogiannidou C, Sotiriadis PM, Felicia PC, Tsolaki M. Adjustment of the MIND diet tool for discriminating Greek patients with dementia: A confirmatory factor analysis.

Front Neurol. 2022 Sep 7;13:811314. doi: 10.3389/fneur.2022.811314. eCollection 2022. IF=3552

 

  1. 5286. Giannouli V, Tsolaki M. What Biological Factors, Social Determinants, and Psychological and Behavioral Symptoms of Patients with Mild Alzheimer's Disease Correlate with Caregiver Estimations of Financial Capacity? Bringing Biases Against Older Women Into Focus. J Alzheimers Dis Rep. 2022 Aug 5;6(1):503-507. If=3,1

 

  1. 5282. Tatiana-Danai D, John P, Anastasia K, Dimitrios K, Loukas A, Panagiotis I, Efrosini K, Thomas T, Magda T Non-Pharmacological Interventions for the Hallucinations in Patients with Dementia. A Cross-Over Randomized Controlled Trial.

.J Clin Cases Rep. 2022;5(4):139-148. Epub 2022 Jan 31. IF=0,532

 

  1.   Jansen IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, Dalmasso MC, Grenier-Boley B, Zettergren A, Mishra A, Ali M, Andrade V, Bellenguez C, Kleineidam L, Küçükali F, Sung YJ, Tesí N, Vromen EM, Wightman DP, Alcolea D, Alegret M, Alvarez I, Amouyel P, Athanasiu L, Bahrami S, Bailly H, Belbin O, Bergh S, Bertram L, Biessels GJ, Blennow K, Blesa R, Boada M, Boland A, Buerger K, Carracedo Á, Cervera-Carles L, Chene G, Claassen JAHR, Debette S, Deleuze JF, de Deyn PP, Diehl-Schmid J, Djurovic S, Dols-Icardo O, Dufouil C, Duron E, Düzel E; EADB consortium, Fladby T, Fortea J, Frölich L, García-González P, Garcia-Martinez M, Giegling I, Goldhardt O, Gobom J, Grimmer T, Haapasalo A, Hampel H, Hanon O, Hausner L, Heilmann-Heimbach S, Helisalmi S, Heneka MT, Hernández I, Herukka SK, Holstege H, Jarholm J, Kern S, Knapskog AB, Koivisto AM, Kornhuber J, Kuulasmaa T, Lage C, Laske C, Leinonen V, Lewczuk P, Lleó A, de Munain AL, Lopez-Garcia S, Maier W, Marquié M, Mol MO, Montrreal L, Moreno F, Moreno-Grau S, Nicolas G, Nöthen MM, Orellana A, Pålhaugen L, Papma JM, Pasquier F, Perneczky R, Peters O, Pijnenburg YAL, Popp J, Posthuma D, Pozueta A, Priller J, Puerta R, Quintela I, Ramakers I, Rodriguez-Rodriguez E, Rujescu D, Saltvedt I, Sanchez-Juan P, Scheltens P, Scherbaum N, Schmid M, Schneider A, Selbæk G, Selnes P, Shadrin A, Skoog I, Soininen H, Tárraga L, Teipel S; GR@ACE study group, Tijms B, Tsolaki M, Van Broeckhoven C, Van Dongen J, van Swieten JC, Vandenberghe R, Vidal JS, Visser PJ, Vogelgsang J, Waern M, Wagner M, Wiltfang J, Wittens MMJ, Zetterberg H, Zulaica M, van Duijn CM, Bjerke M, Engelborghs S, Jessen F, Teunissen CE, Pastor P, Hiltunen M, Ingelsson M, Andreassen OA, Clarimón J, Sleegers K, Ruiz A, Ramirez A, Cruchaga C, Lambert JC, van der Flier W. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.

Acta Neuropathol. 2022 Sep 6. IF= 15.887

 

  1. Giannouli V, Tsolaki M. Neuropsychological Performance and Engagement in Estate Planning and Advance Care Planning Preparation of Patients With Neurocognitive Disorders and Healthy Older Adults: Is the Situation Alarming or Reassuring in Greece?

Gerontol Geriatr Med. 2022 Aug 25;8:23337214221119053.IF=1470

 

  1. Giannouli V, Tsolaki M. Elder financial abuse and the COVID-19 pandemic: A call to action through training programmes?

Psychiatriki. 2022 Aug 30.IF=1.113

 

  1. Stamovlasis D, Giannouli V, Vaiopoulou J, Tsolaki MCatastrophe Theory Applied to Neuropsychological Data: Nonlinear Effects of Depression on Financial Capacity in Amnestic Mild Cognitive Impairment and Dementia. Entropy (Basel). 2022 Aug 7;24(8):1089.IF= 2.524

 

  1. Giannouli V, Tsolaki M. Self-Awareness of Cognitive Efficiency, Cognitive Status, Insight, and Financial Capacity in Patients with Mild AD, aMCI, and Healthy Controls: An Intriguing Liaison with Clinical Implications? Neurol Int. 2022 Jul 30;14(3):628-637.IF=1,1

 

  1. Tsolaki M, Sia E, Giannouli V.Anesthesia and dementia: an up-to-date review of the existing literature. Appl Neuropsychol Adult. 2022 Aug 18:1-10. 2.248. IF=1.10

 

  1. 5246. Chatzikostopoulos A, Moraitou D, Tsolaki M, Masoura E, Papantoniou G, Sofologi M, Papaliagkas V, Kougioumtzis G, Papatzikis E. Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's Disease Dementia (ADD): Using the "Doors and People" Tool to Differentiate between Early aMCI-Late aMCI-Mild ADD Diagnostic Groups.

Diagnostics (Basel). 2022 Jul 21;12(7):1768. IF=3992

 

  1. Dimitriou T, Papatriantafyllou J, Konsta A, Kazis D, Athanasiadis L, Ioannidis P, Koutsouraki E, Tegos T, Tsolaki M. Assess of Combinations of Non-Pharmacological Interventions for the Reduction of Irritability in Patients with Dementia and their Caregivers: A Cross-Over RCT. Brain Sci. 2022 May 26;12(6):691. IF= 3.333

 

  1. 5233. Teichmann B, Gkioka M, Kruse A, Tsolaki M. Informal Caregivers' Attitude Toward Dementia: The Impact of Dementia Knowledge, Confidence in Dementia Care, and the Behavioral and Psychological Symptoms of the Person with Dementia. A Cross-Sectional Study. J Alzheimers Dis. 2022 Jun 13. doi: 10.3233/JAD-215731. IF= 4.472

 

  1. 5231. Zygouris S, Segkouli S, Triantafyllidis A, Giakoumis D, Tsolaki M, Votis K, Tzovaras D. Usability of the Virtual Supermarket Test for Older Adults with and without Cognitive Impairment. J Alzheimers Dis Rep. 2022 May 13;6(1):229-234. IF= 4.472

 

  1. 5226. Delvenne A, Gobom J, Tijms B, Bos I, Reus LM, Dobricic V, Kate MT, Verhey F, Ramakers I, Scheltens P, Teunissen CE, Vandenberghe R, Schaeverbeke J, Gabel S, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Tsolaki M, Freund-Levi Y, Lovestone S, Streffer J, Barkhof F, Bertram L, Blennow K, Zetterberg H, Visser PJ, Vos SJB. Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.

Alzheimers Dement. 2022 Jun 14. doi: 10.1002/alz.12713 ΙF= 21.566

 

  1. 5214. Le Guen Y, Belloy ME, Grenier-Boley B, de Rojas I, Castillo-Morales A, Jansen I, Nicolas A, Bellenguez C, Dalmasso C, Küçükali F, Eger SJ, Rasmussen KL, Thomassen JQ, Deleuze JF, He Z, Napolioni V, Amouyel P, Jessen F, Kehoe PG, van Duijn C, Tsolaki M, Sánchez-Juan P, Sleegers K, Ingelsson M, Rossi G, Hiltunen M, Sims R, van der Flier WM, Ramirez A, Andreassen OA, Frikke-Schmidt R, Williams J, Ruiz A, Lambert JC, Greicius MD; Members of the EADB, GR@ACE, DEGESCO, DemGene, GERAD, and EADI Groups, Arosio B, Benussi L, Boland A, Borroni B, Caffarra P, Daian D, Daniele A, Debette S, Dufouil C, Düzel E, Galimberti D, Giedraitis V, Grimmer T, Graff C, Grünblatt E, Hanon O, Hausner L, Heilmann-Heimbach S, Holstege H, Hort J, Jürgen D, Kuulasmaa T, van der Lugt A, Masullo C, Mecocci P, Mehrabian S, de Mendonça A, Moebus S, Nacmias B, Nicolas G, Olaso R, Papenberg G, Parnetti L, Pasquier F, Peters O, Pijnenburg YAL, Popp J, Rainero I, Ramakers I, Riedel-Heller S, Scarmeas N, Scheltens P, Scherbaum N, Schneider A, Seripa D, Soininen H, Solfrizzi V, Spalletta G, Squassina A, van Swieten J, Tegos TJ, Tremolizzo L, Verhey F, Vyhnalek M, Wiltfang J, Boada M, García-González P, Puerta R, Real LM, Álvarez V, Bullido MJ, Clarimon J, García-Alberca JM, Mir P, Moreno F, Pastor P, Piñol-Ripoll G, Molina-Porcel L, Pérez-Tur J, Rodríguez-Rodríguez E, Royo JL, Sánchez-Valle R, Dichgans M, Rujescu D.Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.

JAMA Neurol. 2022 May 31. IF=11,5

 

  1. 5207. Wesenhagen KEJ, Gobom J, Bos I, Vos SJB, Martinez-Lage P, Popp J, Tsolaki M, Vandenberghe R, Freund-Levi Y, Verhey F, Lovestone S, Streffer J, Dobricic V, Bertram L; Alzheimer's Disease Neuroimaging Initiative, Blennow K, Pikkarainen M, Hallikainen M, Kuusisto J, Laakso M, Soininen H, Scheltens P, Zetterberg H, Teunissen CE, Visser PJ, Tijms BM. Effects of age, amyloid, sex, and APOEε4 on the CSF proteome in normal cognition.

Alzheimers Dement (Amst). 2022 May 6;14(1):e12286. IF= 2.497

 

  1. 5206. Visser PJ, Reus LM, Gobom J, Jansen I, Dicks E, van der Lee SJ, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Freund-Levi Y, Froelich L, Sleegers K, Dobricic V, Lovestone S, Streffer J, Vos SJB, Bos I; ADNI, Smit AB, Blennow K, Scheltens P, Teunissen CE, Bertram L, Zetterberg H, Tijms BMCorrection: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease.

.Mol Neurodegener. 2022 May 13;17(1):37. doi: 10.1186/s13024-022-00540-0. IF=14.195

 

  1. 5191. Bellenguez C, Küçükali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, Holmans PA, Boland A, Damotte V, van der Lee SJ, Costa MR, Kuulasmaa T, Yang Q, de Rojas I, Bis JC, Yaqub A, Prokic I, Chapuis J, Ahmad S, Giedraitis V, Aarsland D, Garcia-Gonzalez P, Abdelnour C, Alarcón-Martín E, Alcolea D, Alegret M, Alvarez I, Álvarez V, Armstrong NJ, Tsolaki A, Antúnez C, Appollonio I, Arcaro M, Archetti S, Pastor AA, Arosio B, Athanasiu L, Bailly H, Banaj N, Baquero M, Barral S, Beiser A, Pastor AB, Below JE, Benchek P, Benussi L, Berr C, Besse C, Bessi V, Binetti G, Bizarro A, Blesa R, Boada M, Boerwinkle E, Borroni B, Boschi S, Bossù P, Bråthen G, Bressler J, Bresner C, Brodaty H, Brookes KJ, Brusco LI, Buiza-Rueda D, Bûrger K, Burholt V, Bush WS, Calero M, Cantwell LB, Chene G, Chung J, Cuccaro ML, Carracedo Á, Cecchetti R, Cervera-Carles L, Charbonnier C, Chen HH, Chillotti C, Ciccone S, Claassen JAHR, Clark C, Conti E, Corma-Gómez A, Costantini E, Custodero C, Daian D, Dalmasso MC, Daniele A, Dardiotis E, Dartigues JF, de Deyn PP, de Paiva Lopes K, de Witte LD, Debette S, Deckert J, Del Ser T, Denning N, DeStefano A, Dichgans M, Diehl-Schmid J, Diez-Fairen M, Rossi PD, Djurovic S, Duron E, Düzel E, Dufouil C, Eiriksdottir G, Engelborghs S, Escott-Price V, Espinosa A, Ewers M, Faber KM, Fabrizio T, Nielsen SF, Fardo DW, Farotti L, Fenoglio C, Fernández-Fuertes M, Ferrari R, Ferreira CB, Ferri E, Fin B, Fischer P, Fladby T, Fließbach K, Fongang B, Fornage M, Fortea J, Foroud TM, Fostinelli S, Fox NC, Franco-Macías E, Bullido MJ, Frank-García A, Froelich L, Fulton-Howard B, Galimberti D, García-Alberca JM, García-González P, Garcia-Madrona S, Garcia-Ribas G, Ghidoni R, Giegling I, Giorgio G, Goate AM, Goldhardt O, Gomez-Fonseca D, González-Pérez A, Graff C, Grande G, Green E, Grimmer T, Grünblatt E, Grunin M, Gudnason V, Guetta-Baranes T, Haapasalo A, Hadjigeorgiou G, Haines JL, Hamilton-Nelson KL, Hampel H, Hanon O, Hardy J, Hartmann AM, Hausner L, Harwood J, Heilmann-Heimbach S, Helisalmi S, Heneka MT, Hernández I, Herrmann MJ, Hoffmann P, Holmes C, Holstege H, Vilas RH, Hulsman M, Humphrey J, Biessels GJ, Jian X, Johansson C, Jun GR, Kastumata Y, Kauwe J, Kehoe PG, Kilander L, Ståhlbom AK, Kivipelto M, Koivisto A, Kornhuber J, Kosmidis MH, Kukull WA, Kuksa PP, Kunkle BW, Kuzma AB, Lage C, Laukka EJ, Launer L, Lauria A, Lee CY, Lehtisalo J, Lerch O, Lleó A, Longstreth W Jr, Lopez O, de Munain AL, Love S, Löwemark M, Luckcuck L, Lunetta KL, Ma Y, Macías J, MacLeod CA, Maier W, Mangialasche F, Spallazzi M, Marquié M, Marshall R, Martin ER, Montes AM, Rodríguez CM, Masullo C, Mayeux R, Mead S, Mecocci P, Medina M, Meggy A, Mehrabian S, Mendoza S, Menéndez-González M, Mir P, Moebus S, Mol M, Molina-Porcel L, Montrreal L, Morelli L, Moreno F, Morgan K, Mosley T, Nöthen MM, Muchnik C, Mukherjee S, Nacmias B, Ngandu T, Nicolas G, Nordestgaard BG, Olaso R, Orellana A, Orsini M, Ortega G, Padovani A, Paolo C, Papenberg G, Parnetti L, Pasquier F, Pastor P, Peloso G, Pérez-Cordón A, Pérez-Tur J, Pericard P, Peters O, Pijnenburg YAL, Pineda JA, Piñol-Ripoll G, Pisanu C, Polak T, Popp J, Posthuma D, Priller J, Puerta R, Quenez O, Quintela I, Thomassen JQ, Rábano A, Rainero I, Rajabli F, Ramakers I, Real LM, Reinders MJT, Reitz C, Reyes-Dumeyer D, Ridge P, Riedel-Heller S, Riederer P, Roberto N, Rodriguez-Rodriguez E, Rongve A, Allende IR, Rosende-Roca M, Royo JL, Rubino E, Rujescu D, Sáez ME, Sakka P, Saltvedt I, Sanabria Á, Sánchez-Arjona MB, Sanchez-Garcia F, Juan PS, Sánchez-Valle R, Sando SB, Sarnowski C, Satizabal CL, Scamosci M, Scarmeas N, Scarpini E, Scheltens P, Scherbaum N, Scherer M, Schmid M, Schneider A, Schott JM, Selbæk G, Seripa D, Serrano M, Sha J, Shadrin AA, Skrobot O, Slifer S, Snijders GJL, Soininen H, Solfrizzi V, Solomon A, Song Y, Sorbi S, Sotolongo-Grau O, Spalletta G, Spottke A, Squassina A, Stordal E, Tartan JP, Tárraga L, Tesí N, Thalamuthu A, Thomas T, Tosto G, Traykov L, Tremolizzo L, Tybjærg-Hansen A, Uitterlinden A, Ullgren A, Ulstein I, Valero S, Valladares O, Broeckhoven CV, Vance J, Vardarajan BN, van der Lugt A, Dongen JV, van Rooij J, van Swieten J, Vandenberghe R, Verhey F, Vidal JS, Vogelgsang J, Vyhnalek M, Wagner M, Wallon D, Wang LS, Wang R, Weinhold L, Wiltfang J, Windle G, Woods B, Yannakoulia M, Zare H, Zhao Y, Zhang X, Zhu C, Zulaica M; EADB; GR@ACE; DEGESCO; EADI; GERAD; Demgene; FinnGen; ADGC; CHARGE, Farrer LA, Psaty BM, Ghanbari M, Raj T, Sachdev P, Mather K, Jessen F, Ikram MA, de Mendonça A, Hort J, Tsolaki M, Pericak-Vance MA, Amouyel P, Williams J, Frikke-Schmidt R, Clarimon J, Deleuze JF, Rossi G, Seshadri S, Andreassen OA, Ingelsson M, Hiltunen M, Sleegers K, Schellenberg GD, van Duijn CM, Sims R, van der Flier WM, Ruiz A, Ramirez A, Lambert JC.New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022 Apr 4. doi: 10.1038/s41588-022-01024-z. Online ahead of print. PMID: 35379992. IF= 38.333

 

  1. 5189. Lazarou I, Georgiadis K, Nikolopoulos S, Oikonomou VP, Stavropoulos TG, Tsolaki A, Kompatsiaris I, Tsolaki M; and the RADAR-AD Consortiume. Exploring Network Properties Across Preclinical Stages of Alzheimer's Disease Using a Visual Short-Term Memory and Attention Task with High-Density Electroencephalography: A Brain-Connectome Neurophysiological Study. J Alzheimers Dis. 2022 Apr 1. doi: 10.3233/JAD-215421. IF= 4,472

 

  1. 5187. Nikolaidou E, Tsatali M, Eleftheriou M, Wang H, Karagiozi K, Margaritidou P, Tsolaki M. Emotional Function, Negative Thoughts about the Pandemic, and Adaptability Skills among Dementia Caregivers during the COVID-19 Pandemic. Brain Sci. 2022 Mar 29;12(4):459. IF= 3.114

 

  1. 5182. 457. Visser PJ, Reus LM, Gobom J, Jansen I, Dicks E, van der Lee SJ, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Freund-Levi Y, Froelich L, Sleegers K, Dobricic V, Lovestone S, Streffer J, Vos SJB, Bos I; ADNI, Smit AB, Blennow K, Scheltens P, Teunissen CE, Bertram L, Zetterberg H, Tijms BM. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease. Mol Neurodegener. 2022 Mar 28;17(1):27. IF= 14.195

 

  1. 5173. Giannouli V, Tsolaki M. Liberating older adults from the bonds of vascular risk factors: What is their impact on financial capacity in aMCI? Psychiatry Clin Neurosci. 2022 Mar 9. IF=5.188

 

  1. 5165. Dimitriou T, Papatriantafyllou J, Konsta A, Kazis D, Athanasiadis L, Ioannidis P, Koutsouraki E, Tegos T, Tsolaki M.Non-Pharmacological Interventions for Wandering/Aberrant Motor Behavior in Patients with Dementia. Brain Sci. 2022 Jan 19;12(2):130. IF=3.394

 

  1. 5164. Tsatali M, Avdikou K, Gialaouzidis M, Minopoulou D, Emmanouel A, Kouroundi E, Tsolaki M. The discriminant validity of Rey Complex Figure Test (RCFT) in subjective cognitive decline, mild cognitive impairment (multiple domain) and Alzheimer's disease dementia (ADD; mild stage) in Greek older adults. Appl Neuropsychol Adult. 2022 Feb 21:1. IF= 2,248

 

  1. 5161. Sexton C, Solis M, Aharon-Peretz J, Alexopoulos P, Apostolova LG, Bayen E, Birkenhager B, Cappa S, Constantinidou F, Fortea J, Gerritsen DL, Hassanin HI, Ibanez A, Ioannidis P, Karageorgiou E, Korczyn A, Leroi I, Lichtwarck B, Logroscino G, Lynch C, Mecocci P, Molinuevo JL, Papatriantafyllou J, Papegeorgiou S, Politis A, Raman R, Ritchie K, Sanchez-Juan P, Sano M, Scarmeas N, Spiru L, Stathi A, Tsolaki M, Yener G, Zaganas I, Zygouris S, Carrillo M. Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium. Alzheimers Dement. 2022 Feb 20. ΙF= 21.566

 

  1. 5147. Giannouli V, Tsolaki M. Financial Incapacity of Patients with Mild Alzheimer's Disease: What Neurologists Need to Know about Where the Impairment Lies. Neurol Int. 2022 Jan 11;14(1):90-98. IF=1,22

 

  1. 5139. Giannouli V, Stamovlasis D, Tsolaki M.Longitudinal Study of Depression on Amnestic Mild Cognitive Impairment and Financial Capacity. Clin Gerontol. 2022 Jan 5:1-7. IF=2.24

 

  1. 5101. Ntracha A, Iakovakis D, Hadjidimitriou S, Charisis VS, Tsolaki M, Hadjileontiadis LJ. Detection of Mild Cognitive Impairment Through Natural Language and Touchscreen Typing Processing. Front Digit Health. 2020 Oct 8;2:567158. doi: 10.3389/fdgth.2020.567158. IF=5.175.

 

  1. 5133. Delaby C, Teunissen CE, Blennow K, Alcolea D, Arisi I, Amar EB, Beaume A, Bedel A, Bellomo G, Bigot-Corbel E, Bjerke M, Blanc-Quintin MC, Boada M, Bousiges O, Chapman MD, DeMarco ML, D'Onofrio M, Dumurgier J, Dufour-Rainfray D, Engelborghs S, Esselmann H, Fogli A, Gabelle A, Galloni E, Gondolf C, Grandhomme F, Grau-Rivera O, Hart M, Ikeuchi T, Jeromin A, Kasuga K, Keshavan A, Khalil M, Körtvelyessy P, Kulczynska-Przybik A, Laplanche JL, Lewczuk P, Li QX, Lleó A, Malaplate C, Marquié M, Masters CL, Mroczko B, Nogueira L, Orellana A, Otto M, Oudart JB, Paquet C, Paoletti FP, Parnetti L, Perret-Liaudet A, Peoc'h K, Poesen K, Puig-Pijoan A, Quadrio I, Quillard-Muraine M, Rucheton B, Schraen S, Schott JM, Shaw LM, Suárez-Calvet M, Tsolaki M, Tumani H, Udeh-Momoh CT, Vaudran L, Verbeek MM, Verde F, Vermunt L, Vogelgsang J, Wiltfang J, Zetterberg H, Lehmann S. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview. Alzheimers Dement. 2021 Dec 22. IF= 21.566

 

  1. 4780. Makri M, Christakidou A, Tsolaki M. English Lessons with the Use of Songs for People with Mild Cognitive Impairment. Alzheimers Dement. 2021 Dec;17 Suppl 12:e058651. ΙF=21.566

 

  1. 5126. Janssen O, Jansen WJ, Vos SJB, Boada M, Parnetti L, Gabryelewicz T, Fladby T, Molinuevo JL, Villeneuve S, Hort J, Epelbaum S, Lleó A, Engelborghs S, van der Flier WM, Landau S, Popp J, Wallin A, Scheltens P, Rikkert MO, Snyder PJ, Rowe C, Chételat G, Ruíz A, Marquié M, Chipi E, Wolfsgruber S, Heneka M, Boecker H, Peters O, Jarholm J, Rami L, Tort-Merino A, Binette AP, Poirier J, Rosa-Neto P, Cerman J, Dubois B, Teichmann M, Alcolea D, Fortea J, Sánchez-Saudinós MB, Ebenau J, Pocnet C, Eckerström M, Thompson L, Villemagne V, Buckley R, Burnham S, Delarue M, Freund-Levi Y, Wallin ÅK, Ramakers I, Tsolaki M, Soininen H, Hampel H, Spiru L; Alzheimer's Disease Neuroimaging Initiative; FACEHBI study group; PREVENT-AD research group, Tijms B, Ossenkoppele R, Verhey FRJ, Jessen F, Visser PJ. Characteristics of subjective cognitive decline associated with amyloid positivity. Alzheimers Dement. 2021 Dec 8. ΙF= 21.566

 

  1. 5121. Xu J, Green R, Kim M, Lord J, Ebshiana A, Westwood S, Baird AL, Nevado-Holgado AJ, Shi L, Hye A, Snowden SG, Bos I, Vos SJB, Vandenberghe R, Teunissen CE, Kate MT, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck EE, Engelborghs S, Sleegers K, Bordet R, Rami L, Kettunen P, Tsolaki M, Verhey FRJ, Alcolea D, Lleó A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Proitsi P, Legido-Quigley C, On Behalf Of The European Medical Information Framework Consortium. Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort.Biomedicines. 2021 Nov 3;9(11):1610. ΙF=5.612

 

  1. 5111. Giannouli V, Tsolaki M. Financial Capacity and Illiteracy: Does Education Matter in Amnestic Mild Cognitive Impairment? J Alzheimers Dis Rep. 2021 Sep 6;5(1):715-719.IF= 4.472

 

  1. 5107. Tzekaki EE, Tsolaki M, Geromichalos GD, Pantazaki ΑA. Extra Virgin Olive Oil consumption from Mild Cognitive Impairment patients attenuates oxidative and nitrative stress reflecting on the reduction of the PARP levels and DNA damage. Exp Gerontol. 2021 Dec:156:111621. doi: 10.1016/j.exger.2021.111621.IF= 3,376

 

  1. 5093. Lazarou I, Moraitou D, Papatheodorou M, Vavouras I, Lokantidou C, Agogiatou C, Gialaoutzis M, Nikolopoulos S, Stavropoulos TG, Kompatsiaris IY, Tsolaki M. Adaptation and Validation of the Memory Alteration Test (M@T) in Greek Middle-Aged, Older, and Older-Old Population with Subjective Cognitive Decline and Mild Cognitive Impairment. J Alzheimers Dis. 2021 Oct 10. doi: 10.3233/JAD-210558. IF= 4.472

 

  1. 5091. Katsipis G, Tzekaki EE, Tsolaki M, Pantazaki AA. Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis. J Neuroimmunol. 2021 Oct 9;361:577744. doi: 10.1016/j.jneuroim.2021.577744. IF=3.478

 

  1. 4709. Dimitriadis SI, Tarnanas I, Wiederhold M, Wiederhold B, Tsolaki M, Fleisch E.Mnemonic strategy training of the elderly at risk for dementia enhances integration of information processing via cross-frequency coupling. Alzheimers Dement (N Y). 2016 Sep 15;2(4):241-249. doi: 10.1016/j.trci.2016.08.004. eCollection 2016 IF=17,127

 

  1. 5051. Simrén J, Leuzy A, Karikari TK, Hye A, Benedet AL, Lantero-Rodriguez J, Mattsson-Carlgren N, Schöll M, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Aarsland D; AddNeuroMed consortium, Hansson O, Rosa-Neto P, Westman E, Blennow K, Zetterberg H, Ashton NJ.The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease. Alzheimers Dement. 2021 Jul;17(7):1145-1156. doi: 10.1002/alz.12283. IF=17,127

 

  1. 5071. Tsatali M, Moraitou D, Poptsi E, Sia E, Agogiatou C, Gialaouzidis M, Tabakis IM, Avdikou K, Bakoglidou E, Batsila G, Bekiaridis-Moschou D, Chatziroumpi O, Diamantidou A, Gavra A, Kouroundi E, Liapi D, Markou N, Ouzouni F, Papasozomenou C, Soumpourou A, Tsolaki M. Are There Any Cognitive and Behavioral Changes Potentially Related to Quarantine Due to the COVID-19 Pandemic in People with Mild Cognitive Impairment and AD Dementia? A Longitudinal Study. Brain Sci. 2021 Aug 31;11(9):1165. IF= 3.578

 

  1. 5058. Stavropoulos TG, Meditskos G, Lazarou I, Mpaltadoros L, Papagiannopoulos S, Tsolaki M, Kompatsiaris I. Detection of Health-Related Events and Behaviours from Wearable Sensor Lifestyle Data Using Symbolic Intelligence: A Proof-of-Concept Application in the Care of Multiple Sclerosis. Sensors (Basel). 2021 Sep 17;21(18):6230. IF=3,576

 

  1. 5068. Tsolaki M, Tsatali M, Gkioka M, Poptsi E, Tsolaki A, Papaliagkas V, Tabakis IM, Lazarou I, Makri M, Kazis D, Papagiannopoulos S, Kiryttopoulos A, Koutsouraki E, Tegos T. Memory Clinics and Day Care Centers in Thessaloniki, Northern Greece: 30 Years of Clinical Practice and Experience. Front Neurol. 2021 Aug 25;12:683131. IF=3,62
  2. 5070. Tijms BM, Gobom J, Teunissen C, Dobricic V, Tsolaki M, Verhey F, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuévo JL, Engelborghs S, Freund-Levi Y, Froelich L, Bertram L, Lovestone S, Streffer J, Vos S, Adni, Blennow K, Scheltens P, Zetterberg H, Visser PJ.CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals. Proteomes. 2021 Aug 2;9(3):36. doi: 10.3390/proteomes9030036. IF=2,91

 

  1. 5069. Tsatali M, Moraitou D, Papantoniou G, Foutsitzi E, Bonti E, Kougioumtzis G, Ntritsos G, Sofologi M, Tsolaki M. Measuring Impulsivity in Greek Adults: Psychometric Properties of the Barratt Impulsiveness Scale (BIS-11) and Impulsive Behavior Scale (Short Version of UPPS-P). Brain Sci. 2021 Jul 29;11(8):1007. IF=3.110

 

  1. 5063. Lazarou I, Stavropoulos TG, Mpaltadoros L, Nikolopoulos S, Koumanakos G, Tsolaki M, Kompatsiaris IY. Human Factors and Requirements of People with Cognitive Impairment, Their Caregivers, and Healthcare Professionals for mHealth Apps Including Reminders, Games, and Geolocation Tracking: A Survey-Questionnaire Study. J Alzheimers Dis Rep. 2021 Jun 11;5(1):497-513. IF=4.472.

 

  1. 5061. Lazarev VF, Tsolaki M, Mikhaylova ER, Benken KA, Shevtsov MA, Nikotina AD, Lechpammer M, Mitkevich VA, Makarov AA, Moskalev AA, Kozin SA, Margulis BA, Guzhova IV, Nudler E.Extracellular GAPDH Promotes Alzheimer Disease Progression by Enhancing Amyloid-β Aggregation and Cytotoxicity. Aging Dis. 2021 Aug 1;12(5):1223-1237. IF=6.745

 

  1. 5052. Dimitriadis SI, Lyssoudis C, Tsolaki AC, Lazarou E, Kozori M, Tsolaki M.Greek High Phenolic Early Harvest Extra Virgin Olive Oil Reduces the Over-Excitation of Information-Flow Based on Dominant Coupling Mode Model in Patients with Mild Cognitive Impairment: An EEG Resting-State Validation Approach. J Alzheimers Dis. 2021 Jul 19. doi: 10.3233/JAD-210454. ΙF=3.909

 

  1. 5046. Karagiozi K, Margaritidou P, Tsatali M, Marina M, Dimitriou T, Apostolidis H, Tsiatsos T, Tsolaki M.Comparison of on Site versus Online Psycho Education Groups and Reducing Caregiver Burden. Clin Gerontol. 2021 Jul 5:1-11. IF=1,375

 

  1. 5045. Giannouli V, Tsolaki M.Is Depression or Apathy Playing a Key Role in Predicting Financial Capacity in Parkinson's Disease with Dementia and Frontotemporal Dementia? Brain Sci. 2021 Jun 14;11(6):785. IF=3.110

 

  1. 5044. Tsatali M, Poptsi E, Moraitou D, Agogiatou C, Bakoglidou E, Gialaouzidis M, Papasozomenou C, Soumpourou A, Tsolaki M. Discriminant Validity of the WAIS-R Digit Symbol Substitution Test in Subjective Cognitive Decline, Mild Cognitive Impairment (Amnestic Subtype) and Alzheimer's Disease Dementia (ADD) in Greece. Brain Sci. 2021 Jun 30;11(7):881. IF=3.110

 

  1. 5036. Kladi A, Iliadou P, Tsolaki M, Moraitou D. Age-related Differences in Mu rhythm during Emotional Destination Memory. Curr Aging Sci. 2021 Jun 7. IF=1,78

 

  1. 5031. de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, Pedersen NL, Stringa N, Zettergren A, Hernández I, Montrreal L, Antúnez C, Antonell A, Tankard RM, Bis JC, Sims R, Bellenguez C, Quintela I, González-Perez A, Calero M, Franco-Macías E, Macías J, Blesa R, Cervera-Carles L, Menéndez-González M, Frank-García A, Royo JL, Moreno F, Huerto Vilas R, Baquero M, Diez-Fairen M, Lage C, García-Madrona S, García-González P, Alarcón-Martín E, Valero S, Sotolongo-Grau O, Ullgren A, Naj AC, Lemstra AW, Benaque A, Pérez-Cordón A, Benussi A, Rábano A, Padovani A, Squassina A, de Mendonça A, Arias Pastor A, Kok AAL, Meggy A, Pastor AB, Espinosa A, Corma-Gómez A, Martín Montes A, Sanabria Á, DeStefano AL, Schneider A, Haapasalo A, Kinhult Ståhlbom A, Tybjærg-Hansen A, Hartmann AM, Spottke A, Corbatón-Anchuelo A, Rongve A, Borroni B, Arosio B, Nacmias B, Nordestgaard BG, Kunkle BW, Charbonnier C, Abdelnour C, Masullo C, Martínez Rodríguez C, Muñoz-Fernandez C, Dufouil C, Graff C, Ferreira CB, Chillotti C, Reynolds CA, Fenoglio C, Van Broeckhoven C, Clark C, Pisanu C, Satizabal CL, Holmes C, Buiza-Rueda D, Aarsland D, Rujescu D, Alcolea D, Galimberti D, Wallon D, Seripa D, Grünblatt E, Dardiotis E, Düzel E, Scarpini E, Conti E, Rubino E, Gelpi E, Rodriguez-Rodriguez E, Duron E, Boerwinkle E, Ferri E, Tagliavini F, Küçükali F, Pasquier F, Sanchez-Garcia F, Mangialasche F, Jessen F, Nicolas G, Selbæk G, Ortega G, Chêne G, Hadjigeorgiou G, Rossi G, Spalletta G, Giaccone G, Grande G, Binetti G, Papenberg G, Hampel H, Bailly H, Zetterberg H, Soininen H, Karlsson IK, Alvarez I, Appollonio I, Giegling I, Skoog I, Saltvedt I, Rainero I, Rosas Allende I, Hort J, Diehl-Schmid J, Van Dongen J, Vidal JS, Lehtisalo J, Wiltfang J, Thomassen JQ, Kornhuber J, Haines JL, Vogelgsang J, Pineda JA, Fortea J, Popp J, Deckert J, Buerger K, Morgan K, Fließbach K, Sleegers K, Molina-Porcel L, Kilander L, Weinhold L, Farrer LA, Wang LS, Kleineidam L, Farotti L, Parnetti L, Tremolizzo L, Hausner L, Benussi L, Froelich L, Ikram MA, Deniz-Naranjo MC, Tsolaki M, Rosende-Roca M, Löwenmark M, Hulsman M, Spallazzi M, Pericak-Vance MA, Esiri M, Bernal Sánchez-Arjona M, Dalmasso MC, Martínez-Larrad MT, Arcaro M, Nöthen MM, Fernández-Fuertes M, Dichgans M, Ingelsson M, Herrmann MJ, Scherer M, Vyhnalek M, Kosmidis MH, Yannakoulia M, Schmid M, Ewers M, Heneka MT, Wagner M, Scamosci M, Kivipelto M, Hiltunen M, Zulaica M, Alegret M, Fornage M, Roberto N, van Schoor NM, Seidu NM, Banaj N, Armstrong NJ, Scarmeas N, Scherbaum N, Goldhardt O, Hanon O, Peters O, Skrobot OA, Quenez O, Lerch O, Bossù P, Caffarra P, Dionigi Rossi P, Sakka P, Hoffmann P, Holmans PA, Fischer P, Riederer P, Yang Q, Marshall R, Kalaria RN, Mayeux R, Vandenberghe R, Cecchetti R, Ghidoni R, Frikke-Schmidt R, Sorbi S, Hägg S, Engelborghs S, Helisalmi S, Botne Sando S, Kern S, Archetti S, Boschi S, Fostinelli S, Gil S, Mendoza S, Mead S, Ciccone S, Djurovic S, Heilmann-Heimbach S, Riedel-Heller S, Kuulasmaa T, Del Ser T, Lebouvier T, Polak T, Ngandu T, Grimmer T, Bessi V, Escott-Price V, Giedraitis V, Deramecourt V, Maier W, Jian X, Pijnenburg YAL; EADB contributors; GR@ACE study group; DEGESCO consortium; IGAP (ADGC, CHARGE, EADI, GERAD); PGC-ALZ consortia, Kehoe PG, Garcia-Ribas G, Sánchez-Juan P, Pastor P, Pérez-Tur J, Piñol-Ripoll G, Lopez de Munain A, García-Alberca JM, Bullido MJ, Álvarez V, Lleó A, Real LM, Mir P, Medina M, Scheltens P, Holstege H, Marquié M, Sáez ME, Carracedo Á, Amouyel P, Schellenberg GD, Williams J, Seshadri S, van Duijn CM, Mather KA, Sánchez-Valle R, Serrano-Ríos M, Orellana A, Tárraga L, Blennow K, Huisman M, Andreassen OA, Posthuma D, Clarimón J, Boada M, van der Flier WM, Ramirez A, Lambert JC, van der Lee SJ, Ruiz A.Common variants in Alzheimer's disease and risk stratification by polygenic risk scores. Nat Commun. 2021 Jun 7;12(1):3417. doi: 10.1038/s41467-021-22491-8. IF=14.919.
  2. 5027.Andreadou EG, Katsipis G, Tsolaki M, Pantazaki AA. Involvement and relationship of bacterial lipopolysaccharides and cyclooxygenases levels in Alzheimer's Disease and Mild Cognitive Impairment patients. J Neuroimmunol. 2021 Mar 30;357:577561. doi: 10.1016/j.jneuroim.2021.577561.ΙF=3,125

 

  1. 5013. Tsentidou G, Moraitou D, Tsolaki M. Similar Theory of Mind Deficits in Community Dwelling Older Adults with Vascular Risk Profile and Patients with Mild Cognitive Impairment: The Case of Paradoxical Sarcasm Comprehension.

Brain Sci. 2021 May 13;11(5):627. IF=3,110

 

  1. 5024.Poptsi E, Tsatali M, Agogiatou C, Bakoglidou E, Batsila G, Dellaporta D, Kounti-Zafeiropoulou F, Liapi D, Lysitsas K, Markou N, Mouzakidis C, Ouzouni F, Papasozomenou C, Soumpourou A, Vasiloglou M, Zafeiropoulos S, Tsolaki M. Longitudinal Cognitive and Physical Training Effectiveness in MCI, Based on the Experience of the Alzheimer's Hellas Day Care Centre. J Geriatr Psychiatry Neurol. 2021 Jun 1:8919887211016057. doi: 10.1177/08919887211016057. IF=2.125

 

  1. 5015. Chalkias IN, Tegos T, Topouzis F, Tsolaki M. . Ocular biomarkers and their role in the early diagnosis of neurocognitive disorders. Eur J Ophthalmol. 2021 May 17:11206721211016311. IF= 1.642

 

  1. 5008. Limoncu H, Boz HE, Zygouris S, Tsolaki M, Giakoumis D, Votis K, Tzovaras D, Öztürk V, Yener GG A Virtual Reality-Based Screening Test for Cognitive Impairment in Small Vessel Disease. J Alzheimers Dis Rep. 2021 Mar 8;5(1):161-169. IF= 3.909

 

  1. 4782. Stavropoulos TG, Lazarou I, Diaz A, Gove D, Georges J, Manyakov NV, Pich EM, Hinds C, Tsolaki M, Nikolopoulos S, Kompatsiaris I; Wearable Devices for Assessing Function in Alzheimer's Disease: A European Public Involvement Activity About the Features and Preferences of Patients and Caregivers. RADAR-AD Consortium. Front Aging Neurosci. 2021 Apr 12; IF=4,504

 

  1. 4776. Schneider J, Gkioka M, Papagiannopoulos S, Moraitou D, Metz B, Tsolaki M, Kruse A, Teichmann B. Expectations of nursing personnel and physicians on dementia training : A descriptive survey in general hospitals in Germany and Greece. Z Gerontol Geriatr. 2021 Apr 21. IF= 0.919

 

  1. 4762. Tzekaki EE, Tsolaki M, Pantazaki ΑA, Geromichalos G, Lazarou E, Kozori M, Sinakos Z. The pleiotropic beneficial intervention of olive oil intake on the Alzheimer's disease onset via fibrinolytic system. Exp Gerontol. 2021 Jul 15:150:111344.

 doi: 10.1016/j.exger.2021.111344.: IF= 3,376

 

  1. 4756. Giannouli V, Tsolaki M. Frontotemporal dementia and financial capacity: facing the Cerberus of overestimation or underestimation? Australas Psychiatry. 2021 Apr 5: IF=0,943

 

  1. 5071. Tsatali M, Moraitou D, Poptsi E, Sia E, Agogiatou C, Gialaouzidis M, Tabakis IM, Avdikou K, Bakoglidou E, Batsila G, Bekiaridis-Moschou D, Chatziroumpi O, Diamantidou A, Gavra A, Kouroundi E, Liapi D, Markou N, Ouzouni F, Papasozomenou C, Soumpourou A, Tsolaki M.Are There Any Cognitive and Behavioral Changes Potentially Related to Quarantine Due to the COVID-19 Pandemic in People with Mild Cognitive Impairment and AD Dementia? A Longitudinal Study. Brain Sci. 2021 Aug 31;11(9):1165. IF=3.110

 

  1. 4754. Shi L, Winchester LM, Westwood S, Baird AL, Anand SN, Buckley NJ, Hye A, Ashton NJ, Bos I, Vos SJB, Kate MT, Scheltens P, Teunissen CE, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lléo A, Sala I, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Legido-Quigley C, Barkhof F, Andreasson U, Blennow K, Zetterberg H, Streffer J, Lill CM, Bertram L, Visser PJ, Kolb HC, Narayan VA, Lovestone S, Nevado-Holgado AJ. Replication study of plasma proteins relating to Alzheimer's pathology. Alzheimers Dement. 2021 Mar 31 IF= 17.127

 

  1. 4752. Nabais MF, Laws SM, Lin T, Vallerga CL, Armstrong NJ, Blair IP, Kwok JB, Mather KA, Mellick GD, Sachdev PS, Wallace L, Henders AK, Zwamborn RAJ, Hop PJ, Lunnon K, Pishva E, Roubroeks JAY, Soininen H, Tsolaki M, Mecocci P, Lovestone S, Kłoszewska I, Vellas B; Australian Imaging Biomarkers and Lifestyle study; Alzheimer’s Disease Neuroimaging Initiative, Furlong S, Garton FC, Henderson RD, Mathers S, McCombe PA, Needham M, Ngo ST, Nicholson G, Pamphlett R, Rowe DB, Steyn FJ, Williams KL, Anderson TJ, Bentley SR, Dalrymple-Alford J, Fowder J, Gratten J, Halliday G, Hickie IB, Kennedy M, Lewis SJG, Montgomery GW, Pearson J, Pitcher TL, Silburn P, Zhang F, Visscher PM, Yang J, Stevenson AJ, Hillary RF, Marioni RE, Harris SE, Deary IJ, Jones AR, Shatunov A, Iacoangeli A, van Rheenen W, van den Berg LH, Shaw PJ, Shaw CE, Morrison KE, Al-Chalabi A, Veldink JH, Hannon E, Mill J, Wray NR, McRae AF. Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders. Genome Biol. 2021 Mar 26;22(1):90. IF= 10.806

 

  1. 4749. Giannouli V, Tsolaki M.APOE ɛ4 Allele and Financial Capacity Performance in Mild Alzheimer's Disease: A Pilot Study. J Alzheimers Dis Rep. 2021 Jan 29;5(1):93-97. doi: 10.3233/ADR-200254 IF= 3.909

 

  1. 4748. Hassandra M, Galanis E, Hatzigeorgiadis A, Goudas M, Mouzakidis C, Karathanasi EM, Petridou N, Tsolaki M, Zikas P, Evangelou G, Papagiannakis G, Bellis G, Kokkotis C, Panagiotopoulos SR, Giakas G, Theodorakis Y. Α Virtual Reality App for Physical and Cognitive Training of Older People With Mild Cognitive Impairment: Mixed Methods Feasibility Study. JMIR Serious Games. 2021 Mar 24;9(1):e24170. doi: 10.2196/24170. IF=3.530

 

  1. 4742. Poptsi E, Tsolaki M, Bergh S, Cesana BM, Ciccone A, Fabbo A, Frisoni GB, Frölich L, Lavolpe S, Guazzarini AG, Hugon J, Fascendini S, Mecocci P, Defanti CA. Rationale, Design, and Methodology of a Prospective Cohort Study for Coping with Behavioral and Psychological Symptoms of Dementia: The RECage Project. J Alzheimers Dis. 2021 Mar 10. doi: 10.3233/JAD-201215. ΙF=3.909

 

  1. 4709. Nifli AP, Tsolaki M, Tournoy J, Ide K. Editorial: Cognitive Impairment: Therapy Momentum in the Continuum of Life. Front Pharmacol. 2021 Jan 29;11:618344. IF=4.225

 

  1. 4704. Chalkias E, Topouzis F, Tegos T, Tsolaki M. The Contribution of Ocular Biomarkers in the Differential Diagnosis of Alzheimer's Disease versus Other Types of Dementia and Future Prospects. J Alzheimers Dis. 2021 Feb 1. ΙF=3.909

Τέλος φόρμας

Αρχή φόρμας

Τέλος φόρμας

 

  1. 4755. Eleni G. Andreadou, Georgios Katsipis, Magda Tsolaki , and Anastasia A. Pantazaki. Bacterial rhamnolipids (RLs) in saliva of Alzheimer's disease and Mild Cognitive Impairment patients and correlation with neuroinflammation and cognitive state.  GSC Advanced Research and Reviews, 2021, 06(03), 209–219  

 

  1. 4634. Iliadou P, Paliokas I, Zygouris S, Lazarou E, Votis K, Tzovaras D, Tsolaki M.A Comparison of Traditional and Serious Game-Based Digital Markers of Cognition in Older Adults with Mild Cognitive Impairment and Healthy Controls. J Alzheimers Dis. 2021 Jan 14. ΙF=3.909

 

  1. 4633. Hassanin HI, Tawfik HM, Zygouris S, Tsatali M, Sweed HS, Tsolaki M.Setting Up a Cognitive Training Service for Egyptian Older Adults. J Alzheimers Dis. 2021 Jan 8. doi: 10.3233/JAD-201278 IF=3.909

 

  1. 4631. Giannouli V, Tsolaki M. Mild Alzheimer Disease, Financial Capacity, and the Role of Depression: Eyes Wide Shut? Alzheimer Dis Assoc Disord. 2021 Jan 11 IF=2,44
  2. 4629. Tijms BM, Gobom J, Reus L, Jansen I, Hong S, Dobricic V, Kilpert F, Ten Kate M, Barkhof F, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Bertram L, Lovestone S, Streffer J, Vos S, Bos I; Alzheimer’s Disease Neuroimaging Initiative (ADNI), Blennow K, Scheltens P, Teunissen CE, Zetterberg H, Visser PJ. Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics. Brain. 2020 Dec 1;143(12):3776-3792. IF=11.337
  3. 4626. Whiley L, Chappell KE, D'Hondt E, Lewis MR, Jiménez B, Snowden SG, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Swann JR, Hye A, Lovestone S, Legido-Quigley C, Holmes E; AddNeuroMed consortium. Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease. Alzheimers Res Ther. 2021 Jan 9;13(1):20. doi: 10.1186/s13195-020-00741-z. ΙF=5.015

 

  1. 4613. Gkioka M, Teichmann B, Moraitou D, Papagiannopoulos S, Tsolaki M. Effects of a Person Centered Dementia Training Program in Greek Hospital Staff-Implementation and Evaluation. Brain Sci. 2020 Dec 12;10(12):E976. ΙF= 3.332

 

  1. 4612. Kurbatova N, Garg M, Whiley L, Chekmeneva E, Jiménez B, Gómez-Romero M, Pearce J, Kimhofer T, D'Hondt E, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Aarsland D, Nevado-Holgado A, Liu B, Snowden S, Proitsi P, Ashton NJ, Hye A, Legido-Quigley C, Lewis MR, Nicholson JK, Holmes E, Brazma A, Lovestone S. Urinary metabolic phenotyping for Alzheimer's disease. Sci Rep. 2020 Dec 10;10(1):21745. IF= 3.998

 

  1. 4610. Tzekaki EE, Papaspyropoulos A, Tsolaki M, Lazarou E, Kozori M, Pantazaki ΑA. Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease. Exp Gerontol. 2020 Dec 5:111178.IF= 3.376

 

  1. 4599. Ribaldi F, Altomare D, Jovicich J, Ferrari C, Picco A, Pizzini FB, Soricelli A, Mega A, Ferretti A, Drevelegas A, Bosch B, Müller BW, Marra C, Cavaliere C, Bartrés-Faz D, Nobili F, Alessandrini F, Barkhof F, Gros-Dagnac H, Ranjeva JP, Wiltfang J, Kuijer J, Sein J, Hoffmann KT, Roccatagliata L, Parnetti L, Tsolaki M, Constantinidis M, Aiello M, Salvatore M, Montalti M, Caulo M, Didic M, Bargallo N, Blin O, Rossini P, Schonknecht P, Floridi P, Payoux P, Visser PJ, Bordet R, Lopes R, Tarducci R, Bombois S, Hensch T, Fiedler U, Richardson JC, Frisoni GB, Marizzoni M. Accuracy and reproducibility of automated white matter hyper-intensities segmentation with lesion segmentation tool: A European multi-site 3T study. Magn Reson Imaging. 2020 Nov 18:S0730-725X(20)30643-3. doi: 10.1016/j.mri.2020.11.008. ΙF=2.053

 

  1. 4641. Zygouris S, Gkioka M, Moraitou D, Teichmann B, Tsiatsos T, Papagianopoulos S, Tsolaki M. Assessing the Attitudes of Greek Nurses Toward Computerized Dementia Screening. J Alzheimers Dis. 2020 Nov 8. ΙF=3.909

 

  1. 4594. Visser PJ, Reus LM, Gobom J, Jansen I, Dicks E, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Freund-Levi Y, Froelich L, Sleegers K, Dobricic V, Hong S, Lovestone S, Streffer J, Vos SJB, Bos I, Smit AB, Blennow K, Scheltens P, Teunissen CE, Bertram L, Zetterberg H, Tijms BM. Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's disease. medRxiv. 2020 Nov 3:2020.10.29.20211920.

 

  1. 4589. Giannouli V, Tsolaki M. Unraveling Ariadne's Thread Into the Labyrinth of aMCI: Depression and Financial Capacity. Alzheimer Dis Assoc Disord. 2020 Oct 30. IF= 2.098

 

  1. 4586. Gkioka M, Schneider J, Kruse A, Tsolaki M, Moraitou D, Teichmann B. Evaluation and Effectiveness of Dementia Staff Training Programs in General Hospital Settings: A Narrative Synthesis with Holton's Three-Level Model Applied. J Alzheimers Dis. 2020 Oct 20. doi: 10.3233/JAD-200741. Online ahead of print. ΙF=3.909

 

  1. 4576. Tsolaki M, Lazarou E, Kozori M, Petridou N, Tabakis I, Lazarou I, Karakota M, Saoulidis I, Melliou E, Magiatis P. A Randomized Clinical Trial of Greek High Phenolic Early Harvest Extra Virgin Olive Oil in Mild Cognitive Impairment: The MICOIL Pilot Study. J Alzheimers Dis. 2020; 78(2):801-817. doi: 10.3233/JAD-200405. ΙF=3.909

 

https://ygeia50plus.gr/clinical-studies/apu-kliniki-meleth-micoil-elaiolado-to-framako-gia-to-alzheimer/

 

 

  1. 4574. Tsatali M, Emmanouel A, Gialaouzidis M, Avdikou K, Stefanatos C, Diamantidou A, Kouroundi E, Messini C, Tsolaki M. Rey Complex Figure Test (RCFT): Norms for the Greek older adult population. Appl Neuropsychol Adult. 2020 Oct 12:1-9.IF=1.350

 

  1. 4566. Mårtensson G, Ferreira D, Granberg T, Cavallin L, Oppedal K, Padovani A, Rektorova I, Bonanni L, Pardini M, Kramberger MG, Taylor JP, Hort J, Snædal J, Kulisevsky J, Blanc F, Antonini A, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Aarsland D, Westman E.The reliability of a deep learning model in clinical out-of-distribution MRI data: A multicohort study. Med Image Anal. 2020 May 1;66:101714. IF= 15.583

 

  1. 4565. Zygouris S, Iliadou P, Lazarou E, Giakoumis D, Votis K, Alexiadis A, Triantafyllidis A, Segkouli S, Tzovaras D, Tsiatsos T, Papagianopoulos S, Tsolaki M.Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy? J Alzheimers Dis. 2020 Sep 25. ΙF=3.909

 

  1. 4547. Dyer AH, Murphy C, Lawlor B, Kennelly SP; NILVAD StudyGroup. Sedative Load in Community-Dwelling Older Adults with Mild-Moderate Alzheimer's Disease: Longitudinal Relationships with Adverse Events, Delirium and Falls. Drugs Aging. 2020 Sep 14. IF= 2.925

 

  1. 4528. Buegler M, Harms R, Balasa M, Meier IB, Exarchos T, Rai L, Boyle R, Tort A, Kozori M, Lazarou E, Rampini M, Cavaliere C, Vlamos P, Tsolaki M, Babiloni C, Soricelli A, Frisoni G, Sanchez-Valle R, Whelan R, Merlo-Pich E, Tarnanas I. Digital biomarker-based individualized prognosis for people at risk of dementia. Alzheimers Dement (Amst). 2020 Aug 19;12(1):e12073. doi: 10.1002/dad2.12073. eCollection 2020. PMID: 32832589 Free PMC article. IF=

 

  1. 4529. Shi L, Winchester LM, Liu BY, Killick R, Ribe EM, Westwood S, Baird AL, Buckley NJ, Hong S, Dobricic V, Kilpert F, Franke A, Kiddle S, Sattlecker M, Dobson R, Cuadrado A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Ten Kate M, Scheltens P, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lleó A, Alcolea D, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Teunissen CE, Freund-Levi Y, Frölich L, Legido-Quigley C, Barkhof F, Blennow K, Rasmussen KL, Nordestgaard BG, Frikke-Schmidt R, Nielsen SF, Soininen H, Vellas B, Kloszewska I, Mecocci P, Zetterberg H, Morgan BP, Streffer J, Visser PJ, Bertram L, Nevado-Holgado AJ, Lovestone S. Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology. J Alzheimers Dis. 2020 Aug 20. doi: 10.3233/JAD-200208. ΙF=3.909

 

  1. 4517. Karakostas A, König A, Crispim-Junior CF, Bremond F, Derreumaux A, Lazarou I, Kompatsiaris I, Tsolaki M, Robert P. A French-Greek Cross-Site Comparison Study of the Use of Automatic Video Analyses for the Assessment of Autonomy in Dementia Patients. Biosensors (Basel). 2020 Aug 21;10(9):E103. doi: 10.3390/bios10090103. IF= 3.240
  2. 4510. Gkioka M, Tsolaki M, Papagianopoulos S, Teichmann B, Moraitou D. Psychometric properties of dementia attitudes scale, dementia knowledge assessment tool 2 and confidence in dementia scale in a Greek sample. Nurs Open. 2020 Jul 3;7(5):1623-1633. doi: 10.1002/nop2.546. IF= 1.363

 

  1. 4511. Roubroeks JAY, Smith AR, Smith RG, Pishva E, Ibrahim Z, Sattlecker M, Hannon EJ, Kłoszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Wahlund LO, Aarsland D, Proitsi P, Hodges A, Lovestone S, Newhouse SJ, Dobson RJB, Mill J, van den Hove DLA, Lunnon K. An epigenome-wide association study of Alzheimer's disease blood highlights robust DNA hypermethylation in the HOXB6 gene. Neurobiol Aging. 2020 Jul 3;95:26-45. doi: 10.1016/j.neurobiolaging.2020.06.023. IF=4.398

 

  1. 4509. Elvsåshagen T, Bahrami S, van der Meer D, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Beyer MK, Blasi G, Borgwardt S, Boye B, Buitelaar J, Bøen E, Celius EG, Cervenka S, Conzelmann A, Coynel D, Di Carlo P, Djurovic S, Eisenacher S, Espeseth T, Fatouros-Bergman H, Flyckt L, Franke B, Frei O, Gelao B, Harbo HF, Hartman CA, Håberg A, Heslenfeld D, Hoekstra PJ, Høgestøl EA, Jonassen R, Jönsson EG; Karolinska Schizophrenia Project (KaSP) consortium, Kirsch P, Kłoszewska I, Lagerberg TV, Landrø NI, Le Hellard S, Lesch KP, Maglanoc LA, Malt UF, Mecocci P, Melle I, Meyer-Lindenberg A, Moberget T, Nordvik JE, Nyberg L, Connell KSO, Oosterlaan J, Papalino M, Papassotiropoulos A, Pauli P, Pergola G, Persson K, de Quervain D, Reif A, Rokicki J, van Rooij D, Shadrin AA, Schmidt A, Schwarz E, Selbæk G, Soininen H, Sowa P, Steen VM, Tsolaki M, Vellas B, Wang L, Westman E, Ziegler GC, Zink M, Andreassen OA, Westlye LT, Kaufmann T.The genetic architecture of human brainstem structures and their involvement in common brain disorders. Nat Commun. 2020 Aug 11;11(1):4016. IF=12,121

 

  1. 4504. Poptsi E, Moraitou D, Tsardoulias E, Symeonidis AL, Tsolaki M. Is the Discrimination of Subjective Cognitive Decline from Cognitively Healthy Adulthood and Mild Cognitive Impairment Possible? A Pilot Study Utilizing the R4Alz Battery.

J Alzheimers Dis. 2020 Jul 24. doi: 10.3233/JAD-200562. ΙF=3.909

 

  1. 4494. Dyer AH, Murphy C, Briggs R, Lawlor B, Kennelly SP; NILVAD Study Group, Lawlor B, Segurado R, Kennelly S, Marcel GM, Howard R, Pasquier F, Borjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, Senechal O, Devendeville A, Calais G, Crawford F, Mullan M, Aalten P, Berglund MA, Claassen JA, De Heus RA, De Jong DLK, Godefroy O, Hutchinson S, Ioannou A, Jonsson M, Kent A, Kern J, Nemtsas P, Panidou MK, Abdullah L, Paris D, Santoso AM, van Spijker GJ, Spiliotou M, Thomoglou G, Wallin A. Antidepressant Use and Orthostatic Hypotension in Older Adults Living with Mild-to-Moderate Alzheimer Disease. Int J Geriatr Psychiatry. 2020 Jul 15. doi: 10.1002/gps.5377. ΙF= 3.141
  2. 4473. Lazarou I, Georgiadis K, Nikolopoulos S, Oikonomou VP, Tsolaki A, Kompatsiaris I, Tsolaki M, Kugiumtzis D. A Novel Connectome-Based Electrophysiological Study of Subjective Cognitive Decline Related to Alzheimer's Disease by Using Resting-State High-Density EEG EGI GES 300. Brain Sci. 2020 Jun 19;10(6):E392. doi: 10.3390/brainsci10060392. IF=2.786
  3. 4460. Konijnenberg E, Tijms BM, Gobom J, Dobricic V, Bos I, Vos S, Tsolaki M, Verhey F, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Frölich L, Lovestone S, Streffer J, Bertram L, Blennow K, Teunissen CE, Veerhuis R, Smit AB, Scheltens P, Zetterberg H, Visser PJ. APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease. Alzheimers Res Ther. 2020 May 27;12(1):65. IF= 5.015
  4. 4453. Dimitriou TD, Verykouki E, Papatriantafyllou J, Konsta A, Kazis D, Tsolaki M. Non-Pharmacological interventions for the anxiety in patients with dementia. A cross-over randomised controlled trial. Behav Brain Res. 2020 May 16;390:112617. IF= 2.770
  5. 4445. Quattrini G, Pievani M, Jovicich J, Aiello M, Bargalló N, Barkhof F, Bartres-Faz D, Beltramello A, Pizzini FB, Blin O, Bordet R, Caulo M, Constantinides M, Didic M, Drevelegas A, Ferretti A, Fiedler U, Floridi P, Gros-Dagnac H, Hensch T, Hoffmann KT, Kuijer JP, Lopes R, Marra C, Müller BW, Nobili F, Parnetti L, Payoux P, Picco A, Ranjeva JP, Roccatagliata L, Rossini PM, Salvatore M, Schonknecht P, Schott BH, Sein J, Soricelli A, Tarducci R, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Frisoni GB, Marizzoni M; PharmaCog Consortium. Amygdalar nuclei and hippocampal subfields on MRI: test-retest reliability of automated volumetry across different MRI sites and vendors. Neuroimage. 2020 May 13:116932. IF=5812.
  6. 4443. Giannouli V, Tsolaki M. Vascular Dementia, Depression, and Financial Capacity Assessment. Alzheimer Dis Assoc Disord. 2020 May 1 IF= 1.16
  7. 4436. Papaspyropoulos A, Tsolaki M, Foroglou N, Pantazaki AA. Modeling and Targeting Alzheimer's Disease With Organoids. Front Pharmacol. 2020 Mar 31;11:396. doi: 10.3389/fphar.2020.00396. eCollection 2020. PMID: 32300301 Free PMC article. Review. IF= 3.845
  8. 4419. Dyer AH, Lawlor B, Kennelly SP; NILVAD Study Group. Gait speed, cognition and falls in people living with mild-to-moderate Alzheimer disease: data from NILVAD. BMC Geriatr. 2020 Mar 30;20(1):117. IF=2.818
  9. 4417. Abdullah L, Crawford F, Tsolaki M, Börjesson-Hanson A, Olde Rikkert M, Pasquier F, Wallin A, Kennelly S, Ait-Ghezala G, Paris D, Hendrix S, Blennow K, Lawlor B, Mullan M. The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial. Front Neurol. 2020 Mar 6;11:149.IF=3,552
  10. 4411. Tsolaki AC, Tsolaki M, Pandria N, Lazarou E, Gkatzima O, Zilidou V, Karagianni M, Iakovidou-Kritsi Z, Kimiskidis VK, Bamidis PD. Web-Based Intervention Effects on Mild Cognitive Impairment Based on Apolipoprotein E Genotype: Quasi-Experimental Study. J Med Internet Res. 2020 May 7;22(5):e14617. doi: 10.2196/14617 ΙF=4.945
  11. 4404. Koutsouraki E, Michmizos D, Patsi O, Tzartos J, Spilioti M, Arnaoutoglou M, Tsolaki M. A probable role of copper in the comorbidity in Wilson's and Creutzfeldt-Jakob's Diseases: a case report. Virol J. 2020 Mar 13;17(1):35. IF= 2.464
  12. 4401. Papagiannis I, Tsolaki M, Kiryttopoulos A, Antoniadi E, Kyriakogianni C, Fotiou D, Notas K, Liougka E, Myrou A, Hatzitolios A, Haloudis P, Papaioannou M, Spilioti M, Papa A, Tegos T.West Nile neuroinvasive disease. Report of four cases in Northern Greece, 2018. J Med Virol. 2020 Mar 1. IF= 2.373
  13. 4387. Lim B, Tsolaki M, Batruch I, Anastasiou A, Frontistis A, Prassas I, Diamandis EP. Putative autoantibodies in the cerebrospinal fluid of Alzheimer's disease patients.. F1000Res. 2019 Nov 11;8:1900. doi: 10.12688/f1000research.21140.1. eCollection 2019. IF= 2.64
  14. 4380. Brzezińska A, Bourke J, Rivera-Hernández R, Tsolaki M, Woźniak J, Kaźmierski J. Depression in Dementia or Dementia in Depression? Systematic Review of Studies and Hypotheses. Curr Alzheimer Res. 2020 Feb 16. doi: 10.2174/1567205017666200217104114. [Epub ahead of print] IF= 3.289
  15. 5159. Neumann A, Küçükali F, Bos I, Vos SJB, Engelborghs S, De Pooter T, Joris G, De Rijk P, De Roeck E, Tsolaki M, Verhey F, Martinez-Lage P, Tainta M, Frisoni G, Blin O, Richardson J, Bordet R, Scheltens P, Popp J, Peyratout G, Johannsen P, Frölich L, Vandenberghe R, Freund-Levi Y, Streffer J, Lovestone S, Legido-Quigley C, Ten Kate M, Barkhof F, Strazisar M, Zetterberg H, Bertram L, Visser PJ, van Broeckhoven C, Sleegers K; EMIF-AD study group. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation. Mol Psychiatry. 2022 Feb 16. IF=12.384
  16. 4322. Stamate D, Kim M, Proitsi P, Westwood S, Baird A, Nevado-Holgado A, Hye A, Bos I, Vos SJB, Vandenberghe R, Teunissen CE, Kate MT, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck E, Engelborghs S, Sleegers K, Bordet R, Ramit L, Kettunen P, Tsolaki M, Verhey F, Alcolea D, Lléo A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Legido-Quigley C. A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort. Alzheimers Dement (N Y). 2019 Dec 18;5:933-938. IF= 14.423
  17. 4301. Balestrino R, Hurtado-Gonzalez CA, Stocchi F, Radicati FG, Chaudhuri KR, Rodriguez-Blazquez C, Martinez-Martin P; PDCS European Study Group. Applications of the European Parkinson's Disease Association sponsored Parkinson's Disease Composite Scale (PDCS). NPJ Parkinsons Dis. 2019 Nov 27;5:26. doi: 10.1038/s41531-019-0097-1. eCollection 2019. IF=1.529
  18. 4302. Sofologi M, Koutsouraki E, Tsolaki M, Tsolaki A, Koukoulidis T, Theofilidis A, Papantoniou G, Moraitou D. Analyzing social cognition and understanding of social inferences in patients with multiple sclerosis. A comparative study. Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:15-26. IF=1,008

364.4303.  Giannouli V, Tegos T, Zilakaki M, Tsolaki M. Elders and mental capacity: Using a qualitative approach to examine views on independence and protection across the Balkans. Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:122-139. IF=1,008

  1. 4304. Tzekaki EE, Tsolaki M, Pantazaki AA, Geromichalos G, Lazarou E, Kozori M, Sinakos Z. Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease.AD. Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:181. IF=1,008
  2. 4274. Tsatali M, Egkiazarova M, Toumpalidou M, Karagiozi K, Margaritidou P, Tsolaki M. Greek Adaptation of the Positive Aspects of Caregiving (PAC) Scale in Dementia Caregivers. Clin Gerontol. 2019 Nov 5:1-10. IF= 1.01
  3. 4372. Marizzoni M, Ferrari C, Babiloni C, Albani D, Barkhof F, Cavaliere L, Didic M, Forloni G, Fusco F, Galluzzi S, Hensch T, Jovicich J, Marra C, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ranjeva JP, Ribaldi F, Rolandi E, Rossini PM, Salvatore M, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB. CSF cutoffs for MCI due to AD depend on APOEε4 carrier status. Neurobiol Aging. 2019 Dec 30. IF=4398
  4. 4261. Zygouris S, Gkioka M, Moraitou D, Teichmann B, Tsiatsos T, Papagianopoulos S, Tsolaki M. Views of nursing staff on computerized dementia screening : A validation and pilot study in a general hospital. Z Gerontol Geriatr. 2019 Oct 22. IF= 0.919
  5. 4260. Poptsi E, Tsardoulias E, Moraitou D, Symeonidis AL, Tsolaki M. REMEDES for Alzheimer-R4Alz Battery: Design and Development of a New Tool of Cognitive Control Assessment for the Diagnosis of Minor and Major Neurocognitive Disorders. J Alzheimers Dis. 2019 Oct 18. IF=3.517
  6. 4257. Satizabal CL, Adams HHH, Hibar DP, White CC, Knol MJ, Stein JL, Scholz M, Sargurupremraj M, Jahanshad N, Roshchupkin GV, Smith AV, Bis JC, Jian X, Luciano M, Hofer E, Teumer A, van der Lee SJ, Yang J, Yanek LR, Lee TV, Li S, Hu Y, Koh JY, Eicher JD, Desrivières S, Arias-Vasquez A, Chauhan G, Athanasiu L, Rentería ME, Kim S, Hoehn D, Armstrong NJ, Chen Q, Holmes AJ, den Braber A, Kloszewska I, Andersson M, Espeseth T, Grimm O, Abramovic L, Alhusaini S, Milaneschi Y, Papmeyer M, Axelsson T, Ehrlich S, Roiz-Santiañez R, Kraemer B, Håberg AK, Jones HJ, Pike GB, Stein DJ, Stevens A, Bralten J, Vernooij MW, Harris TB, Filippi I, Witte AV, Guadalupe T, Wittfeld K, Mosley TH, Becker JT, Doan NT, Hagenaars SP, Saba Y, Cuellar-Partida G, Amin N, Hilal S, Nho K, Mirza-Schreiber N, Arfanakis K, Becker DM, Ames D, Goldman AL, Lee PH, Boomsma DI, Lovestone S, Giddaluru S, Le Hellard S, Mattheisen M, Bohlken MM, Kasperaviciute D, Schmaal L, Lawrie SM, Agartz I, Walton E, Tordesillas-Gutierrez D, Davies GE, Shin J, Ipser JC, Vinke LN, Hoogman M, Jia T, Burkhardt R, Klein M, Crivello F, Janowitz D, Carmichael O, Haukvik UK, Aribisala BS, Schmidt H, Strike LT, Cheng CY, Risacher SL, Pütz B, Fleischman DA, Assareh AA, Mattay VS, Buckner RL, Mecocci P, Dale AM, Cichon S, Boks MP, Matarin M, Penninx BWJH, Calhoun VD, Chakravarty MM, Marquand AF, Macare C, Kharabian Masouleh S, Oosterlaan J, Amouyel P, Hegenscheid K, Rotter JI, Schork AJ, Liewald DCM, de Zubicaray GI, Wong TY, Shen L, Sämann PG, Brodaty H, Roffman JL, de Geus EJC, Tsolaki M, Erk S, van Eijk KR, Cavalleri GL, van der Wee NJA, McIntosh AM, Gollub RL, Bulayeva KB, Bernard M, Richards JS, Himali JJ, Loeffler M, Rommelse N, Hoffmann W, Westlye LT, Valdés Hernández MC, Hansell NK, van Erp TGM, Wolf C, Kwok JBJ, Vellas B, Heinz A, Olde Loohuis LM, Delanty N, Ho BC, Ching CRK, Shumskaya E, Singh B, Hofman A, van der Meer D, Homuth G, Psaty BM, Bastin ME, Montgomery GW, Foroud TM, Reppermund S, Hottenga JJ, Simmons A, Meyer-Lindenberg A, Cahn W, Whelan CD, van Donkelaar MMJ, Yang Q, Hosten N, Green RC, Thalamuthu A, Mohnke S, Hulshoff Pol HE, Lin H, Jack CR Jr, Schofield PR, Mühleisen TW, Maillard P, Potkin SG, Wen W, Fletcher E, Toga AW, Gruber O, Huentelman M, Davey Smith G, Launer LJ, Nyberg L, Jönsson EG, Crespo-Facorro B, Koen N, Greve DN, Uitterlinden AG, Weinberger DR, Steen VM, Fedko IO, Groenewold NA, Niessen WJ, Toro R, Tzourio C, Longstreth WT Jr, Ikram MK, Smoller JW, van Tol MJ, Sussmann JE, Paus T, Lemaître H, Schroeter ML, Mazoyer B, Andreassen OA, Holsboer F, Depondt C, Veltman DJ, Turner JA, Pausova Z, Schumann G, van Rooij D, Djurovic S, Deary IJ, McMahon KL, Müller-Myhsok B, Brouwer RM, Soininen H, Pandolfo M, Wassink TH, Cheung JW, Wolfers T, Martinot JL, Zwiers MP, Nauck M, Melle I, Martin NG, Kanai R, Westman E, Kahn RS, Sisodiya SM, White T, Saremi A, van Bokhoven H, Brunner HG, Völzke H, Wright MJ, van 't Ent D, Nöthen MM, Ophoff RA, Buitelaar JK, Fernández G, Sachdev PS, Rietschel M, van Haren NEM, Fisher SE, Beiser AS, Francks C, Saykin AJ, Mather KA, Romanczuk-Seiferth N, Hartman CA, DeStefano AL, Heslenfeld DJ, Weiner MW, Walter H, Hoekstra PJ, Nyquist PA, Franke B, Bennett DA, Grabe HJ, Johnson AD, Chen C, van Duijn CM, Lopez OL, Fornage M, Wardlaw JM, Schmidt R, DeCarli C, De Jager PL, Villringer A, Debette S, Gudnason V, Medland SE, Shulman JM, Thompson PM, Seshadri S, Ikram MA. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat Genet. 2019 Oct 21. IF= 25.455
  7. 4353. Westwood S, Baird AL, Anand SN, Nevado-Holgado AJ, Kormilitzin A, Shi L, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Baker S, Buckley NJ, Ten Kate M, Scheltens P, Teunissen CE, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lléo A, Sala I, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Legido-Quigley C, Bertram L, Barkhof F, Zetterberg H, Morgan BP, Streffer J, Visser PJ, Lovestone S. Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort. J Alzheimers Dis. 2020 Jan 22. doi: 10.3233/JAD-190434.
  8. 4244. Dyer AH, Murphy C, Lawlor B, Kennelly SP; NILVAD Study Group. Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD. J Am Med Dir Assoc. 2019 Oct 8. pii: S1525-8610(19)30615-2. doi: 10.1016/j.jamda.2019.08.006, ΙF= 5.775
  9. 4221. Tsentidou G, Moraitou D, Tsolaki M. Cognition in Vascular Aging and Mild Cognitive Impairment. J Alzheimers Dis. 2019 Sep 23. IF=3.517
  10. 4204. Lazarou I, Nikolopoulos S, Dimitriadis SI, Yiannis Kompatsiaris I, Spilioti M, Tsolaki M. Is brain connectome research the future frontier for subjective cognitive decline? A systematic review. Clin Neurophysiol. 2019 Oct;130(10):1762-1780. doi: 10.1016/j.clinph.2019.07.004. Epub 2019 Jul 19. IF=3.675
  11. 4203. Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, Buitelaar J, Celius EG, Cervenka S, Conzelmann A, Córdova-Palomera A, Dale AM, de Quervain DJF, Carlo P, Djurovic S, Dørum ES, Eisenacher S, Elvsåshagen T, Espeseth T, Fatouros-Bergman H, Flyckt L, Franke B, Frei O, Haatveit B, Håberg AK, Harbo HF, Hartman CA, Heslenfeld D, Hoekstra PJ, Høgestøl EA, Jernigan TL, Jonassen R, Jönsson EG; Karolinska Schizophrenia Project (KaSP), Kirsch P, Kłoszewska I, Kolskår KK, Landrø NI, Hellard S, Lesch KP, Lovestone S, Lundervold A, Lundervold AJ, Maglanoc LA, Malt UF, Mecocci P, Melle I, Meyer-Lindenberg A, Moberget T, Norbom LB, Nordvik JE, Nyberg L, Oosterlaan J, Papalino M, Papassotiropoulos A, Pauli P, Pergola G, Persson K, Richard G, Rokicki J, Sanders AM, Selbæk G, Shadrin AA, Smeland OB, Soininen H, Sowa P, Steen VM, Tsolaki M, Ulrichsen KM, Vellas B, Wang L, Westman E, Ziegler GC, Zink M, Andreassen OA, Westlye LT. Common brain disorders are associated with heritable patterns of apparent aging of the brain. Nat Neurosci. 2019 Oct;22(10):1617-1623. doi: 10.1038/s41593-019-0471-7. Epub 2019 Sep 24. IF=21.403
  12. 4200. van Maurik IS, Vos SJ, Bos I, Bouwman FH, Teunissen CE, Scheltens P, Barkhof F, Frolich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Frisoni GB, Spiru L, Freund-Levi Y, Wallin AK, Hampel H, Soininen H, Tsolaki M, Verhey F, Kłoszewska I, Mecocci P, Vellas B, Lovestone S, Galluzzi S, Herukka SK, Santana I, Baldeiras I, de Mendonça A, Silva D, Chetelat G, Egret S, Palmqvist S, Hansson O, Visser PJ, Berkhof J, van der Flier WM; Alzheimer's Disease Neuroimaging Initiative. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. Lancet Neurol. 2019 Sep 13. pii: S1474-4422(19)30283-2. doi: 10.1016/S1474-4422(19)30283-2. IF=27,138
  13. 4201. Shi L, Westwood S, Baird AL, Winchester L, Dobricic V, Kilpert F, Hong S, Franke A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Buckley NJ, Kate MT, Scheltens P, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lleó A, Alcolea D, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Teunissen CE, Freund-Levi Y, Frölich L, Legido-Quigley C, Barkhof F, Blennow K, Zetterberg H, Baker S, Morgan BP, Streffer J, Visser PJ, Bertram L, Lovestone S, Nevado-Holgado AJ. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. Alzheimers Dement. 2019 Sep 5. IF= 14.423
  14. 5148. Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, Van Berckel B, Binette AP, Blennow K, Boada M, Boecker H, Bottlaender M, den Braber A, Brooks DJ, Van Buchem MA, Camus V, Carill JM, Cerman J, Chen K, Chételat G, Chipi E, Cohen AD, Daniels A, Delarue M, Didic M, Drzezga A, Dubois B, Eckerström M, Ekblad LL, Engelborghs S, Epelbaum S, Fagan AM, Fan Y, Fladby T, Fleisher AS, Van der Flier WM, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Frings L, Frisoni GB, Fröhlich L, Gabryelewicz T, Gertz HJ, Gill KD, Gkatzima O, Gómez-Tortosa E, Grimmer T, Guedj E, Habeck CG, Hampel H, Handels R, Hansson O, Hausner L, Hellwig S, Heneka MT, Herukka SK, Hildebrandt H, Hodges J, Hort J, Huang CC, Iriondo AJ, Itoh Y, Ivanoiu A, Jagust WJ, Jessen F, Johannsen P, Johnson KA, Kandimalla R, Kapaki EN, Kern S, Kilander L, Klimkowicz-Mrowiec A, Klunk WE, Koglin N, Kornhuber J, Kramberger MG, Kuo HC, Van Laere K, Landau SM, Landeau B, Lee DY, de Leon M, Leyton CE, Lin KJ, Lleó A, Löwenmark M, Madsen K, Maier W, Marcusson J, Marquié M, Martinez-Lage P, Maserejian N, Mattsson N, de Mendonça A, Meyer PT, Miller BL, Minatani S, Mintun MA, Mok VCT, Molinuevo JL, Morbelli SD, Morris JC, Mroczko B, Na DL, Newberg A, Nobili F, Nordberg A, Olde Rikkert MGM, de Oliveira CR, Olivieri P, Orellana A, Paraskevas G, Parchi P, Pardini M, Parnetti L, Peters O, Poirier J, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Reiman EM, Rinne JO, Rodrigue KM, Rodríguez-Rodriguez E, Roe CM, Rosa-Neto P, Rosen HJ, Rot U, Rowe CC, Rüther E, Ruiz A, Sabri O, Sakhardande J, Sánchez-Juan P, Sando SB, Santana I, Sarazin M, Scheltens P, Schröder J, Selnes P, Seo SW, Silva D, Skoog I, Snyder PJ, Soininen H, Sollberger M, Sperling RA, Spiru L, Stern Y, Stomrud E, Takeda A, Teichmann M, Teunissen CE, Thompson LI, Tomassen J, Tsolaki M, Vandenberghe R, Verbeek MM, Verhey FRJ, Villemagne V, Villeneuve S, Vogelgsang J, Waldemar G, Wallin A, Wallin ÅK, Wiltfang J, Wolk DA, Yen TC, Zboch M, Zetterberg H.Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol. 2022 Jan 31. ΙF=18,3
  15. 4195. Eraslan Boz H, Limoncu H, Zygouris S, Tsolaki M, Giakoumis D, Votis K, Tzovaras D, Öztürk V, Yener GG. A new tool to assess amnestic mild cognitive impairment in Turkish older adults: virtual supermarket (VSM). Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2019 Sep 4:1-15. IF= 1,919
  16. 3844. Lim B, Tsolaki M, Soosaipillai A, Brown M, Zilakaki M, Tagaraki F, Fotiou D, Koutsouraki E, Grosi E, Prassas I, Diamandis EP. Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer's disease. Clin Chem Lab Med. 2019 Aug 15. IF= 3.638
  17. 4435. Tsatali M, Fotiadou F, Giaglis G, Tsolaki M. The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly. Aging Clin Exp Res. 2019 Sep;31(9):1305-1312. doi: 10.1007/s40520-018-1076-9. Epub 2018 Nov 23. IF=2.331
  18. 4164. Manolopoulos A, Andreadis P, Malandris K, Avgerinos I, Karagiannis T, Kapogiannis D, Tsolaki M, Tsapas A, Bekiari E. Intravenous Immunoglobulin for Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis. Am J Alzheimers Dis Other Demen. 2019 Aug;34(5):281-289. IF=1.774
  19. 4149. Lazarou I, Stavropoulos TG, Meditskos G, Andreadis S, Kompatsiaris IY, Tsolaki M. Long-Term Impact of Intelligent Monitoring Technology on People with Cognitive Impairment: An Observational Study. J Alzheimers Dis. 2019 Jun 24. IF=3,920
  20. 4150. Nielsen TR, Segers K, Vanderaspoilden V, Beinhoff U, Minthon L, Pissiota A, Bekkhus-Wetterberg P, Bjørkløf GH, Tsolaki M, Gkioka M, Waldemar G. Validation of a brief Multicultural Cognitive Examination (MCE) for evaluation of dementia. Int J Geriatr Psychiatry. 2019 Jul;34(7):982-989. IF= 3.141
  21. 4131. Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, Kern S, Ousset PJ, Maruff P, Skoog I, Verhey FRJ, Freund-Levi Y, Tsolaki M, Wallin ÅK, Olde Rikkert M, Soininen H, Spiru L, Zetterberg H, Blennow K, Scheltens P, Muniz-Terrera G, Visser PJ; Alzheimer Disease Neuroimaging Initiative; AIBL Research Group; ICTUS/DSA study groups. Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype. Alzheimers Dement. 2019 Jun 1. IF=12.740
  22. 4122. Poptsi E, Moraitou D, Eleftheriou M, Kounti-Zafeiropoulou F, Papasozomenou C, Agogiatou C, Bakoglidou E, Batsila G, Liapi D, Markou N, Nikolaidou E, Ouzouni F, Soumpourou A, Vasiloglou M, Tsolaki M. Normative Data for the Montreal Cognitive Assessment in Greek Older Adults With Subjective Cognitive Decline, Mild Cognitive Impairment and Dementia. J Geriatr Psychiatry Neurol. 2019 Sep;32(5):265-274. IF=2.109
  23. 4109. Kim M, Snowden S, Suvitaival T, Ali A, Merkler DJ, Ahmad T, Westwood S, Baird A, Proitsi P, Nevado-Holgado A, Hye A, Bos I, Vos S, Vandenberghe R, Teunissen C, Ten Kate M, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck E, Sleegers K, Bordet R, Rami L, Kettunen P, Tsolaki M, Verhey F, Sala I, Lléo A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Engelborghs S, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Barkhof F, Ashton N, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Legido-Quigley C. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort. Alzheimers Dement. 2019 Apr 28. pii: S1552-5260(19)30074-3. doi: 10.1016/j.jalz.2019.03.004. IF=12.740
  24. 4010. Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleó A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum. Alzheimers Dement. 2019 May;15(5):644-654. IF=12.740
  25. 4077. Morgan AR, Touchard S, Leckey C, O'Hagan C, Nevado-Holgado AJ; NIMA Consortium, Barkhof F, Bertram L, Blin O, Bos I, Dobricic V, Engelborghs S, Frisoni G, Frölich L, Gabel S, Johannsen P, Kettunen P, Kłoszewska I, Legido-Quigley C, Lleó A, Martinez-Lage P, Mecocci P, Meersmans K, Molinuevo JL, Peyratout G, Popp J, Richardson J, Sala I, Scheltens P, Streffer J, Soininen H, Tainta-Cuezva M, Teunissen C, Tsolaki M, Vandenberghe R, Visser PJ, Vos S, Wahlund LO, Wallin A, Westwood S, Zetterberg H, Lovestone S, Morgan BP; Annex: NIMA–Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer's Disease. Inflammatory biomarkers in Alzheimer's disease plasma. Alzheimers Dement. 2019 Apr 29. pii: S1552-5260(19)30078-0. IF=12.740
  26. 4075. Martinez-Martin P, Radicati FG, Rodriguez Blazquez C, Wetmore J, Kovacs N, Ray Chaudhuri K, Stocchi F; PDCS European Study Group. Extensive validation study of the Parkinson's Disease Composite Scale. Eur J Neurol. 2019 Oct;26(10):1281-1288. IF= 4.387
  27. 2192. Canevelli M, Adali N, Cantet C, Andrieu S, Bruno G, Cesari M, Vellas B; ICTUS/DSA Group. Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study. J Neurol. 2013 Jul;260(7):1859-65. doi: 10.1007/s00415-013-6893-3. Epub 2013 Mar 17.

 

  1. 4059. Poptsi E, Lazarou I, Markou N, Vassiloglou M, Nikolaidou E, Diamantidou A, Siatra V, Karathanassi E, Karakostas A, Zafeiropoulou FK, Tsiatsos T, Tsolaki M. A Comparative Single-Blind Randomized Controlled Trial With Language Training in People With Mild Cognitive Impairment. Am J Alzheimers Dis Other Demen. 2019 May;34(3):176-187. IF= 1.16
  2. 4057. Lleó A, Alcolea D, Martínez-Lage P, Scheltens P, Parnetti L, Poirier J, Simonsen AH, Verbeek MM, Rosa-Neto P, Slot RER, Tainta M, Izaguirre A, Reijs BLR, Farotti L, Tsolaki M, Vandenbergue R, Freund-Levi Y, Verhey FRJ, Clarimón J, Fortea J, Frolich L, Santana I, Molinuevo JL, Lehmann S, Visser PJ, Teunissen CE, Zetterberg H, Blennow K. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study. Alzheimers Dement. 2019 Apr 6. IF=12.740
  3. 4055. Marizzoni M, Ferrari C, Macis A, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Pizzini F, Rossini PM, Salvatore M, Schönknecht P, Soricelli A, Del Percio C, Hensch T, Hegerl U, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium. Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease. J Alzheimers Dis. 2019 Apr 1. IF=3,920
  4. 4023. Kountouras J, Doulberis M, Polyzos SA, Katsinelos T, Vardaka E, Kountouras C, Arapoglou S, Exadaktylos AK, Deretzi G, Tsolaki M, Boziki M, Katsinelos P. Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on incidence of all-cause and Alzheimer's dementia. Alzheimers Dement. 2019 Mar 11. pii: S1552-5260(19)30029-9. doi: 10.1016/j.jalz.2019.01.008. IF=12.740
  5. 4024. Lougiaki P, Tsolaki M, Pantazaki A. [Bioinks and in vitro neurovascular unit production - New prospects in Alzheimer's disease research]. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:209-222. Greek, Modern. IF=1,008
  6. 4025. Tzekaki E, Tsolaki M, Pantazaki A.[Technical characteristics of Alzheimer model based on organ technology (organoid)]. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:195-208. Greek, Modern. IF=1,008
  7. 4026. Kalogiannis G, Chassapis G, Tsolaki M. Removing muscle artifacts from EEG data of people with cognitive impairment using high order statistic methods. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:165-173. IF=1,008
  8. 4027. Giannouli V, Tsolaki M. Are left angular gyrus and amygdala volumes important for financial capacity in mild cognitive impairment? Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:160-164. IF=1,008
  9. 4028. Messinis L, Apostolopoulos D, Spiridonidis T, Nasios G, Giazkoulidou A, Tsolaki M, Panagiotopoulos V. Robust regional cerebral blood flow perfusion deficits in relapsing-remitting multiple sclerosis patients with executive function impairment. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:147-159. IF=1,008
  10. 4029. Solias AA, Chaldogeridis AE, Batzikosta AV, Tsolaki M. Comparison of two electronic screening tests (culturally neutral & culturally customized) for major and minor neurocognitive disorders. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:111-122. IF=1,008
  11. 4030. Tsolaki M. Future strategies of management of Alzheimer's Disease. The role of homotaurine. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:82-94. IF=1,008
  12. 4031. Karypidou E, Megagiannis P, Papaoikonomou D, Pelteki N, Gkatzima O, Tsolaki M. Callosal Angle and Evans Index predict beta amyloid and tau protein in patients with dementia. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:51-58. IF=1,008
  13. 4032. Katsouri I, Athanasiadis L, Bekiaris E, Tsolaki M. Differences between professional and non-professional drivers with cognitive disorders. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:17-31. IF=1,008
  14. 4033. Triantafyllidou E, Moraitou D, Kaklamanaki E, Georgiadou T, Athanasaki M, Malliopoulou E, Schina C, Hamoli M, Moschou S, Petropoulou Z, Mpoulakis P, Douli E, Pagoni K, Nikolaidou S, Nouli CD, Masoura E, Tsolaki M, Papantoniou Retrogenetic models of working memory: Preliminary multi-group analysis. Hell J Nucl Med. 2019 Jan-Apr;22 Suppl:4-1. IF=1,008
  15. 4010. Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleó A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum. Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30018-4. doi: 10.1016/j.jalz.2019.01.004. [Epub ahead of print]. IF=12.740
  16. 3998. Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, Dardiotis E, Guillo-Benarous F, Hampel H, Kochan NA, Lista S, Luck T, Maruff P, Molinuevo JL, Kornhuber J, Reisberg B, Riedel-Heller SG, Risacher SL, Roehr S, Sachdev PS, Scarmeas N, Scheltens P, Shulman MB, Saykin AJ, Verfaillie SCJ, Visser PJ, Vos SJB, Wagner M, Wolfsgruber S, Jessen F; Alzheimer's Disease Neuroimaging Initiative; DESCRIPA working group; INSIGHT-preAD study group; SCD-I working group, van der Flier WM. Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia. Alzheimers Dement. 2019 Mar;15(3):465-476. doi: 10.1016/j.jalz.2018.10.003. Epub 2018 Dec 13. IF=12.740
  17. 3990. Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamujić-Čomić H, Frosch MP, Thonberg H, Maier W, Roschupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hernández I, Kamboh MI, Brundin R, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT Jr, Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Andre Uitterlinden AG, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, George-Hyslop PS, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu CK, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo Á, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Frölich L, Barral S, McGuinness B, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, McQuillin A, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, DeCarli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, Kölsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, Hüll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin LW, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, LaFerla FM, Jöckel KH, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann HE, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, Nöthen MM, Masliah E, Hooper NM, McCormick WC, Daniele A, McCurry SM, Bayer A, McDavid AN, Gallacher J, McKee AC, van den Bussche H, Mesulam M, Brayne C, Miller BL, Riedel-Heller S, Miller CA, Miller JW, Al-Chalabi A, Morris JC, Shaw CE, Myers AJ, Wiltfang J, O'Bryant S, Olichney JM, Alvarez V, Parisi JE, Singleton AB, Paulson HL, Collinge J, Perry WR, Mead S, Peskind E, Cribbs DH, Rossor M, Pierce A, Ryan NS, Poon WW, Nacmias B, Potter H, Sorbi S, Quinn JF, Sacchinelli E, Raj A, Spalletta G, Raskind M, Caltagirone C, Bossù P, Orfei MD, Reisberg B, Clarke R, Reitz C, Smith AD, Ringman JM, Warden D, Roberson ED, Wilcock G, Rogaeva E, Bruni AC, Rosen HJ, Gallo M, Rosenberg RN, Ben-Shlomo Y, Sager MA, Mecocci P, Saykin AJ, Pastor P, Cuccaro ML, Vance JM, Schneider JA, Schneider LS, Slifer S, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tang M, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu CE, Yu L, Saba Y; Alzheimer Disease Genetics Consortium (ADGC),; European Alzheimer’s Disease Initiative (EADI),; Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE),; Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES),, Pilotto A, Bullido MJ, Peters O, Crane PK, Bennett D, Bosco P, Coto E, Boccardi V, De Jager PL, Lleo A, Warner N, Lopez OL, Ingelsson M, Deloukas P, Cruchaga C, Graff C, Gwilliam R, Fornage M, Goate AM, Sanchez-Juan P, Kehoe PG, Amin N, Ertekin-Taner N, Berr C, Debette S, Love S, Launer LJ, Younkin SG, Dartigues JF, Corcoran C, Ikram MA, Dickson DW, Nicolas G, Campion D, Tschanz J, Schmidt H, Hakonarson H, Clarimon J, Munger R, Schmidt R, Farrer LA, Van Broeckhoven C, C O'Donovan M, DeStefano AL, Jones L, Haines JL, Deleuze JF, Owen MJ, Gudnason V, Mayeux R, Escott-Price V, Psaty BM, Ramirez A, Wang LS, Ruiz A, van Duijn CM, Holmans PA, Seshadri S, Williams J, Amouyel P, Schellenberg GD, Lambert JC, Pericak-Vance MA. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet. 2019 Mar;51(3):414-430. doi: 10.1038/s41588-019-0358-2. Epub 2019 Feb 28. IF=27.125
  18. 3988. Ashraf A, Stosnach H, Parkes HG, Hye A, Powell J; AddNeuroMed consortium, So PW. Pattern of Altered Plasma Elemental Phosphorus, Calcium, Selenium, Iron and Copper in Alzheimer's Disease. Sci Rep. 2019 Feb 28;9(1):3147. doi: 10.1038/s41598-018-37431-8. IF=4.609.
  19. 3949. Douka S, Zilidou VI, Lilou O, Tsolaki M. Greek Traditional Dances: A Way to Support Intellectual, Psychological, and Motor Functions in Senior Citizens at Risk of Neurodegeneration. Front Aging Neurosci. 2019 Jan 25;11:6. ΙF= 3.582
  20. 3935. Boccardi V, Westman E, Pelini L, Lindberg O, Muehlboeck JS, Simmons A, Tarducci R, Floridi P, Chiarini P, Soininen H, Kloszewska I, Tsolaki M, Vellas B, Spenger C, Wahlund LO, Lovestone S, Mecocci P. Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer's Disease. Front Aging Neurosci. 2019 Jan 17;10:439. doi: 10.3389/fnagi.2018.00439. eCollection 2018. ΙF= 3.582
  21. 3890. Vivas AB, Ypsilanti A, Ladas AI, Kounti F, Tsolaki M, Estévez AF.Enhancement of Visuospatial Working Memory by the Differential Outcomes Procedure in Mild Cognitive Impairment and Alzheimer's Disease. Front Aging Neurosci. 2018 Nov 13;10:364. doi: 10.3389/fnagi.2018.00364. eCollection 2018. IF= 3.582
  22. 3882. Poptsi E, Lazarou L, Markou N, Vassiloglou M, Nikolaidou E, Diamantidou A, Siatra V, Karathanassi E, Karakostas A, Zafeiropoulou FK, Tsiatsos T, Tsolaki M. A Comparative Single-Blind Randomized Controlled Trial With Language Training in People With Mild Cognitive Impairment. Am J Alzheimers Dis Other Demen. 2018 Dec 5:IF=1,602
  23. 3873. Kazmierski J, Messini-Zachou C, Gkioka M, Tsolaki M. The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2018 Sep;33(6):385-393 IF=1,602
  24. 3872. Tsatali M, Fotiadou F, Giaglis G, Tsolaki M. The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly. Aging Clin Exp Res. 2018 Nov 23. ΙF= 2.121
  25. 3865. Dimitriou TD, Verykouki E, Papatriantafyllou J, Konsta A, Kazis D, Tsolaki M. Non-pharmacological interventions for agitation/aggressive behaviour in patients with dementia: a randomized controlled crossover trial. Funct Neurol. 2018 Jul/Sept;33(3):143-147. IF=0,77
  26. 3860. Peloso GM, van der Lee SJ; International Genomics of Alzheimer's Project (IGAP), Destefano AL, Seshardi S. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. Alzheimers Dement (Amst). 2018 Sep 22;10:595-598. doi: 10.1016/j.dadm.2018.08.008. eCollection 2018.IF=12, 74
  27. 3859. Jovicich J, Babiloni C, Ferrari C, Marizzoni M, Moretti DV, Del Percio C, Lizio R, Lopez S, Galluzzi S, Albani D, Cavaliere L, Minati L, Didic M, Fiedler U, Forloni G, Hensch T, Molinuevo JL, Bartrés Faz D, Nobili F, Orlandi D, Parnetti L, Farotti L, Costa C, Payoux P, Rossini PM, Marra C, Schönknecht P, Soricelli A, Noce G, Salvatore M, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Frisoni GB. Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity. J Alzheimers Dis. 2018 Oct 29. doi: 10.3233/JAD-180158. [Epub ahead of print] IF=3,920
  28. 3825. de Matos MR, Ferreira C, Herukka SK, Soininen H, Janeiro A, Santana I, Baldeiras I, Almeida MR, Lleó A, Dols-Icardo O, Alcolea D, Benussi L, Binetti G, Paterlini A, Ghidoni R, Nacmias B, Meulenbroek O, van Waalwijk van Doorn LJC, Kuiperij HB, Hausner L, Waldemar G, Simonsen AH, Tsolaki M, Gkatzima O, de Oliveira CR, Verbeek MM, Clarimon J, Hiltunen M, de Mendonça A, Martins M. Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers. J Alzheimers Dis. 2018 Oct 9. IF=3,920
  29. 3815. Avdikou K, Stefanatos C, Tsatali M, Gouva M, Tsolaki M. The Role of Gender in Shame, Hostility, and Aggression Experienced by Caregivers for Patients With Dementia. Am J Alzheimers Dis Other Demen. 2018 Oct 7:1533317518802458. doi: 10.1177/1533317518802458. [Epub ahead of print] IF=1,602
  30. 3806. Ten Kate M, Redolfi A, Peira E, Bos I, Vos SJ, Vandenberghe R, Gabel S, Schaeverbeke J, Scheltens P, Blin O, Richardson JC, Bordet R, Wallin A, Eckerstrom C, Molinuevo JL, Engelborghs S, Van Broeckhoven C, Martinez-Lage P, Popp J, Tsolaki M, Verhey FRJ, Baird AL, Legido-Quigley C, Bertram L, Dobricic V, Zetterberg H, Lovestone S, Streffer J, Bianchetti S, Novak GP, Revillard J, Gordon MF, Xie Z, Wottschel V, Frisoni G, Visser PJ, Barkhof F. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study. Alzheimers Res Ther. 2018 Sep 27;10(1):100. doi: 10.1186/s13195-018-0428-1. IF= 6.206
  31. 3799. Nielsen TR, Segers K, Vanderaspoilden V, Beinhoff U, Minthon L, Pissiota A, Bekkhus-Wetterberg P, Bjørkløf GH, Tsolaki M, Gkioka M, Waldemar G. Validation of a European Cross-Cultural Neuropsychological Test Battery (CNTB) for evaluation of dementia. Int J Geriatr Psychiatry. 2019 Jan;34(1):144-152.IF=2,94
  32. 3801. Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial. PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep.IF=11.675
  33. 3781. Tsolaki AC, Gatzima O, Daniilidou M, Lazarou E, Bamidis PD, Verykouki E, Iakovidou-Kritsi Z, Tsolaki M. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study. Neurodegener Dis. 2018 Sep 11;18(4):216-224. doi: 10.1159/000491764. [Epub ahead of print] IF= 2.785
  34. 3778. Begcevic I, Tsolaki M, Brinc D, Brown M, Martinez-Morillo E, Lazarou I, Kozori M, Tagaraki F, Nenopoulou S, Gkioka M, Lazarou E, Lim B, Batruch I, Diamandis EP.Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progression. F1000Res. 2018 Jul 5;7:1012. doi: 10.12688/f1000research.15095.1. eCollection 2018.
  35. 3771. Albani D Marizzoni M, Ferrari C, Fusco F, Boeri L, Raimondi I, Jovicich J, Babiloni C, Soricelli A, Lizio R, Galluzzi S, Cavaliere L, Didic M, Schönknecht P, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Bocchio L, Salvatore M, Rossini PM, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Forloni G, Frisoni GB, Consortium P. Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study., J Alzheimers Dis. 2018 Aug 20. IF=3,920
  36. 3764. Lazarou I, Adam K, Georgiadis K, Tsolaki A, Nikolopoulos S, Yiannis Kompatsiaris I, Tsolaki M. Can a Novel High-Density EEG Approach Disentangle the Differences of Visual Event Related Potential (N170), Elicited by Negative Facial Stimuli, in People with Subjective Cognitive Impairment? J Alzheimers Dis. 2018 Jul 28. doi: 10.3233/JAD-180223. [Epub ahead of print] IF=3,920
  37. 3758. Mårtensson G, Pereira JB, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Volpe G, Westman E. Stability of graph theoretical measures in structural brain networks in Alzheimer's disease. Sci Rep. 2018 Aug 2;8(1):11592. doi: 10.1038/s41598-018-29927-0. IF= 4.259
  38. 3720. Nielsen TR, Segers K, Vanderaspoilden V, Bekkhus-Wetterberg P, Bjørkløf GH, Beinhoff U, Minthon L, Pissiota A, Tsolaki M, Gkioka M, Waldemar G. Validation of the Rowland Universal Dementia Assessment Scale (RUDAS) in a multicultural sample across five Western European countries: diagnostic accuracy and normative data. Int Psychogeriatr. 2018 Jul 18:1-10. doi: 10.1017/S1041610218000832. IF=2,261
  39. 3714. Bos I, Vos SJB, Jansen WJ, Vandenberghe R, Gabel S, Estanga A, Ecay-Torres M, Tomassen J, den Braber A, Lleó A, Sala I, Wallin A, Kettunen P, Molinuevo JL, Rami L, Chetelat G, de la Sayette V, Tsolaki M, Freund-Levi Y, Johannsen P; Alzheimer's Disease Neuroimaging Initiative, Novak GP, Ramakers I, Verhey FR, Visser PJ. Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data. Front Aging Neurosci. 2018 Jun 25;10:193. doi: 10.3389/fnagi.2018.00193. eCollection 2018. IF= 4.504
  40. 3688. Brainstorm Consortium, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, Duncan L, Escott-Price V, Falcone GJ, Gormley P, Malik R, Patsopoulos NA, Ripke S, Wei Z, Yu D, Lee PH, Turley P, Grenier-Boley B, Chouraki V, Kamatani Y, Berr C, Letenneur L, Hannequin D, Amouyel P, Boland A, Deleuze JF, Duron E, Vardarajan BN, Reitz C, Goate AM, Huentelman MJ, Kamboh MI, Larson EB, Rogaeva E, St George-Hyslop P, Hakonarson H, Kukull WA, Farrer LA, Barnes LL, Beach TG, Demirci FY, Head E, Hulette CM, Jicha GA, Kauwe JSK, Kaye JA, Leverenz JB, Levey AI, Lieberman AP, Pankratz VS, Poon WW, Quinn JF, Saykin AJ, Schneider LS, Smith AG, Sonnen JA, Stern RA, Van Deerlin VM, Van Eldik LJ, Harold D, Russo G, Rubinsztein DC, Bayer A, Tsolaki M, Proitsi P, Fox NC, Hampel H, Owen MJ, Mead S, Passmore P, Morgan K, Nöthen MM, Rossor M, Lupton MK, Hoffmann P, Kornhuber J, Lawlor B, McQuillin A, Al-Chalabi A, Bis JC, Ruiz A, Boada M, Seshadri S, Beiser A, Rice K, van der Lee SJ, De Jager PL, Geschwind DH, Riemenschneider M, Riedel-Heller S, Rotter JI, Ransmayr G, Hyman BT, Cruchaga C, Alegret M, Winsvold B, Palta P, Farh KH, Cuenca-Leon E, Furlotte N, Kurth T, Ligthart L, Terwindt GM, Freilinger T, Ran C, Gordon SD, Borck G, Adams HHH, Lehtimäki T, Wedenoja J, Buring JE, Schürks M, Hrafnsdottir M, Hottenga JJ, Penninx B, Artto V, Kaunisto M, Vepsäläinen S, Martin NG, Montgomery GW, Kurki MI, Hämäläinen E, Huang H, Huang J, Sandor C, Webber C, Muller-Myhsok B, Schreiber S, Salomaa V, Loehrer E, Göbel H, Macaya A, Pozo-Rosich P, Hansen T, Werge T, Kaprio J, Metspalu A, Kubisch C, Ferrari MD, Belin AC, van den Maagdenberg AMJM, Zwart JA, Boomsma D, Eriksson N, Olesen J, Chasman DI, Nyholt DR, Avbersek A, Baum L, Berkovic S, Bradfield J, Buono R, Catarino CB, Cossette P, De Jonghe P, Depondt C, Dlugos D, Ferraro TN, French J, Hjalgrim H, Jamnadas-Khoda J, Kälviäinen R, Kunz WS, Lerche H, Leu C, Lindhout D, Lo W, Lowenstein D, McCormack M, Møller RS, Molloy A, Ng PW, Oliver K, Privitera M, Radtke R, Ruppert AK, Sander T, Schachter S, Schankin C, Scheffer I, Schoch S, Sisodiya SM, Smith P, Sperling M, Striano P, Surges R, Thomas GN, Visscher F, Whelan CD, Zara F, Heinzen EL, Marson A, Becker F, Stroink H, Zimprich F, Gasser T, Gibbs R, Heutink P, Martinez M, Morris HR, Sharma M, Ryten M, Mok KY, Pulit S, Bevan S, Holliday E, Attia J, Battey T, Boncoraglio G, Thijs V, Chen WM, Mitchell B, Rothwell P, Sharma P, Sudlow C, Vicente A, Markus H, Kourkoulis C, Pera J, Raffeld M, Silliman S, Boraska Perica V, Thornton LM, Huckins LM, William Rayner N, Lewis CM, Gratacos M, Rybakowski F, Keski-Rahkonen A, Raevuori A, Hudson JI, Reichborn-Kjennerud T, Monteleone P, Karwautz A, Mannik K, Baker JH, O'Toole JK, Trace SE, Davis OSP, Helder SG, Ehrlich S, Herpertz-Dahlmann B, Danner UN, van Elburg AA, Clementi M, Forzan M, Docampo E, Lissowska J, Hauser J, Tortorella A, Maj M, Gonidakis F, Tziouvas K, Papezova H, Yilmaz Z, Wagner G, Cohen-Woods S, Herms S, Julià A, Rabionet R, Dick DM, Ripatti S, Andreassen OA, Espeseth T, Lundervold AJ, Steen VM, Pinto D, Scherer SW, Aschauer H, Schosser A, Alfredsson L, Padyukov L, Halmi KA, Mitchell J, Strober M, Bergen AW, Kaye W, Szatkiewicz JP, Cormand B, Ramos-Quiroga JA, Sánchez-Mora C, Ribasés M, Casas M, Hervas A, Arranz MJ, Haavik J, Zayats T, Johansson S, Williams N, Dempfle A, Rothenberger A, Kuntsi J, Oades RD, Banaschewski T, Franke B, Buitelaar JK, Arias Vasquez A, Doyle AE, Reif A, Lesch KP, Freitag C, Rivero O, Palmason H, Romanos M, Langley K, Rietschel M, Witt SH, Dalsgaard S, Børglum AD, Waldman I, Wilmot B, Molly N, Bau CHD, Crosbie J, Schachar R, Loo SK, McGough JJ, Grevet EH, Medland SE, Robinson E, Weiss LA, Bacchelli E, Bailey A, Bal V, Battaglia A, Betancur C, Bolton P, Cantor R, Celestino-Soper P, Dawson G, De Rubeis S, Duque F, Green A, Klauck SM, Leboyer M, Levitt P, Maestrini E, Mane S, De-Luca DM, Parr J, Regan R, Reichenberg A, Sandin S, Vorstman J, Wassink T, Wijsman E, Cook E, Santangelo S, Delorme R, Rogé B, Magalhaes T, Arking D, Schulze TG, Thompson RC, Strohmaier J, Matthews K, Melle I, Morris D, Blackwood D, McIntosh A, Bergen SE, Schalling M, Jamain S, Maaser A, Fischer SB, Reinbold CS, Fullerton JM, Guzman-Parra J, Mayoral F, Schofield PR, Cichon S, Mühleisen TW, Degenhardt F, Schumacher J, Bauer M, Mitchell PB, Gershon ES, Rice J, Potash JB, Zandi PP, Craddock N, Ferrier IN, Alda M, Rouleau GA, Turecki G, Ophoff R, Pato C, Anjorin A, Stahl E, Leber M, Czerski PM, Cruceanu C, Jones IR, Posthuma D, Andlauer TFM, Forstner AJ, Streit F, Baune BT, Air T, Sinnamon G, Wray NR, MacIntyre DJ, Porteous D, Homuth G, Rivera M, Grove J, Middeldorp CM, Hickie I, Pergadia M, Mehta D, Smit JH, Jansen R, de Geus E, Dunn E, Li QS, Nauck M, Schoevers RA, Beekman AT, Knowles JA, Viktorin A, Arnold P, Barr CL, Bedoya-Berrio G, Bienvenu OJ, Brentani H, Burton C, Camarena B, Cappi C, Cath D, Cavallini M, Cusi D, Darrow S, Denys D, Derks EM, Dietrich A, Fernandez T, Figee M, Freimer N, Gerber G, Grados M, Greenberg E, Hanna GL, Hartmann A, Hirschtritt ME, Hoekstra PJ, Huang A, Huyser C, Illmann C, Jenike M, Kuperman S, Leventhal B, Lochner C, Lyon GJ, Macciardi F, Madruga-Garrido M, Malaty IA, Maras A, McGrath L, Miguel EC, Mir P, Nestadt G, Nicolini H, Okun MS, Pakstis A, Paschou P, Piacentini J, Pittenger C, Plessen K, Ramensky V, Ramos EM, Reus V, Richter MA, Riddle MA, Robertson MM, Roessner V, Rosário M, Samuels JF, Sandor P, Stein DJ, Tsetsos F, Van Nieuwerburgh F, Weatherall S, Wendland JR, Wolanczyk T, Worbe Y, Zai G, Goes FS, McLaughlin N, Nestadt PS, Grabe HJ, Depienne C, Konkashbaev A, Lanzagorta N, Valencia-Duarte A, Bramon E, Buccola N, Cahn W, Cairns M, Chong SA, Cohen D, Crespo-Facorro B, Crowley J, Davidson M, DeLisi L, Dinan T, Donohoe G, Drapeau E, Duan J, Haan L, Hougaard D, Karachanak-Yankova S, Khrunin A, Klovins J, Kučinskas V, Lee Chee Keong J, Limborska S, Loughland C, Lönnqvist J, Maher B, Mattheisen M, McDonald C, Murphy KC, Nenadic I, van Os J, Pantelis C, Pato M, Petryshen T, Quested D, Roussos P, Sanders AR, Schall U, Schwab SG, Sim K, So HC, Stögmann E, Subramaniam M, Toncheva D, Waddington J, Walters J, Weiser M, Cheng W, Cloninger R, Curtis D, Gejman PV, Henskens F, Mattingsdal M, Oh SY, Scott R, Webb B, Breen G, Churchhouse C, Bulik CM, Daly M, Dichgans M, Faraone SV, Guerreiro R, Holmans P, Kendler KS, Koeleman B, Mathews CA, Price A, Scharf J, Sklar P, Williams J, Wood NW, Cotsapas C, Palotie A, Smoller JW, Sullivan P, Rosand J, Corvin A, Neale BM. Analysis of shared heritability in common disorders of the brain. Science. 2018 Jun 22;360(6395). pii: eaap8757. doi: 10.1126/science.aap8757. IF=37,205
  41. 3686. Bos I, Verhey FR, Ramakers IHGB, Jacobs HIL, Soininen H, Freund-Levi Y, Hampel H, Tsolaki M, Wallin ÅK, van Buchem MA, Oleksik A, Verbeek MM, Rikkert MO, van der Flier WM, Scheltens P, Aalten P, Visser PJ, Vos SJB. Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline. Alzheimers Res Ther. 2018 Jun 20;10(1):56. doi: 10.1186/s13195-018-0391-x. IF=6,154
  42. 3687. Marizzoni M, Ferrari C, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ribaldi F, Rossini PM, Schönknecht P, Soricelli A, Hensch T, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium. Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers. J Alzheimers Dis. 2018 Jun 9. doi: 10.3233/JAD-180152. IF=3,920
  43. 3619. Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimella R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka SK, Johannsen P, van Laere K, de Leon M, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimers Dement. 2018 Mar 27 ΙF=9.478
  44. 3592. Giannouli V, Stamovlasis D, Tsolaki M. Exploring the Role of Cognitive Factors in a New Instrument for Elders' Financial Capacity Assessment. J Alzheimers Dis. 2018 Mar 1. doi: 10.3233/JAD-170812 IF=3,920
  45. 3568. Lazarou I, Nikolopoulos S, Petrantonakis PC, Kompatsiaris I, Tsolaki M. EEG-Based Brain-Computer Interfaces for Communication and Rehabilitation of People with Motor Impairment: A Novel Approach of the 21 st Century. Front Hum Neurosci. 2018 Jan 31;12:14. ΙF=3,209
  46. 3563. Poulakis K, Pereira JB, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E. Heterogeneous patterns of brain atrophy in Alzheimer's disease. Neurobiol Aging. 2018 Jan 31;65:98-108. IF=5,117
  47. 3537. Nielsen TR, Segers K, Vanderaspoilden V, Bekkhus-Wetterberg P, Minthon L, Pissiota A, Bjørkløf GH, Beinhoff U, Tsolaki M, Gkioka M, Waldemar G. Performance of middle-aged and elderly European minority and majority populations on a Cross-Cultural Neuropsychological Test Battery (CNTB). Clin Neuropsychol. 2018 Jan 24:1-20. doi: 10.1080/13854046.2018.1430256. IF=1.564
  48. 3526. Kalafatakis F, Bekiaridis-Moschou D, Gkioka E, Tsolaki M. Mobile phone use for 5 minutes can cause significant memory impairment in humans. Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:146-154. ΙF=1.048
  49. 3527. Papasozomenou C, Poptsi E, Tabaki EM, Tsolaki M. The operation of the Day Care Centre of Alzheimer Hellas "Saint Helen" and of the Memory Clinic of Papanikolaou General Hospital from 2007 to 2017. Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:136-145. ΙF=1.048
  50. 3528, Papaoikonomou D, Karypidou E, Megagiannis P, Tsolaki-Tagaraki F, Nenopoulou S, Gkatzima O, Tsolaki M. The correlation of Evans index with CSF protein levels and ventriculomegaly. Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:123-130. ΙF=1.048
  51. 3529. Papaliagkas V, Papantoniou G, Tsolaki M, Moraitou D. Self-report instruments of cognitive failures as screening tools for Subjective Cognitive Impairment in older adults. Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:58-70. ΙF=1.048
  52. 3530. Papageorgakopoulos TN, Moraitou D, Papanikolaou M, Tsolaki M. The association between Alzheimer's disease and cancer: Systematic review - Meta-analysis. Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:45-57. ΙF=1.048
  53. 3513. Bos I, Verhey FR, Ramakers IHGB, Jacobs HIL, Soininen H, Freund-Levi Y, Hampel H, Tsolaki M, Wallin ÅK, van Buchem MA, Oleksik A, Verbeek MM, Olde Rikkert M, van der Flier WM, Scheltens P, Aalten P, Visser PJ, Vos SJB. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline. Alzheimers Res Ther. 2017 Dec 29;9(1):101. doi: 10.1186/s13195-017-30328-9. IF=6.154
  54. 3507. Dimitriadis SI, Liparas D, Tsolaki MN; Alzheimer's Disease Neuroimaging Initiative. Random Forest Feature Selection, Fusion and Ensemble Strategy: Combining Multiple Morphological MRI Measures to Discriminate among healhy elderly, MCI, cMCI and Alzheimer's disease patients: from the Alzheimer's disease neuroimaging initiative (ADNI) database. J Neurosci Methods. 2017 Dec 18. IF=2,15

282. 3487. Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Köhler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodríguez-Rodríguez E, Roe CM, Rot U, Rüther E, Santana I, Schröder J, Seo SW, Sorininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Zetterberg H. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry. 2017 Nov 29. doi: 10.1001/jamapsychiatry.2017.3391.IF= 15.307

  1. 3484. Verheijen J, van der Zee J, Gijselinck I, Van den Bossche T, Dillen L, Heeman B, Gómez-Tortosa E, Lladó A, Sanchez-Valle R, Graff C, Pastor P, Pastor MA, Benussi L, Ghidoni R, Binetti G, Clarimon J, de Mendonça A, Gelpi E, Tsolaki M, Diehl-Schmid J, Nacmias B, Almeida MR, Borroni B, Matej R, Ruiz A, Engelborghs S, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, Sleegers K; BELNEU Consortium; EU EOD Consortium. Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort. Neurobiol Aging. 2017 Oct 25. IF=5.153
  2. 3448. Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, O'Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG.Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2017 Oct 19. IF=3,920
  3. 3427. Reijs BLR, Vos SJB, Soininen H, Lötjonen J, Koikkalainen J, Pikkarainen M, Hall A, Vanninen R, Liu Y, Herukka SK, Freund-Levi Y, Frisoni GB, Frölich L, Nobili F, Rikkert MO, Spiru L, Tsolaki M, Wallin ÅK, Scheltens P, Verhey F, Visser PJ. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study. J Alzheimers Dis. 2017 Oct 11. doi: 10.3233/JAD-170039. IF=3,920
  4. 3433.Reijs BLR, Ramakers IHGB, Köhler S, Teunissen CE, Koel-Simmelink M, Nathan PJ, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Vandenberghe R, Johannsen P, Blackwell A, Vanderstichele H, Verhey F, Visser PJ. Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study. J Alzheimers Dis. 2017;60(3):1119-1128. doi: 10.3233/JAD-160766. IF=3,920
  5. 3434. Reijs BLR, Ramakers IHGB, Elias-Sonnenschein L, Teunissen CE, Koel-Simmelink M, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Johannsen P, Vanderstichele H, Verhey F, Devanand DP, Visser PJ. Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition. J Alzheimers Dis. 2017;60(3):1025-1034. doi: 10.3233/JAD-170564. IF=3,920
  6. 3393. Segkouli S, Paliokas I, Tzovaras D, Lazarou I, Karagiannidis C, Vlachos F, Tsolaki M. A computerized test for the assessment of mild cognitive impairment subtypes in sentence processing. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Sep 15:1-23. doi: IF=1,763
  7. 3385. Lazarou I, Parastatidis T, Tsolaki A, Gkioka M, Karakostas A, Douka S, Tsolaki M. International Ballroom Dancing Against Neurodegeneration: A Randomized Controlled Trial in Greek Community-Dwelling Elders With Mild Cognitive impairment. Am J Alzheimers Dis Other Demen. 2017 Dec;32(8):489-499.. doi: 10.1177/1533317517725813. IF=1,614

http://journals.sagepub.com/doi/pdf/10.1177/1533317517725813

  1. 3367. Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, Sleegers K, Vronskaya M, Ruiz A, Graham RR, Olaso R, Hoffmann P, Grove ML, Vardarajan BN, Hiltunen M, Nöthen MM, White CC, Hamilton-Nelson KL, Epelbaum J, Maier W, Choi SH, Beecham GW, Dulary C, Herms S, Smith AV, Funk CC, Derbois C, Forstner AJ, Ahmad S, Li H, Bacq D, Harold D, Satizabal CL, Valladares O, Squassina A, Thomas R, Brody JA, Qu L, Sánchez-Juan P, Morgan T, Wolters FJ, Zhao Y, Garcia FS, Denning N, Fornage M, Malamon J, Naranjo MCD, Majounie E, Mosley TH, Dombroski B, Wallon D, Lupton MK, Dupuis J, Whitehead P, Fratiglioni L, Medway C, Jian X, Mukherjee S, Keller L, Brown K, Lin H, Cantwell LB, Panza F, McGuinness B, Moreno-Grau S, Burgess JD, Solfrizzi V, Proitsi P, Adams HH, Allen M, Seripa D, Pastor P, Cupples LA, Price ND, Hannequin D, Frank-García A, Levy D, Chakrabarty P, Caffarra P, Giegling I, Beiser AS, Giedraitis V, Hampel H, Garcia ME, Wang X, Lannfelt L, Mecocci P, Eiriksdottir G, Crane PK, Pasquier F, Boccardi V, Henández I, Barber RC, Scherer M, Tarraga L, Adams PM, Leber M, Chen Y, Albert MS, Riedel-Heller S, Emilsson V, Beekly D, Braae A, Schmidt R, Blacker D, Masullo C, Schmidt H, Doody RS, Spalletta G, Jr WTL, Fairchild TJ, Bossù P, Lopez OL, Frosch MP, Sacchinelli E, Ghetti B, Yang Q, Huebinger RM, Jessen F, Li S, Kamboh MI, Morris J, Sotolongo-Grau O, Katz MJ, Corcoran C, Dunstan M, Braddel A, Thomas C, Meggy A, Marshall R, Gerrish A, Chapman J, Aguilar M, Taylor S, Hill M, Fairén MD, Hodges A, Vellas B, Soininen H, Kloszewska I, Daniilidou M, Uphill J, Patel Y, Hughes JT, Lord J, Turton J, Hartmann AM, Cecchetti R, Fenoglio C, Serpente M, Arcaro M, Caltagirone C, Orfei MD, Ciaramella A, Pichler S, Mayhaus M, Gu W, Lleó A, Fortea J, Blesa R, Barber IS, Brookes K, Cupidi C, Maletta RG, Carrell D, Sorbi S, Moebus S, Urbano M, Pilotto A, Kornhuber J, Bosco P, Todd S, Craig D, Johnston J, Gill M, Lawlor B, Lynch A, Fox NC, Hardy J; ARUK Consortium, Albin RL, Apostolova LG, Arnold SE, Asthana S, Atwood CS, Baldwin CT, Barnes LL, Barral S, Beach TG, Becker JT, Bigio EH, Bird TD, Boeve BF, Bowen JD, Boxer A, Burke JR, Burns JM, Buxbaum JD, Cairns NJ, Cao C, Carlson CS, Carlsson CM, Carney RM, Carrasquillo MM, Carroll SL, Diaz CC, Chui HC, Clark DG, Cribbs DH, Crocco EA, DeCarli C, Dick M, Duara R, Evans DA, Faber KM, Fallon KB, Fardo DW, Farlow MR, Ferris S, Foroud TM, Galasko DR, Gearing M, Geschwind DH, Gilbert JR, Graff-Radford NR, Green RC, Growdon JH, Hamilton RL, Harrell LE, Honig LS, Huentelman MJ, Hulette CM, Hyman BT, Jarvik GP, Abner E, Jin LW, Jun G, Karydas A, Kaye JA, Kim R, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lunetta KL, Lyketsos CG, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Morris JC, Murrell JR, Myers AJ, O'Bryant S, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Perry W, Peskind E, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rogaeva E, Rosen HJ, Rosenberg RN, Sager MA, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu CE, Yu L, Garzia F, Golamaully F, Septier G, Engelborghs S, Vandenberghe R, De Deyn PP, Fernadez CM, Benito YA, Thonberg H, Forsell C, Lilius L, Kinhult-Stählbom A, Kilander L, Brundin R, Concari L, Helisalmi S, Koivisto AM, Haapasalo A, Dermecourt V, Fievet N, Hanon O, Dufouil C, Brice A, Ritchie K, Dubois B, Himali JJ, Keene CD, Tschanz J, Fitzpatrick AL, Kukull WA, Norton M, Aspelund T, Larson EB, Munger R, Rotter JI, Lipton RB, Bullido MJ, Hofman A, Montine TJ, Coto E, Boerwinkle E, Petersen RC, Alvarez V, Rivadeneira F, Reiman EM, Gallo M, O'Donnell CJ, Reisch JS, Bruni AC, Royall DR, Dichgans M, Sano M, Galimberti D, St George-Hyslop P, Scarpini E, Tsuang DW, Mancuso M, Bonuccelli U, Winslow AR, Daniele A, Wu CK; GERAD/PERADES, CHARGE, ADGC, EADI, Peters O, Nacmias B, Riemenschneider M, Heun R, Brayne C, Rubinsztein DC, Bras J, Guerreiro R, Al-Chalabi A, Shaw CE, Collinge J, Mann D, Tsolaki M, Clarimón J, Sussams R, Lovestone S, O'Donovan MC, Owen MJ, Behrens TW, Mead S, Goate AM, Uitterlinden AG, Holmes C, Cruchaga C, Ingelsson M, Bennett DA, Powell J, Golde TE, Graff C, De Jager PL, Morgan K, Ertekin-Taner N, Combarros O, Psaty BM, Passmore P, Younkin SG, Berr C, Gudnason V, Rujescu D, Dickson DW, Dartigues JF, DeStefano AL, Ortega-Cubero S, Hakonarson H, Campion D, Boada M, Kauwe JK, Farrer LA, Van Broeckhoven C, Ikram MA, Jones L, Haines JL, Tzourio C, Launer LJ, Escott-Price V, Mayeux R, Deleuze JF, Amin N, Holmans PA, Pericak-Vance MA, Amouyel P, van Duijn CM, Ramirez A, Wang LS, Lambert JC, Seshadri S, Williams J, Schellenberg GD. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 Jul 17. doi: 10.1038/ng.3916. [Epub ahead of print] (IF=31.694)
  2. 3346. Andreadou E, Pantazaki AA, Daniilidou M, Tsolaki M. Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease. J Alzheimers Dis. 2017; 59 (1) :209-222. doi: 10.3233/JAD-161020. IF=3,920
  3. 3345. Lupton MK, Benyamin B, Proitsi P, Nyholt DR, Ferreira MA, Montgomery GW, Heath AC, Madden PA, Medland SE, Gordon SD; GERAD1 Consortium; Alzheimer’s Disease Neuroimaging Initiative, Lovestone S, Tsolaki M, Kloszewska I, Soininen H, Mecocci P, Vellas B, Powell JF, Bush AI, Wright MJ, Martin NG, Whitfield JB. No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease. J Alzheimers Dis. 2017 May 30. IF=3,920
  4. 3342. Meiland F, Innes A, Mountain G, Robinson L, van der Roest H, García-Casal JA, Gove D, Thyrian JR, Evans S, Dröes RM, Kelly F, Kurz A, Casey D, Szcześniak D, Dening T, Craven MP, Span M, Felzmann H, Tsolaki M, Franco-Martin M. Technologies to Support Community-Dwelling Persons With Dementia: A Position Paper on Issues Regarding Development, Usability, Effectiveness and Cost-Effectiveness, Deployment, and Ethics. JMIR Rehabil Assist Technol. 2017 Jan 16;4(1):e1. doi: 10.2196/rehab.6376. ΙF=3,4
  5. 3336. Iliadou VV, Bamiou DE, Sidiras C, Moschopoulos NP, Tsolaki M, Nimatoudis I, Chermak GD. The Use of the Gaps-In-Noise Test as an Index of the Enhanced Left Temporal Cortical Thinning Associated with the Transition between Mild Cognitive Impairment and Alzheimer's Disease. J Am Acad Audiol. 2017 May;28(5):463-471. doi: 10.3766/jaaa.16075. IF= 1.344
  6. 3329. Bos I, Vos SJ, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Engelborghs S, Niemantsverdriet E, De Roeck EE, Tsolaki M, Freund-Levi Y, Johannsen P, Vandenberghe R, Lleó A, Alcolea D, Frisoni GB, Galluzzi S, Nobili F, Morbelli S, Drzezga A, Didic M, van Berckel BN, Salmon E, Bastin C, Dauby S, Santana I, Baldeiras I, de Mendonça A, Silva D, Wallin A, Nordlund A, Coloma PM, Wientzek A, Alexander M, Novak GP, Gordon MF; Alzheimer's Disease Neuroimaging Initiative., Wallin ÅK, Hampel H, Soininen H, Herukka SK, Scheltens P, Verhey FR, Visser PJ. The frequency and influence of dementia risk factors in prodromal Alzheimer's disease. Neurobiol Aging. 2017 Apr 8;56:33-40. IF=5.153
  7. 3323.Tsolaki M., Gkioka M, Verykouki E, Galoutzi N, Kavalou E, Pattakou-Parasyri V. Prevalence of Dementia, Depression, and Mild Cognitive Impairment in a Rural Area of the Island of Crete, Greece. Am J Alzheimers Dis Other Demen. 2017 Aug;32(5):252-264. doi: 10.1177/1533317517698789. IF=1,614
  8. 3325. Tsolaki AC, Kosmidou V, Kompatsiaris IY, Papadaniil C, Hadjileontiadis L, Adam A, Tsolaki M. Brain source localization of MMN and P300 ERPs in mild cognitive impairment and Alzheimer's disease: a high-density EEG approach. Neurobiol Aging. 2017 Jul;55:190-201. doi: 10.1016/j.neurobiolaging.2017.03.025.. IF=5.153
  9. 3308. De Roeck A, Van den Bossche T, van der Zee J, Verheijen J, De Coster W, Van Dongen J, Dillen L, Baradaran-Heravi Y, Heeman B, Sanchez-Valle R, Lladó A, Nacmias B, Sorbi S, Gelpi E, Grau-Rivera O, Gómez-Tortosa E, Pastor P, Ortega-Cubero S, Pastor MA, Graff C, Thonberg H, Benussi L, Ghidoni R, Binetti G, de Mendonça A, Martins M, Borroni B, Padovani A, Almeida MR, Santana I, Diehl-Schmid J, Alexopoulos P, Clarimon J, Lleó A, Fortea J, Tsolaki M, Koutroumani M, Matěj R, Rohan Z, De Deyn P, Engelborghs S, Cras P, Van Broeckhoven C, Sleegers K; European Early-Onset Dementia (EU EOD) consortium.. "Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's disease. Acta Neuropathol. 2017 Apr 27. doi: 10.1007/s00401-017-1714-x. ΙF= 11.360
  10. 3304. Ferreira D, Hansson O, Barroso J, Molina Y, Machado A, Hernández-Cabrera JA, Muehlboeck JS, Stomrud E, Nägga K, Lindberg O, Ames D, Kalpouzos G, Fratiglioni L, Bäckman L, Graff C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Ahlström H, Lind L, Larsson EM, Wahlund LO, Simmons A, Westman E; and for the AddNeuroMed consortium, for the Alzheimer's Disease Neuroimaging Initiative (ADNI).; Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) research group..The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals. Hippocampus. 2017 Feb 28. IF=4.074

 

  1. 3260. Dimitriou TD, Tsolaki M. Evaluation of the efficacy of randomized controlled trials of sensory stimulation interventions for sleeping disturbances in patients with dementia: a systematic review. Clin Interv Aging. 2017 Mar 17;12:543-548. IF= 2.314.
  2. 3266. Bosco P, Redolfi A, Bocchetta M, Ferrari C, Mega A, Galluzzi S, Austin M, Chincarini A, Collins DL, Duchesne S, Maréchal B, Roche A, Sensi F, Wolz R, Alegret M, Assal F, Balasa M, Bastin C, Bougea A, Emek-Savaş DD, Engelborghs S, Grimmer T, Grosu G, Kramberger MG, Lawlor B, Mandic Stojmenovic G, Marinescu M, Mecocci P, Molinuevo JL, Morais R, Niemantsverdriet E, Nobili F, Ntovas K, O'Dwyer S, Paraskevas GP, Pelini L, Picco A, Salmon E, Santana I, Sotolongo-Grau O, Spiru L, Stefanova E, Popovic KS, Tsolaki M, Yener GG, Zekry D, Frisoni GB. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study. Alzheimers Dement. 2017 Mar 2. IF= 12.407
  3. 3252. Handels RL, Vos SJ, Kramberger MG, Jelic V, Blennow K, van Buchem M, van der Flier W, Freund-Levi Y, Hampel H, Olde Rikkert M, Oleksik A, Pirtosek Z, Scheltens P, Soininen H, Teunissen C, Tsolaki M, Wallin AK, Winblad B, Verhey FR, Visser PJ. Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers. Alzheimers Dement. 2017 Aug;13(8):903-912. doi: 10.1016/j.jalz.2016.12.015.IF= 12.407
  4. 3243. Lunnon K, Keohane A, Pidsley R, Newhouse S, Riddoch-Contreras J, Thubron EB, Devall M, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Schalkwyk L, Dobson R, Malik AN, Powell J, Lovestone S, Hodges A; AddNeuroMed Consortium. Mitochondrial genes are altered in blood early in Alzheimer's disease. Neurobiol Aging. 2017 Jan 7; 53: 36-47. Doi : 10.1016/j.neurobiolaging.2016.12.029. ΙF=5.153
  5. 3245. Nathan PJ, Lim YY, Abbott R, Galluzzi S, Marizzoni M, Babiloni C, Albani D, Bartres-Faz D, Didic M, Farotti L, Parnetti L, Salvadori N, Müller BW, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Payoux P, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI). Neurobiol Aging. 2017 Jan 18;53:1-10. doi: 10.1016/j.neurobiolaging.2017.01.013. ΙF=5.153
  6. 3148. Khan W, Giampietro V, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaître H, Nees F, Paus T, Pausova Z, Rietschel M, Smolka MN, Ströhle A, Gallinat J, Vellas B, Soininen H, Kloszewska I, Tsolaki M, Mecocci P, Spenger C, Villemagne VL, Masters CL, Muehlboeck JS, Bäckman L, Fratiglioni L, Kalpouzos G, Wahlund LO, Schumann G, Lovestone S, Williams SC, Westman E, Simmons A; Alzheimer–s Disease Neuroimaging Initiative.; AddNeuroMed Consortium, Australian, Imaging, Biomarkers, and Lifestyle Study Research Group.; IMAGEN consortium. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease. J Alzheimers Dis. 2017;56(3):1159-1174. doi: 10.3233/JAD-161097. IF=3,920
  7. 3130. Hibar DP, Adams HH, Jahanshad N, Chauhan G, Stein JL, Hofer E, Renteria ME, Bis JC, Arias-Vasquez A, Ikram MK, Desrivières S, Vernooij MW, Abramovic L, Alhusaini S, Amin N, Andersson M, Arfanakis K, Aribisala BS, Armstrong NJ, Athanasiu L, Axelsson T, Beecham AH, Beiser A, Bernard M, Blanton SH, Bohlken MM, Boks MP, Bralten J, Brickman AM, Carmichael O, Chakravarty MM, Chen Q, Ching CR, Chouraki V, Cuellar-Partida G, Crivello F, Den Braber A, Doan NT, Ehrlich S, Giddaluru S, Goldman AL, Gottesman RF, Grimm O, Griswold ME, Guadalupe T, Gutman BA, Hass J, Haukvik UK, Hoehn D, Holmes AJ, Hoogman M, Janowitz D, Jia T, Jørgensen KN, Karbalai N, Kasperaviciute D, Kim S, Klein M, Kraemer B, Lee PH, Liewald DC, Lopez LM, Luciano M, Macare C, Marquand AF, Matarin M, Mather KA, Mattheisen M, McKay DR, Milaneschi Y, Muñoz Maniega S, Nho K, Nugent AC, Nyquist P, Loohuis LM, Oosterlaan J, Papmeyer M, Pirpamer L, Pütz B, Ramasamy A, Richards JS, Risacher SL, Roiz-Santiañez R, Rommelse N, Ropele S, Rose EJ, Royle NA, Rundek T, Sämann PG, Saremi A, Satizabal CL, Schmaal L, Schork AJ, Shen L, Shin J, Shumskaya E, Smith AV, Sprooten E, Strike LT, Teumer A, Tordesillas-Gutierrez D, Toro R, Trabzuni D, Trompet S, Vaidya D, Van der Grond J, Van der Lee SJ, Van der Meer D, Van Donkelaar MM, Van Eijk KR, Van Erp TG, Van Rooij D, Walton E, Westlye LT, Whelan CD, Windham BG, Winkler AM, Wittfeld K, Woldehawariat G, Wolf C, Wolfers T, Yanek LR, Yang J, Zijdenbos A, Zwiers MP, Agartz I, Almasy L, Ames D, Amouyel P, Andreassen OA, Arepalli S, Assareh AA, Barral S, Bastin ME, Becker DM, Becker JT, Bennett DA, Blangero J, van Bokhoven H, Boomsma DI, Brodaty H, Brouwer RM, Brunner HG, Buckner RL, Buitelaar JK, Bulayeva KB, Cahn W, Calhoun VD, Cannon DM, Cavalleri GL, Cheng CY, Cichon S, Cookson MR, Corvin A, Crespo-Facorro B, Curran JE, Czisch M, Dale AM, Davies GE, De Craen AJ, De Geus EJ, De Jager PL, De Zubicaray GI, Deary IJ, Debette S, DeCarli C, Delanty N, Depondt C, DeStefano A, Dillman A, Djurovic S, Donohoe G, Drevets WC, Duggirala R, Dyer TD, Enzinger C, Erk S, Espeseth T, Fedko IO, Fernández G, Ferrucci L, Fisher SE, Fleischman DA, Ford I, Fornage M, Foroud TM, Fox PT, Francks C, Fukunaga M, Gibbs JR, Glahn DC, Gollub RL, Göring HH, Green RC, Gruber O, Gudnason V, Guelfi S, Håberg AK, Hansell NK, Hardy J, Hartman CA, Hashimoto R, Hegenscheid K, Heinz A, Le Hellard S, Hernandez DG, Heslenfeld DJ, Ho BC, Hoekstra PJ, Hoffmann W, Hofman A, Holsboer F, Homuth G, Hosten N, Hottenga JJ, Huentelman M, Pol HE, Ikeda M, Jack CR Jr, Jenkinson M, Johnson R, Jönsson EG, Jukema JW, Kahn RS, Kanai R, Kloszewska I, Knopman DS, Kochunov P, Kwok JB, Lawrie SM, Lemaître H, Liu X, Longo DL, Lopez OL, Lovestone S, Martinez O, Martinot JL, Mattay VS, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Mecocci P, Melle I, Meyer-Lindenberg A, Mohnke S, Montgomery GW, Morris DW, Mosley TH, Mühleisen TW, Müller-Myhsok B, Nalls MA, Nauck M, Nichols TE, Niessen WJ, Nöthen MM, Nyberg L, Ohi K, Olvera RL, Ophoff RA, Pandolfo M, Paus T, Pausova Z, Penninx BW, Pike GB, Potkin SG, Psaty BM, Reppermund S, Rietschel M, Roffman JL, Romanczuk-Seiferth N, Rotter JI, Ryten M, Sacco RL, Sachdev PS, Saykin AJ, Schmidt R, Schmidt H, Schofield PR, Sigursson S, Simmons A, Singleton A, Sisodiya SM, Smith C, Smoller JW, Soininen H, Steen VM, Stott DJ, Sussmann JE, Thalamuthu A, Toga AW, Traynor BJ, Troncoso J, Tsolaki M, Tzourio C, Uitterlinden AG, Hernández MC, Van der Brug M, van der Lugt A, van der Wee NJ, Van Haren NE, van 't Ent D, Van Tol MJ, Vardarajan BN, Vellas B, Veltman DJ, Völzke H, Walter H, Wardlaw JM, Wassink TH, Weale ME, Weinberger DR, Weiner MW, Wen W, Westman E, White T, Wong TY, Wright CB, Zielke RH, Zonderman AB, Martin NG, Van Duijn CM, Wright MJ, Longstreth WT, Schumann G, Grabe HJ, Franke B, Launer LJ, Medland SE, Seshadri S, Thompson PM, Ikram MA. Novel genetic loci associated with hippocampal volume. Nat Commun. 2017 Jan 18;8:13624. doi: 10.1038/ncomms13624.ΙF= 11.470
  8. 3115. van Waalwijk van Doorn LJ, Gispert JD, Kuiperij HB, Claassen JA, Arighi A, Baldeiras I, Blennow K, Bozzali M, Castelo-Branco M, Cavedo E, Emek-Savaş DD, Eren E, Eusebi P, Farotti L, Fenoglio C, Ormaechea JF, Freund-Levi Y, Frisoni GB, Galimberti D, Genc S, Greco V, Hampel H, Herukka SK, Liu Y, Lladó A, Lleó A, Nobili FM, Oguz KK, Parnetti L, Pereira J, Picco A, Pikkarainen M, de Oliveira CR, Saka E, Salvadori N, Sanchez-Valle R, Santana I, Scarpini E, Scheltens P, Soininen H, Tarducci R, Teunissen C, Tsolaki M, Urbani A, Martinez EV, Visser PJ, Wallin AK, Yener G, Molinuevo JL, Meulenbroek O, Verbeek MM. Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes. J Alzheimers Dis. 2017;56(2):543-555. doi: 10.3233/JAD-160668.IF=3,920
  9. 3113. Zygouris S, Ntovas K, Giakoumis D, Votis K, Doumpoulakis S, Segkouli S, Karagiannidis C, Tzovaras D, Tsolaki M. A Preliminary Study on the Feasibility of Using a Virtual Reality Cognitive Training Application for Remote Detection of Mild Cognitive Impairment. J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160518. IF= 3,920
  10. 3100. Skrobot OA, O'Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group., Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. The Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2016 Dec 10. pii: S1552-5260(16)33073-4. doi: 10.1016/j.jalz.2016.10.007. [Epub ahead of print] ΙF= ΙF= 11.619
  11. 3082. Kim M, Nevado-Holgado A, Whiley L, Snowden SG, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Thambisetty M, Dobson RJ, Powell JF, Lupton MK, Simmons A, Velayudhan L, Lovestone S, Proitsi P, Legido-Quigley C. Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease. J Alzheimers Dis. 2017;60(3):809-817. doi: 10.3233/JAD-160645.IF= 3,920
  12. 3059. Tsolaki AC, Kosmidou VE, Yiannis Kompatsiaris I, Papadaniil C, Hadjileontiadis L, Tsolaki M. Age-induced differences in brain neural activation elicited by visual emotional stimuli: A High-Density EEG study. Neuroscience. 2017 Jan 6;340:268-278. doi: 10.1016/j.neuroscience.2016.10.059. Epub 2016 Nov 1. ΙF=3.23
  13. 3027. Proitsi P, Kim M, Whiley L, Simmons A, Sattlecker M, Velayudhan L, Lupton MK, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Powell JF, Dobson RJ, Legido-Quigley C. Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis. Alzheimers Dement. 2017 Feb;13(2):140-151. doi: 10.1016/j.jalz.2016.08.003. Epub 2016 Sep 28.ΙF= 11.619
  14. 3018. Athanasopoulos D, Karagiannis G, Tsolaki M. Recent Findings in Alzheimer Disease and Nutrition Focusing on Epigenetics. Adv Nutr. 2016 Sep 15;7(5):917-27. doi: 10.3945/an.116.012229. Print 2016 Sep. Review. IF= 5.386

 

  1. 2929. Lazarou I, Karakostas A, Stavropoulos TG, Tsompanidis T, Meditskos G, Kompatsiaris I, Tsolaki M. A Novel and Intelligent Home Monitoring System for Care Support of Elders with Cognitive Impairment. J Alzheimers Dis. 2016 Oct 18;54(4):1561-1591. IF= 3,920

http://www.voria.gr/article/apth-exipno-sistima-ex-apostaseos-parakolouthisis-ilikiomenon-me-ania

http://techit.gr/2016/11/eks-apostaseos-parakolouthisi/

  1. 2961. Albi A, Pasternak O, Minati L, Marizzoni M, Bartrés-Faz D, Bargalló N, Bosch B, Rossini PM, Marra C, Müller B, Fiedler U, Wiltfang J, Roccatagliata L, Picco A, Nobili FM, Blin O, Sein J, Ranjeva JP, Didic M, Bombois S, Lopes R, Bordet R, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Frisoni G, Jovicich J; PharmaCog Consortium. Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects. Hum Brain Mapp. 2016 Aug 13. doi: 10.1002/hbm.23350. IF= 4.962
  2. 2987. Papadaniil CD, Kosmidou VE, Tsolaki A, Tsolaki M, Kompatsiaris IY, Hadjileontiadis LJ. Cognitive MMN and P300 in Mild Cognitive Impairment and Alzheimer's Disease: A High Density EEG-3D Vector Field Tomography Approach. Brain Res. 2016 Oct 1;1648(Pt A):425-433. doi: 10.1016/j.brainres.2016.07.043. ΙF= 2.843
  3. 2984. Kalincik T, Kuhle J, Pucci E, Rojas JI, Tsolaki M, Sirbu CA, Slee M, Butzkueven H; MSBase Scientific Leadership Group and MSBase Study Group. Data quality evaluation for observational multiple sclerosis registries. Mult Scler. 2016 Aug 1. pii: 1352458516662728. IF=4.822
  4. 2929. Tsolaki M, Karathanasi E, Lazarou I, Dovas K, Verykouki E, Karakosta A, Georgiadis K, Tsolaki A, Adam K, Kompatsiaris I, Sinakos Z. Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial. J Alzheimers Dis. 2016 Jul 27 54, issue 1 (August 2016). IF=3,920

http://www.j-alz.com/ 

http://www.j-alz.com/content/efficacy-and-safety-crocus-sativus-patients-mild-cognitive-impairment

  1. 2973. Meulenbroek O, O'Dwyer S, de Jong D, van Spijker G, Kennelly S, Cregg F, Olde Rikkert M, Abdullah L, Wallin A, Walsh C, Coen R, Kenny RA, Daly L, Segurado R, Borjesson-Hanson A, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Molloy W, Tsolaki M, Howard R, Adams J, Gaynor S, Lawlor B.European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer’s disease—the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow. BMJ Open 2016;6:e011584. doi:10.1136/bmjopen-2016-011584. IF=2.562

http://bmjopen.bmj.com/cgi/content/full/bmjopen-2016-011584?ijkey=KGKWhmV3rvHRtaU&keytype=ref

  1. 2966. Tarnanas I, Tsolaki M, Nef T, M Müri R, Mosimann UP. Can a novel computerized cognitive screening test provide additional information for early detection of Alzheimer's disease? Alzheimers Dement. 2014 Nov;10(6):790-8. doi: 10.1016/j.jalz.2014.01.002. IF=14.483
  2. 2940. Pierrakos C, Attou R, Decorte L, Velissaris D, Cudia A, Gottignies P, Devriendt J, Tsolaki M, De Bels D. Cerebral perfusion alterations and cognitive decline in critically ill sepsis survivors. Acta Clin Belg. 2016 Jun 3:1-6. IF=0,683
  3. 2932. Coley N, Gallini A, Garès V, Gardette V, Andrieu S; ICTUS/DSA group. A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort. J Am Med Dir Assoc. 2015 Dec;16(12):1104.e1. doi: 10.1016/j.jamda.2015.09.010  IF=4.939.

 (242) 2933. Grotz C, Letenneur L, Bonsang E, Amieva H, Meillon C, Quertemont E, Salmon E, Adam S; ICTUS/DSA group. Retirement age and the age of onset of Alzheimer's disease: results from the ICTUS study. PLoS One. 2015 Feb 25;10(2):e0115056. doi: 10.1371/journal.pone.0115056. eCollection 2015.IF= 3.234.

Vellas B, Reynish E, Ousset PJ, Andrieu S, Burns A, Pasquier F, Frisoni G, Salmon E, Michel JP, Zekry DS, Boada M, Dartigues JF, Olde-Rikkert MG, Rigaud AS, Winblad B, Malick A, Sinclair A, Frölich L, Scheltens P, Ribera C, Touchon J, Robert P, Salva A, Waldmar G, Bullock R, Costa-Tsolaki M, Rodriguez G, Spiru L, Jones RW, Stiens G, Stoppe G, Eriksdotter Jönhagen M, Cherubini A, Lage PM, Gomez-Isla T, Camus V, Aguüera-Morales E, Lopez F, Andrieu S, Savy S, Cantet C, Coley N.

(241) 2934. Canevelli M, Adali N, Kelaiditi E, Cantet C, Ousset PJ, Cesari M; ICTUS/DSA Group. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study. Phytomedicine. 2014 May 15;21(6):888-92. doi: 10.1016/j.phymed.2014.01.003. Epub 2014 Feb 16. IF= 3.126

Vellas B, Reynish E, Ousset PJ, Andrieu S, Burns A, Pasquier F, Frisoni G, Salmon E, Michel JP, Zekry DS, Boada M, Dartigues JF, Olde-Rikkert MG, Rigaud AS, Winblad B, Malick A, Sinclair A, Frölich L, Scheltens P, Ribera C, Touchon J, Robert P, Salva A, Waldmar G, Bullock R, Costa-Tsolaki M, Rodriguez G, Spiru L, Jones RW, Stiens G, Stoppe G, Eriksdotter Jönhagen M, Cherubini A, Lage PM, Gomez-Isla T, Camus V, Aguüera-Morales E, Lopez F, Andrieu S, Savy S, Cantet C, Coley N.

(240) 2935. Gardette V, Lapeyre-Mestre M, Piau A, Gallini A, Cantet C, Montastruc JL, Vellas B, Andrieu S; ICTUS Group. A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study. CNS Drugs. 2014 Feb;28(2):157-70. doi: 10.1007/s40263-013-0133-3ν. IF= 5.113.

Vellas B, Jones RW, Burns A, Bullock R, Malick A, Salmon E, Waldemar G, Dartigues JF, Pasquier F, Touchon J, Robert P, Rigaud AS, Camus V, Stiens G, Frölich L, Costa-Tsolaki M, Frisoni G, Rodriguez G, Cherubini A, Spiru L, Boada M, Salva A, Agüera-Morales E, Ribera-Casado JM, Lage PM, Winblad B, Jönhagen ME, Michel JP, Scheltens P, Olde-Rikkert M.

(239) 2936. Canevelli M, Adali N, Cantet C, Andrieu S, Bruno G, Cesari M, Vellas B; ICTUS/DSA Group. Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study. J Neurol. 2013 Jul;260(7):1859-65. doi: 10.1016/j.phymed.2014.01.003.  IF=3.841

Vellas B, Reynish E, Ousset PJ, Andrieu S, Burns A, Pasquier F, Frisoni G, Salmon E, Michel JP, Zekry DS, Boada M, Dartigues JF, Olde-Rikkert MG, Rigaud AS, Winblad B, Malick A, Sinclair A, Frölich L, Scheltens P, Ribera C, Touchon J, Robert P, Salva A, Waldmar G, Bullock R, Costa-Tsolaki M, Rodriguez G, Spiru L, Jones RW, Stiens G, Stoppe G, Eriksdotter Jönhagen M, Cherubini A, Lage PM, Gomez-Isla T, Camus V, Aguüera-Morales E, Lopez F, Andrieu S, Savy S, Cantet C, Coley N.

(238) 2928. Tsolaki M, Papaliagkas V, Frisoni G, Jones R, Touchon J, Spiru L, Vellaz B, Verhey F, Winblad B, Visser PJ. MCI patients in Europe: Medication and comorbidities. The DESCRIPA study. Curr Alzheimer Res. 2016 Jun 2. ΙF=3.889

(237) 2917. Korakas Ν., Tsolaki M. Cognitive Impairment in Multiple Sclerosis: What tests could help us to detect it. A review. Cogn Behav Neurol. 2016 Jun;29(2):55-67.  doi: 10.1097/WNN.0000000000000097. IF= 0,946

(236) 2906. Pereira JB, Mijalkov M, Kakaei E, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO, Volpe G, Westman E; AddNeuroMed consortium, for the Alzheimer's Disease Neuroimaging Initiative. Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease. Cereb Cortex. 2016 Aug;26(8):3476-3493. doi: 10.1093/cercor/bhw128.IF= 8.665

(235) 2739. Lupton MK, Strike L, Hansell NK, Wen W, Mather KA, Armstrong NJ, Thalamuthu A, McMahon KL, de Zubicaray GI, Assareh AA, Simmons A, Proitsi P, Powell JF, Montgomery GW, Hibar DP, Westman E, Tsolaki M, Kloszewska I, Soininen H, Mecocci P, Velas B, Lovestone S; Alzheimer's Disease Neuroimaging Initiative, Brodaty H, Ames D, Trollor JN, Martin NG, Thompson PM, Sachdev PS, Wright MJ. The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume. Neurobiol Aging. 2016 Apr;40:68-77. doi: 10.1016/j.neurobiolaging.2015.12.023. Epub 2016 Jan 11. IF= 4.853

(234) 2740. Theofilou P, Giannouli V, Kolias S, Tsolaki M. Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol. Health Psychol Res. 2015 Apr 13;3(1):1556. doi: 10.4081/hpr.2015.1556ν. eCollection 2015 Apr 13.

(233) 2741. Marchitelli R, Minati L, Marizzoni M, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Schönknecht P, Hensch T, Hoffmann KT, Kuijer JP, Visser PJ, Barkhof F, Frisoni GB, Jovicich J. Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques. Hum Brain Mapp. 2016 Jun;37(6):2114-32. doi: 10.1002/hbm.23157. [Epub ahead of print] IF= 5.969

(232) 2720. Galluzzi S, Marizzoni M, Babiloni C, Albani D, Antelmi L, Bagnoli C, Bartres-Faz D, Cordone S, Didic M, Farotti L, Fiedler U, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Parnetti L, Payoux P, Del Percio C, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium. Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'. J Intern Med. 2016 Jun;279(6):576-91. doi: 10.1111/joim.12482. [Epub ahead of print]. IF=6,063

(231) 2684. Papadaniil CD, Kosmidou VE, Tsolaki A, Tsolaki M, Kompatsiaris I, Hadjileontiadis LJ. Phase-amplitude cross-frequency coupling in EEG-derived cortical time series upon an auditory perception task. Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:4150-4153. doi: 10.1109/EMBC.2015.7319308.

(230) 2685. Kosmidou VE, Adam A, Papadaniil CD, Tsolaki M, Hadjileontiadis LJ, Kompatsiaris I. Gender effect in human brain responses to bottom-up and top-down attention using the EEG 3D-Vector Field Tomography. Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:7574-7577. doi: 10.1109/EMBC.2015.7320145. 

(229) 2683. Orellana C, Ferreira D, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; AddNeuronMed consortium and for the Alzheimer''s Disease Neuroimaging Initiative. Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations. Neurodegener Dis. 2016;16(1-2):77-86. doi: 10.1159/000442443. IF= 3,511

 (228) 279. 2673. Tsolaki M, Zygouris S, Lazarou I, Kompatsiaris I, Chatzileontiadis L, Votis C, Tzovaras D, Karakostas A, Karagkiozi C, Dimitriou T, Tsiatsios T, Dimitriadis S, Tarnanas I, Dranidis D, Bamidis P. Our experience with informative and communication technologies (ICT) in dementia. Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:131-139. IF=0,957

(227) 2664. Sattlecker M, Khondoker M, Proitsi P, Williams S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Dobson RJ. Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease. J Alzheimers Dis. 2015;49(4):1105-14. doi: 10.3233/JAD-140669. IF=4.151

(226) 2660. Ferreira D, Cavallin L, Granberg T, Lindberg O, Aguilar C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging Initiative*. Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition. doi: 10.1007/s00330-015-4101-9. Eur Radiol. 2016 Aug;26(8):2597-610.  IF=4.014

 (225) 2655. Dimitriadis SI, Laskaris NA, Bitzidou MP, Tarnanas I, Tsolaki MN. A novel biomarker of amnestic MCI based on dynamic cross-frequency coupling patterns during cognitive brain responses. Front Neurosci. 2015 Oct 20;9:350. doi: 10.3389/fnins.2015.00350. eCollection 2015. IF=3,7

(224) 2653. Reijs BL, Teunissen CE, Goncharenko N, Betsou F, Blennow K, Baldeiras I, Brosseron F, Cavedo E, Fladby T, Froelich L, Gabryelewicz T, Gurvit H, Kapaki E, Koson P, Kulic L, Lehmann S, Lewczuk P, Lleó A, Maetzler W, de Mendonça A, Miller AM, Molinuevo JL, Mollenhauer B, Parnetti L, Rot U, Schneider A, Simonsen AH, Tagliavini F, Tsolaki M, Verbeek MM, Verhey FR, Zboch M, Winblad B, Scheltens P, Zetterberg H, Visser PJ. The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases. Front Neurol. 2015 Oct 15;6:216. doi: 10.3389/fneur.2015.00216.

(223) 2648. Voyle N, Keohane A, Newhouse S, Lunnon K, Johnston C, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Hodges A, Kiddle S, Dobson RJ. A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.  J Alzheimers Dis. 2015;49(3):659-69.  doi: 10.3233/JAD-150440. IF=4.151

(222) 2630. Falahati F, Ferreira D, Soininen H, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Lovestone S, Eriksdotter M, Wahlund LO, Simmons A, Westman E; AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative. The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects. Brain Topogr. 2016 Mar;29(2):296-307. doi: 10.1007/s10548-015-0455-1. ΙF=3,468

http://link.springer.com/article/10.1007/s10548-015-0455-1 

(221) 2625. Cacace R, Van den Bossche T, Engelborghs S, Geerts N, Laureys A, Dillen L, Graff C, Thonberg H, Chiang HH, Pastor P, Ortega-Cubero S, Pastor MA, Diehl-Schmid J, Alexopoulos P, Benussi L, Ghidoni R, Binetti G, Nacmias B, Sorbi S, Sanchez-Valle R, Lladó A, Gelpi E, Almeida MR, Santana I, Tsolaki M, Koutroumani M, Clarimon J, Lleó A, Fortea J, de Mendonça A, Martins M, Borroni B, Padovani A, Matej R, Rohan Z, Vandenbulcke M, Vandenberghe R, De Deyn PP, Cras P, van der Zee J, Sleegers K, Van Broeckhoven C; Belgium Neurology (BELNEU) Consortium and the European Early-Onset Dementia (EU EOD) Consortium.  Rare Variants in PLD3 do not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort. Hum Mutat. 2015 Dec;36(12):1226-35. doi: 10.1002/humu.22908. IF= 5.34

(220) (271) 2614. Chiam JT, Lunnon K, Voyle N, Proitsi P, Coppola G, Geschwind D, Nelson S, Johnston C, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Hodges A, Lovestone S, Newhouse S, Dobson RJ, Kiddle SJ, Sattlecker M. No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease. J Alzheimers Dis. 2015 Aug 3;47(3):741-750. doi: 10.3233/JAD-150289. IF=4.151

(219) (272). 2615. Travassos M, Santana I, Baldeiras I, Tsolaki M, Gkatzima O, Sermin G, Yener GG, Simonsen A, Hasselbalch SG, Kapaki E, Mara B, Cunha RA, Agostinho P, Blennow K, Zetterberg H, Mendes VM, Manadas B, de Mendon A. Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease? J Alzheimers Dis. 2015 Aug 11;47(4):1069-1078. doi: 10.3233/JAD-150374. IF=4.151

(218) 2603. Duits FH, Martinez-Lage P, Paquet C, Engelborghs S, Lleó A, Hausner L, Molinuevo JL, Stomrud E, Farotti L, Ramakers IH, Tsolaki M, Skarsgård C, Åstrand R, Wallin A, Vyhnalek M, Holmber-Clausen M, Forlenza OV, Ghezzi L, Ingelsson M, Hoff EI, Roks G, de Mendonça A, Papma JM, Izagirre A, Taga M, Struyfs H, Alcolea DA, Frölich L, Balasa M, Minthon L, Twisk JW, Persson S, Zetterberg H, van der Flier WM, Teunissen CE, Scheltens P, Blennow K. Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study. Alzheimers Dement. 2016 Feb;12(2):154-63. doi: 10.1016/j.jalz.2015.08.003. ΙF=12.407

(217) 2579. Segkouli S, Paliokas I, Tzovaras D, Tsakiris T, Tsolaki M, Karagiannidis C. Novel Virtual User Models of Mild Cognitive Impairment for Simulating Dementia.Comput Math Methods Med. 2015;2015:358638. doi: 10.1155/2015/358638. Epub 2015 Aug 3. http://dx.doi.org/10.1155/2015/358638. http://www.hindawi.com/journals/cmmm/2015/358638/ IF= 0.766

(216) 2590. Bamidis PD, Fissler P, Papageorgiou SG, Zilidou V, Konstantinidis EI, Billis AS, Romanopoulou E, Karagianni M, Beratis I, Tsapanou A, Tsilikopoulou G, Grigoriadou E, Ladas A, Kyrillidou A, Tsolaki A, Frantzidis C, Sidiropoulos E, Siountas A, Matsi S, Papatriantafyllou J, Margioti E, Nika A, Schlee W, Elbert T, Tsolaki M, Vivas AB, Kolassa IT. Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorder. Front Aging Neurosci. 2015 Aug 7;7:152. doi: 10.3389/fnagi.2015.00152. IF= 4.000

(215) 2532. Jovicich J, Minati L, Marizzoni M, Marchitelli R, Sala-Llonch R, Bartrés-Faz D, Arnold J, Benninghoff J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Schönknecht P, Hensch T, Hoffmann KT, Kuijer JP, Visser PJ, Scheltens P, Frisoni GB; PharmaCog Consortium. Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study. Neuroimage. 2016 Jan 1;124(Pt A):442-54. doi: 10.1016/j.neuroimage.2015.07.010. IF=6.357

(214) 2494. Chouliaras L, Kenis G, Visser PJ, Scheltens P, Tsolaki M, Jones RW, Kehoe PG, Graff C, Girtler NG, Wallin ÅK, Rikkert MO, Spiru L, Elias-Sonnenschein LS, Ramakers IH, Pishva E, Os JV, Steinbusch HW, Verhey FR, van den Hove D, Rutten BP. DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts. Epigenomics. 2015 Jun;7(4):533-537. doi: 10.2217/epi.15.22. ΙF= 4.649

(213) 2488. Kruse N, Persson S, Alcolea D, Bahl JM, Baldeiras I, Capello E, Chiasserini D, Bocchio Chiavetto L, Emersic A, Engelborghs S, Eren E, Fladby T, Frisoni G, García-Ayllón MS, Genc S, Gkatzima O, Heegaard NH, Janeiro AM, Kováčech B, Kuiperij HB, Leitão MJ, Lleó A, Martins M, Matos M, Mollergard HM, Nobili F, Öhrfelt A, Parnetti L, de Oliveira CR, Rot U, Sáez-Valero J, Struyfs H, Tanassi JT, Taylor P, Tsolaki M, Vanmechelen E, Verbeek MM, Zilka N, Blennow K, Zetterberg H, Mollenhauer B. Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study. Neurobiol Aging. 2015 May 15. pii: S0197-4580(15)00250-X. doi: 10.1016/j.neurobiolaging.2015.05.003. IF= 4.853

(212) 2489. Kiddle SJ, Steves CJ, Mehta M, Simmons A, Xu X, Newhouse S, Sattlecker M, Ashton NJ, Bazenet C, Killick R, Adnan J, Westman E, Nelson S, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Curtis C, Breen G, Williams SC, Lovestone S, Spector TD, Dobson RJ. Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes. Transl Psychiatry. 2015 Jun 16;5:e584. doi: 10.1038/tp.2015.78. IF=5.620

 (211) 2469. Marizzoni M, Antelmi L, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Salvadori N, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Hoffmann KT, Hensch T, Schönknecht P, Kuijer JP, Visser PJ, Barkhof F, Bordet R, Frisoni GB, Jovicich J; Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly. PharmaCog Consortium. Hum Brain Mapp. 2015 Sep;36(9):3516-27. doi: 10.1002/hbm.22859. IF= 6.924

(210) 2452. Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ; and the Amyloid Biomarker Study Group, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BN, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, Förster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, Gómez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, Köhler S, Koglin N, Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lleó A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendonça A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, Møllergård HM, Morris JC, Mroczko B, Van der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Resende de Oliveira C, Rinne JO, Rodrigue KM, Rodríguez-Rodríguez E, Roe CM, Rot U, Rowe CC, Rüther E, Sabri O, Sanchez-Juan P, Santana I, Sarazin M, Schröder J, Schütte C, Seo SW, Soetewey F, Soininen H, Spiru L, Struyfs H, Teunissen CE, Tsolaki M, Vandenberghe R, Verbeek MM, Villemagne VL, Vos SJ, van Waalwijk van Doorn LJ, Waldemar G, Wallin A, Wallin ÅK, Wiltfang J, Wolk DA, Zboch M, Zetterberg H. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis. JAMA. 2015 May 19;313(19):1924-1938. doi: 10.1001/jama.2015.4668. IF= 30.387

 (209) 2432. Tarnanas I, Papagiannopoulos S, Kazis D, Wiederhold M, Widerhold B, Tsolaki M. Reliability of a novel serious game using dual-task gait profiles to early characterize aMCI. Front Aging Neurosci. 2015 Apr 22;7:50. doi: 10.3389/fnagi.2015.00050. eCollection 2015. IF=2,8

(208) 2426. Kountouras J, Tsolaki F, Tsolaki M, Gavalas E, Zavos C, Polyzos SA, Boziki M, Katsinelos P, Kountouras C, Vardaka E, Tagarakis GI, Deretzi G. Helicobacter pylori-related ApoE 4 polymorphism may be associated with dysphagic symptoms in older adults. Dis Esophagus. 2015 Apr 15. doi: 10.1111/dote.12364. IF=2.057

 (207) 2415. Jekel K, Damian M, Wattmo C, Hausner L, Bullock R, Connelly PJ, Dubois B, Eriksdotter M, Ewers M, Graessel E, Kramberger MG, Law E, Mecocci P, Molinuevo JL, Nygård L, Olde-Rikkert MG, Orgogozo JM, Pasquier F, Peres K, Salmon E, Sikkes SA, Sobow T, Spiegel R, Tsolaki M, Winblad B, Frölich L. Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review. Alzheimers Res Ther. 2015 Mar 18;7(1):17. eCollection 2015. doi: 10.1186/s13195-015-0099-0. IF=3,5

 (206) 2403. Tsolaki F, Kountouras J, Topouzis F, Tsolaki M. Helicobacter pylori infection, dementia and primary open-angle glaucoma: are they connected? BMC Ophthalmol. 2015 Dec;15(1):6. doi: 10.1186/s12886-015-0006-2. IF=1.08

(205) 2404. Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC, Kunkle BW, Wang LS, Bis JC, Bellenguez C, Harold D, Lunetta KL, Destefano AL, Grenier-Boley B, Sims R, Beecham GW, Smith AV, Chouraki V, Hamilton-Nelson KL, Ikram MA, Fievet N, Denning N, Martin ER, Schmidt H, Kamatani Y, Dunstan ML, Valladares O, Laza AR, Zelenika D, Ramirez A, Foroud TM, Choi SH, Boland A, Becker T, Kukull WA, van der Lee SJ, Pasquier F, Cruchaga C, Beekly D, Fitzpatrick AL, Hanon O, Gill M, Barber R, Gudnason V, Campion D, Love S, Bennett DA, Amin N, Berr C, Tsolaki M, Buxbaum JD, Lopez OL, Deramecourt V, Fox NC, Cantwell LB, Tárraga L, Dufouil C, Hardy J, Crane PK, Eiriksdottir G, Hannequin D, Clarke R, Evans D, Mosley TH Jr, Letenneur L, Brayne C, Maier W, De Jager P, Emilsson V, Dartigues JF, Hampel H, Kamboh MI, de Bruijn RF, Tzourio C, Pastor P, Larson EB, Rotter JI, O'Donovan MC, Montine TJ, Nalls MA, Mead S, Reiman EM, Jonsson PV, Holmes C, St George-Hyslop PH, Boada M, Passmore P, Wendland JR, Schmidt R, Morgan K, Winslow AR, Powell JF, Carasquillo M, Younkin SG, Jakobsdóttir J, Kauwe JS, Wilhelmsen KC, Rujescu D, Nöthen MM, Hofman A, Jones L; IGAP Consortium, Haines JL, Psaty BM, Van Broeckhoven C, Holmans P, Launer LJ, Mayeux R, Lathrop M, Goate AM, Escott-Price V, Seshadri S, Pericak-Vance MA, Amouyel P, Williams J, van Duijn CM, Schellenberg GD, Farrer LA. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. 2016 Jan;21(1):108-17. doi: 10.1038/mp.2015.23.  IF= 15.147

(204) 2398. Ferreira D, Cavallin L, Larsson EM, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; The AddNeuroMed consortium, the Alzheimer's Disease Neuroimaging, Initiative.Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment. J Intern Med. 2015 Sep;278(3):277-90. doi: 10.1111/joim.12358. IF=5.785

 (203) 2395. Gross AL, Sherva R, Mukherjee S, Newhouse S, Kauwe JS, Munsie LM, Waterston LB, Bennett DA, Jones RN, Green RC, Crane PK; Alzheimer's Disease Neuroimaging Initiative; GENAROAD Consortium; AD Genetics Consortium. Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets. Neuroepidemiology. 2014;43(3-4):194-205. IF=2.476

 

(202) 2379. Vos SJ, Verhey F, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Morbelli S, Frisoni GB, Drzezga A, Didic M, van Berckel BN, Simmons A, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Muscio C, Herukka SK, Salmon E, Bastin C, Wallin A, Nordlund A, de Mendonça A, Silva D, Santana I, Lemos R, Engelborghs S, Van der Mussele S; The Alzheimer’s Disease Neuroimaging Initiative, Freund-Levi Y, Wallin ÅK, Hampel H, van der Flier W, Scheltens P, Visser PJ. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. Brain. 2015 May;138(Pt 5):1327-38. doi: 10.1093/brain/awv029. IF= 10.226

(201) 2374. Tarnanas I, Schlee W, Tsolaki M, Müri R, Mosimann U, Nef T. Ecological validity of virtual reality daily living activities screening for early dementia: longitudinal study. JMIR Serious Games. 2013 Aug 6;1(1):e1. doi: 10.2196/games.2778. ΙF=4.7

(200) 2364. Khondoker M, Newhouse S, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Dobson R, Simmons A. Linking Genetics of Brain Changes to Alzheimer's Disease: Sparse Whole Genome Association Scan of Regional MRI Volumes in the ADNI and AddNeuroMed Cohorts. J Alzheimers Dis. 2015;45(3):851-64. doi: 10.3233/JAD-142214. IF=4,17

(199) 2352. Proitsi P, Kim M, Whiley L, Pritchard M, Leung R, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Sham P, Lovestone S, Powell JF, Dobson RJ, Legido-Quigley C. Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease. Transl Psychiatry. 2015 Jan 13;5:e494. doi: 10.1038/tp.2014.127. IF= 4.044

(198) 2347. Nho K, Kim S, Risacher SL, Shen L, Corneveaux JJ, Swaminathan S, Lin H, Ramanan VK, Liu Y, Foroud TM, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta KL, Farrer LA, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, McDonald BC, Farlow MR, Ghetti B, Huentelman MJ, Saykin AJ; for the Indiana Memory, Aging Study; for the Alzheimer's Disease Neuroimaging Initiative (ADNI); for the Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study; for the AddNeuroMed Consortium. Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol. 2015 Jan 5. doi: 10.1002/ana.24349. IF=11.91

(197) 2344. Jones L, Lambert JC, Wang LS, Choi SH, Harold D, Vedernikov A, Escott-Price V, Stone T, Richards A, Bellenguez C, Ibrahim-Verbaas CA, Naj AC, Sims R, Gerrish A, Jun G, DeStefano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Schmidt H, Kunkle BW, Dunstan ML, Ruiz A, Bihoreau MT, Reitz C, Pasquier F, Hollingworth P, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letteneur L, Kornhuber J, Tárraga L, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Emilsson V, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Kehoe P, Rogaeva E, Gallacher J, St George-Hyslop P, Clarimon J, Lleò A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Sanchez Garcia F, Fox N, Hardy J, Deniz Naranjo MC, Razquin C, Bosco P, Clarke R, Brayne C, Galimberti D, Mancuso M, Moebus S, Mecocci P, Del Zompo M, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, Nacmias B, Gilbert JR, Mayhaus M, Jessen F, Dichgans M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alavarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O'Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH Jr, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Pastor P, Schmidt R, Rujescu D, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Haines JL, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Ramirez A, Schellenberg GD, Seshadri S, Amouyel P, Williams J, Holmans PA. Convergent genetic and expression data implicate immunity in Alzheimer's disease. International Genomics of Alzheimer's Disease Consortium (IGAP); Alzheimers Dement. 2015 Jun;11(6):658-71. doi: 10.1016/j.jalz.2014.05.1757. IF=17.472

(196) 2342. Hall A, Mattila J, Koikkalainen J, Lötjonen J, Wolz R, Scheltens P, Frisoni G, Tsolaki M, Nobili F, Freund-Levi Y, Minthon L, Frölich L, Hampel H, Visser PT, Soininen H. Predicting Progression from Cognitive Impairment to Alzheimer's Disease with the Disease State Index. Curr Curr Alzheimer Res. 2015;12(1):69-79. IF=3,796

(195) 2339. Lleó A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, Ghidoni R, Lewczuk P, Jeromin A, Winblad B, Tsolaki M, Mroczko B, Visser PJ, Santana I, Svenningsson P, Blennow K, Aarsland D, Molinuevo JL, Zetterberg H, Mollenhauer B. Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases. Nat Rev Neurol. 2014 Dec 16. doi: 10.1038/nrneurol.2014.232. IF=14.103

(194) 2301. Tsolaki A, Kosmidou V, Hadjileontiadis L, Kompatsiaris IY, Tsolaki M. Brain source localization of MMN, P300 and N400: Aging and gender differences. Brain Res. 2015 Apr 7;1603:32-49. doi: 10.1016/j.brainres.2014.10.004. IF= 2.957

(193) (238) 2327. Tarnanas I, Laskaris N, Tsolaki M, Muri R, Nef T, Mosimann UP. On the comparison of a novel serious game and electroencephalography biomarkers for early dementia screening.Adv Exp Med Biol. 2015;821:63-77. doi: 10.1007/978-3-319-08939-3_11. IF= 1.953

(192) (239) 2329. Zygouris S, Giakoumis D, Votis K, Doumpoulakis S, Konstantinos N, Segkouli S, Charalampos K, Tzovaras D, Tsolaki M. Can a Virtual Reality Cognitive Training Application Fulfill a Dual Role? Using the Virtual Supermarket Cognitive Training Application as a Screening Tool for Mild Cognitive Impairment. J Alzheimers Dis. 2015;44(4):1333-47. doi: 10.3233/JAD-141260. IF=4,17

https://www.auth.gr/news/press/18225 και το αγγλικό εδώ: http://www.j-alz.com/content/virtual-reality-brain-training-game-can-detect-mild-cognitive-impairment-condition-often

 

- Le Courrier de Russie: http://www.lecourrierderussie.com/2015/06/virtual-supermarket/

- Ta Nea: http://www.tanea.gr/impact-journalism-day/article/5250394/to-eikoniko-soypermarket/

- The Daily Star: http://www.thedailystar.net/impact-journalism-day/virtual-supermarket-game-detect-memory-problems-older-adults-100078

- La Regione Ticino: http://www.laregione.ch/articolo/il-videogioco-che-salva-dallalzheimer/10427

(191) 2319. Ramanan VK, Nho K, Shen L, Risacher SL, Kim S, McDonald BC, Farlow MR, Foroud TM, Gao S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Aisen PS, Petersen RC, Jack CR Jr, Shaw LM, Trojanowski JQ, Weiner MW, Green RC, Toga AW, De Jager PL, Yu L, Bennett DA, Saykin AJ. FASTKD2 is associated with memory and hippocampal structure in older adults. Mol Psychiatry. 2015 Oct;20(10):1197-204. doi: 10.1038/mp.2014.142. IF= 15.147

(190) 2312.  Lebedev AV, Westman E, Van Westen GJ, Kramberger MG, Lundervold A, Aarsland D, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Simmons A; Alzheimer's Disease Neuroimaging Initiative and the AddNeuroMed consortium. Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness. Neuroimage Clin. 2014 Aug 28;6:115-25. doi: 10.1016/j.nicl.2014.08.023. eCollection 2014. IF=

(189) 2315. Khan W, Westman E, Jones N, Wahlund LO, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Muehlboeck JS, Simmons A; for the AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging Initiative. Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts. Brain Topogr. 2015 Sep;28(5):746-59. doi: 10.1007/s10548-014-0415-1. ΙF= 2.519

(188). 2284. Lawlor B, Kennelly S, O'Dwyer S, Cregg F, Walsh C, Coen R, Kenny RA, Howard R, Murphy C, Adams J, Daly L, Segurado R, Gaynor S, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Wallin A, Borjesson A, Molloy W, Tsolaki M, Olde Rikkert M. NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease. BMJ Open. 2014 Oct 9;4(10):e006364. doi: 10.1136/bmjopen-2014-006364. IF=2,063

(187). 2283. Tsolaki M. Clinical workout for the early detection of cognitive decline and dementia. Eur J Clin Nutr. 2014 Nov;68(11):1186-91. doi: 10.1038/ejcn.2014.189. IF=2,95

(186). 2254. Proitsi P, Lupton MK, Velayudhan L, Newhouse S, Fogh I, Tsolaki M, Daniilidou M, Pritchard M, Kloszewska I, Soininen H, Mecocci P, Vellas B; Alzheimer's Disease Neuroimaging Initiative, Williams J; GERAD1 Consortium, Stewart R, Sham P, Lovestone S, Powell JF. Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a mendelian randomization analysis. PLoS Med. 2014 Sep 16;11(9):e1001713. doi: 10.1371/journal.pmed.1001713. e1001713. IF= 4.24

(185). 2251. Frantzidis CA, Vivas AB, Tsolaki A, Klados MA, Tsolaki M, Bamidis PD. Functional disorganization of small-world brain networks in mild Alzheimer's Disease and amnestic Mild Cognitive Impairment: an EEG study using Relative Wavelet Entropy (RWE). Front Aging Neurosci. 2014 Aug 26;6:224. doi: 10.3389/fnagi.2014.00224. eCollection 2014. IF= 5.2

(184). 2249. Hall A, Muñoz-Ruiz M, Mattila J, Koikkalainen J, Tsolaki M, Mecocci P, Kloszewska I, Vellas B, Lovestone S, Visser PJ, Lötjonen J, Soininen H. Generalizability of the Disease State Index Prediction Model for Identifying Patients Progressing from Mild Cognitive Impairment to Alzheimer's Disease. J Alzheimers Dis. 2015;44(1):79-92. doi: 10.3233/JAD-140942. IF=4,17

(183). 2244. Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, Hasselbalch SG, Hausner L, Heuser I, Jessen F, Jones RW, Kurz A, Lawlor B, Lleo A, Martinez-Lage P, Mecocci P, Mehrabian S, Monsch A, Nobili F, Nordberg A, Olde Rikkert M, Orgogozo JM, Pasquier F, Peters O, Salmon E, Sánchez-Castellano C, Santana I, Sarazin M, Traykov L, Tsolaki M, Visser PJ, Wallin AK, Wilcock G, Wilkinson D, Wolf H, Yener G, Zekry D, Frisoni GB. The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey. Alzheimers Dement. 2015 Feb;11(2):195-206.e1. doi: 10.1016/j.jalz.2014.06.006.  IF= 14.483.

(182). 2245. Proitsi P, Lupton MK, Velayudhan L, Hunter G, Newhouse S, Lin K, Fogh I, Tsolaki M, Daniilidou M, Pritchard M, Craig D, Todd S, Johnston JA, McGuinness B, Kloszewska I, Soininen H, Mecocci P, Vellas B, Passmore PA, Sims R, Williams J, Brayne C; for the Alzheimer's Disease Neuroimaging Initiative; for the GERAD1 Consortium, Stewart R, Sham P, Lovestone S, Powell JF. Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer's disease. Neurobiol Aging. 2014 Jul 24. pii: S0197-4580(14)00492-8. doi: 10.1016/j.neurobiolaging.2014.07.023. Ι.F. =6,634

(181). 2246. Doyle OM, Westman E, Marquand AF, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Williams SC, Simmons A.Predicting progression of Alzheimer's disease using ordinal regression. PLoS One. 2014 Aug 20;9(8):e105542. doi: 10.1371/journal.pone.0105542.:e105542. IF= 4.24

(180). 2240. Menni C, Kiddle SJ, Mangino M, Viñuela A, Psatha M, Steves C, Sattlecker M, Buil A, Newhouse S, Nelson S, Williams S, Voyle N, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Spector TD, Dobson R, Valdes AM.Circulating Proteomic Signatures of Chronological Age. J Gerontol A Biol Sci Med Sci. 2015 Jul;70(7):809-16. doi: 10.1093/gerona/glu121. IF= 4.984

(179). (223) 2227. Jovicich J, Marizzoni M, Bosch B, Bartrés-Faz D, Arnold J, Benninghoff J, Wiltfang J, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Chanoine V, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Ragucci M, Soricelli A, Salvadori N, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini P, Marra C, Otto J, Reiss-Zimmermann M, Hoffmann KT, Galluzzi S, Frisoni GB; The PharmaCog Consortium. Multisite Longitudinal Reliability of Tract-Based Spatial Statistics in Diffusion Tensor Imaging of Healthy Elderly Subjects. Neuroimage. 2014 Nov 1;101:390-403. doi: 10.1016/j.neuroimage.2014.06.075. IF=7.063

(178). (221). 2223. Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, Westman E, Simmons A, Dobson R, Sattlecker M, Lupton M, Lunnon K, Keohane A, Ward M, Pike I, Zucht HD, Pepin D, Zheng W, Tunnicliffe A, Richardson J, Gauthier S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement. 2014 Nov;10(6):799-807.e2. doi: 10.1016/j.jalz.2014.05.1749. IF= 14.483.

(177). (222). 2224. Aguilar C, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Wahlund LO, Simmons A, Westman E; AddNeuroMed Consortium. Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort. Front. Aging Neurosci., 2014 Jul 14;6:145.| doi: 10.3389/fnagi.2014.00145.  IF=5,2.

http://www.frontiersin.org/Journal/Abstract.aspx?s=18&name=aging_neuroscience&ART_DOI=10.3389/fnagi.2014.00145&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&journalName=Frontiers_in_Aging_Neuroscience&id=93619

(176). (219). 2219. Tsatali M, Papaliagkas V, Damigos D, Mavreas V, Gouva M, Tsolaki M. Depression and Anxiety Levels Increase Chronic Musculoskeletal Pain in Patients with Alzheimer's Disease. Curr Alzheimer Res. 2014 Jun 17.  IF= 4.953.

(175). (218). 2214. Escott-Price V, Bellenguez C, Wang LS, Choi SH, Harold D, Jones L, Holmans P, Gerrish A, Vedernikov A, Richards A, DeStefano AL, Lambert JC, Ibrahim-Verbaas CA, Naj AC, Sims R, Jun G, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Denning N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Schmidt H, Kunkle B, Dunstan ML, Vronskaya M; the United Kingdom Brain Expression Consortium, Johnson AD, Ruiz A, Bihoreau MT, Reitz C, Pasquier F, Hollingworth P, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Baldwin C, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Hernández I, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, George-Hyslop PS, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Garcia FS, Fox NC, Hardy J, Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Scarpini E, Bonuccelli U, Mancuso M, Siciliano G, Moebus S, Mecocci P, Zompo MD, Maier W, Hampel H, Pilotto A, Frank-García A, Panza F, Solfrizzi V, Caffarra P, Nacmias B, Perry W, Mayhaus M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O'Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH Jr, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Schmidt R, Rujescu D, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Haines JL, Lathrop M, Pericak-Vance MA, Launer LJ, Van Broeckhoven C, Farrer LA, van Duijn CM, Ramirez A, Seshadri S, Schellenberg GD, Amouyel P, Williams J. Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease. PLoS One. 2014 Jun 12;9(6):e94661. doi: 10.1371/journal.pone.0094661. eCollection 2014. IF= 4.24

(174) 2173. Tsolaki A, Kazis D, Kompatsiaris I, Kosmidou V, Tsolaki M. Electroencephalogram and Alzheimer's Disease: Clinical and Research Approaches. Int J Alzheimers Dis. 2014;2014:349249. doi: 10.1155/2014/349249. Epub 2014 Apr 24. Review. IF=4,17

(173)  2184. Mukaetova-Ladinska EB, Krsteska R, Vaskova O, Makazlieva T, Tsolaki M. Dementia and Depression in Older Adults: A Southeast European Perspective: Summary of a Dementia Psychogeriatric Symposium held in Ohrid, 23 May 2013. J Alzheimers Dis. 2014;41(4):1251-60. doi: 10.3233/JAD-131640. IF=4,17

(172) 2175. Sattlecker M, Kiddle SJ, Newhouse S, Proitsi P, Nelson S, Williams S, Johnston C, Killick R, Simmons A, Westman E, Hodges A, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S; the AddNeuroMed Consortium, Dobson RJ.Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimers Dement. 2014 Nov;10(6):724-34. doi: 10.1016/j.jalz.2013.09.016. ΙF= 14.483

(171) 2170. Duits FH, Teunissen CE, Bouwman FH, Visser PJ, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N, Marcusson J, Wallin A, Rikkert MO, Tsolaki M, Parnetti L, Herukka SK, Hampel H, De Leon MJ, Schröder J, Aarsland D, Blankenstein MA, Scheltens P, van der Flier WM. The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean? Alzheimers Dement. 2014 Nov;10(6):713-723.e2. doi: 10.1016/j.jalz.2013.12.023. ΙF= 14.483

(170) 2166. Tarnanas I, Tsolaki A, Wiederhold M, Wiederhold B, Tsolaki M. Five-year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps? Alzheimers Dement (Amst). 2015 Nov 14;1(4):521-32. doi: 10.1016/j.dadm.2015.10.005ν eCollection 2015 Dec. IF=2,706

(169) 2145. Zygouris S, Tsolaki M. Computerized Cognitive Testing for Older Adults: A review. Am J Alzheimers Dis Other Demen. 2015 Feb;30(1):13-28. doi: 10.1177/1533317514522852. ΙF=1,518

http://aja.sagepub.com/cgi/reprint/30/1/13.pdf?ijkey=EcNpCqJZHR7OiSb&keytype=finite

(168) 2140. Paajanen T, Hänninen T, Aitken A, Hallikainen M, Westman E, Wahlund LO, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Spenger C, Lovestone S, Simmons A, Soininen H; AddNeuroMed Consortium.CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease. Dement Geriatr Cogn Dis Extra. 2013 Nov 30;3(1):446-58.IF= 2.787

  1. 2133. Frantzidis CA, Ladas AK, Vivas AB, Tsolaki M, Bamidis PD.Cognitive and physical training for the elderly: evaluating outcome efficacy by means of neurophysiological synchronization. Int J Psychophysiol. 2014 Jul;93(1):1-11. doi: 10.1016/j.ijpsycho.2014.01.007. IF=2,661
  2. 2123. Giannouli V, Tsolaki M. Legal capacity of the elderly in Greece.Hell J Nucl Med. 2014 Jan-Apr;17 Suppl 1:2-6. IF= 0.86

(165) 1120. Papapostolou P, Goutsaridou F, Arvaniti M, Emmanouilidou M, Tezapsidis G, Tsolaki M, Tsitouridis I. Is total brain volume correlated to cognitive function and education in patients with Alzheimer disease? Neuroradiol J. 2008 Oct 1;21(4):500-4.IF= 0.522.

(164). 1147. Papapostolou P, Arvaniti M, Goutsaridou F, Emmanouilidou M, Tezapsidis G, Chondromatidou S, Tsolaki M, Tsitouridis I. 3D MR Models and Volumetric Measurements of the Brain in Patients with Alzheimer's Disease. Neuroradiol J. 2008 Dec 17;21(5):611-7. IF= 0.522.

(163). 2097. Paajanen T, Hänninen T, Tunnard C, Hallikainen M, Mecocci P, Sobow T, Tsolaki M, Vellas B, Lovestone S, Soininen H. CERAD Neuropsychological Compound Scores are Accurate in Detecting Prodromal Alzheimer's Disease: A Prospective AddNeuroMed Study. Dement Geriatr Cogn Dis Extra. 2013 Nov 30;3(1):446-58. doi: 10.1159/000356725. IF=4,261

(162) 2073. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, Jun G, Destefano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Gerrish A, Schmidt H, Kunkle B, Dunstan ML, Ruiz A, Bihoreau MT, Choi SH, Reitz C, Pasquier F, Hollingworth P, Ramirez A, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Baldwin C, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Morón FJ, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Green R, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, St George-Hyslop P, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Sanchez-Garcia F, Fox NC, Hardy J, Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Mancuso M, Matthews F; European Alzheimer's Disease Initiative (EADI); Genetic and Environmental Risk in Alzheimer's Disease (GERAD); Alzheimer's Disease Genetic Consortium (ADGC); Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE), Moebus S, Mecocci P, Del Zompo M, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, Nacmias B, Gilbert JR, Mayhaus M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O'Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH Jr, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Schmidt R, Rujescu D, Wang LS, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013 Dec;45(12):1452-8. doi: 10.1038/ng.2802.  IF= 35.209

 

Ελεύθερος τύπος 30/10/2013

 

(161). 2064. Kiddle SJ, Sattlecker M, Proitsi P, Simmons A, Westman E, Bazenet C, Nelson SK, Williams S, Hodges A, Johnston C, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Newhouse S, Lovestone S, Dobson R.Candidate Blood Proteome Markers of Alzheimer's Disease Onset and Progression: A Systematic Review and Replication Study. J Alzheimers Dis. 2014;38(3):515-31. doi: 10.3233/JAD-130380. ΙF. =4,261

 

(160). 2065. Pereira JB, Cavallin L, Spulber G, Aguilar C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Aarsland D, Lovestone S, Simmons A, Wahlund LO, Westman E; The AddNeuroMed consortium for the Alzheimer's Disease Neuroimaging Initiative.Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs. J Intern Med. 2014 Mar;275(3):317-30. doi: 10.1111/joim.12148. IF.= 6,455

 

 (159) 2050. Proitsi P, Lee SH, Lunnon K, Keohane A, Powell J, Troakes C, Al-Sarraj S, Furney S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Hodges A; AddNeuroMed Consortium. Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood. Neurobiol Aging. 2014 Feb;35(2):279-90. doi: 10.1016/j.neurobiolaging.2013.08.002. Ι.F. =6,634

 

(158) 2051. Lupton MK, Proitsi P, Lin K, Hamilton G, Daniilidou M, Tsolaki M, Powell JF. The Role of ABCA1 Gene Sequence Variants on Risk of Alzheimer's Disease. J Alzheimers Dis. 2014;38(4):897-906. doi: 10.3233/JAD-131121. IF=4,261

(157) 2052. Whiley L, Sen A, Heaton J, Proitsi P, García-Gómez D, Leung R, Smith N, Thambisetty M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Lovestone S, Legido-Quigley C; AddNeuroMed Consortium. Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.Neurobiol Aging. 2013 Sep 13. Ι.F. =6,634

 (156) 2026. Nho K, Corneveaux JJ, Kim S, Lin H, Risacher SL, Shen L, Swaminathan S, Ramanan VK, Liu Y, Foroud T, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta K, Farrer LA; Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H; AddNeuroMed Consortium, McDonald BC, Farlow MR, Ghetti B; Indiana Memory and Aging Study, Huentelman MJ, Saykin AJ. Identification of functional  variants from whole-exome sequencing, combined with neuroimaging genetics. Mol Psychiatry. 2013 Jul;18(7):739. ΙF= 13.668

(155) 2027. Leung R, Proitsi P, Simmons A, Lunnon K, Güntert A, Kronenberg D, Pritchard M, Tsolaki M, Mecocci P, Kloszewska I, Vellas B, Soininen H, Wahlund LO, Lovestone S. Inflammatory proteins in plasma are associated with severity of Alzheimer's disease. PLoS One. 2013 Jun 10;8(6). IF= 4.09

(154) 2009. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, Heun R, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2013 May 29;45(6):712. ΙF=35.532

(153) 1984. Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, Boada M, Bullock R, De Deyn PP, Frisoni GB, Hampel H, Jones RW, Kehoe P, Lenoir H, Minthon L, Olde Rikkert MG, Rodriguez G, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Verhey FR, Winblad B, Wahlund LO, Wilcock G, Visser PJ. Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study. Dement Geriatr Cogn Disord. 2013 May 3;36(1-2):1-19. IF= 3.142

(152) 1981. Tsantali E, Economidis D, Tsolaki M. Could language deficits really differentiate Mild Cognitive Impairment (MCI) from mild Alzheimer's disease? Arch Gerontol Geriatr. 2013 2013 Nov-Dec;57(3):263-70. IF=1,496

(151) 1978. Nho K, Corneveaux JJ, Kim S, Lin H, Risacher SL, Shen L, Swaminathan S, Ramanan VK, Liu Y, Foroud T, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta K, Farrer LA; for the Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H; for the AddNeuroMed Consortium, McDonald BC, Farlow MR, Ghetti B; for the Indiana Memory and Aging Study, Huentelman MJ, Saykin AJ. Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry. 2013 Apr 23. ΙF=13,668

(150) 1966. Aguilar C, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Spenger C, Simmons A, Wahlund LO. Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment. Psychiatry Res. 2013 Mar 29. ΙF=2.768

(149) 1964.  Clerx L, van Rossum IA, Burns L, Knol DL, Scheltens P, Verhey F, Aalten P, Lapuerta P, van de Pol L, van Schijndel R, de Jong R, Barkhof F, Wolz R, Rueckert D, Bocchetta M, Tsolaki M, Nobili F, Wahlund LO, Minthon L, Frölich L, Hampel H, Soininen H, Visser PJ. Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment. Neurobiol Aging. 2013 Mar 26. ΙF=6,634

(148) 1939. Vos SJ, van Rossum IA, Verhey F, Knol DL, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Frisoni GB, Froelich L, Nobili F, van der Flier W, Blennow K, Wolz R, Scheltens P, Visser PJ. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology. 2013 Feb 27. IF=8,31

(147) 1916. Koutroumani M, Daniilidou M, Giannakouros T, Proitsi P, Liapi D, Germanou A, Nikolakaki E, Tsolaki M. The deletion variant of a2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment. J Neurol Sci. 2013 Mar 15. IF=2.441

 (146) 1914. Vermeiren AP, Bosma H, Visser PJ, Zeegers MP, Graff C, Ewers M, Frisoni GB, Frölich L, Hampel H, Jones RW, Kehoe PG, Lenoir H, Minthon L, Nobili FM, Olde Rikkert M, Rigaud AS, Scheltens P, Soininen H, Spiru L, Tsolaki M, Wahlund LO, Vellas B, Wilcock G, Elias-Sonnenschein LS, Verhey FR.The Association Between APOE ε4 and Alzheimer-type Dementia among Memory Clinic Patients is Confined to those with a Higher Education. The DESCRIPA Study. J Alzheimers Dis. 2013 Feb 4.  ΙF:4,261

(145) 1909. Mangialasche F, Westman E, Kivipelto M, Muehlboeck JS, Cecchetti R, Baglioni M, Tarducci R, Gobbi G, Floridi P, Soininen H, Kłoszewska I, Tsolaki M, Vellas B, Spenger C, Lovestone S, Wahlund LO, Simmons A, Mecocci P; The AddNeuroMed consortium. Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol. J Intern Med. 2013 Jan 24. ΙF: 5.483

(144) 1900. Spulber G, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Wahlund LO, Westman E; The AddNeuroMed consortium for the Alzheimer Disease Neuroimaging Initiative. An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment. J Intern Med. 2012 Dec 27. ΙF: 5.483

(143) 1901. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J; Alzheimer Genetic Analysis Group. TREM2 variants in Alzheimer's disease. N Engl J Med. 2013 Jan 10;368(2):117-27. Free Article ΙF:53.298

(142) Laskaris NA, Tarnanas I, Tsolaki MN, Vlaikidis N, Karlovasitou AK. Improved detection of amnestic MCI by means of discriminative vector quantization of single-trial cognitive ERP responses. J Neurosci Methods. 2012 Nov 9;212(2):344-354. ΙF:2,4

(141) 1854. Greco I, Day N, Riddoch-Contreras J, Reed J, Soininen H, K 322 Oszewska I, Tsolaki M, Vellas B, Spenger C, Mecocci P, Wahlund LO, Simmons A, Barnes J, Lovestone SS. Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation. J Transl Med. 2012 Oct 31;10(1):217. ΙF: 3.47

(140) 1824. Kiddle SJ, Thambisetty M, Simmons A, Riddoch-Contreras J, Hye A, Westman E, Pike I, Ward M, Johnston C, Lupton MK, Lunnon K, Soininen H, Kloszewska I, Tsolaki M, Vellas B, Mecocci P, Lovestone S, Newhouse S, Dobson R; for the Alzheimer’s Disease Neuroimaging Initiative. Plasma Based Markers of [(11)C] PiB-PET Brain Amyloid Burden. PLoS One. 2012;7(9):e44260. ΙF: 4,411

 (139) 1826. Lunnon K, Sattlecker M, Furney SJ, Coppola G, Simmons A, Proitsi P, Lupton MK, Lourdusamy A, Johnston C, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Geschwind D, Lovestone S, Dobson R, Hodges A. A Blood Gene Expression Marker of Early Alzheimer's Disease. J Alzheimers Dis. 2012 Oct 5. ΙF =4,261

(138) 1827. Velayudhan L, Proitsi P, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Hodges A, Powell J, Lovestone S, Simmons A. Entorhinal Cortex Thickness Predicts Cognitive Decline in Alzheimer's Disease. J Alzheimers Dis. 2012 Oct 9. Ι.F. =4,261

(137) (181) 1821. van Rossum IA, Vos SJ, Burns L, Knol DL, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, L'italien G, van der Flier WM, Teunissen CE, Blennow K, Barkhof F, Rueckert D, Wolz R, Verhey F, Visser PJ. Injury markers predict time to dementia in subjects with MCI and amyloid pathology.  Neurology. 2012 Sep 26. IF=8,31

(136) (180) 1815. Tarnanas I, Laskaris N, Tsolaki M. On The Comparison of VR-Responses, as Performance Measures in Prospective Memory, with Auditory P300 Responses in MCI Detection. Stud Health Technol Inform. 2012;181:156-61. IF=4,08

(135) (179) 1805. Vellas B, Hausner L, Frölich L, Cantet C, Gardette V, Reynish E, Gillette S, Ag Era-Morales E, Auriacombe S, Boada-Rovira M, Bullock R, Byrne J, Cherubini A, Eriksdotter-J Nhagen M, Frisoni G, Hasselbalch S, Jones R, Martinez-Lage P, Rikkert M, Tsolaki M, Ousset PJ, Pasquier F, Ribera-Casado JM, Rigaud AS, Robert P, Rodriguez G, Salmon E, A S, Scheltens P, Schneider A, Spiru L, Touchon J, Zekry D, Winblad B, Andrieu S. Progression of Alzheimer disease in Europe: Data from the European ICTUS study. Curr Alzheimer Res. 2012 Jun 26. IF=4,97

(134). (174) 1779. Tagarakis GI, Voucharas C, Tsolaki F, Daskalopoulos ME, Papaliagkas V, Parisis C, Gogaki E, Tsagalas I, Sataitidis I, Tsolaki M, Tsilimingas NB. Ondasetron versus haloperidol for the treatment of postcardiotomy delirium: a prospective, randomized, double-blinded study. J Cardiothorac Surg. 2012 Mar 21;7(1):25. Ι.F. =0,91

(133). (175) 1780. Proitsi P, Lupton MK, Dudbridge F, Tsolaki M, Hamilton G, Daniilidou M, Pritchard M, Lord K, Martin BM, Craig D, Todd S, McGuinness B, Hollingworth P, Harold D, Kloszewska I, Soininen H, Mecocci P, Velas B, Gill M, Lawlor B, Rubinsztein DC, Brayne C, Passmore PA, Williams J, Lovestone S, Powell JF. Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation. Neurobiol Aging. 2012 Jan 31. Ι.F. =6,634

(132). (176) 1781. Mattsson N, Rosén E, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek MM, Olde Rikkert M, Tsolaki M, Mulugeta E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Wallin A, Eriksdotter-Jönhagen M, Minthon L, Winblad B, Blennow K, Zetterberg H. Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology. 2012 Feb 14;78(7):468-76.  Ι.F. =8,17

(131). (177) 1782. Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, Sattlecker M, Furney S, Saleem M, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Coppola G, Geschwind D, Simmons A, Lovestone S, Dobson R, Hodges A. Mitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood. J Alzheimers Dis. 2012 Mar 30. ΙF =4,261

(130). (178) 1783. Lourdusamy A, Newhouse S, Lunnon K, Proitsi P, Powell J, Hodges A, Nelson SK, Stewart A, Williams S, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Lovestone S; on behalf of the AddNeuroMed Consortium, Dobson R; for the Alzheimer’s Disease Neuroimaging Initiative. Identification of cis- regulatory variation influencing protein abundance levels in human plasma. Hum Mol Genet. 2012 May 16. IF.= 8,058

(129) 1714. Vos S, van Rossum I, Burns L, Knol D, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Handels R, L'italien G, van der Flier W, Aalten P, Teunissen C, Barkhof F, Blennow K, Wolz R, Rueckert D, Verhey F, Visser PJ. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol Aging. 2012 Jan 19. IF=5,559

(128) 1715.Tsolaki F, Gogaki E, Sakkias F, Skatharoudi C, Lopatatzidi C, Tsoulopoulos V, Lampoura S, Topouzis F, Tsolaki M, Kountouras J. Helicobacter pylori infection and primary open-angle glaucoma: is there a connection? Clin Ophthalmol. 2012;6:45-7. IF= 1.755


URL:https://www.dovepress.com/articles.php?article_id=9009&l=PrNOEuiFKQ6oOjxs8SoNZbYY67447

(127) 1716. Bamidis PD, Konstantinidis EI, Billis A, Frantzidis C, Tsolaki M, Hlauschek W, Kyriacou E,  A Web services-based exergaming platform for senior citizens: The long lasting memories project approach to e-health care.  Conf Proc IEEE Eng Med Biol Soc. 2011 Aug;2011:2505-9. IF=3,673

(126) 1717. Liu Y, Julkunen V, Paajanen T, Westman E, Wahlund LO, Aitken A, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Spenger C, Lovestone S, Simmons A, Soininen H; AddNeuroMed Consortium.Education increases reserve against Alzheimer's disease-evidence from structural MRI analysis. Neuroradiology. 2012 Jan 14. IF=2,87

(125) 1718. Thambisetty M, Simmons A, Hye A, Campbell J, Westman E, Zhang Y, Wahlund LO, Kinsey A, Causevic M, Killick R, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S; for the AddNeuroMed consortium. Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease. PLoS One. 2011;6(12):e28527. ΙF: 4,411

(124) 1719. Mangialasche F, Xu W, Kivipelto M, Costanzi E, Ercolani S, Pigliautile M, Cecchetti R, Baglioni M, Simmons A, Soininen H, Tsolaki M, Kloszewska I, Vellas B, Lovestone S, Mecocci P; AddNeuroMed Consortium. Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol Aging. 2011 Dec 20. IF=5,559

(123) 1720. Sikkes SA, Visser PJ, Knol DL, de Lange-de Klerk ES, Tsolaki M, Frisoni GB, Nobili F, Spiru L, Rigaud AS, Frölich L, Rikkert MO, Soininen H, Touchon J, Wilcock G, Boada M, Hampel H, Bullock R, Vellas B, Pijnenburg YA, Scheltens P, Verhey FR, Uitdehaag BM. Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the development of screening guidelines and diagnostic criteria for predementia Alzheimer's disease study. J Am Geriatr Soc. 2011 Dec;59(12):2273-81.IF=3,913

(122)1721. Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RC, Griffith P, Obisesan TO, Shatz R, Borenstein A, Cupples LA, Lunetta KL, Fallin MD, Baldwin CT, Farrer LA; Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study Group.A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol. 2011 Dec;68(12):1569-79. ΙF=6,31

(121) 1722. Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO; AddNeuroMed consortium; Alzheimer's Disease Neuroimaging Initiative. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage. 2011 Oct 1;58(3):818-28. . ΙF : 6,817

 (120) 1691. Furney SJ, Kronenberg D, Simmons A, Güntert A, Dobson RJ, Proitsi P, Wahlund LO, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S. Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression. J Alzheimers Dis. 2011;26 Suppl 3:395-405. ΙF:3,82

(119) 1692. Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Johnston JA, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Kölsch H, Heun R, Schürmann B, Bussche HV, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Davies G, Harris SE, Starr JM, Deary IJ, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Jones L, Holmans PA, O'Donovan MC, Owen MJ, Williams J. The Role of Variation at AβPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease. J Alzheimers Dis. 2011 Oct 25. ΙF:3,82

(118) 1693. Koliaki CC, Messini C, Tsolaki M. Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study*. CNS Neurosci Ther. 2011 Feb 26. ΙF:3,492

(117) 1676.Logue MW, Posner H, Green RC, Moline M, Cupples LA, Lunetta KL, Zou H, Hurt SW, Farrer LA, Decarli C; MIRAGE Study Group. Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients. Alzheimers Dement. 2011 Sep;7(5):493-500. ΙF:4,55

(116) 1662. Norberg J, Graff C, Almkvist O, Ewers M, Frisoni GB, Frölich L, Hampel H, Jones RW, Kehoe PG, Lenoir H, Minthon L, Nobili F, Olde Rikkert M, Rigaud AS, Scheltens P, Soininen H, Spiru L, Tsolaki M, Wahlund LO, Vellas B, Wilcock G, Elias-Sonnenschein LS, Verhey FR, Visser PJ. Regional Differences in Effects of APOE ε4 on Cognitive Impairment in Non-Demented Subjects. Dement Geriatr Cogn Disord. 2011 Sep 22;32(2):135-142. ΙF:2,58

(115) 1638. Westman E, Cavallin L, Muehlboeck JS, Zhang Y, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO; AddNeuroMed consortium. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One. 2011;6(7):e22506.  ΙF: 4,411

(114) 1639. Daniilidou M, Tsolaki M, Giannakouros T, Nikolakaki E. Detection of elevated antibodies against SR protein kinase 1 in the serum of Alzheimer's disease patients. J Neuroimmunol. 2011 Sep 15;238(1-2):67-72. Epub 2011 Jul 27. ΙF: 2,942

 (113) 1625. Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO; for the AddNeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative.  AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage. 2011 Jul 1. ΙF: 6,817

(112)  1626. Tsolaki F, Gogaki E, Tiganita S, Skatharoudi C, Lopatatzidi C, Topouzis F, Tsolaki M. Alzheimer's disease and primary open-angle glaucoma: is there a connection? Clin Ophthalmol. 2011;5:887-90. Epub 2011 Jun 28. ΙF = 1.755

(111)1627. Whitehead D, Tunnard C, Hurt C, Wahlund LO, Mecocci P, Tsolaki M, Vellas B, Spenger C, Kłoszewska I, Soininen H, Cromb D, Lovestone S, Simmons A.  Frontotemporal atrophy associated with paranoid delusions in women with Alzheimer's disease. Int Psychogeriatr. 2011 Jul 11:1-9. ΙF = 2.478.

(110) 1628. Fountoulakis KN, Pavlidis I, Tsolaki M. Life events and dementia: What is the nature of their relationship? Psychiatry Res. 2011 Nov 30;190(1):156-8ΙF: 2.344

(109) 1567. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Rüther E, Schürmann B, Heun R, Kölsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Gallacher J, Hüll M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC; the Alzheimer's Disease Neuroimaging Initiative, van Duijn CM, Breteler MM, Ikram MA, Destefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S; CHARGE consortium, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alpérovitch A, Lathrop M; EADI1 consortium, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snædal J, Björnsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossù P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P, Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011 May;43(5):429-35.. IF=24,176.

(108) 1568. Daniilidou M, Koutroumani M, Tsolaki M. Epigenetic Mechanisms in Alzheimer's Disease. Curr Med Chem. 2011 Apr 5. Curr Med Chem. 2011;18(12):1751-6. IF=4,708

(107). 1549. Lupton MK, Proitsi P, Danillidou M, Tsolaki M, Hamilton G, Wroe R, Pritchard M, Lord K, Martin BM, Kloszewska I, Soininen H, Mecocci P, Vellas B, Harold D, Hollingworth P, Lovestone S, Powell JF. Deep sequencing of the nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease. PLoS One. 2011 Feb 25;6(2):e17298.  ΙF =4,411

(106). 1544. Costafreda SG, Dinov ID, Tu Z, Shi Y, Liu CY, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Wahlund LO, Spenger C, Toga AW, Lovestone S, Simmons A. Automated hippocampal shape analysis predicts the onset of dementia in Mild Cognitive Impairment. Neuroimage. 2011 Jan 24. IF=5.739

(105) 1540. Papaliagkas VT, Kimiskidis VK, Tsolaki MN, Anogianakis G. Cognitive event-related potentials: Longitudinal changes in mild cognitive impairment. Clin Neurophysiol. 2011 Jan 10. ΙF=3.122

(104) 1529. Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C.

The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. Int J Geriatr Psychiatry. 2011 Jan;26(1):75-82. ΙF=1,981

 

(103) 1519. Tsolaki M, Kounti F, Agogiatou C, Poptsi E, Bakoglidou E, Zafeiropoulou M, Soumbourou A, Nikolaidou E, Batsila G, Siambani A, Nakou S, Mouzakidis C, Tsiakiri A, Zafeiropoulos S, Karagiozi K, Messini C, Diamantidou A, Vasiloglou M. Effectiveness of Nonpharmacological Approaches in Patients with Mild Cognitive Impairment. Neurodegener Dis. 2011;8(3):138-45. IF=3,496.

 

(102) 1520.Badiavas K, Molyvda E, Iakovou I, Tsolaki M, Psarrakos K, Karatzas N. SPECT imaging evaluation in movement disorders: far beyond visual assessment. Med Mol Imaging. 2010 Dec 2. IF=2,525 Eur J Nucl Medicine 12/2010; 38(4):764-73 IF=4.53

 

(101) 1521. Furney SJ, Simmons A, Breen G, Pedroso I, Lunnon K, Proitsi P, Hodges A, Powell J, Wahlund LO, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lathrop M, Shen L, Kim S, Saykin AJ, Weiner MW, Lovestone S. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol Psychiatry. 2010 Nov 30. IF=15,049

(100) 1491. Paajanen T, Hänninen T, Tunnard C, Mecocci P, Sobow T, Tsolaki M, Vellas B, Lovestone S, Soininen H, For The Addneuromed Consortium. CERAD Neuropsychological Battery Total Score in Multinational Mild Cognitive Impairment and Control Populations: The AddNeuroMed Study. J Alzheimers Dis. 2010 Oct 7. IF=5,101

(99) 1492. Gustavsson A, Jonsson L, Rapp T, Reynish E, Ousset PJ, Andrieu S, Cantet C, Winblad B, Vellas B, Wimo A; ICTUS Study Group. Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study. J Nutr Health Aging. 2010 Aug;14(8):648-54. IF=2,321

(98) 1493. Tunnard C, Whitehead D, Hurt C, Wahlund L, Mecocci P, Tsolaki M, Vellas B, Spenger C, Kłoszewska I, Soininen H, Lovestone S, Simmons A; on behalf of the AddNeuroMed Consortium.Apathy and cortical atrophy in Alzheimer's disease. Int J Geriatr Psychiatry. 2010 Sep 27. ΙF=1,981

(97) 1494. Liu Y, Paajanen T, Westman E, Zhang Y, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium. APOE ε2 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord. 2010;30(3):229-37. IF=3,142

(96) 1495. Westman E, Simmons A, Zhang Y, Muehlboeck JS, Tunnard C, Liu Y, Collins L, Evans A, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Spenger C, Wahlund LO; for the AddNeuroMed consortium. Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage. 2010 Aug 25. IF=5.739

(95) 1496. Jacobs HI, Visser PJ, Van Boxtel MP, Frisoni GB, Tsolaki M, Papapostolou P, Nobili F, Wahlund LO, Minthon L, Frölich L, Hampel H, Soininen H, van de Pol L, Scheltens P, Tan FE, Jolles J, Verhey FR.The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol Aging. 2010 Aug 23. IF=5,559

(94)  1497. Emre M, Tsolaki M, Bonuccelli U, Destée A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladström A, Jones R; 11018 Study Investigators. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010 Oct;9(10):969-77. IF=18,13

(93) 1481. Liu Y, Paajanen T, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen For The Addneuromed Consortium H. Effect of APOE epsilon4 Allele on Cortical Thicknesses and Volumes: The AddNeuroMed Study. J Alzheimers Dis. 2010 Aug 6. IF=5,101

(92) 1482. Perneczky R, Wagenpfeil S, Lunetta KL, Cupples LA, Green RC, Decarli C, Farrer LA, Kurz A; MIRAGE Study Group. Head circumference, atrophy, and cognition: implications for brain reserve in Alzheimer disease. Neurology. 2010 Jul 13;75(2):137-42.  IF=5,690

(91) 1483. Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, Wahlund LO, Westman E, Kinsey A, Güntert A, Proitsi P, Powell J, Causevic M, Killick R, Lunnon K, Lynham S, Broadstock M, Choudhry F, Howlett DR, Williams RJ, Sharp SI, Mitchelmore C, Tunnard C, Leung R, Foy C, O'Brien D, Breen G, Furney SJ, Ward M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Hodges A, Murphy DG, Parkins S, Richardson JC, Resnick SM, Ferrucci L, Wong DF, Zhou Y, Muehlboeck S, Evans A, Francis PT, Spenger C, Lovestone S. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry. 2010 Jul;67(7):739-48. IF=14.27

(90) 1484. Lindesay J, Bullock R, Daniels H, Emre M, Förstl H, Frölich L, Gabryelewicz T, Martínez-Lage P, Monsch AU, Tsolaki M, van Laar T. Turning principles into practice in Alzheimer's disease. Int J Clin Pract. 2010 Aug;64(9):1198-209. IF= 2.245

(89) 1485. Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging. 2010 Aug;31(8):1375-85. IF=5,559

(88) 1475. Papaliagkas VT, Tsolaki M, Anogianakis G. Cerebrospinal Fluid Proteins in the Diagnosis of Alzheimer's Disease. Recent Pat CNS Drug Discov. 2010 Mar 19.

(87) 1474. Emre M, Bernabei R, Blesa R, Bullock R, Cunha L, Daniëls H, Dziadulewicz E, Förstl H, Frölich L, Gabryelewicz T, Levin O, Lindesay J, Martínez-Lage P, Monsch A, Tsolaki M, van Laar T. Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease. CNS Neurosci Ther. 2010 Mar 29. IF=4.432

(86) Tsolaki M, Messini CZ, Siapera M, Fotiadou F, Delaporta D, Karatolias A. Depression, extrapyramidal symptoms, dementia and an unexpected outcome: a case report. Cases J. 2010 Feb 2;3(1):47.

(85) Papaliagkas VT, Anogianakis G, Tsolaki M, Koliakos G, Kimiskidis VK. Combination of P300 and CSF beta-Amyloid(1-42) Assays may Provide a Potential Tool in the Early Diagnosis of Alzheimer's Disease. Curr Alzheimer Res. 2009 Nov 26. ΙF=4.132

(84) Tsolaki M, Papaliagkas V, Anogianakis G, Bernabei R, Emre M, Frolich L, Visser PJ, Michel JP, Pirttila T, Olde Rikkert M, Soininen H, Sobow T, Vellas B, Verhey F, Winblad B. Consensus statement on dementia education and training in europe. J Nutr Health Aging. 2010;14(2):131-5. IF=2,321

(83) 1343. Tsolaki  M.,  Papaliagkas V.,  Kounti F.,  Messini C.,  Boziki M.,   Anogianakis G.,  Vlaikidis V.. Severe stress events and dementia: A study of an elderly Greek demented population. Psychiatry Research 2010; 176 (1) :51-4  IF=2,666

(82) 1368. Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C; for the AddNeuroMed Consortium. MRI Measures of Alzheimer's Disease and the AddNeuroMed Study. Ann N Y Acad Sci. 2009 Oct;1180:47-55. IF=1,93

(81) 1369. Lovestone S, Francis P, Kloszewska I, Mecocci P, Simmons A, Soininen H, Spenger C, Tsolaki M, Vellas B, Wahlund LO, Ward M; on behalf of the AddNeuroMed Consortium. AddNeuroMed-The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease. Ann N Y Acad Sci. 2009 Oct;1180:36-46. IF=1,93

(80). 1367. Froelich L, Andreasen N, Tsolaki M, Foucher A, Kavanagh S, Bart Van Baelen, Schwalen S. Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey. Curr Med Res Opin. 2009 Oct 26. IF=3,062

(79) 1280.  Papaliagkas VT, Tsolaki MN, Kimiskidis VK, Anogianakis G. Male patient with mild cognitive impairment and extremely high P300 and Slow-wave latencies: a case report.

Cases J. 2009 Jul 1;2:6157.

(78) 1365. Hurt CS, Banerjee S, Tunnard C, Whitehead D, Tsolaki M, Mecocci P, Kloszewska I, Soininen H, Vellas B, Lovestone S. Insight, Cognition and Quality of Life in Alzheimer's Disease.

J Neurol Neurosurg Psychiatry. 2009 Oct 13. IF=3,630

(77) 1319. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schόrmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frφlich L, Hampel H, Hόll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mόhleisen TW, Nφthen MM, Moebus S, Jφckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.  Nat Genet. 2009 Oct;41(10):1088-93. IF=24,176.

(76) 1311. Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; for the AddNeuroMed Consortium. Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups-The AddNeuroMed study. Neurobiol Aging. 2009 Aug 13. IF=5,559

(75) 1281. van de Pol L, Verhey F, Frisoni G, Tsolaki M, Papapostoulou P, Nobili F, Wahlund LO, Minthon L, Frolich L, Hampel H, Soininen H, Knol D, Barkhof F, Scheltens P, Verhey PJ. White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study.  J Neurol Neurosurg Psychiatry. 2009 Jun 18. IF=3,630

(74) 1288. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosιn E, Aarsland D, Visser PJ, Schrφder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilδ T, Wallin A, Jφnhagen ME, Minthon L, Winblad B, Blennow K. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009 Jul 22;302(4):385-93, IF=31,7

(73) 1289. Papaliagkas VT, Anogianakis G, Tsolaki MN, Koliakos G, Kimiskidis VK. Progression of Mild Cognitive Impairment to Alzheimer's Disease: Improved Diagnostic Value of the Combined Use of N200 Latency and beta-Amyloid(1-42) Levels. Dement Geriatr Cogn Disord. 2009 Jul 23;28(1):30-35. IF=3,142

(72) 1276. Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund-Levi Y, Tsolaki M, Minthon L, Wallin AK, Hampel H, Bόrger K, Pirttila T, Soininen H, Rikkert MO, Verbeek MM, Spiru L, Blennow K. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.  Lancet Neurol. 2009 Jun 10. IF=18,13

(71) 1277. Papaliagkas VT, Anogianakis G, Tsolaki MN, Koliakos G, Kimiskidis VK. Prediction of conversion from mild cognitive impairment to Alzheimer's disease by CSF cytochrome c levels and N200 latency.  Curr Alzheimer Res. 2009 Jun;6(3):279-84, IF=4,132

(70). 1266. Proitsi P, Hamilton G, Tsolaki M, Lupton M, Daniilidou M, Hollingworth P, Archer N, Foy C, Stylios F, McGuinness B, Todd S, Lawlor B, Gill M, Brayne C, Rubinsztein DC, Owen M, Williams J, Craig D, Passmore P, Lovestone S, Powell JF. A Multiple Indicators Multiple Causes (MIMIC) model of Behavioural and Psychological Symptoms in Dementia (BPSD).

Neurobiol Aging. 2009 Apr 20; IF= 5,559

(69). 1239. Birks J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE. Rivastigmine for Alzheimer's disease.  Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001191. IF=5.653

(68). 1240. Tsolaki M, Eleftheriou M, Karavida N. Alzheimer's dementia and post-traumatic stress disorder differences and similarities in neuroimaging.

Hell J Nucl Med. 2009 Jan-Apr;12(1):41-6. IF=0,71

(67). Cuenco KT, Friedland R, Baldwin CT, Guo J, Vardarajan B, Lunetta KL, Cupples LA, Green RC, DeCarli C, Farrer LA; MIRAGE Study Group. Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families. Neurobiol Aging. 2011 Feb;32(2):249-56. IF=5,559       

(66).1241. Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Grigoriadis N, Tsolaki M, Chatzopoulos D, Katsinelos P, Tzilves D, Zabouri A, Michailidou I. Increased cerebrospinal fluid helicobacter pylori antibody in Alzheimer's disease.

Int J Neurosci. 2009;119(6):765-77. IF=0,831

(65). 1222. Kountouras J, Boziki M, Gavalas E, Zavos C, Grigoriadis N, Deretzi G, Tzilves D, Katsinelos P, Tsolaki M, Chatzopoulos D, Venizelos I. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.  J Neurol. 2009 Feb 25. IF=2,984

(64). 1193.Tsolaki M, Kounti F, Karamavrou S. Severe Psychological Stress in Elderly Individuals: A Proposed Model of Neurodegeneration and Its Implications.

Am J Alzheimers Dis Other Demen. 2009 Apr-May;24(2):85-94. IF=3.142

(63). 1205. T Cuenco K, Lunetta KL, Baldwin CT, McKee AC, Guo J, Cupples LA, Green RC, St George-Hyslop PH, Chui H, DeCarli C, Farrer LA; MIRAGE Study Group.Farrer LA, Green RC, Baldwin CT, Cupples LA, Lunetta KL, Cuenco KT, Auerbach S, Logue M, Akomolafe A, Ashley A, Freedman L, Ofili E, Chui H, DeCarli C, Duara R, Foroud T, Farlow M, Friedland R, Go R, Kurz A, Obisesan T, Petrovitch H, White L, Sabbagh M, Sadovnick D, Tsolaki M. Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. Arch Neurol. 2008 Dec;65(12):1640-8. IF=5,204

(62). (1172) Tsolaki M, Paraskevi S, Karamavrou S, Degleris N. Attitudes and Perceptions Regarding Alzheimer's Disease in Greece.

Am J Alzheimers Dis Other Demen. 2009;24:21-26. IF=3.142

(61). 1197.Nieoullon A, Bentuι-Ferrer D, Bordet R, Tsolaki M, Fφrstl H. Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine. Curr Med Res Opin. 2008 Dec;24(12):3357-67. IF=3,062

(60). Papaliagkas V, Kimiskidis V, Tsolaki M, Anogianakis G. Usefulness of event-related potentials in the assessment of mild cognitive impairment.

BMC Neurosci. 2008 Nov 5;9(1):107. IF=2,85

(59). 1179. Maiovis P, Gavopoulou E, Eleftheriou M, Tsokanari I, Tsolaki M. Diagnostic uncertainty in a severely demented male patient: a case report. Cases J. 2008 Oct 19;1(1):250.

(58). Cuenco KT, Green RC, Zhang J, Lunetta K, Erlich PM, Cupples LA, Farrer LA, DeCarli C; MIRAGE Study Group. Baldwin CT, Auerbach S, Akomolafe A, Freedman L, Ofili E, Chui H, DeCarli C, Duara R, Foroud T, Farlow M, Friedland R, Go R, Kurz A, Obisesan T, Petrovitch H, White L, Relkin N, Sabbagh M, Sadovnick D, Tsolaki M, Morey P, Adamiak B, Ade-Okanlami A, Cowden L, Cramer B, Dandiilidou M, Dwosh E, Grady E, Humphrey S, Imamura C, Kolody H, Long N, Luis M, Martelli K, Wainwright J, Farrell J, Huyck M, Johnson D. Magnetic resonance imaging traits in siblings discordant for Alzheimer disease.  J Neuroimaging. 2008 Jul;18(3):268-75. IF=1,811

(57). Hurt C, Bhattacharyya S, Burns A, Camus V, Liperoti R, Marriott A, Nobili F, Robert P, Tsolaki M, Vellas B, Verhey F, Byrne EJ. Patient and Caregiver Perspectives of Quality of Life in Dementia. An Investigation of the Relationship to Behavioural and Psychological Symptoms in Dementia. Dement Geriatr Cogn Disord. 2008 Aug 4;26(2):138-146. IF=2,511

(56)-78- 1137. Visser PJ, Verhey FR, Boada M, Bullock R, De Deyn PP, Frisoni GB, Frolich L, Hampel H, Jolles J, Jones R, Minthon L, Nobili F, Olde Rikkert M, Ousset PJ, Rigaud AS, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Wahlund LO, Wilcock G, Winblad B. Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology. 2008;30(4):254-65. IF=2,352

(55). Tagarakis GI, Tsolaki-Tagaraki F, Tsolaki M, Diegeler A, Stylianakis GE, Kazis D, Tsilimingas NB, Papassotiropoulos A. Are genetic components related to cognitive decline after coronary artery surgery? Genetics and brain function after bypass heart surgery. J Card Surg. 2008 May-Jun;23(3):280-1. IF=0,709

(54). Petrovic M, Hurt C, Collins D, Burns A, Camus V, Liperoti R, Marriott A, Nobili F, Robert P, Tsolaki M, Vellas B, Verhey F, Byrne EJ. Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer's disease consortium (EADC) study.

Acta Clin Belg. 2007 Nov-Dec;62(6):426-32. IF=0,637

(53). Castro-Costa E, Dewey M, Stewart R, Banerjee S, Huppert F, Mendonca-Lima C, Bula C, Reisches F, Wancata J, Ritchie K, Tsolaki M, Mateos R, Prince M.

Ascertaining late-life depressive symptoms in Europe: an evaluation of the survey version of the EURO-D scale in 10 nations. The SHARE project.

Int J Methods Psychiatr Res. 2008;17(1):12-29. IF=1,979

(52). Aalten P, Verhey FR, Boziki M, Brugnolo A, Bullock R, Byrne EJ, Camus V, Caputo M, Collins D, De Deyn PP, Elina K, Frisoni G, Holmes C, Hurt C, Marriott A, Mecocci P, Nobili F, Ousset PJ, Reynish E, Salmon E, Tsolaki M, Vellas B, Robert PH. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II.

Dement Geriatr Cogn Disord. 2008;25(1):1-8. Review. IF=2,511

(51). Sakka P, Tsolaki M, Hort J, Hager K, Soininen H, Lσpez Pousa S, Li C, Schwam E. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy. Curr Med Res Opin. 2007 Dec;23(12):3153-65. IF=3,062

(50). Aalten P, Verhey FR, Boziki M, Bullock R, Byrne EJ, Camus V, Caputo M, Collins D, De Deyn PP, Elina K, Frisoni G, Girtler N, Holmes C, Hurt C, Marriott A, Mecocci P, Nobili F, Ousset PJ, Reynish E, Salmon E, Tsolaki M, Vellas B, Robert PH. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.

Dement Geriatr Cogn Disord. 2007;24(6):457-63. IF=2,511

(49). Castro-Costa E, Dewey M, Stewart R, Banerjee S, Huppert F, Mendonca-Lima C, Bula C, Reisches F, Wancata J, Ritchie K, Tsolaki M, Mateos R, Prince M.

Prevalence of depressive symptoms and syndromes in later life in ten European countries: the SHARE study.  Br J Psychiatry. 2007 Nov;191:393-401. IF=5,436

 

(48). Kountouras J, Tsolaki M, Boziki M, Gavalas E, Zavos C, Stergiopoulos C, Kapetanakis N, Chatzopoulos D, Venizelos I. Association between Helicobacter pylori infection and mild cognitive impairment. Eur J Neurol. 2007 Sep;14(9):976-82. IF=2,437

(47). Tagarakis GI, Tsolaki-Tagaraki F, Tsolaki M, Diegeler A, Tsilimingas NB, Papassotiropoulos A. The role of apolipoprotein E in cognitive decline and delirium after bypass heart operations.

Am J Alzheimers Dis Other Demen. 2007 Jun-Jul;22(3):223-8. IF=3.142

(46). Tagarakis GI, Tsolaki-Tagaraki F, Tsolaki M, Diegeler A, Kazis D, Rouska E, Papassotiropoulos A. The role of SOAT-1 polymorphisms in cognitive decline and delirium after bypass heart surgery. Clin Res Cardiol. 2007 Sep;96(9):600-3. IF=2.958

(45). Wollmer MA, Sleegers K, Ingelsson M, Zekanowski C, Brouwers N, Maruszak A, Brunner F, Huynh KD, Kilander L, Brundin RM, Hedlund M, Giedraitis V, Glaser A, Engelborghs S, De Deyn PP, Kapaki E, Tsolaki M, Daniilidou M, Molyva D, Paraskevas GP, Thal DR, Barcikowska M, Kuznicki J, Lannfelt L, Van Broeckhoven C, Nitsch RM, Hock C, Papassotiropoulos A.Association study of cholesterol-related genes in Alzheimer's disease. Neurogenetics. 2007 Aug;8(3):179-88. IF=4,250

(44). 67-943. Pearson JV, Huentelman MJ, Halperin RF, Tembe WD, Melquist S, Homer N, Brun M, Szelinger S, Coon KD, Zismann VL, Webster JA, Beach T, Sando SB, Aasly JO, Heun R, Jessen F, Kolsch H, Tsolaki M, Daniilidou M, Reiman EM, Papassotiropoulos A, Hutton ML, Stephan DA, Craig DW. Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies.

Am J Hum Genet. 2007 Jan;80(1):126-39. IF=12,629

(43). (862) Tsolaki M, Alexiadou A, Kiosseoglou G, Kounti F. Correlations between the Functional-Cognitive Assessment Scale and the Alzheimer's Disease Assessment Scale when administered to patients with dementia residing in long-term care.

Am J Alzheimers Dis Other Demen. 2006 Aug-Sep;21(4):274-80. IF= 3,142

(42). Papassotiropoulos A, Lambert JC, Wavrant-De Vriθze F, Wollmer MA, von der Kammer H, Streffer JR, Maddalena A, Huynh KD, Wolleb S, Lutjohann D, Schneider B, Thal DR, Grimaldi LM, Tsolaki M, Kapaki E, Ravid R, Konietzko U, Hegi T, Pasch T, Jung H, Braak H, Amouyel P, Rogaev EI, Hardy J, Hock C, Nitsch RM.

Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease. Neurodegener Dis. 2005;2(5):233-41. IF=3,496

(41). 291. Kounti F, Tsolaki M, Kiosseoglou G. Functional cognitive assessment scale (FUCAS): a new scale to assess executive cognitive function in daily life activities in patients with dementia and mild cognitive impairment. Hum Psychopharmacol. 2006 Jul;21(5):305-11. IF=2,386

(40). Wollmer MA, Kapaki E, Hersberger M, Muntwyler J, Brunner F, Tsolaki M, Akatsu H, Kosaka K, Michikawa M, Molyva D, Paraskevas GP, Lόtjohann D, von Eckardstein A, Hock C, Nitsch RM, Papassotiropoulos A. Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2006 Jul 5;141B(5):534-6. IF=4,463

(39). Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I. Relationship between Helicobacter pylori infection and Alzheimer disease.

Neurology. 2006 Mar 28;66(6):938-40. IF=5,690

(38). Tsolaki M, Trontzos C, Kazis A. [The contribution of nuclear medicine procedures in the diagnosis of dementia of Alzheimer's type. Imaging beta amyloid plaques]. Hell J Nucl Med. 2005 Sep-Dec;8(3):187-90. Review. Greek, Modern. IF-0,71

(37). Robert PH, Verhey FR, Byrne EJ, Hurt C, De Deyn PP, Nobili F, Riello R, Rodriguez G, Frisoni GB, Tsolaki M, Kyriazopoulou N, Bullock R, Burns A, Vellas B. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry. 2005 Nov;20(7):490-6. Epub 2005 Jan 27.IF=1,463

(36). Gerasimou G, Tsolaki M, Bostanjopoulou S, Liaros G, Papanastasiou E, Balaris V, Katsarou Z, Fotiou F, Dedousi E, Baloyannis S, Milonas I. [Findings from molecular imaging with SPET camera and 123I-ioflupane in the differential diagnosis of Parkinsonism and essential tremor]  Hell J Nucl Med. 2005 May-Aug;8(2):81-5. Greek, Modern. IF-0,71 

(35). 674. Papassotiropoulos A, Wollmer MA, Tsolaki M, Brunner F, Molyva D, Lόtjohann D, Nitsch RM, Hock C. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease.

J Clin Psychiatry. 2005 Jul;66(7):940-7. IF=5,553

(34). Tsolaki M, Grammaticos P, Karanasou C, Balaris V, Kapoukranidou D, Kalpidis I, Petsanis K, Dedousi E. Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer's dementia. Hell J Nucl Med. 2005 Jan-Apr;8(1):39-42. IF=0,71

(33). Papassotiropoulos A, Tsolaki M, Wollmer MA, Molyva D, Thal DR, Huynh KD, Tracy J, Staehelin HB, Monsch AU, Nitsch RM, Hock C. No association of a non-synonymous PLAU polymorphism with Alzheimer's disease and disease-related traits. Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):21-3. IF=4,463

(32). Chen F, Wollmer MA, Hoerndli F, Mόnch G, Kuhla B, Rogaev EI, Tsolaki M, Papassotiropoulos A, Gφtz J. Role for glyoxalase I in Alzheimer's disease. Proc Natl Acad Sci U S A. 2004 May 18;101(20):7687-92. IF=10,452

(31). de Quervain DJ, Poirier R, Wollmer MA, Grimaldi LM, Tsolaki M, Streffer JR, Hock C, Nitsch RM, Mohajeri MH, Papassotiropoulos A. Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Hum Mol Genet. 2004 Jan 1;13(1):47-52. IF=8,099

(30). Wollmer MA, Streffer JR, Tsolaki M, Grimaldi LM, Lόtjohann D, Thal D, von Bergmann K, Nitsch RM, Hock C, Papassotiropoulos A. Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease. Mol Psychiatry. 2003 Jun;8(6):635-8. IF=11,804

(29). Kapinas K, Kimiskidis VK, Kazis AD, Kokkas B, Tsolaki M, Georgiadis G. Myasthenia gravis: correlation of age with clinical course and anti-AChr antibody levels.

Int J Immunopathol Pharmacol. 1999 Sep;12(3):127-131. IF=3,213

(28). Wollmer MA, Streffer JR, Lόtjohann D, Tsolaki M, Iakovidou V, Hegi T, Pasch T, Jung HH, Bergmann K, Nitsch RM, Hock C, Papassotiropoulos A. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease.

Neurobiol Aging. 2003 May-Jun;24(3):421-6. IF=5,599

(27). Streffer JR, Papassotiropoulos A, Kurosinski P, Signorell A, Wollmer MA, Tsolaki M, Iakovidou V, Horndli F, Bosset J, Gφtz J, Nitsch RM, Hock C. Saitohin gene is not associated with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):362-3. IF=3,630

(26). Tsolaki M, Kartali N. Folic acid and Alzheimer's disease.

Int J Geriatr Psychiatry. 2003 Feb;18(2):187-8. No abstract available. IF=1,930

(25). Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, Iakovidou V, Maddalena A, Lόtjohann D, Ghebremedhin E, Hegi T, Pasch T, Trδxler M, Brόhl A, Benussi L, Binetti G, Braak H, Nitsch RM, Hock C. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.

Arch Neurol. 2003 Jan;60(1):29-35. IF=5,204

(24). Bozikas VP, Kosmidis MH, Kourtis A, Gamvrula K, Melissidis P, Tsolaki M, Karavatos A.

Clock drawing test in institutionalized patients with schizophrenia compared with Alzheimer's disease patients. Schizophr Res. 2003 Feb 1;59(2-3):173-9. IF= 4,264

(23). Tsolaki M. Evaluation of tiapride in agitated elderly outpatients: an open study.

Hum Psychopharmacol. 2001 Jul;16(5):417-422. IF=2,386

(22). Tsolaki M, Iakovidou V, Papadopoulou E, Aminta M, Nakopoulou E, Pantazi T, Kazis A.

Greek validation of the seven-minute screening battery for Alzheimer's disease in the elderly.

Am J Alzheimers Dis Other Demen. 2002 May-Jun;17(3):139-48. IF=3,142

(21). Tsolaki M, Kokarida K, Iakovidou V, Stilopoulos E, Meimaris J, Kazis A.

Extrapyramidal symptoms and signs in Alzheimer's disease: prevalence and correlation with the first symptom. Am J Alzheimers Dis Other Demen. 2001 Sep-Oct;16(5):268-78. IF=3,142

 

(20). Tsolaki M, Sakka V, Gerasimou G, Dimacopoulos N, Chatzizisi O, Fountoulakis KN, Kyriazis G, Papanastasiou J, Kazis A. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects.

Am J Alzheimers Dis Other Demen. 2001 Jan-Feb;16(1):21-31. IF=3,142

 

(19). Tsolaki M, Pantazi T, Kazis A. Efficacy of acetylcholinesterase inhibitors versus nootropics in Alzheimer's disease: a retrospective, longitudinal study.

J Int Med Res. 2001 Jan-Feb;29(1):28-36. IF=0,665

(18). Birks J, Grimley Evans J, Iakovidou V, Tsolaki M. Rivastigmine for Alzheimer's disease.

Cochrane Database Syst Rev. 2000;(4):CD001191. Review. IF=5,653

(17). Fountoulakis KN, Tsolaki M, Paulopoulos H, Kazis A.

Validation of the epidemiological dementia index in geriatric outpatients.

Int Psychogeriatr. 2000 Jun;12(2):195-208. IF=1,745

(16). Tsolaki M, Iakovidou V, Navrozidou H, Aminta M, Pantazi T, Kazis A.

Hindi Mental State Examination (HMSE) as a screening test for illiterate demented patients.

Int J Geriatr Psychiatry. 2000 Jul;15(7):662-4. IF=2.525

(15). Fotiou F, Fountoulakis KN, Tsolaki M, Goulas A, Palikaras A.

Changes in pupil reaction to light in Alzheimer's disease patients: a preliminary report.

Int J Psychophysiol. 2000 Jul;37(1):111-20. IF=2,247

(14). Birks J, Iakovidou V, Tsolaki M.

Rivastigmine for Alzheimer's disease.

Cochrane Database Syst Rev. 2000;(2):CD001191. Review. Update in: Cochrane Database Syst Rev. 2000;(4):CD001191.

(13). Fountoulakis KN, Tsolaki M, Iacovides A, Yesavage J, O'Hara R, Kazis A, Ierodiakonou C.

The validation of the short form of the Geriatric Depression Scale (GDS) in Greece.

Aging (Milano). 1999 Dec;11(6):367-72. IF=1,068

(12). Fountoulakis K, Fotiou F, Iacovides A, Tsiptsios J, Goulas A, Tsolaki M, Ierodiakonou C. Changes in pupil reaction to light in melancholic patients.

Int J Psychophysiol. 1999 Jan;31(2):121-8. IF=2,247

(11). Fountoulakis KN, Tsolaki M, Mohs RC, Kazis A.

Epidemiological dementia index: a screening instrument for Alzheimer's disease and other types of dementia suitable for use in populations with low education level.

Dement Geriatr Cogn Disord. 1998 Nov-Dec;9(6):329-38. IF=2,511 

(10). Tsolaki M, Fountoulakis K, Chantzi E, Kazis A.

Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of a Greek population. Int Psychogeriatr. 1997 Sep;9(3):327-41. IF=1,745

(9). Tsolaki M, Fountoulakis K, Nakopoulou E, Kazis A, Mohs RC. Alzheimer's Disease Assessment Scale: the validation of the scale in Greece in elderly demented patients and normal subjects. Dement Geriatr Cogn Disord. 1997 Sep-Oct;8(5):273-80. IF=2,511

(8). Lehfeld H, Reisberg B, Finkel S, Kanowski S, Wied V, Pittas J, Tsolaki M, Informant-rated activities-of-daily-living (ADL) assessments: results of a study of 141 items in the U.S.A., Germany, Russia, and Greece from the International ADL Scale Development Project.Alzheimer Dis Assoc Disord. 1997;11 Suppl 4:S39-44. IF=3,142

(7). Gorgias N, Maidatsi P, Tsolaki M, Alvanou A, Kiriazis G, Kaidoglou K, Giala M.

Hypoxic pretreatment protects against neuronal damage of the rat hippocampus induced by severe hypoxia.

Brain Res. 1996 Apr 1;714(1-2):215-25. ΙF=2,341

(6). Tsolaki M, Drevelegas A, Karachristianou S, Kapinas K, Divanoglou D, Routsonis K.

Correlation of dementia, neuropsychological and MRI findings in multiple sclerosis.

Dementia. 1994 Jan-Feb;5(1):48-52. IF=2,511

(5). Botsios D, Economou L, Manthos A, Tsolaki M, Sioga A, Agelopoulos S, Dadoukis I, Foroglou C. Ultrastructural alterations of the rat intestinal epithelium fed with polymeric, oligopeptidic or elementary full diet, following starvation.

Histol Histopathol. 1993 Jul;8(3):527-35. IF=2,182

(4). Drevelengas A, Kalaitzoglou I, Tsolaki M.

Tolosa-Hunt syndrome with sellar erosion: case report.

Neuroradiology. 1993;35(6):451-3. IF=1,625

(3). Petridou M, Mourelatos D, Tsolaki M, Kazis A, Kourakis A, Routsonis K.

Cytogenetic damage by melphalan and hyperthermia in patients with an initial epileptic attack. Mutat Res. 1992 Aug;280(2):143-8. IF=4,111

 

(2). Manthos A, Tsolaki M, Kaidoglou K, Alvanou A, Hatjinikolaou K, Hatjiagorakis A, Giala M, Foroglou C.

Ultrastructure of the rat hippocampus after isobaric respirative hyperoxia.

Histol Histopathol. 1991 Jan;6(1):73-8. IF=2,182

 

(1). Tsolaki M, Yannacou-Peftoulidou M, Grammaticos P, Sofianos E, Foroglou G.

Phenytoin plasma levels after intraoperative administration, for the prevention of post-craniotomy seizures.

Acta Neurochir (Wien). 1987;84(1-2):36-8. IF=1,212